<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: "…"
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>TW200418849A - Compositions and methods for hydroxylating epothilones 
      - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/TW200418849A/en">
    <meta name="description" content="
     Isolated nucleic acid sequences and polypeptides encoded thereby for epothilone B hydroxylase and mutants and variants thereof and a ferredoxin located downstream from the epothilone B hydroxylase gene are provided. Also provided are vectors and cells containing these vectors. In addition, methods for producing recombinant microorganisms, methods for using these recombinant microorganism to produce hydroxyalkyl-bearing epothilones and an epothilone analog produced by a mutant of epothilone B hydroxylase are provided. 
   
   ">
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="Compositions and methods for hydroxylating epothilones 
     ">
    <meta name="DC.date" content="2003-03-17" scheme="dateSubmitted">
    <meta name="DC.description" content="
     Isolated nucleic acid sequences and polypeptides encoded thereby for epothilone B hydroxylase and mutants and variants thereof and a ferredoxin located downstream from the epothilone B hydroxylase gene are provided. Also provided are vectors and cells containing these vectors. In addition, methods for producing recombinant microorganisms, methods for using these recombinant microorganism to produce hydroxyalkyl-bearing epothilones and an epothilone analog produced by a mutant of epothilone B hydroxylase are provided. 
   
   ">
    <meta name="citation_patent_application_number" content="TW:092105814A">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/61/12/23/f04976b3fac0fc/TW200418849A.pdf">
    <meta name="citation_patent_publication_number" content="TW:200418849:A">
    <meta name="DC.date" content="2004-10-01">
    <meta name="DC.contributor" content="Jonathan D Basch" scheme="inventor">
    <meta name="DC.contributor" content="Shu-Jen Chiang" scheme="inventor">
    <meta name="DC.contributor" content="Suo W Liu" scheme="inventor">
    <meta name="DC.contributor" content="Akbar Nayeem" scheme="inventor">
    <meta name="DC.contributor" content="Yuhua Sun" scheme="inventor">
    <meta name="DC.contributor" content="Li You" scheme="inventor">
    <meta name="DC.contributor" content="Bristol Myers Squibb Co" scheme="assignee">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            Compositions and methods for hydroxylating epothilones 
     </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><abstract mxw-id="PA148981332" lang="EN" source="national office" load-source="docdb" class="style-scope patent-text">
    <div class="abstract style-scope patent-text">Isolated nucleic acid sequences and polypeptides encoded thereby for epothilone B hydroxylase and mutants and variants thereof and a ferredoxin located downstream from the epothilone B hydroxylase gene are provided. Also provided are vectors and cells containing these vectors. In addition, methods for producing recombinant microorganisms, methods for using these recombinant microorganism to produce hydroxyalkyl-bearing epothilones and an epothilone analog produced by a mutant of epothilone B hydroxylase are provided.</div>
  </abstract>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result" hidden="">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Micro-Organisms Or Cultivation Processes Thereof"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Micro-Organisms Or Cultivation Processes Thereof
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Preparation Of Compounds By Using Micro-Organisms"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Preparation Of Compounds By Using Micro-Organisms
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline" style="" hidden="">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">TW200418849A</h2>
                  <p class="tagline style-scope patent-result">Taiwan</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Laid open application for patent or patent of addition</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/61/12/23/f04976b3fac0fc/TW200418849A.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;epothilone&quot;,&quot;seq&quot;,&quot;nucleic acid&quot;,&quot;acid sequence&quot;,&quot;hydroxylase&quot;]" data-before="20011226"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/TW200418849A"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  
                    <dt class="style-scope patent-result">Other languages</dt>
                    <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TW200418849A/zh"><a id="link" href="#" class="style-scope state-modifier">Chinese</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Jonathan D Basch"><a id="link" href="#" class="style-scope state-modifier">Jonathan D Basch</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Shu-Jen Chiang"><a id="link" href="#" class="style-scope state-modifier">Shu-Jen Chiang</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Suo W Liu"><a id="link" href="#" class="style-scope state-modifier">Suo W Liu</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Akbar Nayeem"><a id="link" href="#" class="style-scope state-modifier">Akbar Nayeem</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Yuhua Sun"><a id="link" href="#" class="style-scope state-modifier">Yuhua Sun</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Li You"><a id="link" href="#" class="style-scope state-modifier">Li You</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">2003</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/TW200418849A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline" this="">TW</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: TW092105814A</div>
                <div class="style-scope application-timeline">Filing date: 2003-03-17</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application TW092105814A events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline"><div date="" class="external-priority style-scope application-timeline">2002-12-17</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US6884608B2/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Priority claimed from US10/321,188</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">2003-03-17</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="Bristol Myers Squibb Co"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by Bristol Myers Squibb Co</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">2004-10-01</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/TW200418849A/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of TW200418849A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (1)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=TW&amp;NR=200418849A&amp;KC=A&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/TW/200418849/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/TW200418849A">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result">translated from Chinese</div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><description mxw-id="PDES113261702" lang="EN" load-source="google" class="style-scope patent-text">
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">I I200418849 (1) 玖、發明說明 【發明所屬之技術領域】 本發明係有關埃坡黴素B羥化酶和其突變體與變異 體’及位於該埃坡黴素B羥化酶基因下游處的鐵氧化還原 蛋白的經離析的核酸序列和其所編碼的多肽。此外也有關 可表現出埃坡黴素B羥化酶和其突變體與變異體及/或鐵 氧化還原蛋白的重組體微生物，彼等可羥基化具有末端院 基的小有機分子化合物，例如埃坡黴素類，而產生具有末 端羥烷基的化合物。也提出重組地產生此等微生物的方 法’以及使用此等重組體微生物合成具有末端經基院基的 化合物之方法。本發明組成物和方法可用來製備在醫藥領 域中具有多種用處之埃坡黴素類。來述及使用本發明埃坡 黴素B羥化酶突變體產生的埃坡黴素類似物。 【先前技術】 埃坡黴素類爲在醫藥領域中有用處的大環內酯化合 物。例如，具有下列構造的埃坡黴素A和B :</span>I I200418849 (1) (ii) Description of the invention [Technical field to which the invention belongs] The present invention relates to epothilone B hydroxylase and its mutants and variants' and is located downstream of the epothilone B hydroxylase gene The isolated nucleic acid sequence of the ferredoxin and the polypeptide encoded by it. It is also related to recombinant microorganisms that can exhibit epothilone B hydroxylase and its mutants and variants and / or ferredoxin, which can hydroxylate small organic molecular compounds with terminal courtyards, such as Paxomycins produce compounds with terminal hydroxyalkyl groups. A method for the recombinant production of these microorganisms' and a method for synthesizing a compound having a terminal motif based on these recombinant microorganisms are also proposed. The composition and method of the present invention can be used to prepare epothilones which have multiple uses in the medical field. The epothilone analog produced by using the epothilone B hydroxylase mutant of the present invention will be described. [Prior art] Epothilones are macrolide compounds useful in the medical field. For example, epothilone A and B having the following structures:</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">埃坡黴素A R = Η 埃坡黴素B R = Me 業經發現會發出類似於太平洋紫杉酚（pa C1 it axel) (2) 200418849 (TAXOL®)的微管-穩定化作用因而具有對抗快速增生性細 胞，例如腫瘤細胞或與其他高度增生性細胞型疾病相關聯 的細胞等之細胞毒性活性，參閱 Bollag et al.，Cancer Res·，Vol. 55，No. 11，2 3 2 5 -2 3 3 3 ( 1 9 9 5 )〇</span>Epothilone AR = 埃 Epothilone BR = Me It has been found to emit microtubules similar to paclitaxel (pa C1 it axel) (2) 200418849 (TAXOL®) and is therefore stable against rapid proliferation Cytotoxic activity of sex cells, such as tumor cells or cells associated with other highly proliferative cell diseases, see Bollag et al., Cancer Res ·, Vol. 55, No. 11, 2 3 2 5 -2 3 3 3 (1 9 9 5) 〇</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">埃坡黴素A和B爲纖維堆囊菌（Sorangium cellulosum) 所產生的天然抗癌劑，彼等係由Hofle等首先離析且鑑定 出者，DE 4 1 3 8 042 ; WO 93/10121 ; Angew. Chem. Int. Ed. Engl. Vol. 35， No. 1 3 / 1 4, 1567-1569 ( 1 99 6)；和 J. Antibiot.， Vol. 49，No. 6， 560-563(1996)。隨後，由</span>Epothilone A and B are natural anticancer agents produced by Sorangium cellulosum. They were first isolated and identified by Hofle et al., DE 4 1 3 8 042; WO 93/10121; Angew Chem. Int. Ed. Engl. Vol. 35, No. 1 3/1 4, 1567-1569 (1 99 6); and J. Antibiot., Vol. 49, No. 6, 560-563 (1996) . Subsequently, by</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Balog, et al.， Angew. Chem. Int. Ed. Engl., Vol. 35， No.2 3 /24, 2 8 0 1 -2 8 03 ； Meng et al., J. Am. Chem. Soc.,</span>Balog, et al., Angew. Chem. Int. Ed. Engl., Vol. 35, No. 2 3/24, 2 8 0 1-2 8 03; Meng et al., J. Am. Chem. Soc. ,</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Vol. 119，No. 42，1 0073 - 1 0092 ( 1 997) ； Nicolaou et al.? J. Am. Chem. Soc·，Vol. 119, No, 34，7974-7991 (1997)；</span>Vol. 119, No. 42, 1 0073-1 0092 (1 997); Nicolaou et al.? J. Am. Chem. Soc ·, Vol. 119, No, 34, 7974-7991 (1997);</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Schinzer et al., Angew. Chem. Int. Ed. Engl., Vol. 36, No. 5, 523-524 (1997);和 Yang et al., Angew. Chem. Int. Ed. Engl., Vol. 36，No.1/2，1 6 6 - 1 6 8，1 9 9 7 等公開埃坡黴素 A 和B的總體合成。WO 9 8/25 929揭示出埃坡黴素A，埃坡 黴素B，埃坡黴素的類似物與埃坡黴素類似物庫的化學合 成方法。在 WO 98/2 2461中揭示出埃坡黴素 C，D，E， 和F所具構造與從纖維堆囊菌d S Μ 6 7 7 3的產生。圖1提 出一圖解說明在 WO 00/3 92 76 所述在放線菌株 SC15847(ATCC P T - 1 0 4 3 )—後來經鑑定爲東方鍵黴囷 (Amycolatopsis orientalis)體內，埃坡黴素B變成埃坡 黴素F的生物轉換。 -8- (3) (3)200418849 細胞色素P-4 5 0酵素存在於原核生物和真核生物細胞 之內且共同地具有一^血色素（heme)結合功㊆部fn ’該功能 部位與一氧化碳複合之後可以經由在45 0奈米（nm)的吸收 峰予以區別。細胞色素P -4 5 0酵素可對主要爲疏水性受質 包括芳族和苯甲族環，與烷類實施一廣範圍的氧化性反 應。於原核生物體內，彼等係以去毒素系統存在且作爲將 受質例如甲苯、苯和樟腦予以代謝的第一酵素性步驟。細 胞色素P-450酵素也存在於二次代謝物得物合成途徑中， 例如在唐德鏈黴菌 （Streptomyces tendae)中的 nikkomycin(Bruntner, C. e t al.， 1 999，Mol. Gen. Genet. 262:1 02- 1 1 4)，doxorubicin (Dickens, M.L.，Strohl, W.R.， 1 996，J. Bacteriol，1 7 8:3 3 8 9-3 3 9 5 )及在纖維堆囊菌的埃坡 黴素生物合成簇中（Julien，B. et al.，2000, Gene, 249:153-16 0)。除了少數例外之外，細胞色素P-4 5 0系統在原核生 物體內係由三種蛋白質所構成··一爲鐵氧化還原蛋白 NADH或NADH依賴性還原酶，一爲鐵-硫鐵氧化還原蛋 白和細胞色素 P-450 酵素（Lewis，D.F., Hlavica，P.，2000, Biochem. Biophys. Acta.，1 460:3 5 3 -3 74)。電子係從鐵氧 化還原蛋白還原酶轉移到鐵氧化還原蛋白且最後到細胞色 素P-450酵素以促成分子氧的分裂。 【發明內容】 本發明的一項目的爲提出編碼埃坡黴素B羥化酶和其 變異體或突變體的經離析核酸序列及編碼鐵氧化還原蛋白 -9- (4) (4)200418849 或其變異體或突變體的經離析核酸序列。 本發明的另一項目的爲提出包括埃坡黴素B經化酶和 其變異體或突變體所具胺基酸序列的經離析多肽與包括鐵 氧化還原蛋白和其變異體或突變體所具胺基酸序列的經離 析多肽。 本發明的另一項目的爲提出埃坡黴素B羥化酶同質性 模型的構造座標。該構造座標爲附錄i中所列出者。本發 明此模型提供一種工具用來設計埃坡黴素B羥化酶所具生 物學功能的調制劑以及具有變更的特異性的埃坡黴素B經 化酶之其他突變體。 本發明的另一項目的爲提出載體（vector)，其包括編 碼埃坡黴素B羥化酶或其變異體或突變體及/或鐵氧化還 原蛋白或其變異體或突變體之經離析核酸序列。於一較佳 具體實例中，此等載體更包括編碼鐵氧化還原蛋白的核酸 序列。 本發明的另一項目的爲提出包括一載體的宿主細胞， 該載體含有編碼埃坡黴素B羥化酶或其變異體或突變體及 /或鐵氧化還原蛋白或其變異體或突變體之核酸序列。 本發明的另一項目的爲提出一種產生重組體微生物的 方法，此等重組體微生物能夠將具有末端烷基的化合物， 特別是埃坡黴素類，予以羥基化而產生具有末端羥烷基的 化合物。 本發明的另一項目的爲提出經重組方式產生的微生 物，其能夠將具有末端烷基的化合物，特別是埃坡黴素 -10- (5) (5)200418849 類’予以羥基化而產生具有末端羥烷基的化合物。 本發明的另一項目的爲提出在此等重組體微生物內將 化合物羥基化之方法。特別者，本發明提出製造載有羥基 院基的埃坡黴素之方法，該等化合物可用違抗腫瘤劑且作 爲其他埃坡黴素類似物的製備中之起始物。 本發明的又另一項目的爲提出一種式A化合物：</span>Schinzer et al., Angew. Chem. Int. Ed. Engl., Vol. 36, No. 5, 523-524 (1997); and Yang et al., Angew. Chem. Int. Ed. Engl., Vol. 36, No. 1/2, 1 6 6-1 6 8, 1 9 9 7 etc. disclose the overall synthesis of epothilones A and B. WO 9 8/25 929 discloses a chemical synthesis method of epothilone A, epothilone B, analogs of epothilone and epothilone analogs. WO 98/2 2461 discloses the structure of epothilones C, D, E, and F and the production from Fibriocystis d S M 6 7 7 3. Figure 1 presents a diagrammatic illustration of epothilone B turning into Escherichia coli in actinomycete strain SC15847 (ATCC PT-1 0 4 3)-later identified as Amycolatopsis orientalis, described in WO 00/3 92 76 Biotransformation of Talimycin F. -8- (3) (3) 200418849 Cytochrome P-4 50 enzymes are present in prokaryotic and eukaryotic cells and collectively have a ^ heme binding function fn 'This functional site is associated with carbon monoxide After recombination, they can be distinguished by the absorption peak at 450 nm. Cytochrome P-4 50 enzymes can perform a wide range of oxidative reactions with alkanes on predominantly hydrophobic substrates, including aromatic and benzoic rings. In prokaryotes, they exist as a detoxification system and serve as the first enzymatic step to metabolize substrates such as toluene, benzene and camphor. Cytochrome P-450 enzymes are also present in secondary metabolite biosynthetic pathways, such as nikkomycin (Bruntner, C. et al., 1 999, Mol. Gen. Genet. 262) in Streptomyces tendae. 1 02- 1 1 4), doxorubicin (Dickens, ML, Strohl, WR, 1 996, J. Bacteriol, 1 7 8: 3 3 8 9-3 3 9 5) and epothilone Biosynthetic clusters (Julien, B. et al., 2000, Gene, 249: 153-16 0). With few exceptions, the cytochrome P-4 50 system is composed of three proteins in prokaryotes ... one is the iron redox protein NADH or NADH-dependent reductase, the other is iron-thioferredoxin and Cytochrome P-450 enzymes (Lewis, DF, Hlavica, P., 2000, Biochem. Biophys. Acta., 1 460: 3 5 3 -3 74). The electron system is transferred from ferredoxin reductase to ferredoxin and finally to the cytochrome P-450 enzyme to promote the division of molecular oxygen. [Summary of the Invention] An object of the present invention is to propose an isolated nucleic acid sequence encoding epothilone B hydroxylase and a variant or mutant thereof, and encode ferredoxin-9- (4) (4) 200418849 or An isolated nucleic acid sequence of a variant or mutant thereof. Another item of the present invention is to propose an isolated polypeptide comprising an amino acid sequence possessed by epothilone B enzyme and its variants or mutants, and an enzyme comprising ferredoxin and its variants or mutants. Isolated polypeptide of amino acid sequence. Another item of the present invention is to propose the structural coordinates of an epothilone B hydroxylase homogeneity model. The structural coordinates are those listed in Appendix i. This model of the present invention provides a tool for designing modulators of the biological functions of epothilone B hydroxylase and other mutants of epothilone B enzyme with altered specificity. Another item of the present invention is to propose a vector comprising an isolated nucleic acid encoding epothilone B hydroxylase or a variant or mutant thereof and / or a ferredoxin or a variant or mutant thereof. sequence. In a preferred embodiment, these vectors further include a nucleic acid sequence encoding a ferredoxin. Another item of the present invention is to propose a host cell comprising a vector containing a vector encoding epothilone B hydroxylase or a variant or mutant thereof and / or a ferredoxin or a variant or mutant thereof. Nucleic acid sequence. Another item of the present invention is to propose a method for producing recombinant microorganisms. These recombinant microorganisms can hydroxylate compounds having terminal alkyl groups, especially epothilones, to produce compounds having terminal hydroxyalkyl groups. Compounds. Another item of the present invention is to propose a recombinantly produced microorganism capable of hydroxylating a compound having a terminal alkyl group, particularly epothilone-10- (5) (5) 200418849 to produce Terminal hydroxyalkyl compounds. Another item of the present invention is to propose a method for hydroxylating a compound in such a recombinant microorganism. In particular, the present invention proposes a method for producing epothilone loaded with a hydroxyl group. These compounds can be used as antitumor agents and as starting materials in the preparation of other epothilone analogs. Another item of the present invention is to propose a compound of formula A:</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">括該式A化合的組成物與製造該組成物的方法。 [發明之詳細說明] 本發明係有關經離析的核酸序列和多肽以及得到在末 端碳位置具有合意的取代基的化合物之方法。特別者，本 發明提出製備載有羥基烷基的埃坡黴素類所用組成物和方 法’該等化合物可用爲抗腫瘤劑且可在其他埃坡黴素類似 物的製備中用爲起始物。 ^坡黴素”一詞，如本文中所使用者，表如本文中所 定義的含有一埃坡黴素核和一側鏈基之化合物。，，埃坡黴 素核”一詞’如本文中所用者，表含有下面的核構造（顯示 出本文所用的環系統位置之編號）之部分體： -11 - ^418849 (6</span>Include the composition of the compound of formula A and the method of manufacturing the composition. [Detailed description of the invention] The present invention relates to an isolated nucleic acid sequence and a polypeptide, and a method for obtaining a compound having a desired substituent at a terminal carbon position. In particular, the present invention proposes compositions and methods for preparing epothilones bearing hydroxyalkyl groups. These compounds can be used as antitumor agents and can be used as starting materials in the preparation of other epothilone analogs. . ^ Poramycin ", as used herein, means a compound containing an epothilone core and a side chain group as defined herein. The term" epothilone "as used herein As used in this table, the table contains parts of the following nuclear structure (showing the number of the ring system position used in this paper): -11-^ 418849 (6</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">其中諸取代基如下： Q係選自包括下列的群組之中者：</span>The substituents are as follows: Q is selected from the group consisting of:</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">w爲0或NR6 ; X係選自包括下列的群組之中者·· Ο，Η和〇R7 ; Μ 爲 Ο、s、NR8、CR9R10 ; B1和B2係選自0RM、〇(：〇1112之中者；</span>w is 0 or NR6; X is selected from the group consisting of: 〇, Η and 〇7; Μ is 0, s, NR8, CR9R10; B1 and B2 are selected from 0RM, 〇 (: 〇1112 Among the</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ri-R5和R^-R〗7係選自包括下歹5J的群組之中者·· Η、 院基、經取代烷基、芳基、和雜環基，且其中R1和R2爲 烷基，彼等可聯合形成一環烷基； R6係選自包括下列的群組之中者：Η、烷基、和經取 代烷基； R7 fD Ri:係選自包括下列的群組之中者：Η、烷基、 經取代烷基、三烷基矽烷基、烷基二芳基矽烷基和二烷基 芳基砂烷基； R8係選自包括下列的群組之中者Η、烷基、經取代烷 -12- (7) (7)200418849 基、r13c = o、r14〇c = o 和 r15so2;且 R9和R1Q係選自包括下列的群組之中者：Η、鹵素、 烷基、經取代烷基、芳基、雜環基、羥基、R i 6 C = Ο、和 R 1 7 〇 C = Ο 〇 “側鏈基” 一詞指的是上面對埃坡黴素A或B所定義 的取代基G或下面所示的Gi和G2。</span>Ri-R5 and R ^ -R〗 7 are selected from the group consisting of 歹 5J Η, 院, 基, substituted alkyl, aryl, and heterocyclic group, and wherein R1 and R2 are alkane R6 is selected from the group consisting of: ；, alkyl, and substituted alkyl; R7 fD Ri: is selected from the group consisting of : Fluorene, alkyl, substituted alkyl, trialkylsilyl, alkyldiarylsilyl, and dialkylarylsalyl; R8 is selected from the group consisting of fluorene, alkyl , Substituted alkan-12- (7) (7) 200418849, r13c = o, r14〇c = o, and r15so2; and R9 and R1Q are selected from the group consisting of: fluorene, halogen, alkyl , Substituted alkyl, aryl, heterocyclyl, hydroxy, R i 6 C = Ο, and R 1 7 OC = 〇 〇 The term "side chain" refers to epothilone A or Substituent G as defined by B or Gi and G2 shown below.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Gi具有下面的式V HO-CH2-(Ai)n-(Q)m-(A2)〇 (V)</span>Gi has the following formula V HO-CH2- (Ai) n- (Q) m- (A2) 〇 (V)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">且g2具有下面的式VI 其中</span>And g2 has the following formula VI where</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ai和A2爲獨立地選自包括下列的群組之中者：視情 況經取代的Ci-Cs烷基和烯基； Q爲視情況經取代的環系統，其含有1到3個環且在 至少一個環中含有至少一個碳對碳雙鍵；且 η，m，和〇爲獨立地選自包括下列的群組之中者：〇 和1，其中m，η或〇中至少有一者爲1。 “末端碳”或”末端烷基”之術語指的是直接鍵結到埃坡 黴素核的1 5 -位置上之部份體所含末端碳或末端甲基或是 鍵結到位置1 5的側鏈基所含末端碳或末端院基。要了解 -13- (8) (8)200418849 者，術語，，烷基”包括本文所定義的烷基和經取代烷基。 術語，，烷基”指視情況經取代的直鏈型或支鏈型飽和烴 基，其具有1到2 0個碳原子，較佳者1到7個碳原子。” 低碳數烷基”之表達指的是具有1到4個碳原子的視情況 經取代烷基。 術語”經取代烷基”指的是含有1到4個，例如，下列 取代基之烷基：三氟曱基、三氟甲氧基、羥基、烷氧基、 環烷氧基、雜環氧基、酮基、烷醯基、芳氧基、烷醯氧 基、胺基、烷胺基、芳胺基、芳烷胺基、環烷胺基、雜環 胺基；經二取代胺，其中胺基上的2個取代基係選自院 基、芳基或芳烷基之中者；烷醯胺基、芳醯胺基、芳院醯 胺基、經取代烷醯胺基、經取代芳胺基、經取代芳院醯胺 基、硫醇基、烷硫基、芳硫基、芳烷硫基、環烷硫基、雜 環硫基、烷硫酮基、芳硫酮基、芳烷硫酮基、烷磺醯基、 芳磺醯基、芳烷磺醯基、磺胺基（例如S〇2NH2)、經取代 磉胺基、硝基、氰基、羧基、胺基甲醯基（例如C〇NH2)、 經取代胺基甲醯基（例如CONH烷基、C0NH芳基、c〇NH 芳烷基或氮上有兩個選自烷基、芳基或芳烷基之中的取代 基者）、烷氧羰基、芳基、經取代芳基、胍基和雜環基， 例如吲哚基、咪唑基、呋喃基、噻吩基、噻唑基、吡咯 基、吡啶基、嘧啶基和類似者。於上文中有提及取代基上 更含有取代基之情況中，其爲鹵素、烷基、烷氧基、芳其 或芳烷基。 &amp;amp; 根據本發明一方面，提出經離析聚核苷酸，其編碼埃 -14- 200418849 Ο) 坡徽素B羥化酶-…一種可將具有末端烷基的埃坡黴素類 經基化以製成具有末端羥烷基的哀坡黴素類之酵素）的經 離析聚核苷酸。 根據本發明另一方面，提出經離析聚核苷酸，其編碼 鐵氧化還原蛋白，該鐵氧化還原蛋白的基因係位於埃坡黴 素B羥化酶基因的下游處。鐵氧化還原蛋白爲細胞色素 P 4 5 〇系統的一種蛋白質。 “聚核苷酸”，如本文中所使用者，意欲包括任何形式 的DNA或RNA例如CDNA或mRNA，彼等係編碼經由選 殖或經由以熟知的化學技術合成地產生之酵素或其活性片 段。DNA可爲雙股型或爲單股型。單股型DNA可包括密 碼股或有意義股或包括非密碼股或反意義股。因此，聚核 苷酸一詞也包括對本文所揭示的序列展現出至少60%或更 高，較佳者至少 80%或更高的同質率（homology)，且可在 迫切條件（stringent conditio η)下雜交到上述聚核苷酸之聚 核苷酸。如本文中所用者，”迫切條件”意指 6 0 °C ，在 2xSSC緩衝液內的雜交條件。更佳者爲可在65°C 3XSSC 的雜交條件下雜交到 S E Q ID N 0 : 1、3 0、3 2、3 4、3 6、 37、38、39、40、41、42、60、62 ' 64、66、68、70、7 2 或74或SEQ ID NO:3所述核酸序列16小時之經離析核酸 分子，或爲能夠雜交到SEQ ID ΝΟ·_ 1、30、32、34、36、 37、38' 39、40' 4 卜 42' 60、62、64、66、68、70、7 2 或74或SEQ ID NO:3所述核酸序列的互補序列Ιό小時之 經離析核酸分子，或可在〇.5X SSC，55°C的洗滌條件下 (10) (10)200418849 保持雜交到 SEQ ID ΝΟ:1、30、32、34、36、37、38、 39 、 40 、 41 、 42 、 60 、 62 、 64 、 66 、 68 、 70 、 72 或 74 ^ SEQ ID NO:3所述核酸序列30分鐘，或雜交到SEQ ID NO : 1、30、32、34、36、37、38、39、40、4 1、42、 60、62、64、66、68、70、72 或 74 或 SEQ ID NO:3 所述 核酸序列的互補序列3 0分鐘之經離析核酸分子。 於一具體實例中，本發明聚核苷酸包括SEQ ID NO: 1 中所示基因組DNA或其同質序列或片段，其編碼具有類 似於此埃坡黴素B羥化酶所具活性之多肽。另外，本發明 聚核苷酸可包括SEQ ID NO:3中所示基因組DNA或其同 質序列或片段，其編碼具有類似於此鐵氧化還原蛋白所具 活性之多肽。因爲遺傳密碼的簡倂性之故，本發明聚核苷 酸也可包括編碼此酵素和衍生物的其他核酸序列，其變異 體或活性片段。 本發明也有關此等聚核苷酸的變異體，其可能爲天然 發生者’亦即存在於微生物例如東方鏈黴菌或Amycolata autouophica體內者，或在土壤或可將核酸離析出的其他 來源之內者，或爲以熟知的突變生成技術製得之突變體。 範例本發明變異體聚核苷酸爲SEQ ID NO :3 6-42中所示 者。 “突變體”一詞，如本文中所使用者，意欲涵蓋相對於 SEQ ID ΝΟ:1或3而言，具有一或更多個點突變，或核酸 的刪除或添加，但仍編碼具有類似於SEQ ID NO : 1或3所 編碼的多肽所具活性之多肽或其片段之核酸序列。於一較 -16- (11) (11)200418849 佳具體實例中，係將突變作成會變更酵素的受質特異性及 /或產率者。針對埃坡黴素B羥化酶基因的一較佳突變區 爲編碼包括該酵素的活性部位的約1 13個胺基酸殘基之核 酸序列區。此外，也爲較佳者爲編碼在SEQ ID NO : 1的胺 基酸位置 GLU31、ARG67、ARG88、ILE92、ALA93、 VAL106 、 ILE130 、 ALA140 、 MET176 、 PHE190 、 GLU231、SER294、PHE237、或 ILE365 處有至少一個胺 基酸取代者。範例本發明聚核苷酸突變體爲SEQ ID NO: 3 0 &amp;gt; 32、34、60、62、64、66、68、70、72、和 74 之中所示者。 編碼埃坡黴素B羥化酶的SEQ ID ΝΟ:1核酸序列之 選殖係使用經由將得自細菌的六種細胞色素P45 0基因所 具核酸序列予以排比所設計出的PCR引子。下列細胞色 素P4 5 0基因爲經排比者： 序歹ij 1 ： Locus : STMSUACB ；登錄號碼：M3 223 8 ; 參考文獻：Omer，C. A.，J. Bacteriol. 1 72:3 3 3 5 -3 3 4 5 ( 1 990) 序歹[]2 ： Locus ： STMSUBCB ;登錄號碼：M3 223 9 ； 參考文獻：Omer，C.A.，J. Bacteriol. 1 72:3 3 3 5 -3 3 4 5 ( 1 990) 序歹 ij 3 ： Locus ： ABO 1 80 74( tu STMORFA)；登錄號 碼：AB 0 1 8074 ;參考文獻：Ueda， K.， J. Antibiot. 48:638-646 (1995) 序列 4 : Locus : SSU65940 ;登錄號碼：U65940 ;參 考文獻：Motamedi，H·， J. Bacteriol. 1 7 8:5243 - 524 8 (1990) (12) (12)200418849 序歹[j 5 ： Locus ： STMOLEP ;登錄號碼：L3 7200 ；參 考文獻：Rodriguez， A.M.， FEM S Microbiol. Lett. 127:117-120 (1995) 序歹[j 6: Locus ： SERCP4 5 0 A ；登錄號碼：M83110; 參考文獻：Andersen，J.F. and Hutchinson， C.R.，J. Bacteriol. 1 74:72 5 - 73 5 ( 1 992) 排比係經由使用 Myers, E.W. and W. Miller, 1 9 8 8. CABIOS 4:1, 11-17 ，得自 Scientific and Education</span>Ai and A2 are independently selected from the group consisting of: optionally substituted Ci-Cs alkyl and alkenyl; Q is optionally substituted ring system containing 1 to 3 rings and in At least one ring contains at least one carbon-to-carbon double bond; and η, m, and 0 are independently selected from the group consisting of: 0 and 1, wherein at least one of m, η, or 0 is 1 . The term "terminal carbon" or "terminal alkyl" refers to the terminal carbon or terminal methyl group contained in the part which is directly bonded to the 15-position of the epothilone core or to the position 15 The side chain group contains a terminal carbon or a terminal courtyard. To understand -13- (8) (8) 200418849, the term "alkyl" includes alkyl and substituted alkyls as defined herein. The term "alkyl" refers to a linear or branched, optionally substituted A chain-type saturated hydrocarbon group having 1 to 20 carbon atoms, preferably 1 to 7 carbon atoms. The expression "low-carbon alkyl group" refers to an optionally substituted alkyl group having 1 to 4 carbon atoms. The term "substituted alkyl" refers to an alkyl group containing 1 to 4 substituents, for example, trifluorofluorenyl, trifluoromethoxy, hydroxyl, alkoxy, cycloalkoxy, heteroepoxy Group, keto group, alkylamino group, aryloxy group, alkyloxy group, amine group, alkylamino group, arylamino group, aralkylamino group, cycloalkylamino group, heterocyclic amino group; The two substituents on the amine group are selected from the group consisting of alkyl, aryl or aralkyl; alkylamino, arylamido, aromaticamido, substituted alkylamino, substituted aromatic Amine, substituted arylamine, thiol, alkylthio, arylthio, aralkylthio, cycloalkylthio, heterocyclicthio, alkylthioketone, arylthioketone, aralkyl Thione, alkanesulfonyl, arylsulfonyl, aralkylsulfonyl, sulfonamido (eg, S02NH2), substituted fluorenylamino, nitro, cyano, carboxyl, aminoformamyl (eg CONH2), substituted aminomethyl amidino (for example, CONH alkyl, CONH aryl, CONH aralkyl, or nitrogen with two substituents selected from alkyl, aryl, or aralkyl Person), alkoxycarbonyl, aryl, Aryl group, guanidino and heterocyclyl, e.g., indolyl, imidazolyl, furyl, thienyl, thiazolyl, pyrrolyl, pyridinyl, pyrimidinyl, and the like. Where it is mentioned above that the substituent further contains a substituent, it is a halogen, an alkyl group, an alkoxy group, an aryl group or an aralkyl group. &amp;amp; According to one aspect of the present invention, an isolated polynucleotide is proposed, which encodes Ang-14-200418849 〇) Polanin B hydroxylase -... a kind of epothilones having terminal alkyl groups To make an isolated polynucleotide with a terminal hydroxyalkyl group of salinomycins). According to another aspect of the present invention, an isolated polynucleotide is proposed which encodes a ferredoxin gene whose gene line is located downstream of the epothilone B hydroxylase gene. Ferredoxin is a protein of the cytochrome P 4 50 system. A "polynucleotide", as used herein, is intended to include any form of DNA or RNA, such as CDNA or mRNA, which encodes an enzyme or an active fragment thereof that is produced by breeding or synthetically produced by well-known chemical techniques . DNA can be double-stranded or single-stranded. Single-stranded DNA can include password or meaningful shares or non-cryptographic or anti-meaning shares. Therefore, the term polynucleotide also includes homology to at least 60% or higher, preferably at least 80% or higher, for the sequences disclosed herein, and can be used under stringent conditio η ) To the above-mentioned polynucleotide. As used herein, "urgent conditions" means hybridization conditions at 60 ° C in 2xSSC buffer. More preferably, it can hybridize to SEQ ID N 0 under the hybridization conditions of 3XSSC at 65 ° C: 1, 3 0, 3 2, 3 4, 3, 6, 37, 38, 39, 40, 41, 42, 60, 62 '64, 66, 68, 70, 7 2 or 74 or 16 hours of isolated nucleic acid molecules of the nucleic acid sequence described in SEQ ID NO: 3, or are capable of hybridizing to SEQ ID NO. 1, 30, 32, 34, 36 , 37, 38 '39, 40' 4 and 42 '60, 62, 64, 66, 68, 70, 7 2 or 74 or the complementary sequence of the nucleic acid sequence described in SEQ ID NO: 3, the nucleic acid molecule is isolated, Or can be hybridized to SEQ ID NO: 1, 30, 32, 34, 36, 37, 38, 39, 40, 41, 42 under wash conditions of 0.5X SSC, 55 ° C (10) (10) 200418849 , 60, 62, 64, 66, 68, 70, 72 or 74 ^ the nucleic acid sequence described in SEQ ID NO: 3 for 30 minutes, or hybridized to SEQ ID NO: 1, 30, 32, 34, 36, 37, 38, 39, 40, 4 1, 42, 60, 62, 64, 66, 68, 70, 72, or 74 or the complementary sequence of the nucleic acid sequence described in SEQ ID NO: 3 The nucleic acid molecule is isolated after 30 minutes. In a specific example, the polynucleotide of the present invention includes the genomic DNA shown in SEQ ID NO: 1 or a homologous sequence or fragment thereof, which encodes a polypeptide having an activity similar to that of epothilone B hydroxylase. In addition, the polynucleotide of the present invention may include the genomic DNA shown in SEQ ID NO: 3 or a homologous sequence or fragment thereof, which encodes a polypeptide having an activity similar to that of the ferredoxin. Because of the simplicity of the genetic code, the polynucleotides of the present invention may also include other nucleic acid sequences, variants or active fragments that encode this enzyme and derivative. The invention also relates to variants of these polynucleotides, which may be naturally occurring 'i.e., present in microorganisms such as Streptomyces orientalis or Amycolata autouophica, or in soil or other sources from which nucleic acids can be isolated Or, it may be a mutant made by a well-known mutation generation technique. Exemplary variant polynucleotides of the invention are those shown in SEQ ID NOs: 3 6-42. The term "mutant", as used herein, is intended to cover deletions or additions of one or more point mutations, or nucleic acids, relative to SEQ ID NO: 1 or 3, but still encoding SEQ ID NO: 1 or 3 The nucleic acid sequence of a polypeptide or a fragment thereof having the activity of the polypeptide encoded by it. In a better specific example of -16- (11) (11) 200418849, mutations were made to alter the substrate specificity and / or yield of the enzyme. A preferred mutation region for the epothilone B hydroxylase gene is a nucleotide sequence region encoding about 113 amino acid residues including the active site of the enzyme. In addition, it is also preferred to be encoded at the amino acid positions GLU31, ARG67, ARG88, ILE92, ALA93, VAL106, ILE130, ALA140, MET176, PHE190, GLU231, SER294, PHE237, or ILE365 in SEQ ID NO: 1 At least one amino acid substituted. Exemplary polynucleotide mutants of the present invention are shown in SEQ ID NO: 3 0 &amp;gt; 32, 34, 60, 62, 64, 66, 68, 70, 72, and 74. The clones of the nucleic acid sequence of SEQ ID NO: 1 encoding epothilone B hydroxylase use PCR primers designed by aligning the nucleic acid sequences of six cytochrome P450 genes obtained from bacteria. The following cytochrome P4 50 genes are ranked by comparison: Sequence 歹 ij 1: Locus: STMSUACB; Accession number: M3 223 8; References: Omer, CA, J. Bacteriol. 1 72: 3 3 3 5 -3 3 4 5 (1 990) Preface [] 2: Locus: STMSUBCB; Registration number: M3 223 9; References: Omer, CA, J. Bacteriol. 1 72: 3 3 3 5 -3 3 4 5 (1 990) Preface歹 ij 3: Locus: ABO 1 80 74 (tu STMORFA); accession number: AB 0 1 8074; reference: Ueda, K., J. Antibiot. 48: 638-646 (1995) sequence 4: Locus: SSU65940; Registration number: U65940; References: Motamedi, H., J. Bacteriol. 1 7 8: 5243-524 8 (1990) (12) (12) 200418849 Preface [j 5: Locus: STMOLEP; Registration number: L3 7200 References: Rodriguez, AM, FEM S Microbiol. Lett. 127: 117-120 (1995) Preface [j 6: Locus: SERCP4 5 0 A; Accession number: M83110; References: Andersen, JF and Hutchinson, CR , J. Bacteriol. 1 74:72 5-73 5 (1 992) The ratio is obtained by using Myers, EW and W. Miller, 1 9 8 8. CABIOS 4: 1, 11-17 from Scientifi c and Education</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Software (Durham，North Carolina，USA)的演算法而實施 的。鑑別出三個高度保守區，在I-螺旋中，含有氧結合性 功能部位，在K-螺旋中，和跨越B-隆起（B-bulge)與L-螺 旋，含有保守血基質結合功能部位。針對在排比中鑑別出 的該三個保守區設計引子。引子P45 0- 1 +(SEQ ID NO:23) 和P4 50-la + (SEQ ID NO:24)係從I螺旋設計出者，引子 P450-2 + (SEQ ID NO:25)係從B-隆起與L·螺旋區設計者且 引子P4 5 0 -3_(SEQ ID NO:27)係經設計成對血基質結合性 蛋白質呈反互補者。 然後，透過聚合酶鏈型反應（PCR)將基因組片段擴 增。於PCR擴增之後，以凝膠電泳分離反應產物並剪出 具有預期尺寸的片段。使用 Qiaquick凝膠萃取程序 (Qiagen，Santa Clarita, California，USA)從瓊!脂糖凝膠切 片萃取出 DNA。然後使用 PCRscript Amp 選殖套劑 (Stratagene)將諸片段選殖到 PCRscript 載體（Stratagene， La Jolla, California，USA)中。於 30-37 °C ’ 以 230-300 (13) 200418849 r pm，16-24小時，將含有插入體的群落撿取到毫升含 有100微克/毫升氨苄青黴素的LB液體培養基。使用Mo Bio 微型質體製備套組（Mo Bio，Solano Beach，California， USA)實施質體分離。使用此質體DNA作爲PCR和定序模 板及用於限制消化分析。</span>Software (Durham, North Carolina, USA). Three highly conserved regions were identified, in the I-helix, containing oxygen-binding functional sites, in the K-helix, and across B-bulge and L-spirals, containing conserved blood matrix-binding functional sites. Primers were designed for the three conserved regions identified in the alignment. Primers P45 0- 1 + (SEQ ID NO: 23) and P4 50-la + (SEQ ID NO: 24) were designed from the I helix, and primer P450-2 + (SEQ ID NO: 25) was from B- The designer of the bulge and L. helix region and primer P4 50 -3_ (SEQ ID NO: 27) was designed to be anti-complementary to blood matrix-binding proteins. The genomic fragment is then amplified by polymerase chain reaction (PCR). After PCR amplification, the reaction product was separated by gel electrophoresis and a fragment having a desired size was cut out. DNA was extracted from agarose gel slices using the Qiaquick gel extraction program (Qiagen, Santa Clarita, California, USA). The fragments were then cloned into a PCRscript vector (Stratagene, La Jolla, California, USA) using a PCRscript Amp selection kit (Stratagene). At 30-37 ° C ′ at 230-300 (13) 200418849 r pm, 16-24 hours, the colonies containing the inserts were picked up in ml of LB liquid medium containing 100 μg / ml of ampicillin. The plastid separation was performed using a Mo Bio mini plastid preparation kit (Mo Bio, Solano Beach, California, USA). Use this plastid DNA as a PCR and sequencing template and for restriction digestion analysis.</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">將經選殖的PCR產物使用得自 Applied Biosystems (Foster* City, California，USA)的 Big-Dye 定序套組予以定 序並使用 ABI310 定序儀（Applied Biosystems，Foster City， California，USA)進行分析。使用插入體的序列經由使用 Altschul，S.F·，et al.，Mol. Biol.215 :403-410 (1990)的方 案來實施非豐盛蛋白質資料庫的TblastX搜索。保留下來 對已知的細胞色素P45 0蛋白質具有明顯類似性之獨特序 列。採用此種做法從 SCI 5 847鑑別出總計9個不同的 P450序列，其中七種來自基因組DNA模板而兩種來自 cDNA。其中兩種P450序列經發現係DNA與cDNA兩模 板之間共有者。於所分析的50種cDNA殖株中，有兩種 序列爲主要者，各具20殖株。接著從基因組DNA選殖出 此兩種序列。 使用Big-Dye定序系統（Applied Biosystems)定出該基 因組DNA的核酸序列並使用ABI3 10定序儀進行分析。此 序列示於SEQ ID NO: 1中。於所選殖的BgluII片段內發 現一編碼具有404個胺基酸的蛋白質且具有44.7 kD a的 預期分子量之開放編閱架構密碼。所導出的此多肽所具胺 基酸序列爲SEQ ID NO :2中所示者。此多肽所具胺基酸序 -19&amp;quot; (14) 200418849</span>The selected PCR products were sequenced using a Big-Dye sequencing kit from Applied Biosystems (Foster * City, California, USA) and performed using an ABI310 sequencer (Applied Biosystems, Foster City, California, USA). analysis. The sequence of the insert was used to perform a TblastX search of a non-abundant protein database via the scheme using Altschul, S.F., et al., Mol. Biol. 215: 403-410 (1990). A unique sequence with significant similarities to known cytochrome P450 proteins is retained. In this way, a total of 9 different P450 sequences were identified from SCI 5 847, of which seven were derived from genomic DNA templates and two were derived from cDNA. Two of these P450 sequences were found to be in common between the two templates of DNA and cDNA. Among the 50 cDNA clones analyzed, there were two sequences as the main ones, each with 20 clones. These two sequences were then selected from the genomic DNA. The nucleic acid sequence of this genomic DNA was determined using a Big-Dye sequencing system (Applied Biosystems) and analyzed using an ABI3 10 sequencer. This sequence is shown in SEQ ID NO: 1. In the selected BgluII fragment, an open editing framework code encoding a protein with 404 amino acids and an expected molecular weight of 44.7 kD a was found. The derived amino acid sequence of this polypeptide is shown in SEQ ID NO: 2. This peptide has an amino acid sequence of -19 &amp;quot; (14) 200418849</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">列經發現與唐德鏈黴菌的NikF蛋白質（Bruntner，C. et al.， 1 999, Mol. Gen. Genet. 262:1 02- 1 1 4)共有 51%的相同率且 與嗜碳鏈黴菌（S. carbophilus)的Sca-2蛋白質共有48%的 相同率。此兩種酵素都屬於細胞色素P45 0族105。在所 有細胞色素P450酵素所含血基質結合功能部位中所發現 的半胱胺酸係出現於殘基3 5 6處。此埃坡黴素B羥化酶基 因經命名爲ebh。具有64個胺基酸的推定鐵氧化還原蛋 白基因的ATG起始密碼子係出現在ebh的停止密碼子下 游 9驗對之處。此酵素經發現與 S. griseoulus(0’Keefe, D.P., et al·, 1991, Biochemistry 3 0:44 7-4 5 5 )和諾爾斯氏 鏈黴菌（S. noursei)(Brautaset，T.，et al.，2000，Chem. Biol. 7: 3 95 -4 03 )的鐵氧化還原蛋白基因共有50%的相同率。編 碼此鐵氧化還原蛋白的核酸序列爲SEQ ID NO:3中所示者 而此鐵氧化還原蛋白多肽的胺基酸序列爲SEQ ID NO :4中 所示者。</span>Li Jing found that the NikF protein (Bruntner, C. et al., 1 999, Mol. Gen. Genet. 262: 1 02- 1 1 4) shared 51% of the same rate with Streptomyces donde and was similar to Streptomyces carbophilus (S carbophilus) Sca-2 protein has a total identity of 48%. Both enzymes belong to the cytochrome P45 0 family 105. The cysteine system found in all blood matrix-binding functional sites contained in all cytochrome P450 enzymes appears at residues 3 56. This epothilone B hydroxylase gene is named ebh. The ATG start codon line of the putative iron redox protein gene with 64 amino acids appears below the stop codon of ebh. This enzyme was found to be associated with S. griseoulus (0'Keefe, DP, et al., 1991, Biochemistry 3 0:44 7-4 5 5) and S. noursei (Brautaset, T., et al., 2000, Chem. Biol. 7: 3 95-4 03), the iron redox protein gene has a 50% identical rate. The nucleic acid sequence encoding the ferredoxin is shown in SEQ ID NO: 3 and the amino acid sequence of the ferredoxin polypeptide is shown in SEQ ID NO: 4.</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ebh基因序列也被用來從其他微生物離析出變異體細 胞色素P4 5 0基因。下面表1列出範例本發明變異體聚核 苷酸 ebh43 49 1 、 ebhl 493 0 、 ebh53 5 60 、 ebh5 3 5 5 0 、 ebh39444、ebh43333、和 ebh35165與離析彼等所用的物 種。此等變異體的核酸序列分別示於SEQ ID NO :3 6-42 中ο -20 - (15) (15)200418849 表1變異體聚核苷酸   ATCC ID 物種 e b h基因編號  43 49 1 東方鏈黴菌 ebh43491  1 4 93 0 東方鏈黴菌 ebh 1 4 93 0  5 3 5 6 0 東方鏈黴菌 ebh53560  5 3 5 5 0 東方鏈黴菌 ebh53550  3 9444 東方鏈黴菌 ebh39444  4 3 3 3 3 東方鏈黴菌 ebh4 3 3 3 3  3 5 165 東方鏈黴菌 e b h 3 5 1 6 5 範例變異體 ebh43491 、 ebhl4930 、 ebh53560 、 ebh53550、ebh39444、ebh43333、和 ebh3 5 1 6 5 所編碼的 胺基酸序列分別示於SEQ ID NO :43 -49之中。表2列出此 等範例變異體的胺基酸取代之摘述。</span>The ebh gene sequence was also used to isolate the mutant cytochrome P4 50 gene from other microorganisms. Table 1 below lists exemplary polynucleotides ebh43 49 1, ebhl 493 0, ebh53 5 60, ebh5 3 5 5 0, ebh39444, ebh43333, and ebh35165 and the species used for isolation of the variants of the present invention. The nucleic acid sequences of these variants are shown in SEQ ID NO: 3 6-42. -20-(15) (15) 200418849 Table 1. Variant polynucleotide ATCC ID species ebh gene number 43 49 1 Streptomyces orientalis ebh43491 1 4 93 0 Streptomyces orientalis ebh 1 4 93 0 5 3 5 6 0 Streptomyces orientalis ebh53560 5 3 5 5 0 Streptomyces orientalis ebh53550 3 9444 Streptomyces orientalis ebh39444 4 3 3 3 3 Streptomyces orientalis ebh4 3 3 3 3 3 5 165 Streptomyces orientalis ebh 3 5 1 6 5 Exemplary variants ebh43491, ebhl4930, ebh53560, ebh53550, ebh39444, ebh43333, and ebh3 5 1 6 5 The amino acid sequences encoded are shown in SEQ ID NOs: 43 -49 In. Table 2 shows a summary of the amino acid substitutions of these exemplary variants.</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">-21 - (16) 200418849 表2 : 胺基酸   位置 e b h 取代 ebh變異體    100 G1 y S e r e b h 1 4 9 3 0 、 ebh4 3 3 3 3 、ebh53550 、     ebh43491    10 1 Ly s Arg ebhl4930    13 0 lie Leu ebhl4930    192 S er Gin ebhl4930    224 S e r Thr ebhl4930 ' ebh43 3 3 3 、ebh53550 、     ebh43491    285 lie Val ebhl4930 、 ebh4 3 3 3 3 、ebh53550 、     ebh43491    69 S e r A s n ebh43333    256 Val Ala ebh43333 、 ebh 5 3 5 5 0、 ebh43 49 1  93 Ala Ser ebh53550    326 Asp G1 u ebh53550 、 eb h4 3 4 9 1   3 3 3 Thr Ala ebh53550 、 ebh4349 1   13 3 Leu Met ebh43 49 1    3 98 His Arg ebh39444</span>-21-(16) 200418849 Table 2: Amino acid position ebh substitution ebh variant 100 G1 y Serebh 1 4 9 3 0, ebh4 3 3 3 3, ebh53550, ebh43491 10 1 Ly s Arg ebhl4930 13 0 lie Leu ebhl4930 192 S er Gin ebhl4930 224 S er Thr ebhl4930 'ebh43 3 3 3, ebh53550, ebh43491 285 lie Val ebhl4930, ebh4 3 3 3 3, ebh53550, ebh43491 69 S er A sn ebh43333 256 Val 5 5 ebh 5 ebh , Ebh43 49 1 93 Ala Ser ebh53550 326 Asp G1 u ebh53550, eb h4 3 4 9 1 3 3 3 Thr Ala ebh53550, ebh4349 1 13 3 Leu Met ebh43 49 1 3 98 His Arg ebh39444</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">於ebh基因的密碼區也導入突變以鑑別出具有改良的 產率、及/或生物轉化率及/或變更的受質特異性。範例本 發明突變型核酸序列爲 SEQ ID NO:30、32、34、60、 62、64、66、68、70、72 和 74 之中所示者。 SEQ ID NO:30的核酸序列矽編碼突變體ebh25-l ’其 -22- (17) (17)200418849 展現出變更的受質特異性。含有此突變基因的質體 pANT 849ebh25-l 業經在布達佩斯公約（the Budapest Treaty)的條款之下爲 The International Depository</span>Mutations were also introduced into the codon of the ebh gene to identify improved substrate yields, and / or biotransformation rates and / or altered substrate specificities. Exemplary mutant nucleic acid sequences of the invention are shown in SEQ ID NOs: 30, 32, 34, 60, 62, 64, 66, 68, 70, 72, and 74. The nucleic acid sequence silicon-encoding mutant ebh25-1 'of SEQ ID NO: 30, whose -22- (17) (17) 200418849 exhibits altered substrate specificity. The pANT 849ebh25-l plastid containing this mutant gene is known under the terms of the Budapest Treaty as The International Depository</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Authority所寄存且接受。該寄存係在2002年11月___日 在 1 0 8 0 1 University Boulevard, Manassas, Virginia 201 10-2209 的 the American Type Culture Collection 完成 的。其AT C C登錄號碼爲________。對於此質體的公開取 得之所有限制都將在此專利申請獲准之後即不可挽回地消 除。該寄存物要保存於該公開寄存所一段於寄存日期之後 3 0年之期間或自最後一次申請樣品之後5年的期間或專 利可執行期限，視何者較長而定。若寄存所不能配發活的 樣品，則該寄存物要更新。 於突變 25(弓| 子 NPB29-mut25f(SEQ ID NO:58)和 NPB29-mut25r(SEQ ID ΝΟ··59))的篩選中所鑑別出的此變 鉛青鏈黴菌（S. lividans)轉形體經發現可產生具有與埃坡 黴素B或埃坡黴素F不同HPLC溶析時間的產物。以LC-MS分析此未知樣品而發現具有5 23之分子量（M.W.)，與 埃坡黴素B的單羥基化一致。從該變鉛青鏈黴菌培養物分 離出質體DNA並於使用引子NPB29-6f (SEQ ID NO:28)和 NPB29-7r (SEQ ID NO:29)的PCR擴增中作爲模板（參看實 施例17)。取得預期的片段並使用Big-Dye定序系統予以 定序。該ebh25-l突變體經發現具有導致蛋白質胺基酸序 列的改變之兩處突變，天東胺醯胺1 95變成絲胺酸及絲胺 酸294變成脯胺酸。導向於在密碼子2 3 8處的突變之位置 (18) (18)200418849 經發現具有一種2個核苷酸的變化，該變化並未導致該蛋 白質所具胺基酸序列的變化。SEQ ID ΝΟ··30所編碼的突 變體多肽所具胺基酸序列經顯示於SEQ ID NO:3 1之中。 SEQ ID NO :32核酸序列編碼突變體ebh 10-53，其展 現出改良的生物轉化產率。 於突變 10(引子 NPB29-mutl0f(SEQ ID NO:54)和 NPB29-mutl0r(SEQ ID Ν Ο : 5 5 ))的篩選中所鑑別出的此變 鉛青鏈黴菌轉形體經發現可產生較大的埃坡黴素F產率。 從該變鉛青鏈黴菌培養物分離出質體DNA並於使用引子 NPB29-6f (SEQ ID NO:28)和 NPB29-7r (SEQ ID NO: 29)的 PCR擴增中作爲模板（參看實施例16)。取得預期的片段並 使用Big-Dye定序系統予以定序。該ebhlO-53突變體經 發現具有導致蛋白質胺基酸序列的改變之兩處突變，榖胺 酸23 1變成精胺酸及苯丙胺酸190變成酪胺酸。位置23 1 爲突變生成之目標，於殘基190處的改變爲突變生成程序 人爲產物的意外變化。SEQ ID NO: 32所編碼的突變體多 肽所具胺基酸序列經顯示於SEQ ID NO :33之中。 SEQ ID NO:34核酸序列編碼突變體ebh24-16，其也 展現出改良的生物轉化產率。於突變 24(引子NPB 29-mut24f(SEQ ID N0.56)和 NPB29_mut24r(SEQ ID NO:57)) 的篩選中所鑑別出的此變鉛青鏈黴菌轉形體，ebh24-16， 也可產生較大的埃坡黴素F產率。從該變鉛青鏈黴菌培養 物分離出質體DNA並於使用引子 NPB29-6f (SEQ ID NO:28)和 NPB29-7r (SEQ ID NO:29)的 PCR 擴增中作爲模 (19) (19)200418849 板。取得預期的片段並使用Big-Dye定序系統予以定序。 該ebh24-16突變體經發現具有導致蛋白質胺基酸序列的 改變之兩處突變，苯丙胺酸23 7變成丙胺酸及異白胺酸 92變成纈胺酸。位置2 3 7爲突變生成之目標，於殘基92 處的改變爲突變生成程序人爲產物的意外變化。SEQ ID NO :34所編碼的突變體多肽所具胺基酸序列經顯示於SEQ ID NO:35 之中。 SEQ ID NO:60核酸序列編碼突變體ebh24-16d8，其 也展現出改良的生物轉化產率。於突變59(引子NPB 29-mut59(SEQ ID NO:77)的篩選中所鑑別出的此龜裂鏈黴菌 (S. rimosus)轉形體，ebh24-16d8，也可產生較大的埃坡黴 素F產率。從該龜裂鏈黴菌培養物分離出質體DNA並於 使用引子NPB29-6f(SEQIDNO:2 8)和NPB29-7r(SEQID NO: 2 9)的PCR擴增中作爲模板。取得預期的片段並使用 Big-Dye定序系統予以定序。該ebh24-16d8突變體經發現 具有導致蛋白質胺基酸序列的改變之一處突變，精胺酸 6 7變成榖胺醯胺。此改變爲一種突變生成程序的人爲產 物。SEQ ID NO: 60所編碼的突變體多肽所具胺基酸序列 經顯示於SEQ ID NO:61之中。 SEQ ID NO:62核酸序列編碼突變體ebh24-16cl 1，其 也展現出改良的生物轉化產率。於突變59(引子NPB29· mut59(SEQ ID NO:77)的篩選中所鑑別出的此龜裂鏈黴菌 轉形體，ebh24-16cll，也可產生較大的埃坡黴素F產 率。從該龜裂鏈黴菌培養物分離出質體DNA並於使用引 (20) (20)200418849 子 NPB29-6f (SEQ ID NO:28)和 NPB29-7r (SEQ ID NO:29) 的P C R擴增中作爲模板。取得預期的片段並使用B i §- D Υ e 定序系統予以定序。該ebh24_16cl 1突變體經發現具有導 致蛋白質胺基酸序列的改變之兩處突變’丙胺酸9 3變成 甘胺酸且異白胺酸305變成蘇胺酸。位置93爲突變生成 標的，而在3 6 5的改變爲一種突變生成程序的人爲產物。 S E Q ID Ν Ο : 6 2所編碼的突變體多肽所具胺基酸序列經顯 示於SEQ ID NO:63之中。 SEQ ID N〇:64核酸序列編碼突變體ebh24-16-16’其 也展現出改良的生物轉化產率。於ebh24_ 16隨機突變體 的篩選中所鑑別出的此龜裂鏈黴菌轉形體，ebh24-16-16，也可產生較大的埃坡黴素F產率。從該龜裂鏈黴菌培 養物分離出質體DNA並於使用引子NPB29-6f (SEQ ID NO:28)和 NPB29-7r (SEQ ID NO:29)的 PCR 擴增中作爲模 板。取得預期的片段並使用Big-Dye定序系統予以定序。 該ebh24-16-16突變體經發現具有導致蛋白質胺基酸序列 的改變之一額外突變，纈胺酸1〇6變成丙胺酸。SEQ ID NO :64所編碼的突變體多肽所具胺基酸序列經顯示於SEQ ID NO:65 之中。 SEQ ID NO :34核酸序列編碼突變體ebh24-16，其也 展現出改良的生物轉化產率。於突變 24(引子 NPB29-mut24f(SEQ ID NO:56)和 NPB29-mut24r(SEQ ID NO:57)) 的篩選中所鑑別出的此變鉛青鏈黴菌轉形體，ebh2 4-16， 也可產生較大的埃坡黴素F產率。從該變鉛青鏈黴菌培養 -26- (21) (21)200418849 物分離出質體 DNA並於使用引子 NPB29-6f (SEQ ID NO:28)和 NPB29-7r (SEQ ID NO:29)的 PCR 擴增中作爲模 板。取得預期的片段並使用Big-Dye定序系統予以定序。 該ebh24-16突變體經發現具有導致蛋白質胺基酸序列的 改變之兩處突變，苯丙胺酸2 3 7變成丙胺酸及異白胺酸 92變成纈胺酸。位置23 7爲突變生成之目標，於殘基92 處的改變爲突變生成程序人爲產物的意外變化。SEQ ID NO :34所編碼的突變體多肽所具胺基酸序列經顯示於SEQ ID NO : 3 5 之中。 SEQ ID NO:60核酸序列編碼突變體ebh24-16d8，其 也展現出改良的生物轉化產率。於突變59(引子NPB 29-mut59(SEQ ID NO:77)的篩選中所鑑別出的此龜裂鏈黴菌 (S. rimosns)轉形體，ebh24-16d8，也可產生較大的埃坡黴 素F產率。從該龜裂鏈黴菌培養物分離出質體DNA並於 使用引子NPB29-6f(SEQIDNO:28)和NPB29-7r(SEQID NO:29)的PCR擴增中作爲模板。取得預期的片段並使用 Big-Dye定序系統予以定序。該ebh24-16d8突變體經發現 具有導致蛋白質胺基酸序列的改變之一處突變，精胺酸 6 7變成榖胺醯胺。此改變爲一種突變生成程序的人爲產 物。SEQ ID NO: 6〇所編碼的突變體多肽所具胺基酸序列 經顯示於S E Q ID N 0 : 6 1之中。 SEQ ID NO:62核酸序列編碼突變體ebh24-16cl 1，其 也展現出改良的生物轉化產率。於突變59(引子NPB29-mut59(SEQ ID NO··77)的篩選中所鑑別出的此龜裂鏈黴菌 (22) 200418849 轉形體，ebh24-16cl 1，也可產生較大的埃坡黴素 F產 率。從該龜裂鏈黴菌培養物分離出質體DNA並於使用引 子 NPB29-6f (SEQ ID NO:28)和 NPB29-7r (SEQ ID NO :29)</span>Authorized and accepted by Authority. The deposit was completed on November ___, 2002 at the American Type Culture Collection at 1 08 0 1 University Boulevard, Manassas, Virginia 201 10-2209. Its AT C C login number is ________. All restrictions on public access to this plastid will be irretrievably removed after this patent application is granted. The deposit shall be kept in the public depository for a period of 30 years after the deposit date or for a period of 5 years after the last sample application or the period of patent enforcement, whichever is longer. If the depository cannot dispense live samples, the deposit must be renewed. This S. lividans transformant identified in mutation 25 (Bow | daughter NPB29-mut25f (SEQ ID NO: 58) and NPB29-mut25r (SEQ ID NO. · 59)) was identified It was found to produce products with different HPLC elution times than epothilone B or epothilone F. This unknown sample was analyzed by LC-MS and found to have a molecular weight (M.W.) of 5 to 23, consistent with the monohydroxylation of epothilone B. Plastid DNA was isolated from this Streptomyces lividans culture and used as a template in PCR amplification using primers NPB29-6f (SEQ ID NO: 28) and NPB29-7r (SEQ ID NO: 29) (see Example 17). The expected fragments were taken and sequenced using the Big-Dye sequencing system. This ebh25-1 mutant was found to have two mutations that caused a change in the amino acid sequence of the protein, asparagine 195 became serine and serine 294 became proline. The position of the mutation directed to the codon 2 38 was (18) (18) 200418849. It was found that there was a 2 nucleotide change which did not cause a change in the amino acid sequence of the protein. The amino acid sequence of the mutant polypeptide encoded by SEQ ID NO ·· 30 is shown in SEQ ID NO: 31. SEQ ID NO: 32 nucleic acid sequence encodes mutant ebh 10-53, which exhibits improved biotransformation yields. The Streptomyces lividans transformants identified in the screening of mutation 10 (primer NPB29-mutl0f (SEQ ID NO: 54) and NPB29-mutl0r (SEQ ID NO: 5 5)) were found to produce larger Epothilone F yield. Plastid DNA was isolated from this Streptomyces lividans culture and used as a template in PCR amplification using primers NPB29-6f (SEQ ID NO: 28) and NPB29-7r (SEQ ID NO: 29) (see Examples 16). The expected fragments were taken and sequenced using the Big-Dye sequencing system. This ebhlO-53 mutant was found to have two mutations that caused a change in the amino acid sequence of the protein, the amino acid 23 1 was changed to arginine and the phenylalanine 190 was changed to tyrosine. Position 23 1 is the target of mutation generation, and the change at residue 190 is an unexpected change of the artificial product of the mutation generation program. The amino acid sequence possessed by the mutant polypeptide encoded by SEQ ID NO: 32 is shown in SEQ ID NO: 33. The nucleic acid sequence of SEQ ID NO: 34 encodes a mutant ebh24-16, which also exhibits improved biotransformation yields. The Streptomyces lividans transformant, ebh24-16, identified in the screening of mutation 24 (primer NPB 29-mut24f (SEQ ID N0.56) and NPB29_mut24r (SEQ ID NO: 57)) can also produce relatively Large epothilone F yield. Plastid DNA was isolated from this Streptomyces lividans culture and used as a model in PCR amplification using primers NPB29-6f (SEQ ID NO: 28) and NPB29-7r (SEQ ID NO: 29) (19) ( 19) 200418849 board. The expected fragments were taken and sequenced using the Big-Dye sequencing system. The ebh24-16 mutant was found to have two mutations that caused a change in the amino acid sequence of the protein, phenylalanine 23 7 changed to alanine and isoleucine 92 changed to valine. Position 2 3 7 is the target of mutation generation, and the change at residue 92 is an unexpected change of the artificial product of the mutation generation program. The amino acid sequence of the mutant polypeptide encoded by SEQ ID NO: 34 is shown in SEQ ID NO: 35. The nucleic acid sequence of SEQ ID NO: 60 encodes mutants ebh24-16d8, which also exhibits improved biotransformation yields. This S. rimosus transformant, ebh24-16d8, identified in the screening of mutation 59 (primer NPB 29-mut59 (SEQ ID NO: 77)) can also produce larger epothilones Yield F. Plastid DNA was isolated from this Streptomyces riftum culture and used as a template in PCR amplification using primers NPB29-6f (SEQ ID NO: 2 8) and NPB29-7r (SEQ ID NO: 29). The expected fragment was sequenced using the Big-Dye sequencing system. The ebh24-16d8 mutant was found to have a mutation that caused one of the changes in the amino acid sequence of the protein, and the spermine 6 7 was changed to amidamine. The artificial product of a mutation generating program. The amino acid sequence of the mutant polypeptide encoded by SEQ ID NO: 60 is shown in SEQ ID NO: 61. The nucleic acid sequence of SEQ ID NO: 62 encodes the mutant ebh24- 16cl 1, which also exhibits improved biotransformation yield. This Streptomyces fissionus transformant, ebh24-16cll, identified in the screening of mutation 59 (primer NPB29 · mut59 (SEQ ID NO: 77)), can also be Produces a larger yield of epothilone F. Plastid DNA is isolated from this Streptomyces spp. Culture and used (20) (20) 200418 849 daughters NPB29-6f (SEQ ID NO: 28) and NPB29-7r (SEQ ID NO: 29) were used as templates in PCR amplification. The expected fragments were obtained and sequenced using the B i §- D Υ e sequencing system The ebh24_16cl 1 mutant was found to have two mutations that cause changes in the amino acid sequence of the protein, 'alanine 9 3 becomes glycine and isoleucine 305 becomes threonine. Position 93 is the target of mutation generation, and The change of 3 6 5 is an artificial product of a mutation generating program. The amino acid sequence of the mutant polypeptide encoded by SEQ ID NO: 6 2 is shown in SEQ ID NO: 63. SEQ ID NO: The 64 nucleic acid sequence encodes a mutant ebh24-16-16 'which also exhibits improved biotransformation yields. This Streptomyces spp. Transformant, identified in the screening of ebh24_16 random mutants, ebh24-16-16, Larger epothilone F yields can also be produced. Plastid DNA is isolated from this Streptomyces spp. Culture and primers NPB29-6f (SEQ ID NO: 28) and NPB29-7r (SEQ ID NO: 29) as template in PCR amplification. The expected fragments were obtained and sequenced using the Big-Dye sequencing system. The ebh24-16-16 Variant has been found to cause changes in the protein amino acid sequence of one of the additional mutations, valine, alanine 1〇6 becomes. The amino acid sequence of the mutant polypeptide encoded by SEQ ID NO: 64 is shown in SEQ ID NO: 65. SEQ ID NO: 34 nucleic acid sequence encodes mutant ebh24-16, which also exhibits improved biotransformation yields. This mutant of Streptomyces lividans, ebh2 4-16, identified in the screening of mutation 24 (primers NPB29-mut24f (SEQ ID NO: 56) and NPB29-mut24r (SEQ ID NO: 57)), can also be Produces greater epothilone F yield. From this culture of Streptomyces lividans -26- (21) (21) 200418849, plastid DNA was isolated and used in primers NPB29-6f (SEQ ID NO: 28) and NPB29-7r (SEQ ID NO: 29). Used as template in PCR amplification. The expected fragments were taken and sequenced using the Big-Dye sequencing system. The ebh24-16 mutant was found to have two mutations that caused a change in the amino acid sequence of the protein, phenylalanine 2 3 7 was changed to alanine and isoleucine 92 was changed to valine. Position 23 7 is the target of mutation generation, and the change at residue 92 is an unexpected change in the artificial product of the mutation generation program. The amino acid sequence of the mutant polypeptide encoded by SEQ ID NO: 34 is shown in SEQ ID NO: 35. The nucleic acid sequence of SEQ ID NO: 60 encodes mutants ebh24-16d8, which also exhibits improved biotransformation yields. This S. rimosns transformant, ebh24-16d8, identified in the screening of mutation 59 (primer NPB 29-mut59 (SEQ ID NO: 77)) can also produce larger epothilone Yield F. Plastid DNA was isolated from this Streptomyces riftum culture and used as a template in PCR amplification using primers NPB29-6f (SEQ ID NO: 28) and NPB29-7r (SEQ ID NO: 29). The expected results were obtained. The fragment was sequenced using the Big-Dye sequencing system. The ebh24-16d8 mutant was found to have a mutation that caused one of the changes in the amino acid sequence of the protein, and the spermine 6 7 was changed to amidamine. This change was a The artificial product of the mutation generation program. The amino acid sequence of the mutant polypeptide encoded by SEQ ID NO: 60 is shown in SEQ ID NO: 61. SEQ ID NO: 62 nucleic acid sequence encodes mutant ebh24 -16cl 1, which also exhibits improved biotransformation yields. This Streptomyces fissureus (22) 200418849 transformant identified in the screening of mutation 59 (primer NPB29-mut59 (SEQ ID NO. · 77)), ebh24-16cl 1 can also produce a larger yield of epothilone F. Plastid DNA was isolated from this Streptomyces spp. culture and used in Primers sub NPB29-6f (SEQ ID NO: 28) and NPB29-7r (SEQ ID NO: 29)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">的PCR擴增中作爲模板。取得預期的片段並使用Big-Dye 定序系統予以定序。該ebh24-16cl 1突變體經發現具有導 致蛋白質胺基酸序列的改變之兩處突變，丙胺酸93變成 甘胺酸且異白胺酸3 65變成蘇胺酸。位置93爲突變生成 標的，而在3 6 5的改變爲一種突變生成程序的人爲產物。 SEQ ID NO:62所編碼的突變體多肽所具胺基酸序列經顯 示於SEQ ID NO:63之中。 SEQ ID NO :66核酸序列編碼突變體ebh24- 1 6-74，其</span>Used as template in PCR amplification. Obtain the expected fragments and sequence them using the Big-Dye sequencing system. This ebh24-16cl1 mutant was found to have two mutations that caused changes in the amino acid sequence of the protein, alanine 93 became glycine and isoleucine 3 65 became threonine. Position 93 is the target of mutation generation, and the change at 3 6 5 is an artifact of a mutation generation program. The amino acid sequence possessed by the mutant polypeptide encoded by SEQ ID NO: 62 is shown in SEQ ID NO: 63. SEQ ID NO: 66 nucleic acid sequence encoding mutant ebh24- 1 6-74, which</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">也展現出改良的生物轉化產率。於ebh24-16隨機突變體 的篩選中所鑑別出的此龜裂鏈黴菌轉形體，ebh24-16-74，也可產生較大的埃坡黴素F產率。從該龜裂鏈黴菌培 養物分離出質體DNA並於使用引子NPB29-6f (SEQ ID NO:28)和 NPB29-7r (SEQ ID NO:29)的 PCR 擴增中作爲模 板。取得預期的片段並使用Big-Dye定序系統予以定序。 該ebh24- 1 6-74突變體經發現具有導致蛋白質胺基酸序列 的改變之一額外突變，精胺酸 88變成組胺酸。SEQ ID NO: 66所編碼的突變體多肽所具胺基酸序列經顯示於SEQ ID NO : 67 之中。 SEQ ID NO:68核酸序列編碼突變體ebh24-Ml8，其 也展現出改良的生物轉化產率。於ebh隨機突變的篩選中 所鑑別出的此龜裂鏈黴菌轉形體，ebh24-M18，也可產生 -28- (23) 200418849</span>It also exhibits improved biotransformation yields. This Streptomyces spp.transformer, ebh24-16-74, identified in the screening of ebh24-16 random mutants can also produce large epothilone F yields. Plastid DNA was isolated from this Streptomyces riftum culture and used as a template for PCR amplification using primers NPB29-6f (SEQ ID NO: 28) and NPB29-7r (SEQ ID NO: 29). The expected fragments were taken and sequenced using the Big-Dye sequencing system. The ebh24-1 6-74 mutant was found to have one additional mutation that resulted in a change in the amino acid sequence of the protein, and arginine 88 became histidine. The amino acid sequence of the mutant polypeptide encoded by SEQ ID NO: 66 is shown in SEQ ID NO: 67. The nucleic acid sequence of SEQ ID NO: 68 encodes mutant ebh24-M18, which also exhibits improved biotransformation yields. The ebh24-M18 transformant identified in the screening of ebh random mutations can also produce -28- (23) 200418849</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">較大的埃坡黴素F產率。從該龜裂鏈黴菌培養物分離出質 體 DNA並於使用引子 NPB29-6f (SEQ ID NO:28)和 NPB29-7r (SEQ ID NO:29)的PCR擴增中作爲模板。取得 預期的片段並使用Big-Dye定序系統予以定序。該ebh24-M 1 8突變體經發現具有導致蛋白質胺基酸序列的改變之兩 處突變，榖胺酸3 1變成離胺酸及甲硫胺酸1 76變成纈胺 酸。SEQ ID NO: 68所編碼的突變體多肽所具胺基酸序列 經顯示於SEQ ID NO: 69之中。</span>Larger epothilone F yield. Plastid DNA was isolated from this Streptomyces riftum culture and used as a template in PCR amplification using primers NPB29-6f (SEQ ID NO: 28) and NPB29-7r (SEQ ID NO: 29). The expected fragments were taken and sequenced using the Big-Dye sequencing system. The ebh24-M 1 8 mutant was found to have two mutations that caused a change in the amino acid sequence of the protein, the amino acid 31 was changed to lysine and the methionine 1 76 was changed to valine. The amino acid sequence of the mutant polypeptide encoded by SEQ ID NO: 68 is shown in SEQ ID NO: 69.</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">SEQ ID NO:72核酸序列編碼突變體ebh24-16g8，其 也展現出改良的生物轉化產率。於突變 50(引子NPB29-mut50(SEQ ID NO:78)的篩選中所鑑別出的此龜裂鏈黴菌 轉形體，ebh24-16g8，也可產生較大的埃坡黴素F產率。 從該龜裂鏈黴菌培養物分離出質體DNA並於使用引子 NPB29-6f (SEQ ID NO:28)和 ΝΡΒ29-7Γ (SEQ ID NO:29)的 PCR擴增中作爲模板。取得預期的片段並使用Big-Dye定 序系統予以定序。該ebh24-16g8突變體經發現具有導致 蛋白質胺基酸序列的改變之兩處額外突變，甲硫胺酸1 7 6 變成丙胺酸及異白胺酸1 3 0變成蘇胺酸。位置1 76爲突變 生成標的，而在1 3 0的改變爲一種突變生成程序的人爲產 物。SEQ ID NO: 72所編碼的突變體多肽所具胺基酸序列 經顯示於SEQ ID NO: 73之中。 SEQ ID NO:74核酸序列編碼突變體ebh24-16b9，其 也展現出改良的生物轉化產率。於突變50(引子NPB 29-mut50(SEQ ID ΝΟ·.78)的篩選中所鑑別出的此龜裂鏈黴菌 -29- (24) (24)200418849 轉形體，ebh24-16b9，也可產生較大的埃坡黴素ρ產率。 從該龜裂鏈黴菌培養物分離出質體DNA並於使用引子 NPB29-6f (SEQ ID NO:28)和 NPB29-7r (SEQ ID NO:29)的 PCR擴增中作爲模板。取得預期的片段並使用Big-Dye定 序系統予以定序。該ebh24-1 6b9突變體經發現具有導致 蛋白質胺基酸序列的改變之兩處額外突變，甲硫胺酸1 7 6 變成絲胺酸及丙胺酸1 40變成蘇胺酸。位置1 76爲突變生 成標的，而在140的改變爲一種突變生成程序的人爲產 物。SEQ ID NO·· 74所編碼的突變體多肽所具胺基酸序列 經顯示於SEQ ID NO·· 75之中。 此等9個突變體基因所用質體PANT849ebh24-16、 pANT849ebh24- 1 0-5 3 、 p ANT849ebh24-1 6d8 、 pANT849ebh24-16cll 、 p AN T 8 4 9 e b h 2 4 -1 6 - 1 6 、 p AN T849ebh24 - 16-74 、 p AN T 8 4 9 e b h 2 4 - 1 6b9 、 p ANT849ebh24-Ml 8、和 p ANT849ebh24 -16g8 業經在布達 佩斯公約的條款之下爲 The International Depository Authority所寄存且接受。該寄存係在2002年1 1月_—日 在 1 0 8 0 1 University Boulevard, Manassas， Virginia 20110-2209 的 the American Type Culture Collection 完成 的。其A T C C登錄號碼爲________。對於此質體的公開取 得之所有限制都將在此專利申請獲准之後即不可挽回地消 除。該寄存物要保存於該公開寄存所一段於寄存日期之後 3 0年之期間或自最後一次申請樣品之後5年的期間或專 利可執行期限，視何者較長而定。若寄存所不能配發活的 -30- (25) (25)200418849 樣品，則該寄存物要更新。 如此’根據本發明另一方面提出經離析的埃坡黴素B 經化酶多肽和其變異體與突變體及經離析的鐵氧化還原蛋 白多肽或其變異體。於本發明一具體實例中，，，多肽，，意欲 包括SEQ ID NO:2胺基酸序列，和其片段或變異體，其保 留住基本上與此埃坡黴素B羥化酶相同的生物活性及/或 功能。於本發明另一具體實例中，，，多肽，，意欲包括SEQ ID NO:4胺基酸序列，和其片段及/或變異體，其保留住基 本上與此鐵氧化還原蛋白相同的生物活性及/或功能。 “變異體”，如本發明所用者，意欲包括其胺基酸序列 相對於SEQ ID NO :2或4而言，具有保守性胺基酸取代且 其經證實展現出類似於SEQ ID NO:2或4的生物學活性或 功能之多肽。”保守性胺基酸取代”意欲包括脂族胺基酸例 如 Ala、Val、Leu與lie之間，羥基殘基Ser與Thr之 間，酸性殘基Asp與Glu之間，及醯胺殘基Asn與Gin 之間彼此的置換。範例本發明變異體胺基酸序列爲SEQ ID Ν Ο : 4 3 - 4 9之中所示者且此等範例變異體的胺基酸取代 皆載於上文的表2之中。 “突變體”一詞如本文中所用者意欲包括爲相對於SEQ ID NO : 1或3而言具有一或更多個點突變，或核酸的刪除 或添加之核酸序列所編碼’但仍具有類似於該SEQ ID Ν Ο : 1或3所編碼的多肽所具活性之多肽。於一較佳具體 實例中，對核酸所作的突變爲可變更由其所編碼的多肽之 受質特異性及/或產率者。針對埃坡黴素B羥化酶基因的 -31 - (26) 200418849 較佳突變區爲編碼包括該酵素所具活性部位的大約113個 胺基酸殘基之核酸序列區。此外，也爲較佳者爲在SEQ ID ΝΟ:1的下列胺基酸位置處有至少一胺基酸取代之突變 體：GLU31 ， ARG67 ， ARG88 ， ILE92 ， ALA93 ， VAL106 ， ILE130 ， ALA140 ， MET 176 ， PHE190 ， GLU23 1，SER2 94，PHE2 3 7，或 ILE3 65。範例突變體爲 ebh25- 1 、 ebhl0-53 、 ebh24-16 &amp;gt; ebh24-16d8 、 ebh24-</span>The nucleic acid sequence of SEQ ID NO: 72 encodes mutants ebh24-16g8, which also exhibits improved biotransformation yields. This Streptomyces spp.transformer, ebh24-16g8, identified in the screening of mutation 50 (primer NPB29-mut50 (SEQ ID NO: 78)) can also produce a larger yield of epothilone F. From this The plastid DNA was isolated from the Streptomyces riftum culture and used as a template in PCR amplification using primers NPB29-6f (SEQ ID NO: 28) and NPB29-7Γ (SEQ ID NO: 29). The expected fragment was obtained and used Sequenced by the Big-Dye sequencing system. The ebh24-16g8 mutant was found to have two additional mutations that caused changes in the amino acid sequence of the protein, methionine 1 7 6 to alanine and isoleucine 1 3 0 becomes threonine. Position 1 76 is the target of mutation generation, and the change at 1 3 0 is the artificial product of a mutation generation program. The amino acid sequence of the mutant polypeptide encoded by SEQ ID NO: 72 is shown In SEQ ID NO: 73. The nucleic acid sequence of SEQ ID NO: 74 encodes mutants ebh24-16b9, which also exhibits improved biotransformation yield. In mutation 50 (primer NPB 29-mut50 (SEQ ID NO. · 78 The Streptomyces fissures 29- (24) (24) 200418849 identified in the screening of), also produced ebh24-16b9. Large epothilone p production. Plastid DNA was isolated from this Streptomyces riftum culture and used for PCR with primers NPB29-6f (SEQ ID NO: 28) and NPB29-7r (SEQ ID NO: 29) Amplified as a template. The expected fragments were obtained and sequenced using the Big-Dye sequencing system. The ebh24-1 6b9 mutant was found to have two additional mutations that caused changes in the amino acid sequence of the protein, methionine 1 7 6 becomes serine and alanine 1 40 becomes threonine. Position 1 76 is the target of mutation generation, while change at 140 is an artificial product of the mutation generation program. The mutation encoded by SEQ ID NO. 74 The amino acid sequence of the somatic polypeptide is shown in SEQ ID NO ·· 75. The plastids PANT849ebh24-16, pANT849ebh24- 1 0-5 3, p ANT849ebh24-1 6d8, pANT849ebh24- used in these 9 mutant genes are shown. 16cll, p AN T 8 4 9 ebh 2 4 -1 6-1 6, p AN T849ebh24-16-74, p AN T 8 4 9 ebh 2 4-1 6b9, p ANT849ebh24-Ml 8, and p ANT849ebh24 -16g8 It has been deposited and accepted by The International Depository Authority under the terms of the Budapest Convention. The deposit was completed on January 1st, 2002 at the American Type Culture Collection at University Boulevard, Manassas, Virginia 20110-2209. Its A T C C login number is ________. All restrictions on public access to this plastid will be irretrievably removed after this patent application is granted. The deposit shall be kept in the public depository for a period of 30 years after the deposit date or for a period of 5 years after the last sample application or the period of patent enforcement, whichever is longer. If the depository cannot dispense live -30- (25) (25) 200418849 samples, the deposit must be renewed. Thus, according to another aspect of the present invention, an isolated epothilone B melanase polypeptide and its variants and mutants, and an isolated ferredoxin polypeptide or its variant are proposed. In a specific embodiment of the present invention, the polypeptide is intended to include the amino acid sequence of SEQ ID NO: 2 and a fragment or variant thereof that retains organisms that are substantially the same as this epothilone B hydroxylase Activity and / or function. In another embodiment of the present invention, the polypeptide is intended to include the amino acid sequence of SEQ ID NO: 4, and a fragment and / or variant thereof that retain substantially the same biological activity as this iron redox protein And / or features. A "variant", as used in the present invention, is intended to include its amino acid sequence with conservative amino acid substitutions relative to SEQ ID NO: 2 or 4, and it has been shown to exhibit similarity to SEQ ID NO: 2 Or 4 biologically active or functional polypeptide. "Conservative amino acid substitution" is intended to include aliphatic amino acids such as between Ala, Val, Leu and lie, between hydroxyl residues Ser and Thr, between acidic residues Asp and Glu, and amidine residues Asn Permutation with Gin. Exemplary amino acid sequences of the variants of the present invention are shown in SEQ ID NO: 4 3-4 9 and the amino acid substitutions of these exemplary variants are listed in Table 2 above. The term "mutant" as used herein is intended to include a nucleic acid sequence encoded by one or more point mutations, or deletions or additions of a nucleic acid, but still similar, as compared to SEQ ID NO: 1 or 3 A polypeptide having activity in the polypeptide encoded by SEQ ID NO: 1 or 3. In a preferred embodiment, a mutation in a nucleic acid is one that alters the specificity and / or yield of the polypeptide encoded by it. The -31-(26) 200418849 preferred mutation region for the epothilone B hydroxylase gene is a nucleic acid sequence region encoding approximately 113 amino acid residues including the active site of the enzyme. In addition, a mutant having at least one amino acid substitution at the following amino acid positions of SEQ ID NO: 1 is also preferred: GLU31, ARG67, ARG88, ILE92, ALA93, VAL106, ILE130, ALA140, MET 176 , PHE190, GLU23 1, SER2 94, PHE2 3 7, or ILE3 65. Example mutants are ebh25- 1, ebhl0-53, ebh24-16 &amp;gt; ebh24-16d8, ebh24-</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1 6c 1 1、ebh24-16-16、ebh24- 1 6- 74、ebh24-16g8、ebh24-1 6b 9和且編碼本發明此等突變體的核酸序列分別示於 SEQ ID NO:31、33、35、61、63、65、67、69、71、73 和 75，及 SEQ ID NO:30、32、34、60、62、64、66、 68、70、72 和 74 之中。 此夕f，也根據 Greer et al.(Comparative modeling of homologous proteins. Methods in Enzymology 20223 9-52， 19 9 1)，Lesk et al.(Homology Modeling: Inferences</span>1 6c 1 1, ebh24-16-16, ebh24- 1 6- 74, ebh24-16g8, ebh24-1 6b 9 and the nucleic acid sequences encoding these mutants of the invention are shown in SEQ ID NOs: 31, 33, 35, 61, 63, 65, 67, 69, 71, 73, and 75, and SEQ ID NOs: 30, 32, 34, 60, 62, 64, 66, 68, 70, 72, and 74. Now, f, also according to Greer et al. (Comparative modeling of homologous proteins. Methods in Enzymology 20223 9-52, 19 9 1), Lesk et al. (Homology Modeling: Inferences</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">from Tables of Aligned Sequences. Curr. Op. Struc. Biol. (2) 2 4 2-247, 1 992)，和 Cardozo et al. (Homology modeling by the ICM method. Proteins 23, 4 0 3 - 1 4, 1 99 5 ) 等的一般敘述於已知的同源蛋白質EryF (PDB Code 1 KIN 鏈A)所具構造之基礎上構造出埃坡黴素B羥化酶的立體 模型。此等序列之間的同質率爲3 4%。圖3繪示出埃坡黴 素B羥化酶序列（SEQ ID NO:2)與EryF序列（PDB Code 1KIN鏈 A ; SEQ ID NO:76)的排比。圖4繪示出根據與 EryF的序列排比所得埃坡黴素B羥化酶的同質模型。 -32- (27) (27)200418849 此外也製備出相對於EryF (PDB Code 1KIN)的埃坡徽 素B羥化酶之能量標繪圖且示於圖5之中。使用在一所給 殘基位置的5 1個殘基之平均窗尺寸來計算以該所給殘基 爲中心位置的序列中所含該5 1個殘基的能量平均値。如 圖5中所示者，沿著序列的所有能量都低於0，因而顯不 如圖4和附錄1所揭示的模型構造係合理者。 在圖4埃坡黴素B羥化酶同質模型中所表的立體構造 係由在附錄1中所列出的一組構造座標所界定者。”構造 座標”一術語指的是從該同質模型的構建中產生的笛卡爾 座標（Cartesian coordinates)。不過，如諸於此技者所了解 者，對於一蛋白質的一組構造座標爲界定在三次元內的形 狀之一相對點組。因此，一完全不同的座標組可能界定一 類似或相同的形狀。再者，個別座標的輕微變異，如在產 生同質模型中使用不同的排比模板及/或使用不同的方法 產生類似的同質模型所發生者，對於整體形狀都會有小幅 影響。座標的變異也會因爲構造座標的數學演算而產生。 例如，附錄1中所列出的構造座標可經由構造座標的分數 化（fractionalization)來演算；對構造座標組的整數的加或 減，構造座標的反演（inversion)或上述的任何組合。 所以需要各種計算分析來決定一分子或其部份相對於 上文所述埃坡黴素B羥化酶的全部或部份足夠相似到可視 爲相同之程度。此等分析都可以在現行的軟體應用中進 行，例如 SYBYL 第 6.7 版或 INSIGHTII(Molecular Simulations Inc., San Diego，CA)第 2000 版以及如在所附 (28) (28)200418849 的使用者指引中所述者。 舉例而言，在程式SYBYL中的重疊工具可用來在不 同的構造之間及在相同構造的不同構象（conformation)之 間進行比較。於S YB YL中比較構造所用的程序係分爲四 個步驟：1 )裝載所要比較的構造；2)在此等構造中界定 原子等價（equivalency) ; 3)實施擬合運算；及4)分析 結果。每一構造都由一名稱所鑑別。一構造經鑑別爲標的 (亦即，固定構造）；第二構造（亦即，移動構造）經鑑別爲 # 來源構造。由於SYBYL內的原子等價係由使用者輸入所 界定，爲了本發明此方面的目的，乃將等價原子定義爲對 於要比較的兩種構造之間的所有保守性殘基所含的蛋白質 骨架原子（N、C a、C和0)。另外，只有考慮剛性擬合運 算。於使用剛性擬合方法之時，將所操作的構造平移和旋 轉以得到與標的構造之最佳擬合。該擬合運算係使用可計 算出要施用於移動構造的最佳平移和旋轉之算法，使得對 所指定的等價原子對所得擬合値之均方根差値爲一絕對最 I 低値。此値隨即由SYBYL以埃（Α)爲單位報告出。 爲本發明目的而言，任何埃坡黴素B羥化酶同質模型 在重疊於附錄1中所列構造座標所述的對應骨架原子時， 其保守性殘基骨架原子（N、C a、C、0)所具均方根差値 小於約4.0 Α者皆視爲是相同者。更佳者，該均方根差値 爲小於約3.0 A者。更佳者，該均方根差値爲小於約2.0 A者。 爲本發明目的而言，任何埃坡黴素B羥化酶同質模型 -34- (29) (29)200418849 在重疊於附錄1中所列構造座標所述的對應骨架原子時， 其保守性殘基骨架原子（N、C a、C、〇)所具均方根差値 小於約2.0 Α者皆視爲是相同者。更佳者，該均方根差値 爲小於約1. ο A者。 於本發明另一具體實例中，其骨架原子經其他元素所 取代的構造模型在重疊於對應骨架原子時，具有低均方根 差値者皆視爲是相同者。例如，其原來的骨架碳，及/或 氮及/或氧原子經用其他元素所取代之同質模型在重疊於 附錄1中所列構造座標所述的對應骨架原子時，具有約 4 · 0 A、更佳者約3.0 A，甚至更佳者約2 A的均方根差値 者即視爲是相同者。 “均方根差値”一詞意指相對於平均値的偏差値之平方 的算術平均値之方根。其爲表達對一趨勢或一目標的偏差 或變異之方式。爲本發明目的，“均方根差値，，係界定一蛋 白質骨架相對於如本文所述構造座標所界定的複合物所含 埃坡黴素B羥化酶部份所具骨架中的相關部份之變異。 如同質模型所體現的本發明可促成埃坡黴素B羥化酶 額外突變體的以構造爲基底之設計。例如，使用本發明的 同質模型，目前已經可以界定出落於埃坡黴素B羥化酶所 含結合性部位的 1 〇 A內之殘基 。此等殘基包括 LEU39,  GLN43， AL A45, MET57, LEU58, HIS62, PHE63, SER64,  SER65， ASP66， ARG67, GLN68, SER69, LEU74, MET75,  VAL76, ALA77, ARG78, GLN79, ILE80, ASP84, LYS85,  PR086, PHE87, ARG88, PR089, SER90, LEU91， ILE92, (30) (30)200418849 ALA93, MET94, ASP95, HIS99，ARG103，PHE110，ILE155,   PHE 1 69, GLN 1 70, C YS 1 72, SERI 73, SER174, ARG1 75,  MET 1 76, LEU 1 77, SERI 78， ARG1 79, ARG1 86, PHE190,  LEU1 93, VAL23 3, GLY23 4, LEU23 5, AL A23 6, PHE23 7,  LEU23 8, LEU23 9, LEU240, ILE241 , ALA242, GLY243,  HIS244, GLU24 5, THR246, THR247, AL A248, ASN249,  MET2 5 0, LEU2 8 3, THR2 8 7, ILE2 8 8, ALA2 8 9, GLU290,  THR29 1 , AL A292, THR293, SER294, ARG2 95， PHE296,  AL A297, THR298, GLU3 12, GLY3 1 3, VAL3 14, VAL3 15,  GLY3 16, VAL3 44, ALA3 45, PHE346, GLY3 47, PHE3 48,  VAL3 5 0, HIS35 1， GLN3 5 2, CYS 3 53， LEU3 54, GLY3 5 5,  GLN3 5 6, LEU 3 5 8, ALA3 5 9, GLU3 62, LYS3 8 9, ASP391,  SER3 92， THR3 9 3， ILE394 和 TYR395 ， 如附錄1 中所列出 者。具有在一或更多個此等位置處的突變之突變體預期會 展現出變更的生物學功能及/或特異性且因而構成本發明 較佳突變體的另一具體實例。較佳突變體的另一具體實例 爲相對於該埃坡黴素B羥化酶所具骨架原子具有不大於約 4.0人的均方根差値之分子 〇 埃坡黴素B羥化酶同質模型的構造座標或其部份都貯 存在一機械可讀取的貯存媒體內。此等資料可用於多種目 的，例如藥物發現。 因此，本發明的另一方面係有關包括爲附錄1中所列 構造座標所涵蓋的資料貯存內容之機械可讀取的資料貯存 - 36- (31) (31)200418849 媒體。 埃坡黴素B羥化酶的三次元模型構造也可以用來鑑別 出生物功能調制劑與酵素的潛在受質。有多種方法或其組 合可以用來鑑別出此等調制劑。 例如，可以根據附錄1將一試驗化合物於空間上擬合 到埃坡黴素B羥化酶中的結合部位。由胺基酸LEU3 9, GLN43, ALA45, MET57，LEU58，HIS62，PHE63，SER64, SER65，ASP66，ARG67，GLN68, SER69, LEU74，MET75, VAL76, ALA77，ARG78，GLN79，ILE80，ASP84，LYS85, PR086，PHE87, ARG88，PR089，SER90，LEU91，ILE92, ALA93, MET94，ASP95，HIS99，ARG103，PHE110，ILE155, PHE 1 69, GLN170, C YS 1 72, SERI 73, SER174， ARG1 75,  MET 1 76, LEU1 77, SERI 78, ARG1 79, ARG1 86, PHE 190,  LEU 1 93， VAL2 3 3, GLY23 4, LEU23 5, AL A23 6, PHE23 7,  LEU23 8, LEU23 9, LEU240, ILE241， ALA242， GLY243,  HIS244, GLU24 5, THR246, THR247, AL A24 8, ASN249,  MET2 5 0, LEU2 8 3, THR2 8 7, ILE2 8 8, AL A28 9, GLU290,  THR29 1 5 AL A292, THR293, SER294, ARG29 5, PHE296,  AL A297, THR2 9 8, GLU3 12, GLY3 1 3, VAL3 14, VAL3 1 5,  GL Y3 1 6, VAL3 44, ALA3 4 5, PHE3 46, GLY3 47, PHE3 4 8,  V AL3 5 0, HIS3 5 1， GLN3 5 2, CYS 3 5 3, LEU3 5 4， GLY 3 5 5,  GLN3 5 6, LEU3 5 8, ALA3 5 9, GLU3 62, LYS 3 8 9, ASP391，  SER3 92, THR3 93, ILE394 和 TYR3 9 5所界定的落於埃坡黴 素B羥化酶結合部位1 0 A內的胺基酸，與配位血基質 -37 - (32) (32)200418849 基，HEM 1，所具構造座標也可以用來鑑別出此等調制劑 的合意構造特色和化學特點。經鑑別出的構造特色和化學 特點即可用來設計或選出作爲潛在的埃坡黴素B羥化酶配 體之化合物。”構造特色和化學特點”意欲包括，但不限 於，共價鍵結，凡得瓦爾交互作用，氫鍵交互作用，電荷 交互作用，疏水性鍵結交互作用，和偶極交互作用。然後 可以合成經鑑別爲埃坡黴素B羥化酶配體的化合物並以具 有將一試驗化合物結合到埃坡黴素B羥化酶的特徵之檢 定，或以鑑定出埃坡黴素B羥化酶在小分子存在中調制一 蛋白酶標的物的能力之檢定中進行篩選。有關可用於潛在 埃坡黴素B羥化酶配體的篩選中之檢定，其例子包括，但 不限於，電腦化篩選（screening in silico)，試管內（in v i t r ο )篩選和高處理量檢定。 如諳於此技者在閱讀本揭示內容所了解者，也可以使 用其他的以構造爲基底的設計方法。於技藝中已有揭示出 多種計算型以構造爲基底的設計方法。例如，可以取得許 多種電腦模型化系統，於其中可以輸入埃坡黴素B羥化酶 序列和埃坡黴素B羥化酶構造（亦即，如附錄〗所提供的 埃坡黴素B羥化酶之原子座標及/或如上文所提供的或於 結合區的1 〇 A內之原子座標）。然後此電腦系統可產生一 潛在埃坡黴素B羥化酶調制劑可結合的一或更多個此等區 所具構造細部使得可以據此定出該潛在調制劑的互補構造 細部。此等模型化系統內的設計通常係以能夠與埃坡黴素 B經化酶物理地和構造上地締合隻化合物爲基礎者。此 -38 - (33) (33)200418849 外’該化合物必須能夠擬出一種可以使其與埃坡黴素B羥 化酶締合之構象。此等模型化系統可在實際合成與檢驗之 前估計一潛在埃坡黴素B羥化酶受質或調制劑所具潛在抑 制效應或結合效應。 針對彼等與一所給蛋白質標的物締合的能力來篩選化 學體或片段所用的方法也是熟知者。此等方法時常是從經 由在電腦螢幕上目視檢查出結合部未開始的。然後將所選 出的片段或化學體配置在埃坡黴素B羥化酶的結合區內。 使用軟體例如 INSIGHTII，QUANTA和 SYBYL，完成停 靠（docking)，接著使用標準分子機械力場例如MMFF， CHARMM和AMBER施以能量最小化與分子動力學。對於 可用於本發明中的化學片段或化學體之選擇有幫助的電腦 程式之例子包括，但不限於，GRID(Goodford, 1 9 8 5 )， AUTODOCK (Goodsell，1 990)，和 DOCK (Kuntz et al.， 1 9 82)° 於選出較佳的化學體或片段之後，可以目視檢查彼等 之間與對埃坡黴素B羥化酶的關係，然後組裝成單一的潛 在調制劑。組裝個別化學體所用的程式包括，但不限於， CAVEAT (Bartlett et al., 1 989)和 3D Database 系統 (Martin 1 992)° 另外，可以使用空的活性部位或視需要包括一已知抑 制劑的某些部份重新（de novo)設計化合物。此種類型的設 計方法包括，但不限於，LUDI (Bohm 1 992)和 LeapFrog (Tripos Inc., St. Louis M0) 〇 -39- (34) 200418849 可以使用諸如DOCK (Kuntz et al.，1 982)之程式於來 自同質模型的原子座標從資料庫或虛擬資料庫鑑別出潛在 配體’該配體可潛在地結合活性部位結合區因而可爲合成 和檢驗所用的適當候選物。 本發明也提出包括本發明聚核苷酸的載體及經使用本 發明載體遺傳處理過的宿主細胞以製造埃坡黴素B羥化酶 或此酵素的活性片段和變異體或突變體及/或鐵氧化還原 蛋白或其活性片段。通常，適合於維持、傳遞或表現聚核 苷酸以在宿主細胞產生此等多肽的任何載體都可用於此方 面的表現。根據本發明此方面，該載體可爲，例如，一種 質體載體、一種單股或雙股噬菌體載體，或單股或雙股 RNA或DNA病毒載體。載體可爲染色體外者或經設計以 整合到宿主染色體之內者。此等載體包括，但不限於，染 色體型、基因附體型和病毒衍生型等載體，例如衍生自下 列之載體··細菌質體、噬菌體、酵母菌基因附體、酵母菌 染色體要素、和病毒例如桿狀病毒、乳多空病毒、 SV4〇、牛痘苗病毒、腺病毒、禽痘病毒、僞狂犬病病毒 和反轉錄病毒，及衍生自彼等的組合之病毒，例如衍生自 質體和噬菌體遺傳要素，粘接質體（cosm id)和噬菌質體 (phagemids)者。 可用於原核生物宿主的表現載體包括，但不限於，細 菌質體，例如來自大腸桿菌（E. coli)、桿菌屬（Bacillus)或 鏈黴菌屬者，包括 pBluescript、pGEX-2T、pUC載體、 PET 載體、ColEl，pCRl、pBR3 22、pMB9、pCW、 (35) (35)200418849</span>from Tables of Aligned Sequences. Curr. Op. Struc. Biol. (2) 2 4 2-247, 1 992), and Cardozo et al. (Homology modeling by the ICM method. Proteins 23, 4 0 3-1 4, 1 99 5) and the like are generally described on the basis of the structure of the known homologous protein EryF (PDB Code 1 KIN chain A) to construct a three-dimensional model of epothilone B hydroxylase. The homogeneity between these sequences is 34%. FIG. 3 shows an alignment of an epothilone B hydroxylase sequence (SEQ ID NO: 2) and an EryF sequence (PDB Code 1KIN chain A; SEQ ID NO: 76). Figure 4 depicts a homogeneous model of epothilone B hydroxylase obtained from sequence alignment with EryF. -32- (27) (27) 200418849 In addition, an energy plot of epothilin B hydroxylase relative to EryF (PDB Code 1KIN) was also prepared and shown in FIG. 5. The average window size of 51 residues at a given residue position is used to calculate the average energy 値 of the 51 residues in a sequence centered at the given residue. As shown in Figure 5, all the energies along the sequence are lower than 0, so it is obvious that the model construction shown in Figure 4 and Appendix 1 is reasonable. The three-dimensional structure shown in Fig. 4 epothilone B hydroxylase homogeneity model is defined by a set of structural coordinates listed in Appendix 1. The term "structural coordinates" refers to Cartesian coordinates derived from the construction of the homogeneous model. However, as known to those skilled in the art, a set of structural coordinates for a protein is a set of relative points of a shape defined within a three-dimensional shape. Therefore, a completely different set of coordinates may define a similar or identical shape. Furthermore, slight variations in individual coordinates, such as those using different alignment templates and / or different methods to generate similar homogeneous models in the generation of homogeneous models, will have a small impact on the overall shape. Variations in coordinates are also caused by mathematical calculations that construct the coordinates. For example, the structural coordinates listed in Appendix 1 may be calculated via fractionalization of the structural coordinates; addition or subtraction of integers from the structural coordinate group, inversion of the structural coordinates, or any combination thereof. Therefore, various computational analyses are required to determine whether a molecule or a part thereof is sufficiently similar to all or a part of the epothilone B hydroxylase described above to be regarded as the same degree. These analyses can be performed in existing software applications, such as SYBYL version 6.7 or INSIGHTII (Molecular Simulations Inc., San Diego, CA) version 2000 and user guides as attached (28) (28) 200418849 As described. For example, the overlap tool in the program SYBYL can be used to compare between different configurations and between different conformations of the same configuration. The procedure for comparing structures in S YB YL is divided into four steps: 1) loading the structures to be compared; 2) defining atomic equivalence in these structures; 3) performing a fitting operation; and 4) Analyze the results. Each construct is identified by a name. One structure was identified as the target (i.e., a fixed structure); the second structure (i.e., a mobile structure) was identified as the #source structure. Since the atomic equivalence in SYBYL is defined by user input, for the purposes of this aspect of the invention, equivalent atoms are defined as the protein backbone contained in all conservative residues between the two constructs to be compared Atoms (N, Ca, C, and 0). In addition, only rigid fit calculations are considered. When using the rigid fitting method, the operated structure is translated and rotated to obtain the best fit with the target structure. This fitting operation uses an algorithm that can calculate the best translation and rotation to be applied to the moving structure, so that the root mean square difference 値 of the fitted 对 for the specified equivalent atom pair is an absolute minimum 値. This case was reported by SYBYL in units of Angstrom (Α). For the purposes of the present invention, when any homogenous model of epothilone B hydroxylase overlaps with the corresponding backbone atom described in the structural coordinates listed in Appendix 1, its conservative residue backbone atom (N, C a, C , 0) Those with a root mean square difference 値 less than about 4.0 A are considered to be the same. More preferably, the root mean square difference 値 is less than about 3.0 A. More preferably, the root mean square difference is less than about 2.0 A. For the purposes of the present invention, any epothilone B hydroxylase homogeneous model-34- (29) (29) 200418849 overlaps with the corresponding backbone atom described in the structural coordinates listed in Appendix 1, its conservative residues The base skeleton atoms (N, C a, C, 〇) have root mean square differences 値 less than about 2.0 A are considered to be the same. More preferably, the root mean square difference 値 is less than about 1. ο A. In another specific example of the present invention, when the structural model in which the skeleton atom is replaced by other elements overlaps with the corresponding skeleton atom, those having a low root mean square difference are considered to be the same. For example, the homogeneous model of its original skeleton carbon and / or nitrogen and / or oxygen atoms replaced with other elements has approximately 4.0 A when overlapping with the corresponding skeleton atoms described in the structural coordinates listed in Appendix 1. The better is about 3.0 A, and even the better is about 2 A. The root mean square difference is considered to be the same. The term "root-mean-square difference" means the square root of the arithmetic mean 平方 of the square of the deviation 値 from the mean 値. It is a way of expressing deviations or variations from a trend or a goal. For the purpose of the present invention, "root mean square difference" refers to the definition of the relevant part of a protein backbone relative to the backbone of the epothilone B hydroxylase moiety contained in the complex defined by the structural coordinates described herein. The present invention, as embodied in the qualitative model, can contribute to the structure-based design of additional mutants of epothilone B hydroxylase. For example, using the homogeneous model of the present invention, it is now possible to define the Residues within 10 A of the binding site contained in the teomycin B hydroxylase. These residues include LEU39, GLN43, AL A45, MET57, LEU58, HIS62, PHE63, SER64, SER65, ASP66, ARG67, GLN68 , SER69, LEU74, MET75, VAL76, ALA77, ARG78, GLN79, ILE80, ASP84, LYS85, PR086, PHE87, ARG88, PR089, SER90, LEU91, ILE92, (30) (30) (30) 200418849 ALA93, MET94, ASP95, HIS99, ARG103, PHE110, ILE155, PHE 1 69, GLN 1 70, C YS 1 72, SERI 73, SER174, ARG1 75, MET 1 76, LEU 1 77, SERI 78, ARG1 79, ARG1 86, PHE190, LEU1 93, VAL23 3, GLY23 4, LEU23 5, AL A23 6, PHE23 7, LEU23 8, LEU23 9, LEU240, ILE241, ALA242, GLY 243, HIS244, GLU24 5, THR246, THR247, AL A248, ASN249, MET2 5 0, LEU2 8 3, THR2 8 7, ILE2 8 8, ALA2 8 9, GLU290, THR29 1, AL A292, THR293, SER294, ARG2 95 , PHE296, AL A297, THR298, GLU3 12, GLY3 1 3, VAL3 14, VAL3 15, GLY3 16, VAL3 44, ALA3 45, PHE346, GLY3 47, PHE3 48, VAL3 5 0, HIS35 1, GLN3 5 2, CYS 3 53, LEU3 54, GLY3 5 5, GLN3 5 6, LEU 3 5 8, ALA3 5 9, GLU3 62, LYS3 8 9, ASP391, SER3 92, THR3 9 3, ILE394 and TYR395, as listed in Appendix 1 By. Mutants with mutations at one or more of these positions are expected to exhibit altered biological function and / or specificity and thus constitute another specific example of a preferred mutant of the invention. Another specific example of a preferred mutant is a molecule having a root mean square difference of not more than about 4.0 humans relative to the backbone atom of the epothilone B hydroxylase. The epothilone B hydroxylase homogeneous model The structural coordinates or parts thereof are stored in a mechanically readable storage medium. This information can be used for a variety of purposes, such as drug discovery. Therefore, another aspect of the present invention is related to the mechanically readable data storage including the data storage content covered by the structural coordinates listed in Appendix 1-36- (31) (31) 200418849 media. The three-dimensional model construction of epothilone B hydroxylase can also be used to identify potential receptors for biological function modulators and enzymes. There are several methods or combinations thereof that can be used to identify such modulators. For example, a test compound can be spatially fitted to the binding site in epothilone B hydroxylase according to Appendix 1. By amino acids LEU3 9, GLN43, ALA45, MET57, LEU58, HIS62, PHE63, SER64, SER65, ASP66, ARG67, GLN68, SER69, LEU74, MET75, VAL76, ALA77, ARG78, GLN79, ILE80, ASP84, LYS85, PR086 , PHE87, ARG88, PR089, SER90, LEU91, ILE92, ALA93, MET94, ASP95, HIS99, ARG103, PHE110, ILE155, PHE 1 69, GLN170, C YS 1 72, SERI 73, SER174, ARG1 75, MET 1 76, LEU1 77, SERI 78, ARG1 79, ARG1 86, PHE 190, LEU 1 93, VAL2 3 3, GLY23 4, LEU23 5, AL A23 6, PHE23 7, LEU23 8, LEU23 9, LEU240, ILE241, ALA242, GLY243, HIS244, GLU24 5, THR246, THR247, AL A24 8, ASN249, MET2 5 0, LEU2 8 3, THR2 8 7, ILE2 8 8, AL A28 9, GLU290, THR29 1 5 AL A292, THR293, SER294, ARG29 5, PHE296, AL A297, THR2 9 8, GLU3 12, GLY3 1 3, VAL3 14, VAL3 1 5, GL Y3 1 6, VAL3 44, ALA3 4 5, PHE3 46, GLY3 47, PHE3 4 8, V AL3 5 0, HIS3 5 1, GLN3 5 2, CYS 3 5 3, LEU3 5 4, GLY 3 5 5, GLN3 5 6, LEU3 5 8, ALA3 5 9, GLU3 62, LYS 3 8 9, ASP391, SER3 92, THR3 93, Epothilone B as defined by ILE394 and TYR 3 9 5 The amino acid in the enzyme binding site 10 A and the coordination blood matrix -37-(32) (32) 200418849 group, HEM 1, the structural coordinates can also be used to identify the desired structure of these modulators Characteristics and chemical characteristics. The identified structural and chemical characteristics can then be used to design or select compounds that are potential epothilone B hydroxylase ligands. "Tectonic and chemical characteristics" are intended to include, but are not limited to, covalent bonds, Van der Waals interactions, hydrogen bonding interactions, charge interactions, hydrophobic bonding interactions, and dipolar interactions. Compounds identified as epothilone B hydroxylase ligands can then be synthesized and tested with characteristics that bind a test compound to epothilone B hydroxylase, or to identify epothilone B hydroxylase Enzymes are screened for assays for their ability to modulate a protease target in the presence of small molecules. Examples of assays that can be used in the screening of potential epothilone B hydroxylase ligands include, but are not limited to, screening in silico, in vitr screening, and high throughput assays . If those skilled in the art understand this reading, they can also use other design methods based on structure. A variety of computational design methods based on structure have been disclosed in the art. For example, many computer modeling systems are available in which epothilone B hydroxylase sequences and epothilone B hydroxylase constructs (ie, epothilone B hydroxylase as provided in the Appendix) can be entered. The atomic coordinates of the enzyme and / or the atomic coordinates as provided above or within 10 A of the binding region). The computer system can then generate a structural detail of one or more of these areas that a potential epothilone B hydroxylase modulator can bind to so that the complementary structural details of the potential modulator can be determined accordingly. The design within these modeled systems is usually based on compounds capable of physically and structurally associating with epothilone B chemical enzymes. In addition to this -38-(33) (33) 200418849, the compound must be able to work out a conformation that allows it to associate with epothilone B hydroxylase. These modeled systems can estimate the potential inhibitory or binding effects of a potential epothilone B hydroxylase substrate or modulator before actual synthesis and testing. Methods for screening chemicals or fragments for their ability to associate with a given protein target are also well known. These methods often start without visually checking the joints on a computer screen. The selected fragment or chemical is then placed in the binding region of epothilone B hydroxylase. Docking is done using software such as INSIGHTII, QUANTA and SYBYL, followed by energy minimization and molecular dynamics using standard molecular mechanical force fields such as MMFF, CHARMM and AMBER. Examples of computer programs that are useful in the selection of chemical fragments or chemical bodies that can be used in the present invention include, but are not limited to, GRID (Goodford, 1 9 8 5), AUTODOCK (Goodsell, 1 990), and DOCK (Kuntz et al., 1 9 82) ° After selecting the better chemistries or fragments, they can be visually checked for their relationship with epothilone B hydroxylase and then assembled into a single potential modulator. Programs used to assemble individual chemicals include, but are not limited to, CAVEAT (Bartlett et al., 1 989) and 3D Database system (Martin 1 992) ° In addition, empty active sites can be used or a known inhibitor can be included as needed Some parts of the compound are de novo designed. Design methods of this type include, but are not limited to, LUDI (Bohm 1 992) and LeapFrog (Tripos Inc., St. Louis M0) 〇-39- (34) 200418849. For example, DOCK (Kuntz et al., 1 982) can be used. The formula) identifies potential ligands from a database or virtual database using atomic coordinates from a homogeneous model. 'This ligand can potentially bind the active site binding region and thus can be a suitable candidate for synthesis and testing. The invention also proposes a vector comprising a polynucleotide of the invention and a host cell genetically treated using the vector of the invention to produce epothilone B hydroxylase or an active fragment and variant or mutant of this enzyme and / or Ferredoxin or its active fragment. Generally, any vector suitable for maintaining, delivering, or expressing a polynucleotide to produce such polypeptides in a host cell can be used for such expression. According to this aspect of the invention, the vector may be, for example, a plastid vector, a single-stranded or double-stranded phage vector, or a single-stranded or double-stranded RNA or DNA virus vector. Vectors can be extrachromosomal or designed to integrate into the host chromosome. These vectors include, but are not limited to, chromosome, epigenetic, and virus-derived vectors, such as those derived from the following: • Bacterial plastids, bacteriophages, yeast gene appendages, yeast chromosomal elements, and viruses such as Baculovirus, Papillomavirus, SV40, Vaccinia Virus, Adenovirus, Fowlpox Virus, Pseudorabies Virus and Retroviruses, and Viruses Derived from Their Combinations, such as Plastid and Phage Genetic Elements , Those who adhere to the cosm id and phagemids. Expression vectors useful in prokaryotic hosts include, but are not limited to, bacterial plastids, such as those from E. coli, Bacillus, or Streptomyces, including pBluescript, pGEX-2T, pUC vectors, PET Vector, ColEl, pCRl, pBR3 22, pMB9, pCW, (35) (35) 200418849</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Pbms200、pBMS2020、PI J1 01、PIJ702、p ANT849、 pOJ260、p〇 J446、pSET 152、pKCl 139、pKC 1 2 1 8、 pFD666和彼等的衍生物，較廣宿主範圍載體，例如 RP4 ’噬菌體 DNAs例如噬菌體λ的許多衍生物如 ΝΜ9 8 9、λ GT10和；I GT1 1，及其他噬菌體的衍生物例如 Μ 1 3和絲狀單股唑菌體DNΑ。 用於酵母菌的本發明載體典型地含有一適合用於酵母 菌的複製源與一可在酵母菌體內作用之選擇性標誌物。可 用於本發明中的酵母載體之例子包括，但不限於，酵母菌 整合質體（Yeast Integrating plasmids)(如 ΥΙρ5)和酵母菌 複製質體（YRp和γΕρ系列質體）酵母菌著絲粒質體（YCp 系列質體），以酵母菌線型質體，表爲YLp、pGPD-2、2 // 等質體和其衍生物爲基底的酵母菌人造染色體（Y AC s)，以 及改良的往返載體例如在 Gietz et al.，Gene，74:5 27-3 4( 1 9 8 8 )之中所述者（YlpUc、YEplac 和 YCplac)。 可用於重組表現的哺乳動物載體可包括病毒來源，例 如SV40源（用於可表現大型T-抗原的細胞系例如COS 1和 C 0 S 7細胞中進行複製），乳頭狀瘤病毒源，或EB V源用 於長期的基因附體複製（用於，例如293 -EBNA細胞中， 其可組成地表現EBV EBNA-1基因產物和腺病毒E1A)。 在哺乳動物體內的表現可經由使用下列來達到：多種質 體，包括，但不限於，pSV2、pBC12BI、和 p 9 1 023 ; Pcdna載體以及裂解病毒載體（例如牛痘苗病毒、腺病毒、 和桿狀病毒），基因附體病毒載體（例如牛乳頭狀瘤病 -41 - (36) (36)200418849 毒）’和反轉錄病毒（例如鼠反轉錄病毒）。可用於昆蟲細 胞的載體包括桿狀病毒載體和pvL941。 1合當啓動基因的選擇以導引mRNA轉錄與表現載體的 構成係熟知者。不過，一般而言，表現構成物包含有轉錄 起始和終止所用部位，及，在經轉錄區內的一用於轉譯的 核H體結合部位。由等構成物所表現出的成熟轉錄本所含 密碼部份包括著經恰當地配置在要轉譯的多肽末端之開始 和終止密碼子處之轉譯起始密碼子。 可用於原核生物的啓動基因之例子包括，但不限於， 噬菌體pL啓動基因，trc啓動基因，從trp和lac啓動基 因衍生的雜交物，噬菌體T7啓動基因，TAC或TRC系 統’噬菌體λ的主要操縱基因和啓動基因區，fd被膜蛋 白質的控制區，snpA啓動基因，melC啓動基因，ermE* 啓動基因或araB AD操縱子。可用於酵母菌的啓動基因之 例子包括，但不限於，CYC1啓動基因、GAL1啓動基 因、GAL10啓動基因、ADH1啓動基因、酵母菌α -交配 系統的啓動基因，與GPD啓動基因。可例常地用於哺乳 動物表現載體中的啓動基因之例子包括，但不限於，CMV 儘早期啓動基因、HSV胸線核苷激酶、早期和晚期SV40 啓動基因、反轉錄LTRs啓動基因，例如羅氏肉瘤病毒 (R S V)、和金屬硫新質啓動基因’例如小鼠金屬硫新質-1 啓動基因。 包括聚核苷酸的載體可以使用任何數目的熟知技術包 括感染、轉導、轉染、轉載（transvection)和轉形，予以導 (37) (37)200418849 引到宿主細胞之內。聚核苷酸可以單獨地，或與附加的編 碼，例如，選擇性標誌物或鐵氧化還原蛋白等之聚核苷酸 一起導到宿主體內。於本發明一較佳具體實例中，係將埃 坡黴素B羥化酶和鐵氧化還原蛋白的聚核苷酸都導引到宿 主細胞之內。各種表現構成物所用的宿主細胞都是熟知 者，且諳於此技者都可以根據本發明此方面例常地選擇表 現埃坡黴素B羥化酶及/或鐵氧化還原蛋白所用的宿主細 胞。可用於本發明的哺乳動物表現系統之例子包括，但不 限於，C 127、3T3、CHO、HeLa、人類腎 293 和 BHK 細 胞系，及猴子腎成纖維細胞的COS-7細胞系。 另外，如本文例舉者，埃坡黴素B羥化酶和鐵氧化還 原蛋白都可在微生物體內重組地表現。 因此，本發明另一方面係有關重組地產生之微生物， 該微生物可以單獨地表現埃坡黴素B羥化酶或與鐵氧化還 原蛋白一起且該微生物能夠將一具有末端烷基的化合物， 特別是埃坡黴素，羥基化而製成具有末端羥基烷基者。經 重組產生的微生物矽經由使用包括編碼埃坡黴素B羥化酶 的核酸序列之質體轉形一細胞例如細菌細胞而產生者。於 一較佳具體實例中，該等細胞係使用包括編碼埃坡黴素B ®化酶的核酸序列或其突變體或變異體以及座落在該埃坡 黴素B羥化酶基因下游處的編碼鐵氧化還原蛋白的核酸序 列之質體予以轉形。可以使用此等質體予以轉形以產生本 發明重組微生物的微生物之例子包括，但不限於，大腸桿 菌、巨大芽孢桿菌（Bacillus megaterium)、東方鏈黴菌、 -43- (38) (38)200418849 纖維堆囊菌（S o r a n g i u m c e 11 u 1 o s u m)、紅平紅球菌 (Rhodococcus erythropolis)、和鏈黴菌種例如變鉛青鏈黴 菌、維吉尼鏈黴菌（Streptomyces virginiae)、委內瑞拉鏈 黴菌（Streptomyces venezuelae)、白 色鏈黴菌 (Streptomyces a 1 b u s )、天藍色鏈黴菌（S t r e p t o m y c e s coelicolor)、龜裂鏈黴菌和灰色鏈黴菌（Streptomyces g r i s e u s ) o 本發明重組產生的微生物可用於微生物程序或方法中 用以生產具有末端羥基烷基的化合物，且特別是埃坡黴素 類。通常，可以經由在浸没好氣條件下，於含有可同化性 碳和氮源的水性營養培養基之內，於適當受質存在中，培 養能夠選擇性地羥基化末端碳或烷基的重組產生微生物或 其所衍生的酵素而產生載有羥基烷基的產物。 作爲本發明方法的受質所用的適當埃坡黴素可爲能夠 接受本發明酵素性羥基化的任何具有末端碳或烷基之此等 化合物。起始物，或受質，可以從天然來源，例如纖維堆 囊菌，離析出，或者彼等也可以爲經合成形成的埃坡黴素 類。能夠接受酵素性羥基化的任何具有末端碳或烷基之其 他受質也可爲本發明方法所用。例如，可以使用壓實素 (compactin)作爲受質，其在羥基化之後會形成化合物普伐 他丁（pravastatin)。將壓實素透過馬度拉放線菌 (Actinomadura)菌株予以羥基化成爲普伐他丁所用方法經 載於美國專利5,942,423和美國專利6,274,360之中。 例如，使用本發明重組微生物時，可以製備至少一種 -44 - (39) (39)200418849 埃坡黴素，如在 1999年12月 21日提出申請的 WO 00/39276、美國專利序號〇9M68,854中所述者，其內容以 其全文倂於本文。可以制備成具有下面式I的埃坡黴素 Η Ο - C Η 2 - ( A 1) η - ( Q ) m - ( A 2 ) 〇 - E (I) 其中</span>Pbms200, pBMS2020, PI J1 01, PIJ702, p ANT849, pOJ260, p0J446, pSET 152, pKCl 139, pKC 1 2 1 8, pFD666 and their derivatives, broader host range vectors, such as RP4 'phage DNAs For example, many derivatives of phage lambda such as NM9 89, lambda GT10, and I GT1 1, and other phage derivatives such as M 1 3 and filamentous monozole DNA. The vectors of the invention for yeast typically contain a source of replication suitable for use with yeast and a selectable marker that can function in yeast. Examples of yeast vectors that can be used in the present invention include, but are not limited to, Yeast Integrating plasmids (such as ΥΙρ5) and yeast replicating plastids (YRp and γΕρ series plastids) yeast centromere (YCp series plastids), yeast-type plastids, yeast artificial chromosomes (Y AC s) based on YLp, pGPD-2, 2 // plastids and their derivatives, and improved round trips Vectors are described, for example, in Gietz et al., Gene, 74: 5 27-3 4 (19 8 8) (YlpUc, YEplac, and YCplac). Mammalian vectors that can be used for recombinant expression can include viral sources, such as SV40 sources (for replication in cell lines expressing large T-antigens such as COS 1 and C 0 S 7 cells), papilloma virus sources, or EB The V source is used for long-term gene epithelial replication (used in, for example, 293-EBNA cells, which can constitutively express the EBV EBNA-1 gene product and adenovirus E1A). Performance in mammals can be achieved by using a variety of plastids, including, but not limited to, pSV2, pBC12BI, and p 9 1 023; Pcdna vectors and lytic virus vectors such as vaccinia virus, adenovirus, and rod Viruses), genetic epithelial viral vectors (such as bovine papilloma disease-41-(36) (36) 200418849), and retroviruses (such as murine retrovirus). Vectors useful for insect cells include baculovirus vectors and pvL941. 1 The selection of genes that are suitable for initiating mRNA transcription and expression vectors is well known. However, in general, the expression construct includes a site for transcription initiation and termination, and a nuclear H-body binding site for translation in the transcribed region. The codons contained in mature transcripts expressed by isoforms include translation initiation codons appropriately placed at the start and stop codons of the end of the polypeptide to be translated. Examples of promoters that can be used in prokaryotes include, but are not limited to, phage pL promoter, trc promoter, hybrids derived from trp and lac promoters, phage T7 promoter, TAC or TRC system's main manipulation of phage lambda Gene and promoter region, fd envelope protein control region, snpA promoter, melC promoter, ermE * promoter or araB AD operon. Examples of the promoter genes that can be used in yeast include, but are not limited to, a CYC1 promoter gene, a GAL1 promoter gene, a GAL10 promoter gene, an ADH1 promoter gene, a yeast alpha-mating system promoter gene, and a GPD promoter gene. Examples of promoters that can be routinely used in mammalian expression vectors include, but are not limited to, CMV early promoter, HSV chest ribokinase, early and late SV40 promoter, reverse transcription LTRs promoter, such as Roche A sarcoma virus (RSV), and a new metal sulfur starter gene, such as the mouse metal sulfur new starter gene. Polynucleotide-containing vectors can be introduced into host cells using any number of well-known techniques including infection, transduction, transfection, transvection, and transformation (37) (37) 200418849. The polynucleotide may be introduced into the host alone, or with additional coding, e.g., a selectable marker or a ferredoxin or the like. In a preferred embodiment of the present invention, the polynucleotides of epothilone B hydroxylase and ferredoxin are introduced into host cells. The host cells used for various expression constructs are well known, and those skilled in the art can routinely select host cells used for expressing epothilone B hydroxylase and / or ferredoxin according to this aspect of the present invention. . Examples of mammalian expression systems that can be used in the present invention include, but are not limited to, C 127, 3T3, CHO, HeLa, human kidney 293 and BHK cell lines, and COS-7 cell line of monkey kidney fibroblasts. In addition, as exemplified herein, both epothilone B hydroxylase and ferredoxin can be recombinantly expressed in microorganisms. Therefore, another aspect of the present invention relates to a recombinantly produced microorganism that can express epothilone B hydroxylase alone or together with ferredoxin and that the microorganism is capable of converting a compound having a terminal alkyl group, particularly It is epothilone, which is hydroxylated and made into a terminal hydroxyalkyl group. The recombinantly produced microbial silicon is produced by transforming a cell such as a bacterial cell using a plastid including a nucleic acid sequence encoding an epothilone B hydroxylase. In a preferred embodiment, the cell lines use a nucleic acid sequence comprising an epothilone B ® ase or a mutant or variant thereof, and a cell line located downstream of the epothilone B hydroxylase gene. The plastids of the nucleic acid sequence encoding the ferredoxin are transformed. Examples of microorganisms that can be transformed using these plastids to produce the recombinant microorganism of the present invention include, but are not limited to, E. coli, Bacillus megaterium, Streptomyces orientalis, -43- (38) (38) 200418849 Sorangiumce 11 u 1 osum, Rhodococcus erythropolis, and streptomyces species such as Streptomyces lividans, Streptomyces virginiae, Streptomyces venezuelae , Streptomyces a 1 bus, Streptomyces coelicolor, Streptomyces griseus and Streptomyces griseus o The recombinantly produced microorganisms of the present invention can be used in microbial programs or methods to produce Compounds with terminal hydroxyalkyl groups, and especially epothilones. Generally, a recombinantly-produced microorganism or a microorganism capable of selectively hydroxylating a terminal carbon or an alkyl group can be cultured in an aqueous nutrient medium containing assimilable carbon and nitrogen sources in the presence of an appropriate substrate under submerged aerobic conditions, or The enzymes derived from it produce hydroxyalkyl-loaded products. Suitable epothilones used as substrates in the method of the present invention may be any of these compounds having a terminal carbon or alkyl group capable of accepting the enzymatic hydroxylation of the present invention. The starting materials, or substrates, can be isolated from natural sources, such as P. cellulosae, or they can be synthetically formed epothilones. Any other substrate capable of accepting enzymatic hydroxylation with a terminal carbon or alkyl group can also be used in the method of the present invention. For example, compactin can be used as a substrate, which after hydroxylation will form the compound pravastatin. The method used to hydroxylate compactin through Actinomadura strain to pravastatin is described in U.S. Patent 5,942,423 and U.S. Patent 6,274,360. For example, when using the recombinant microorganism of the present invention, at least one -44-(39) (39) 200418849 epothilone can be prepared, such as WO 00/39276, US Patent No. 09M68, filed on December 21, 1999, The content of 854 is contained in its entirety. Epothilone can be prepared with the following formula I Ο Ο-C Η 2-(A 1) η-(Q) m-(A 2) 〇-E (I) where</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ai和A2爲獨立地選自包括下列的群組中：視需要經 取代的Ci-Cs-烷基和烯基； Q爲視需要經取代的環系統，其包括1到3個環與在 至少一個環中的至少一個碳對碳雙鍵； η，m和〇爲選自包括下列的群組中之整數：〇和1， 此處m或η或〇中至少有一者爲1;且 Ε爲一埃坡黴素核。 此方法包括將至少一種具有下面式II的埃坡黴素 CH3-(A1)n-(Q)m-(A2)〇-E (II) 其中Ai，Q，A2，E，n，m和〇皆爲上面所定義者； 與一種能夠選擇性地催化該式II的羥基化之經重組 方式產生的微生物，或其所衍生的酵素接觸，及促成該羥 基化。 於一較佳具體實例中，起始物爲埃坡黴素B。埃坡黴 素B可以得自纖維堆囊菌So ce90的發酵，如在DE 41 38 (40) (40)200418849 042和WO 93/10121中所述者。該菌株經寄存在Deutsche Sammlung von M i k r ο o r g a n i s m e n (German Collection of Microorganisms) (DSM)編號爲 6773。發酵方法也載於 Hofle，G ., e t a 1., Ang e w . Chem. Int. Ed. Engl., Vo 1. 35, No. 13/14，1 5 6 7- 1 5 69 ( 1 996)之中。埃坡黴素B也可以使 用化學方法獲得，例如下列所揭示者：Meng，D. et al.，J. Am. Chem. Soc.，Vol. 119, No. 42，1 0073 - 1 0092 ( 1 996)；</span>Ai and A2 are independently selected from the group consisting of: optionally substituted Ci-Cs-alkyl and alkenyl; Q is a optionally substituted ring system comprising 1 to 3 rings and at least At least one carbon-to-carbon double bond in a ring; η, m and 0 are integers selected from the group consisting of: 0 and 1, where at least one of m or η or 〇 is 1; and E is An epothilone nucleus. This method includes combining at least one epothilone CH3- (A1) n- (Q) m- (A2) 0-E (II) having the following formula II: Ai, Q, A2, E, n, m and All are as defined above; contact with a recombinantly produced microorganism capable of selectively catalyzing the hydroxylation of Formula II, or an enzyme derived therefrom, and promote the hydroxylation. In a preferred embodiment, the starting material is epothilone B. Epothilone B can be obtained from the fermentation of Fibriocystis soce90, as described in DE 41 38 (40) (40) 200418849 042 and WO 93/10121. The strain was deposited with the Deutsche Sammlung von M i k r ο r g a n i s meen (German Collection of Microorganisms) (DSM) number 6773. The fermentation method is also described in Hofle, G., eta 1., Ang ew. Chem. Int. Ed. Engl., Vo 1. 35, No. 13/14, 1 5 6 7- 1 5 69 (1 996) in. Epothilone B can also be obtained using chemical methods such as those disclosed by Meng, D. et al., J. Am. Chem. Soc., Vol. 119, No. 42, 1 0073-1 0092 (1 996);</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Nicolaou, K. e t a 1., J. Am. Chem. Soc.，Vol. 119，No. 34, 7974-7991 (1997)和 Schinzer，D.，et al.，Chem. Eur. J.，</span>Nicolaou, K. e t a 1., J. Am. Chem. Soc., Vol. 119, No. 34, 7974-7991 (1997) and Schinzer, D., et al., Chem. Eur. J.,</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Vol. 5，No. 9，2483 -249 1 ( 1 999)。 經選用於本方法中的重組產生微生物之生長可由諳於 此技者使用恰當的營養培養基來達到。重組產生微生物生 長所用的恰當培養基包括提供微生物細胞生長所需的營養 者。參看，例如，T. Nagodawithana and J. Μ. Wasileski， Chapter 2: “Media Design for Industrial Fermentation，’’ Nutritional Requirements of Commercially Important Microorganism， edited by T. W. Nagodawithana and G. Reed, Esteekay Associates， Inc., Milwaukee, W1, 18-45 ( 1 998) ； T.l. Miller and B. W. Churchill, Chapter 10:’’Substrates for Large-Scale Fermentations，’’ Manual of Industrial Microbiology and Biotechnology, edited by A. 1. Demain and N. A. Solomon, American Society for</span>Vol. 5, No. 9, 2483 -249 1 (1 999). The growth of recombinantly produced microorganisms selected for use in this method can be achieved by those skilled in the art using appropriate nutrient media. Appropriate media for recombinantly producing microbial growth include those that provide the nutrients needed for microbial cell growth. See, for example, T. Nagodawithana and J. M. Wasileski, Chapter 2: "Media Design for Industrial Fermentation," Nutritional Requirements of Commercially Important Microorganism, edited by TW Nagodawithana and G. Reed, Esteekay Associates, Inc., Milwaukee, W1, 18-45 (1 998); Tl Miller and BW Churchill, Chapter 10: `` Substrates for Large-Scale Fermentations, '' Manual of Industrial Microbiology and Biotechnology, edited by A. 1. Demain and NA Solomon, American Society for</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Microbiology，Washington，D.C.，1 22- 1 3 6 ( 1 9 8 6)。一典型 的生長培養基包括所需的碳源、氮源、和微量元素。也可 -46- (41) 200418849 以在培養基內添加誘導劑。”誘導劑，，一詞於本文中係包括 可在重組產生的細胞內增進合意的酵素活性的形成之任何 化合物。本發明所用的典型誘導劑可包括溶解受質所用的 溶劑，例如二甲亞硕、二甲基甲醯胺、二氧雜環己烷、乙 醇和丙酮。另外，某些受質，例如，埃坡黴素B也可以視 爲是誘導劑。</span>Microbiology, Washington, D.C., 1 22-1 36 (1 9 8 6). A typical growth medium includes the required carbon source, nitrogen source, and trace elements. You can also add -46- (41) 200418849 to the inducer in the medium. "Inducer," as used herein, includes any compound that enhances the formation of a desired enzyme activity in recombinantly produced cells. Typical inducers used in the present invention may include solvents used to dissolve substrates, such as dimethylamine Sodium, dimethylformamide, dioxane, ethanol, and acetone. In addition, certain substrates, such as epothilone B, can also be considered as inducers.</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">碳源可包括糖類例如葡萄糖、果糖、半乳糖、麥芽 糖、蔗糖、甘露糖、山梨糖、甘油、澱粉和類似者；有機 酸例如乙酸鈉、棒檬酸鈉、和類似者；及醇類例如乙醇、 丙醇和類似者。較佳的碳源包括，但不限於、葡萄糖、果 糖、蔗糖、甘油和澱粉。 氮源可包括N-Z胺A、玉米浸液、大豆粉、牛肉萃取 物、胰蛋白腺（tryptone)、胃蛋白腺（peptone)、棉子粉、 花生粉、胺基酸例如榖胺酸鈉和類似者，檸檬酸鈉、硫酸 銨和類似者。</span>Carbon sources may include sugars such as glucose, fructose, galactose, maltose, sucrose, mannose, sorbose, glycerol, starch, and the like; organic acids such as sodium acetate, sodium limonate, and the like; and alcohols such as ethanol , Propanol and the like. Preferred carbon sources include, but are not limited to, glucose, fructose, sucrose, glycerol, and starch. Nitrogen sources may include NZ amine A, corn infusion, soy flour, beef extract, tryptone, peptone, cottonseed flour, peanut flour, amino acids such as sodium glutamate, and the like Among them, sodium citrate, ammonium sulfate and the like.</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">微量元素可包括鎂、錳、鈣、鈷、鎳、鐵、鈉和鉀等 鹽。也可以將磷酸鹽以微量，或較佳者大於微量之量添 加。 發酵所用的培養基可包括一種以上的碳源或氮源或其 他元素。 要根據本發明方法進行重組產生微生物的生長及/或 經基化之時，培養基的pH値較佳者爲約5到約8且其溫 度遲約1 4 °C到約3 7。(：，較佳者該溫度爲2 8 °C。反應持續 m 期間爲1到1 〇〇小時，較佳者8到72小時。 -47- (42) 200418849 培養基要溫置一段依高性能液體層析術（HP LC)監測 而判斷生物轉換完全所需的時間。典型地，完成生物轉換 所需的期間爲添加受質之後1 2到〗00小時且較佳者爲約 72小時。培養基係經放置在一旋轉搖動器（New Brunswick Scientific Innova 5000)之上，以 150 到 300 rpm 且較佳者 約2 5 0 rpm，及2吋的搖動程距操作。 載有羥基烷基的產物可從發酵液體培養基以通常用來 回收其他已知生物活性物質的習用手段予以回收。此等回 收手段的例子包括，但不限於，使用習用的溶劑萃取； pH調整；使用習用的樹脂處理，例如使用陰離子或陽離 子交換樹脂或非離子吸附樹脂處理；使用習用，例如，吸 附劑處理；蒸餾；結晶；或再結晶；和類似者進行分離與 純化。 上述從生物轉換反應混合物得到的萃取物可經由管柱 層析術和分析型薄層層析術予以進一步分離和純化。 本發明重組產生微生物將一具有末端烷基的埃坡黴素 生物轉換成一具有末端羥基烷基的埃坡黴素之能力係經證 貫者。於此等實驗中，係將如實施例1 1中更詳細說明的 包括含有具ebh基因的質體之變鉛青鏈黴菌殖株的培養物 與埃坡黴素B懸浮液在3 0°C下攪拌溫置3天。使用等體 積的25%甲醇：75%正丁醇萃取溫置液，迴轉並使其沉著 5分鐘。將200微升的有機相轉移到一 HpLC管瓶並以 HPLC/MS分析之（實施例12)。於15·9分鐘的溶析時間溶 S7T 析出一埃坡黴素F產物峰，其具有524之質子化分子量。 -48- (43) (43)200418849 埃坡黴素B受質係在19.0分鐘溶析出且具有5〇8之質子 化分子量。譜峰滯留時間和分子量都經使用已知的標準品 予以確定。 可表現ebh的細胞所得埃坡黴素B生物轉換率也相對 於ebh突變株的生物轉換率進行比較。可表現ebh的細胞 包括變鉛青鏈黴菌（pANT849-ebh)的冷凍孢子製備物。可 表現突變體的細胞包括變鉛青鏈黴菌（PANT84 9-ebh 10-5 3) 和變鉛青鏈黴菌（pANT849-ebh24_16)的冷凍孢子製備物。 使用變鉛青鏈黴菌TK24的冷凍孢子製備物作爲對照樣。 將各細胞置於3 0°C下預溫置7天。於此預溫置期之後， 於每一培養物中添加埃坡黴素B/100 % EtOH到〇.〇5 %重 量/體積之最後濃度。除了變鉛青鏈黴菌（pANT8 49-ebh24-16)培養物（其中埃坡黴素B已在48小時之際即完全轉化 爲埃坡黴素F)之外，在〇，24，48和72小時採取樣品。 以HPLC分析諸樣品。將結果計算爲相對於在0時的埃坡 黴素B之百分比。 -49- (44) 200418849 埃坡黴素B : 時 間 (時） TK24 p ANT 8 4 9-eb h p ANT849-ebh 1 0-53 p ANT 849-ebh24- 16  0 1 0 0 % 1 0 0 % 1 0 0 % 1 0 0 %  24 9 9% 7 8% 6 9% 5 6%  48 8 7% 19% 3 9% 0%  72 8 7% 0% 3%   埃坡黴素F :  時 TK24 p ANT 84 9- pANT849-ebhl 0- p ANT849-ebh24-  間  eb h 53 16  (時）      0 0% 0% 0% 0%  24 0% 4% 9% 23%  48 0% 2 1% 2 9% 5 2%  72 0% 14% 41% ___ 此外’也探討可表現ebh的細胞將壓實素生物轉換爲 普伐他丁的能力。於此等實驗中，將變鉛青鏈黴菌 (pANT 8 4 9)或變鉛青鏈黴菌（p ant 8 4 9-ebh)的冷凍孢子製 備物在3 0 °C下生長7天。於預溫置期之後，將一液份的 每一細胞培養液轉移到聚丙烯培養管之內，於每一培養管 讓 內加入壓貫素，並將諸管置於30°C下，以250 rpm保溫 - 50- (45) 200418849 24小時。然後萃取一液份的培養物液體並透過HPLC測 量相對於變鉛青鏈黴菌（pANT8 4 9)培養物的壓實素和普伐 他丁之値。 表爲起始壓實素濃度之壓實素和普伐他丁値 變鉛青鏈黴菌 變鉛青鏈黴菌   (p ANT 849) (p ANT8 4 9-ebh)  壓實素 3 6% 1 1 %  普伐他丁 11% 53%</span>Trace elements may include salts such as magnesium, manganese, calcium, cobalt, nickel, iron, sodium and potassium. Phosphate can also be added in a trace amount, or more preferably in a trace amount. The medium used for fermentation may include more than one carbon or nitrogen source or other elements. When the growth and / or basalization of a recombinantly-producing microorganism according to the method of the present invention is carried out, the pH of the culture medium is preferably about 5 to about 8 and the temperature thereof is about 14 ° C to about 37 later. (:, Preferably, the temperature is 2 8 ° C. The duration of the reaction is 1 to 100 hours, preferably 8 to 72 hours. -47- (42) 200418849 The culture medium should be placed at a high temperature for a period of time. Chromatography (HP LC) monitoring to determine the time required for complete biotransformation. Typically, the period required to complete the biotransformation is 12 to 00 hours and preferably about 72 hours after the substrate is added. Media After being placed on a rotary shaker (New Brunswick Scientific Innova 5000), it is operated at 150 to 300 rpm and preferably about 250 rpm, and a 2-inch rocking distance. The hydroxyalkyl-loaded product can be obtained from The fermentation broth is recovered by conventional means commonly used to recover other known biologically active substances. Examples of such recovery means include, but are not limited to, extraction with conventional solvents; pH adjustment; treatment with conventional resins, such as using anions Or cation exchange resin or non-ion adsorption resin treatment; use of conventional, for example, adsorbent treatment; distillation; crystallization; or recrystallization; and the like for separation and purification. The extract obtained from the mixture can be further separated and purified by column chromatography and analytical thin layer chromatography. The recombinant production microorganism of the present invention converts an epothilone having a terminal alkyl group into a terminal hydroxyalkane The ability of epothilone is based on proven. In these experiments, the culture of Streptomyces lividans strains containing plastids containing the ebh gene will be described in more detail as in Example 11. The substance and epothilone B suspension were stirred and warmed at 30 ° C for 3 days. The warmed solution was extracted with an equal volume of 25% methanol: 75% n-butanol, rotated and allowed to settle for 5 minutes. 200 micrometers The liter of organic phase was transferred to a HpLC vial and analyzed by HPLC / MS (Example 12). An S7T was dissolved at a dissolution time of 15.9 minutes to precipitate an epothilone F product peak with a protonation of 524 The molecular weight is -48- (43) (43) 200418849 The epothilone B substrate elutes in 19.0 minutes and has a protonated molecular weight of 50. Both the peak retention time and molecular weight are determined using known standards. The biotransformation rate of epothilone B obtained from cells expressing ebh is similar. The ebh mutant strains were compared for their bioconversion rates. Cells that can express ebh include frozen spore preparations of Streptomyces lividans (pANT849-ebh). Cells that can express mutants include S. lividans (PANT84 9-ebh 10-5 3) and frozen spore preparation of Streptomyces lividans (pANT849-ebh24_16). A frozen spore preparation of Streptomyces lividans TK24 was used as a control. Each cell was pre-warmed at 30 ° C After 7 days of incubation, epothilone B / 100% EtOH was added to each culture to a final concentration of 0.05% weight / volume. Except for cultures of Streptomyces lividans (pANT8 49-ebh24-16), in which epothilone B has been completely converted to epothilone F within 48 hours, at 0, 24, 48, and 72 Take samples in hours. The samples were analyzed by HPLC. The results were calculated as a percentage relative to epothilone B at 0. -49- (44) 200418849 epothilone B: time (hour) TK24 p ANT 8 4 9-eb hp ANT849-ebh 1 0-53 p ANT 849-ebh24- 16 0 1 0 0% 1 0 0% 1 0 0% 1 0 0% 24 9 9% 7 8% 6 9% 5 6% 48 8 7% 19% 3 9% 0% 72 8 7% 0% 3% epothilone F: TK24 p ANT 84 9- pANT849-ebhl 0- p ANT849-ebh24- inter eb h 53 16 (hours) 0 0% 0% 0% 0% 24 0% 4% 9% 23% 48 0% 2 1% 2 9% 5 2% 72 0% 14% 41% ___ In addition, 'the ability of cells expressing ebh to bioconvert compactin to pravastatin was also explored. In these experiments, frozen spore preparations of Streptomyces lividans (pANT 8 4 9) or Streptomyces lividans (pant 8 4 9-ebh) were grown at 30 ° C for 7 days. After the pre-warming period, transfer one aliquot of each cell culture solution to a polypropylene culture tube, add permedin to each culture tube, and place the tubes at 30 ° C. 250 rpm insulation-50- (45) 200418849 24 hours. One aliquot of the culture liquid was then extracted and the compaction and pravastatin relative to the culture of Streptomyces lividans (pANT8 49) were measured by HPLC. The table shows the initial compaction concentration of compactin and pravastatin tin-lead Streptomyces lividans (p ANT 849) (p ANT8 4 9-ebh) compaction 3 6% 1 1% Pravastatin 11% 53%</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">如上文所討論者，突變體ebh25-l(SEQ ID NO:30)展 現出變更的受質特異性且由此突變體所進行的埃坡黴素B 之生物轉換導致具有與埃坡黴素B或埃坡酶素F都不相 同的HPLC溶析時間之產物。以LC-MS分析此未知樣品 而發現其具有523之分子量（M.W.)，與埃坡黴素b單一羥 基化一致。根據MS和NMR的數據（與埃坡黴素b的數據 相比較），該生物轉換產物的構造經測定爲24-經基-埃坡 黴素B : -51 - 26 (46)200418849</span>As discussed above, the mutant ebh25-1 (SEQ ID NO: 30) exhibits altered substrate specificity and the bioconversion of epothilone B by this mutant results in Or epothelin F are products of different HPLC elution times. This unknown sample was analyzed by LC-MS and found to have a molecular weight (M.W.) of 523, consistent with the single hydroxylation of epothilone b. According to MS and NMR data (compared with the data of epothilone b), the structure of the biotransformation product was determined to be 24-epi-epothilone B: -51-26 (46) 200418849</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">24-羥基-埃坡黴素B 式A</span>24-hydroxy-epothilone B formula A</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">分子式： C27H41NO7S 分子量： 523 質譜： ES + (m/z): 524([M + H]+)，506 LC/MS/MS: +ESI(m/z): 524，506，476，436，320 HRMS ： 對[M + H]+的計算値：524.2682 ;實測値： 524.2701 HPLC(Rt) : 7.3分（於分析型HPLC系統之上） LC/NMR : 觀察到的化學偏移</span>Molecular formula: C27H41NO7S Molecular weight: 523 Mass spectrum: ES + (m / z): 524 ([M + H] +), 506 LC / MS / MS: + ESI (m / z): 524,506,476,436,320 HRMS: Calculated for [M + H] + 4.2: 524.2682; Measured 値: 524.2701 HPLC (Rt): 7.3 points (on analytical HPLC system) LC / NMR: observed chemical shift</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Varian AS-600(質子：5 99.624MHz) 溶劑d2 O/CD3 CN (δ 1.94) 4 / 6   質子： 5 7 • 30 (s，1H)5 6.43 (s，1Η)，5·30  (m，lH)， 4.35 (m，lH)， 3 .81 (m，lH)， 3.74  (m, 1H), 3.68 (m，lH)， 3 .43 (m，lH)， 2.87  (m，1H)， 2.66 (s，3H)， 2. 40 (m，2H)， 1.58  (b，lH)， 1.48 (b，lH)， I.35 (m，3H)， 1.18 -52- (47) (47)200418849 (s，3H)，1 . 1 3 (s，3H)，0. 87 (m，6H) *由於溶劑壓制，在1 . 8 - 2 . 1 p p m之間的譜峰 沒有觀察到。 其質子化學偏移經指定爲：</span>Varian AS-600 (proton: 5 99.624MHz) Solvent d2 O / CD3 CN (δ 1.94) 4/6 Proton: 5 7 • 30 (s, 1H) 5 6.43 (s, 1Η), 5.30 (m, lH ), 4.35 (m, lH), 3.81 (m, lH), 3.74 (m, 1H), 3.68 (m, lH), 3.43 (m, lH), 2.87 (m, 1H), 2.66 ( s, 3H), 2. 40 (m, 2H), 1.58 (b, 1H), 1.48 (b, 1H), I.35 (m, 3H), 1.18 -52- (47) (47) 200418849 (s , 3H), 1.1 3 (s, 3H), 0.87 (m, 6H) * Due to solvent suppression, peaks between 1.8-2.1 ppm were not observed. Its proton chemical shift is specified as:</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">-53- 200418849</span>-53- 200418849</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(48)</span>(48)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">位置 質子 圖樣  1    2 2.40 m  3 4.35 m  4    5    6 3.43 m  7 3.68 m  8 1.58 m  9 1.35 b  10 1.48 b  10 1.3 5 b  11 SSP   12    13 2.87 m  14 SSP   15 5.30 m  16    17 6.43 s  18    19 7.30 s  20    21 2.66 s  22 1.18 s  23 0.87 m  24 3.81 m  24 3.74 m  25 0.87 m  26 1.13 s  27 SSP</span>Position proton pattern 1 2 2.40 m 3 4.35 m 4 5 6 3.43 m 7 3.68 m 8 1.58 m 9 1.35 b 10 1.48 b 10 1.3 5 b 11 SSP 12 13 2.87 m 14 SSP 15 5.30 m 16 17 6.43 s 18 19 7.30 s 20 21 2.66 s 22 1.18 s 23 0.87 m 24 3.81 m 24 3.74 m 25 0.87 m 26 1.13 s 27 SSP</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">*SSP :由於溶劑壓制而沒有觀察到。 -54- (49) 200418849 綜上所述，本發明組成物和方法可以用來生產可作爲 微管-穩定劑（microtubule-stabilizing agents)以及預期可 用爲微管-穩定劑的新化合物包括埃坡黴素類似物例如24-羥基-埃坡黴素B(式A)及其醫藥可接受鹽。使用此等組成 物和方法所製成的微管穩定劑可用來治療多種癌症和其他 增生性疾病包括，但不限於，下面所列者： 癌症，包括膀胱、乳房、結腸、腎、肝、肺、卵巢、 胰臟、胃、子宮頸、甲狀腺和皮膚；包括鱗狀細胞癌； 淋巴樣系的造血性瘤，包括白血病、急性淋巴細胞性 白血病、急性成淋巴細胞性白血病、B-細胞淋巴瘤、T-細 胞淋巴瘤、Η 〇 d g k i n s淋巴瘤、非Η 〇 d g k i n s淋巴瘤、毛細 胞淋巴瘤和Burketts淋巴瘤； 間葉源腫瘤，包括纖維肉瘤和橫紋肌肉瘤，· 其他腫瘤，包括黑瘤、精細胞瘤（S e m i η 〇 m a)、畸胎瘤 (Teratocarcinoma)、神經母細胞瘤和神經膠瘤； 中樞和周圍神經系統的腫瘤，包括星形細胞瘤、神經 母細胞瘤、神經膠瘤、和神經鞘瘤（s c h w a η η 〇 m a s); 間葉源腫瘤’包括纖維肉瘤、橫紋肌肉瘤和骨肉瘤； 及 其他腫瘤’包括黑瘤、xen〇derma pigmentosum、 kefatoactanthoma、精細胞瘤、甲狀腺濾泡癌和畸胎瘤。 ί吏用本發明組成物和方法所製成的微管穩定劑也可以 抑制血管生成’因而可影響腫瘤的生長和提供腫瘤和腫  瘤-相關失調症的治療。此等化合物的此等抗血管生成性 -55- (50) 200418849 質也可用於治療對於抗血管生成劑有反應性的其他狀況包 括，但不限於，與視網膜血管生成相關的某血盲症，關節 炎，特別是炎性關節炎，多發性硬化症，視網膜炎和牛皮 癬等。 使用本發明組成物和方法所製成的微管穩定劑可誘導 或抑制細胞凋亡，一種對於正常發育和體內平衡具有關鍵 性的生理細胞死亡過程。細胞凋亡途徑的變更會助成多種 人類疾病的疾病生成。本發明化合物，例如是I和11與 式 A中所示者，作爲細胞凋亡的調制劑時，可用來治療 多種具有細胞凋亡異常性的人類疾病，包括，但不限於， 癌症和癌前病灶，免疫反應相關疾病，病毒感染，肌肉骨 骼系統的變性疾病與腎臟疾病。 於不希望受任何機制或型態學所拘束之下，使用本發 明組成物和方法所製成的微管穩定劑也可以用來治療癌症 或其他增生性疾病以外的狀況。此等狀況包括，但不限 於，病毒感染例如疱疹病毒，痕病毒，Epstein-Barr病 毒，Sindbis病毒和腺病毒；自體免疫性疾病例如系統性 紅斑狼瘡，免疫媒介血管球性腎炎，風濕性關節炎，牛皮 癬，炎性腸疾病和自體免疫性糖尿病；神經變性疾病例如 阿茲海默爾氏症、AIDS-相關性痴呆、帕金森氏症、肌萎 縮性側索硬化、色素性視網膜炎，脊髓肌肉萎縮和小腦變 性；AIDS ;脊髓發育不良徵候群；成形不全性貧血；與 心肌梗塞相關聯的絕血性傷害；中風和再注輸傷害；再狹 SSS 窄；節律不齊；動脈粥樣硬化；毒素誘導或酒精誘導肝疾 -56- (51) (51)200418849 病；血液學疾病例如慢性貧血和成形不全性貧血；肌肉骨 骼系統變性疾病例如骨質疏鬆症和關節炎；阿斯匹靈-敏 感性鼻竇炎；囊性纖維變性；多發性硬化症；腎臟疾病； 和癌症疼痛。 下面的非限制性實施例係提出用以進一步闡明本發 明。 【實施方式】 實施例 實施例1 :藥劑 R2培養基係按下述製備： 製備含有蔗糖（103克）、K2SO4(0.25克）、MgCl2· 6Η2Ο(10.12 克），葡萄糖（1〇 克），Difco Casamino a c i d s (0 . 1克）和蒸餾水（8 0 0毫升）的溶液。然後將8 0毫升 此溶液倒在200毫升有螺旋蓋的瓶子，瓶內裝有2.2克的 Difco Bacto瓊脂。將瓶子蓋好並壓熱處理。於使用時， 將培養基再熔化並將下列經壓熱處理的溶液依所列順序加 入： 1 毫升 KH2P〇4(0.5%) 8 毫升 CaCl2 · 6H20(3.6 8%) 1.5毫升L-脯胺酸（20%) 10毫升TES緩衝液（5.73%，調整到pH 7.2) 0.2毫升微量元素溶液內含ZnCl2 (40毫克）、FeCl3· 6H20(200 毫克）、CuCl2· 2H2O(10 毫克）、MnCl2· 4H20 (52) (52)200418849 (10 毫克）、Na2B407 · 1〇H20 (10 毫克）、和 (NH4)6M〇7〇24 · H2〇 0.5毫升NaOH (1 N)(不需要滅菌） 0.5毫升營養缺乏所需的生長因子（組胺酸（50微克/毫 升）；半胱胺酸（3 7微克/毫升）；腺嘌呤、鳥嘌呤、胸苷、 和尿嘧啶（7.5微克/毫升）；與維生素（0.5微克/毫升）。 R2YE培養基係以和R2培養基相同的方式製備。不 過，於使用時每一 1〇〇毫升燒瓶中加入5毫升的Difco酵 母萃取物（10%)。 P(原生質體）緩衝液係按下述製備： 製備由下列所組成的基底溶液： 蔗糖（103克） K2SO4(0.25 克）</span>* SSP: Not observed due to solvent pressing. -54- (49) 200418849 In summary, the compositions and methods of the present invention can be used to produce microtubule-stabilizing agents and new compounds that are expected to be useful as microtubule-stabilizing agents, including Ipo Mycin analogs such as 24-hydroxy-epothilone B (formula A) and pharmaceutically acceptable salts thereof. Microtubule stabilizers made using these compositions and methods can be used to treat a variety of cancers and other proliferative diseases including, but not limited to, the following: Cancer, including bladder, breast, colon, kidney, liver, lung , Ovary, pancreas, stomach, cervix, thyroid and skin; including squamous cell carcinoma; lymphoid hematopoietic tumors, including leukemia, acute lymphocytic leukemia, acute lymphoblastic leukemia, B-cell lymphoma , T-cell lymphoma, 〇dgkins lymphoma, non-Ηdgkins lymphoma, hair cell lymphoma, and Burketts lymphoma; tumors of mesenchymal origin, including fibrosarcoma and rhabdomyosarcoma, and other tumors, including melanoma, seminoma Semioma, Teratocarcinoma, neuroblastoma and glioma; tumors of the central and peripheral nervous system, including astrocytoma, neuroblastoma, glioma, and Schwannomas (schwa η η 〇mas); mesenchymal tumors 'including fibrosarcoma, rhabdomyosarcoma and osteosarcoma; and other tumors' including melanoma , Xen〇derma pigmentosum, kefatoactanthoma, seminoma, thyroid follicular carcinoma and teratoma. The microtubule stabilizer prepared by using the composition and method of the present invention can also inhibit angiogenesis, thereby affecting tumor growth and providing treatment for tumors and tumor-related disorders. These anti-angiogenic -55- (50) 200418849 properties of these compounds can also be used to treat other conditions that are responsive to anti-angiogenic agents including, but not limited to, a blood blindness associated with retinal angiogenesis, Arthritis, especially inflammatory arthritis, multiple sclerosis, retinitis and psoriasis. The microtubule stabilizer prepared by using the composition and method of the present invention can induce or inhibit apoptosis, a physiological cell death process that is critical for normal development and homeostasis. Changes in the apoptotic pathway can contribute to the pathogenesis of many human diseases. The compounds of the present invention, such as those shown in I and 11 and Formula A, can be used to treat a variety of human diseases with apoptotic abnormalities when used as modulators of apoptosis, including, but not limited to, cancer and precancerous Lesions, immune response-related diseases, viral infections, degenerative diseases of the musculoskeletal system and kidney disease. Without wishing to be bound by any mechanism or morphology, microtubule stabilizers made using the compositions and methods of the invention can also be used to treat conditions other than cancer or other proliferative diseases. These conditions include, but are not limited to, viral infections such as herpes virus, scar virus, Epstein-Barr virus, Sindbis virus, and adenovirus; autoimmune diseases such as systemic lupus erythematosus, immune-mediated glomerulonephritis, rheumatic joints Inflammation, psoriasis, inflammatory bowel disease and autoimmune diabetes; neurodegenerative diseases such as Alzheimer's disease, AIDS-related dementia, Parkinson's disease, amyotrophic lateral sclerosis, pigmented retinitis, Spinal muscular atrophy and cerebellar degeneration; AIDS; Symptoms of Spinal Cord Dysplasia; Aplastic Anemia; Hemostatic Injury Associated with Myocardial Infarction; Stroke and Reinfusion Injury; Narrow SSS; Narrow Rhythm; Atherosclerosis Toxin-induced or alcohol-induced liver disease -56- (51) (51) 200418849 disease; hematological diseases such as chronic anemia and aplastic anemia; degenerative diseases of the musculoskeletal system such as osteoporosis and arthritis; aspirin- Sensitive sinusitis; cystic fibrosis; multiple sclerosis; kidney disease; and cancer pain. The following non-limiting examples are provided to further illustrate the invention. [Embodiment] Examples Example 1: The R2 medium was prepared as follows: Preparation containing sucrose (103 g), K2SO4 (0.25 g), MgCl2 · 6Η20 (10.12 g), glucose (10 g), Difco Casamino A solution of acids (0.1 g) and distilled water (800 ml). Then 80 ml of this solution was poured into a 200 ml screw cap bottle containing 2.2 g of Difco Bacto agar. Cap the bottle and autoclave. When in use, re-melt the medium and add the following autoclaved solutions in the order listed: 1 ml KH2P04 (0.5%) 8 ml CaCl2 6H20 (3.6 8%) 1.5 ml L-proline %) 10 ml TES buffer (5.73%, adjusted to pH 7.2) 0.2 ml trace element solution contains ZnCl2 (40 mg), FeCl3 · 6H20 (200 mg), CuCl2 · 2H2O (10 mg), MnCl2 · 4H20 (52 ) (52) 200418849 (10 mg), Na2B407 · 10H20 (10 mg), and (NH4) 6M〇7〇24 · H20 0.5 ml NaOH (1 N) (no sterilization required) 0.5 ml nutritional deficiency Growth factors (histidine (50 μg / ml); cysteine (37 μg / ml); adenine, guanine, thymidine, and uracil (7.5 μg / ml); and vitamins (0.5 μg / ml) / Ml). R2YE medium was prepared in the same way as R2 medium. However, 5 ml of Difco yeast extract (10%) was added to each 100 ml flask during use. P (protoplast) buffer system Prepare as follows: Prepare a base solution consisting of: sucrose (103 g) K2SO4 (0.25 g</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">MgCl2 · 6H2O(2.02 克） 如對R2培養基所述的微量元素溶液（2毫升） 蒸餾水到800毫升 然後，分配各8 0毫升的基底溶液液份並壓熱處理。 於使用之前，將下列溶液依所列順序加到每一燒瓶之內： 1 毫升 KH2P〇4(0.50/〇) 1 毫升 CaCl2 · 6 H2〇(3.68%) TES緩衝液（5 ,75%，調整到pH 7.2) T (轉換）緩衝液係經由混合下列無菌溶液而製備： -58- (53) (53)200418849 2 5毫升蔗糖（1 〇 . 3 % ) 7 5毫升蒸餾水 1毫升如對R2培養基所述的微量元素溶液 1 毫升 K 2 S 0 4 ( 2.5 % ) 然後將下列添加到9.3毫升的此溶液： 0.2 毫升 CaCl2 (5M) 〇.5毫升Tris順丁烯二酸緩衝液，其係將1 M Tris溶 液經由添加順丁烯二酸調整到pH 8.0而製備成者。 使用時，係將3體積份的上述溶液添加到1重量份事 先壓熱滅菌過的PEG1000。 L(溶胞）緩衝液係經由混合下列無菌溶液而製備： 100毫升蔗糖（10.3%) 10毫升TES緩衝液（5.73%，調整到pH 7.2) 1 毫升 K2S04(2.5%) 1毫升如對R2培養基所述的微量元素溶液 1 毫升 KH2P〇4(0.5%) 0.1 毫升 MgCl2· 6H20(2.5 Μ) 1 毫升 CaCl2 (〇·25Μ) CRM培養基 於1升dH20中製備含有下列成分的溶液：葡萄糖（10 克）、蔗糖（103 克）、MgCl2· 6H2O(10.12 克），BBLTM 胰化 酪蛋白大豆培養液（trypticase soy broth) (15 克）（Becton (54) 200418849</span>MgCl2 · 6H2O (2.02 g) Trace element solution (2 ml) as described for R2 medium Distilled water to 800 ml Then, each 80 ml of the base solution was dispensed and autoclaved. Prior to use, add the following solutions to each flask in the order listed: 1 ml KH2P04 (0.50 / 〇) 1 ml CaCl2 · 6 H2 0 (3.68%) TES buffer (5, 75%, adjusted (To pH 7.2) T (transition) buffer is prepared by mixing the following sterile solutions: -58- (53) (53) 200418849 2 5 ml sucrose (10.3%) 7 5 ml distilled water 1 ml as for R2 medium The trace element solution was 1 ml of K 2 S 0 4 (2.5%) and then the following was added to 9.3 ml of this solution: 0.2 ml of CaCl2 (5M) and 0.5 ml of Tris maleic acid buffer solution. A 1 M Tris solution was prepared by adding maleic acid to pH 8.0. In use, 3 parts by volume of the above solution was added to 1 part by weight of the autoclaved PEG1000. L (lysis) buffer is prepared by mixing the following sterile solutions: 100 ml sucrose (10.3%) 10 ml TES buffer (5.73%, adjusted to pH 7.2) 1 ml K2S04 (2.5%) 1 ml as for R2 medium The trace element solution 1 ml KH2P04 (0.5%) 0.1 ml MgCl2 6H20 (2.5M) 1 ml CaCl2 (0.25M) CRM medium A solution containing the following ingredients was prepared in 1 liter dH20: glucose (10 g ), Sucrose (103 g), MgCl2 · 6H2O (10.12 g), BBLTM trypticase soy broth (15 g) (Becton (54) 200418849</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Dickinson Microbiology Systems, Sparks, Maryland, USA)、和 BBLTM 酵母萃取物（5 克）（Becton Dickinson Microbiology Systems)。將此溶液壓熱處理 30分鐘。對 於使用質體增殖的培養物，將硫鏈絲菌肽（t h i 〇 s t r e p t ο η )添 加到1 0微克/毫升之濃度。 電穿透緩衝液 於dH20中製備含有30%(重量/體積）PEG 1 000、10% 甘油、和6·5%蔗糖的溶液。經由真空濾過0.22微米纖維 素乙酸酯濾器將此溶液滅菌。</span>Dickinson Microbiology Systems, Sparks, Maryland, USA), and BBLTM Yeast Extract (5 g) (Becton Dickinson Microbiology Systems). This solution was autoclaved for 30 minutes. For cultures using plastid proliferation, thiostrepton (t h i 0 s tr e p t ο η) was added to a concentration of 10 μg / ml. Electropenetration buffer A solution containing 30% (w / v) PEG 1,000, 10% glycerol, and 6.5% sucrose was prepared in dH20. This solution was sterilized by vacuum filtration through a 0.22 micron cellulose acetate filter.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">實施例2 :從菌株SCI 5 847萃取染色體DNA</span>Example 2: Extraction of chromosomal DNA from strain SCI 5 847</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">使用胍-淸潔劑溶胞法，DNAzol劑（Invitrogen, Carlsbad, California，USA)從東方鏈黴菌土壤離析菌株編 號 SC 1 5 8 47 (ATCC PT- 1 043 )者分離出基因組 DNA。將 SC 1 5 847培養物再28°C的F7培養基（葡萄糖2.2%、酵母 菌萃取物1.0%、麥芽萃取物1.0%，胃蛋白腺0.1%、pH 7 . 〇 )中生長2 4小時。經由離心收取2 0毫升培養物並再懸 浮於 20毫升 DNAzol內，經由抽吸予以混合且在 Backman TJ6離心機中離心10分鐘。加入10毫升100% 乙醇，倒轉數次，並存放於室溫下3分鐘。將DNA捲繞 於一玻璃吸量管上，在1 〇〇%乙醇內洗滌並使其空氣乾燥 1〇分鐘。將沉九再懸浮於5 00微升8 mM NaOH內且於溶 解後，使用30微升1 M HEP ES pH 7.2予以中和。 -60- (55) 200418849 實施例3 : PCR反應</span>Genomic DNA was isolated from a Streptomyces orientalis soil isolate strain number SC 1 5 8 47 (ATCC PT-1 043) using a guanidine-detergent lysis method and DNAzol agent (Invitrogen, Carlsbad, California, USA). The SC 1 5 847 culture was grown in F7 medium (glucose 2.2%, yeast extract 1.0%, malt extract 1.0%, gastric protein gland 0.1%, pH 7.0) at 28 ° C for 24 hours. 20 ml of the culture was collected by centrifugation and resuspended in 20 ml of DNAzol, mixed by suction and centrifuged in a Backman TJ6 centrifuge for 10 minutes. Add 10 ml of 100% ethanol, invert several times, and store at room temperature for 3 minutes. The DNA was wound on a glass pipette, washed in 100% ethanol and allowed to air dry for 10 minutes. Shen Jiu was resuspended in 500 microliters of 8 mM NaOH and after dissolution, it was neutralized with 30 microliters of 1 M HEP ES pH 7.2. -60- (55) 200418849 Example 3: PCR reaction</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">PCR反應物係在50微升體積內製備’包含200- 5 0 0 毫微克（ng)的基因組DNA或1.0微升的cDNA，一前向和 反向引子，且該前向引子係P45 0- 1 +(SEQ ID NO:23)或爲 P45 0-la+ (SEQ ID NO:24)或 P45 0-2+ (SEQ ID NO:25)而該 反向引子爲 P45 0-3_(SEQ ID NO:27)或 P45 0-2_(SEQ ID NO: 26)。所有的引子都添加到1.4-2.0 // Μ之最後濃度。 PCR 反應物係用 1 微升的 Taq 酵素（2.5 單 位）（Stratagene)，5微升的Taq緩衝液和4微升的2.5 mM dNTPs，加上 dH20到 50微升。諸循環反應係在 Geneamp®PCR系統上以下述方案實施的：95〇C五分鐘，5 循環的[95°C 30秒鐘，37°C 15秒鐘（30%斜升），72°C</span>The PCR reaction was prepared in a 50 microliter volume containing 200-500 nanograms (ng) of genomic DNA or 1.0 microliter of cDNA, a forward and reverse primer, and the forward primer line P45 0- 1 + (SEQ ID NO: 23) or P45 0-la + (SEQ ID NO: 24) or P45 0-2 + (SEQ ID NO: 25) and the reverse primer is P45 0-3_ (SEQ ID NO: 27) or P45 0-2_ (SEQ ID NO: 26). All primers were added to a final concentration of 1.4-2.0 // M. PCR reactions were performed with 1 µl of Taq enzyme (2.5 units) (Stratagene), 5 µl of Taq buffer and 4 µl of 2.5 mM dNTPs, plus dH20 to 50 µl. The various cycling reactions were performed on the Geneamp® PCR system with the following protocol: 95 ° C for 5 minutes, 5 cycles of [95 ° C for 30 seconds, 37 ° C for 15 seconds (30% ramp up), 72 ° C</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">30秒鐘]，30循環的[94 °C 30秒鐘，65°C 15秒鐘，72 °C 30秒鐘]，72°C 7分鐘。反應物的預期大小爲P45 0-</span>30 seconds], 30 cycles of [94 ° C for 30 seconds, 65 ° C for 15 seconds, 72 ° C for 30 seconds], and 72 ° C for 7 minutes. Expected size of reactant is P45 0-</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1+(SEQ ID NO:23)或爲 P45 0-la+ (SEQ ID NO:24)和 P4 5 0-3'(SEQ ID NO:27)引子對的 3 40 bp 及 P45 0-2 + (SEQ ID 1^0:25)和？450-3_(5丑(^10 1^0:26)引子對的130 6口。 實施例4 :埃坡黴素B羥化酶和鐵氧化還原蛋白基因的選 殖 使用Bglll限制酵素在37°C下消化2〇微克SC 1 5 8 4 7 基因組DNA 6小時。使用一 30k nanosep管柱（Gelman Science，Ann Arbor，Michigan，USA)來濃縮 DNA 及移除 -61 - (56) 200418849 酵素和緩衝劑。將反應液濃縮到40微升並使用2〇〇微升 的TE予以洗滌。然後於0.7%瓊脂糖凝膠上分離消化產物 並從凝膠上切取在1 2〜1 5 kb範圍內的基因組DN A且使用 Qiagen凝膠萃取法予以純化。之後將該基因組DNA連接 到質體 PWB19N (美國專利 5,5 1 6,679)，其係經使用 BamHI 消化且使用 SAP I 酵素（Roche Molecular B i o c h e m i c a 1 s , Indianapolis, Indiana, catalog#l 7 5 8 25 0)</span>1+ (SEQ ID NO: 23) or 3,40 bp of P45 0-la + (SEQ ID NO: 24) and P4 5 0-3 '(SEQ ID NO: 27) primer pair and P45 0-2 + (SEQ ID 1 ^ 0: 25) and? 450-3_ (5 ugly (^ 10 1 ^ 0: 26) primer pairs of 130 6 mouths. Example 4: Epothilone B hydroxylase and ferredoxin gene cloning using Bglll restriction enzyme at 37 ° Digest 20 μg of SC 1 5 8 4 7 genomic DNA for 6 hours at C. Use a 30k nanosep column (Gelman Science, Ann Arbor, Michigan, USA) to concentrate the DNA and remove -61-(56) 200418849 enzymes and buffers The reaction solution was concentrated to 40 microliters and washed with 200 microliters of TE. Then the digestion products were separated on a 0.7% agarose gel and cut from the gel in the range of 1 to 15 kb. Genomic DNA was purified by Qiagen gel extraction. This genomic DNA was then ligated to plastid PWB19N (US Patent 5,5 1 6,679), which was digested with BamHI and SAP I enzyme (Roche Molecular B iochemica 1) s, Indianapolis, Indiana, catalog # l 7 5 8 25 0)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">予以去磷酸過。連接反應係在15微升體積內用1U的T4 DNA連接酶（Invitrogen)在室溫下實施1小時。用1微升 的連接物轉形 1〇〇微生化學生勝任性 DH10B細胞 (Invitrogen)並取100微升在五個含有30微克/毫升新黴素 的LB瓊脂板上於3 7 °C下平板培養。</span>Dephosphorylated. The ligation reaction was performed with 1 U of T4 DNA ligase (Invitrogen) in a volume of 15 μl at room temperature for 1 hour. 100 μl biochemical student competent DH10B cells (Invitrogen) were transformed with 1 μl of the linker and 100 μl were taken on five LB agar plates containing 30 μg / ml neomycin and plated at 37 ° C. to cultivate.</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">將 5 片耐綸（nylon)膜圈（Roche Molecular Biochemicals, Indianapolis，Indiana)編號及標誌取向。將 該等膜放置於該等板上2分鐘，然後使其乾燥5分鐘。接 著將該等膜放置於Whatman濾紙片上，用10% SDS飽和5 分鐘，0.5 N NaOH + 1.5 M NaCl 飽和 5 分鐘，1.5 Μ NaCl + 1·0 M Tris pH 8.0 5 分鐘，及在 2Χ SSC 上 15 分 鐘。按照先·對南方氏雜交（the Southern hybridization) 所述對濾紙進行雜交。將雜交群落檢取在2毫升TB + 3 0 微克/毫升新黴素之上並在37 °C下生長整個晚上。使用 miniprep管柱程序（Mo Bio)分離質體DNA。此質體稱爲 NPB29-1 。 -62- (57) (57)200418849 實施例5 : DNA定序和分析 使用螢光染料標記終止劑循環定序性，Big-Dye定序 套組（Applied Biosystems，Foster City，California，USA)疋 序經選殖的PCR產物並使用雷射誘導螢光毛細管電泳， ABI Prism 310 定序儀（Applied Biosystems)予以分析。 實施例6 :總RNA之萃取 使用Chomczynski和Sacchi法的修改法用單相苯酣 和胍異硫氰酸鹽溶液，Trizol劑（Invitrogen)從 SC 1 5 847 培養物分離總RNA。將5毫升SCI 5 847凍結儲液培養物 解凍並用來製接種在一 5 00-毫升三角瓶內的100毫升F7 培養基。將該培養物在搖動保溫器內於30°C下以23 0 rpm 生長20小時使600奈米（nm)光學密度（ODmo)達到9,0。 將該培養物置於搖動保溫器內於16°C下以23 0 rpm搖動 2 〇分鐘。將5 5毫克埃坡黴素B溶解於1毫升1 〇 〇 %乙醇 內並加到該培養物內。使用第二份的1毫升乙醇從該管淸 洗殘餘埃坡黴素B並加到該培養物內。將該培養物在i 6 t：下以2 3 0 r p m保溫3 0小時。取3 0毫升的培養物轉移到 一 50-毫升管內，於該培養物中加入15〇毫克溶菌酶並將 該培養物置於室溫下保溫5分鐘。取1 〇毫升培養物置於 一 5 0-毫升Falc〇n管中並在TJ6離心機內於4°C下離心5 分鐘。加入2毫升氯仿並激烈混合該管1 5秒鐘。將該管 溫置於室溫下2分鐘，接著在TJ6離心機內以頂速離心 1 0分鐘。將水層轉移到一新的管內並加入2.5毫升的異丙 -63- (58) (58)200418849 醇乙沉澱RN A。將該管溫置於室溫下1 〇分鐘，接著在4 °C下離心1 0分鐘。移除上澄液，使用70%乙醇淸洗沉九 並於真空下稍微乾燥。將該沉九再懸浮於1 5 0微升無 RNase的 dH20中。於該RNA中加入 50微升的 7.5 Μ LiCl並在- 20°C下保溫30分鐘。將該RNA在4它下於一 微型離心機內離心1 〇分鐘予以沉著。使用200微升的 70%乙醇淸洗沉九，於真空下稍微乾燥並再懸浮於150微 升無RNase的dH20中。 _ 使用 DNaseI(Ambion，Austin，Texas，USA)處理該 RNA。加入25微升的總RNA( 5.3微克/微升），2.5微升的 DNasel緩衝液，1.0微升的DNase並在37°C下溫置25分 鐘。加入5微升的DNasel抑活化緩衝液，保溫2分鐘， 離心1分鐘，將上澄液轉移到一新的管中。 實施例7 : cDNA合成 使用 Superscript II 酵素（Invitrogen)從總 RNA 合成 ® cDNA。使用1微升的總RNA(5.3微克/微升），9微升的 dH20，1微升的dNTP混合物（10 mM)，和一微升的隨機 六聚物製備反應物。將反應物在6 5 t下保溫5分鐘後放 置在冰上。然後加入下列成分：4微升的1 st股緩衝液， 1微升RNase抑制劑，2.0微升的0.1 M DTT，和1微升 S u p e r s c r i p t 11酵素。將反應物在室溫下保溫1 〇分鐘，在 42 °C下保溫50分鐘及在7(TC下保溫15分鐘。加入1微 升的RNaseH並在37°C下保溫20分鐘，在70。(：下15分 -64- (59) 200418849 鐘並貯存在4 °C。 實施例8 : DNA標記</span>Orient 5 nylon membrane rings (Roche Molecular Biochemicals, Indianapolis, Indiana) with numbers and signs. The films were placed on the plates for 2 minutes and then allowed to dry for 5 minutes. The membranes were then placed on Whatman filter paper, saturated with 10% SDS for 5 minutes, 0.5 N NaOH + 1.5 M NaCl for 5 minutes, 1.5 mM NaCl + 1.0 M Tris pH 8.0 for 5 minutes, and on 2X SSC for 15 minutes. minute. Filter paper was hybridized as described in the Southern hybridization. The hybrid community was picked on 2 ml TB + 30 μg / ml neomycin and grown at 37 ° C all night. Isolation of plastid DNA using the miniprep column program (Mo Bio). This plastid is called NPB29-1. -62- (57) (57) 200418849 Example 5: DNA sequencing and analysis Cyclic sequencing using a fluorescent dye-labeled terminator, Big-Dye sequencing kit (Applied Biosystems, Foster City, California, USA) 疋The selected PCR products were sequenced and analyzed by laser-induced fluorescence capillary electrophoresis using an ABI Prism 310 sequencer (Applied Biosystems). Example 6: Extraction of total RNA Total RNA was isolated from SC 1 5 847 cultures using a single-phase phenylhydrazone and guanidine isothiocyanate solution, Trizol agent (Invitrogen) using a modified method of the Chomczynski and Sacchi methods. 5 ml of SCI 5 847 frozen stock culture was thawed and used to prepare 100 ml of F7 medium in a 500-ml Erlenmeyer flask. The culture was grown in a shaker incubator at 30 ° C for 20 hours at 23 0 rpm to achieve an optical density (ODmo) of 600 nanometers (nm) of 9,0. The culture was placed in a shaking incubator at 16 ° C for 20 minutes at 23 rpm. 55 mg of epothilone B was dissolved in 1 ml of 100% ethanol and added to the culture. Rinse residual epothilone B from the tube with a second 1 ml ethanol and add to the culture. The culture was incubated for 30 hours at 2 6 r p m at i 6 t :. 30 ml of the culture was transferred to a 50-ml tube, 150 mg of lysozyme was added to the culture, and the culture was incubated at room temperature for 5 minutes. 10 ml of the culture was placed in a 50-ml Falcon tube and centrifuged in a TJ6 centrifuge at 4 ° C for 5 minutes. Add 2 ml of chloroform and mix the tube vigorously for 15 seconds. The tube was left at room temperature for 2 minutes, and then centrifuged at top speed in a TJ6 centrifuge for 10 minutes. The aqueous layer was transferred to a new tube and 2.5 ml of isopropyl-63- (58) (58) 200418849 ethyl alcohol was added to precipitate RN A. The tube was left at room temperature for 10 minutes, and then centrifuged at 4 ° C for 10 minutes. Remove the supernatant, wash the sink with 70% ethanol, and dry slightly under vacuum. This Shen Jiu was resuspended in 150 microliters of RNase-free dH20. Add 50 μl of 7.5 M LiCl to the RNA and incubate at -20 ° C for 30 minutes. The RNA was allowed to settle by centrifuging the RNA in a microcentrifuge for 10 minutes at 4 ° C. Shenjiu was washed with 200 microliters of 70% ethanol, dried slightly under vacuum and resuspended in 150 microliters of RNase-free dH20. _ Treat the RNA with DNaseI (Ambion, Austin, Texas, USA). Add 25 µl of total RNA (5.3 µg / µl), 2.5 µl of DNasel buffer, 1.0 µl of DNase and incubate at 37 ° C for 25 minutes. Add 5 microliters of DNasel inhibitor buffer, incubate for 2 minutes, centrifuge for 1 minute, and transfer the supernatant to a new tube. Example 7: cDNA Synthesis cDNA was synthesized from total RNA using Superscript II enzyme (Invitrogen). The reaction was prepared using 1 μl of total RNA (5.3 μg / μl), 9 μl of dH20, 1 μl of dNTP mixture (10 mM), and one μl of random hexamer. The reaction was incubated at 65 t for 5 minutes and then placed on ice. The following ingredients were then added: 4 microliters of 1 st stock buffer, 1 microliter of RNase inhibitor, 2.0 microliters of 0.1 M DTT, and 1 microliter of Supper s c r i p t 11 enzyme. The reaction was incubated for 10 minutes at room temperature, 50 minutes at 42 ° C and 15 minutes at 7 ° C. Add 1 μl of RNaseH and incubate at 37 ° C for 20 minutes at 70. : 15 minutes below -64- (59) 200418849 minutes and stored at 4 ° C. Example 8: DNA labeling</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">使用從基因組DNA和cDNA擴增P4 5 0特異性產物所 用的條件來擴增質體 pCRscript-29的插入物。質體 pCRscript-29 含有使用引子 P4 5 0- 1 +(SEQ ID NO:23)和 P450-3'(SEQ ID NO:27)從 SC 1 5 84 7 基因組 DNA 擴增所得 一 340 bp PCR片段。使用2微升的質體製備物作爲模 板，進行總共25個循環。使用 Qiaquick凝膠萃取系統 (Qiagen)凝膠純化擴增產物。將所萃取的DNA以乙醇沉 澱並再懸浮於5微升TE內，產量經估計爲5 00毫微克。 使用 chem link 標記劑（Roche Molecular Biochemicals， Indianapolis， Indiana, catalog# 1 836 463)以地高新</span>The conditions used to amplify P4 50-specific products from genomic DNA and cDNA were used to amplify inserts of plastid pCRscript-29. Plastid pCRscript-29 contains a 340 bp PCR fragment amplified from SC 1 5 84 7 genomic DNA using primers P4 50- 1 + (SEQ ID NO: 23) and P450-3 '(SEQ ID NO: 27). A total of 25 cycles were performed using 2 microliters of the plastid preparation as a template. Amplification products were gel purified using a Qiaquick gel extraction system (Qiagen). The extracted DNA was precipitated with ethanol and resuspended in 5 microliters of TE, and the yield was estimated to be 500 nanograms. Use chem link markers (Roche Molecular Biochemicals, Indianapolis, Indiana, catalog # 1 836 463)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(digoxigenin)標記此片段。將5微升的PCR產物與0.5微 升的Dig-chem link混合並加入dH2〇到20微升。將反應 物在8 5 °C下保溫3 0分鐘後加入5微升的溶液。探針的濃 度經估計爲20毫微克/微升。 實施例9 :南方氏DNA雜交</span>(digoxigenin). Mix 5 µl of the PCR product with 0.5 µl of the Dig-chem link and add dH20 to 20 µl. After the reaction was incubated at 85 ° C for 30 minutes, 5 µl of the solution was added. The concentration of the probe was estimated at 20 nanograms / microliter. Example 9: Southern Southern DNA Hybridization</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">使用 BamHI、Bglll、EcoRI、Hindlll 或 Notl 消化 1 〇 微升的基因組DNA( 0.5微克/微升）並於12伏（volt)下分離 1 6小時。將凝膠置於〇. 2 5 N HC 1中去嘌呤1 0分鐘並使用 真空黑占漬器（vacuum b 1 o 11 e r) (B i 〇 - R a d Laboratories, Inc., Hercules，California，USA，catalog#165-5000)於 0.4 N -65- (60) 200418849</span>Use BamHI, Bglll, EcoRI, Hindlll, or Notl to digest 10 μl of genomic DNA (0.5 μg / μl) and isolate at 12 volts for 16 hours. The gel was depurinated in 0.2 5 N HC 1 for 10 minutes and a vacuum b 1 o 11 er was used (Bi-Lab Laboratories, Inc., Hercules, California, USA, catalog # 165-5000) at 0.4 N -65- (60) 200418849</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">NaOH 5” Hg真空下轉移到耐綸膜（Roche Molecular B i o c h e m i c a 1 s)。將該膜置於 1 M乙酸鏡內淸洗並使用 Stratalinker UV Crosslinker (Stratagene)予以 UV-交聯。 將該膜浸於2X S SC內淸洗後貯存在室溫下。</span>NaOH 5 ”Hg was transferred to a nylon membrane (Roche Molecular Biochemica 1 s) under vacuum. The membrane was rinsed in a 1 M acetate lens and UV-crosslinked using a Stratalinker UV Crosslinker (Stratagene). The membrane was dipped Rinse in 2X S SC and store at room temperature.</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">將該膜置於 20毫升 Dig Easy Hyb緩衝液（Roche Molecular Biochemicals)內於 40 °C 下預雜交 1 小時。在 65 °C下將該探針變性1 〇分鐘後置於冰上。取5毫升濃度約 20毫微克/毫升的探針/Dig-Easy Hyb與該膜一起在42°C 下溫置整個晚上。將該膜置於2X SCC + 0.1% SDS中在室 溫下洗滌兩次，然後於〇.5X SCC + 0.1% SDS中在65°C 下洗滌兩次。將該膜置於Genius緩衝液1(10 mM順丁烯 二酸，15 mM NaCl ； pH 7.5 ； 0.3% v/v Tween 20) (Roche Molecular Biochemicals, Indianapolis, Indiana)內 2 分 鐘，然後與2 %阻斷溶液（2 % B 1 o c k i n g r e a g e n t在G e n i u s緩 衝液 1 內）（Roche Molecular Biochemicals，Indianapolis， Indiana)—起在室溫下保溫1小時。將該膜與抗-dig抗體 在50毫升阻斷溶液內的1 : 20,000稀釋液一起保溫30分 鐘。將該膜分別置於50毫升Genius緩衝液1中洗滌15 分鐘兩次。將該膜置於Genius緩衝液3(1〇11^1[1^-HCl，10mMNaCl;pH9.5)內平衡2分鐘。將l毫升 CSPD (3-(4-曱氧基螺{1，2-二氧雜環丁烷-3，2’-(5’-氯）三環 [3.3.1.1.3,7]癸烷卜4-基）苯基磷酸二鈉）（Roche Molecular B i o c h e m i c a 1 s)在G e n i u s緩衝液3中的1 : 1 0 0稀釋液加到 該膜並在室溫下保溫5分鐘，接著在37°C下保溫15分 - 66 _ (61) 200418849 鐘。將該膜接觸 Biomax ML 膜（Kodak, Rochester，New York, US A) 1 小時。 實施例1 〇 :大腸桿菌轉形 勝任性細胞係購自Invitrogen。使用大腸桿菌菌株 DH 1 0B作爲基因選殖的宿主。將化學勝任細胞置於冰上 解凍並取100微升液份加到置於冰上的17 X 100-毫米聚 丙烯管。取1微升的連接混合物加到細胞並在冰上保溫 3 〇分鐘。將該細胞置於42°C下保溫45秒鐘，然後置於冰 上1-2分鐘。加入0.9毫升的SOC培養基（Invitrogen)並 將細胞置於3 0- 3 7 °C下以200-240 rpm保溫1小時。將細 胞置於選擇性培養基（Luria瓊脂，含有濃度分別爲30微 克/毫升或1〇〇微克/毫升的新黴素或氨苄青黴素）上平板培</span>The membrane was prehybridized in 20 ml of Dig Easy Hyb buffer (Roche Molecular Biochemicals) at 40 ° C for 1 hour. The probe was denatured at 65 ° C for 10 minutes and then placed on ice. Take 5 ml of probe / Dig-Easy Hyb with a concentration of about 20 nanograms / ml together with the membrane and incubate at 42 ° C overnight. The membrane was washed twice in 2X SCC + 0.1% SDS at room temperature and then washed twice in 0.5X SCC + 0.1% SDS at 65 ° C. The membrane was placed in Genius buffer 1 (10 mM maleic acid, 15 mM NaCl; pH 7.5; 0.3% v / v Tween 20) (Roche Molecular Biochemicals, Indianapolis, Indiana) for 2 minutes, and then mixed with 2% Blocking solution (2% Bockingreagent in Genius Buffer 1) (Roche Molecular Biochemicals, Indianapolis, Indiana) —incubate at room temperature for 1 hour. The membrane was incubated with a 1: 20,000 dilution of anti-dig antibody in 50 ml of blocking solution for 30 minutes. The membrane was washed twice in 50 ml of Genius Buffer 1 for 15 minutes. The membrane was equilibrated in Genius buffer 3 (1011 ^ 1 [1 ^ -HCl, 10mM NaCl; pH 9.5) for 2 minutes. 1 ml of CSPD (3- (4-Methoxyspiro {1,2-dioxetane-3,2 '-(5'-chloro) tricyclo [3.3.1.1.3,7] decane Alkyl 4-yl) disodium phenyl phosphate (Roche Molecular Biochemica 1 s) in Genius Buffer 3 was added to the membrane in a 1: 1 dilution and incubated at room temperature for 5 minutes, then at 37 Incubate at ° C for 15 minutes-66 _ (61) 200418849 minutes. The membrane was exposed to a Biomax ML membrane (Kodak, Rochester, New York, US A) for 1 hour. Example 10: E. coli transformation competent cell lines were purchased from Invitrogen. E. coli strain DH 1 0B was used as the host for genetic selection. The chemically competent cells were thawed on ice and a 100 microliter portion was added to a 17 X 100-mm polypropylene tube placed on ice. Take 1 μl of the ligation mixture to the cells and incubate on ice for 30 minutes. The cells were incubated at 42 ° C for 45 seconds, and then placed on ice for 1-2 minutes. Add 0.9 ml of SOC medium (Invitrogen) and incubate the cells at 30-37 ° C for 1 hour at 200-240 rpm. Cells were plated on selective medium (Luria agar containing neomycin or ampicillin at a concentration of 30 μg / ml or 100 μg / ml, respectively).</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">實施例1 1 :變鉛青鏈黴菌TK24的轉形 經由使用Hindlll消化質體pWB19N並用SAPI處理 及使用 Hindlll 消化質體 pANT849(Keiser，et al.，2000, Practical Streptomyces Genetics，John Innes)以構成質體 pWB 1 9N849。將兩條經線型化的片段使用1U的T4 DNA 連接酶在室溫下連接1小時。使用1微升的連接反應物轉 形XL-1 Blue電勝任細胞（Stratagene)。將回收的細胞在 LB新黴素（3〇微克/毫升）上於37t下平板培養整個晚上。 將群落撿取到2毫升含有30微克/毫升新黴素的LB上並 -67- (62) 200418849 於3 0°C下保溫整個晚上。對所有培養基實施MoBio質體 微型製備。經由將PWB19N與pANT849連接所構成的質 體在 0.7%瓊脂糖上測定電泳移動率。使用 Hi n dill和 Bglll消化質體pWB19N849以切取相當於使用Bglll和 Hindlll消化pANT8 49所得5.3 kb片段。在瓊脂糖凝膠上 純化此5.3 kb片段並使用Qiaquick凝膠萃取系統萃取。</span>Example 11 1: Transformation of Streptomyces lividans TK24 via Hindlll digestion pWB19N and SAPI treatment and Hindlll digestion pANT849 (Keiser, et al., 2000, Practical Streptomyces Genetics, John Innes) to construct Body pWB 1 9N849. The two linearized fragments were ligated using 1U of T4 DNA ligase at room temperature for 1 hour. XL-1 Blue competent cells (Stratagene) were transformed with 1 microliter of ligation reaction. The recovered cells were plated on LB neomycin (30 μg / ml) at 37 t overnight. The colonies were picked onto 2 ml of LB containing 30 μg / ml neomycin and -67- (62) 200418849 was incubated at 30 ° C overnight. MoBio plastid mini-preparation was performed on all media. The electrophoretic mobility was measured on a 0.7% agarose plastid consisting of PWB19N and pANT849. The plastid pWB19N849 was digested with Hindill and Bglll to cut out a 5.3 kb fragment equivalent to the digestion of pANT8 49 with Bglll and Hindlll. This 5.3 kb fragment was purified on an agarose gel and extracted using a Qiaquick gel extraction system.</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">將含有埃坡黴素B羥化酶基因和下游的鐵氧化還原蛋 白基因之1.469 kb DNA片段使用PCR予以擴增。50微升 的PCR反應物包括5微升Taq緩衝液，2.5微升甘油，1 微升的20毫微克/微升NPB29-1質體，0.4微升的25 mM dNTPs，各 1.0 微升的引子 NPB29-6F(SEQ ID NO:28)和 NPB29-7R(SEQ ID Ν Ο : 2 9 ) ( 5 微微莫耳 / 微升），3 8 · 1 微升 dH2〇 和 〇·5 微升 Taq 酵素（Stratagene)。在 Perkin Elmer 9 700上實施反應，95°C 5分鐘，然後30循環的（96°C</span>A 1.469 kb DNA fragment containing the epothilone B hydroxylase gene and the downstream ferredoxin gene was amplified by PCR. 50 μl of PCR reaction includes 5 μl of Taq buffer, 2.5 μl of glycerol, 1 μl of 20 ng / μl NPB29-1 plastids, 0.4 μl of 25 mM dNTPs, and 1.0 μl of primers each NPB29-6F (SEQ ID NO: 28) and NPB29-7R (SEQ ID NO: 2 9) (5 picomoles / microliter), 3 8 · 1 microliter dH20 and 0.5 microliter Taq enzyme ( Stratagene). The reaction was performed on a Perkin Elmer 9 700, 95 ° C for 5 minutes, and then 30 cycles (96 ° C</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">3 0秒鐘，6 0 °C 3 0秒鐘，7 2 °C 2分鐘），及 7 2 °C 7分 鐘。使用Qiagen微型溶析系統以PCR淸理程序純化PCR 產物。將經純化的產物用Bglll和Hindlll消化並在0.7% 瓊脂糖凝膠上純化。從凝膠上切取一 1.469 kb帶並使用 Qiagen微型溶析管柱予以溶析。取5微升的此PCR產物 與2微升經Bglll和Hindlll消化過的PANT 8 49載體在1〇 微升連接反應物中連接。將反應物在室溫下保溫24小時 後，轉形變鉛青鏈黴菌TK24原生質體。 於20毫升YEME培養基內接種凍結的變鉛青鏈黴菌 ΤΚ〗4孢子懸浮液並在一 125-毫升雙穴燒瓶內生長48小 -68- (63) (63)200418849 時。s亥原生質體系按照在 Practical Streptomyces Genetics 中所述製備成者。將連接反應物與原生質體混合，加入 5 0 0微升的轉形緩衝液，緊接著加入5毫升的p緩衝液。 將轉形反應物以2,7 5 0 r p m旋轉7分鐘，再懸浮於1 〇 〇微 升P緩衝液內並於一 R2YE板上平板培養。將該板置於 2 8 °C保溫2 0小時後，覆蓋上5毫升含有2 5 0微克/毫升硫 鏈絲菌肽的LB 0.7%瓊脂。於7天之後，將菌落撿取到含 有50微克/毫升硫鏈絲菌肽的R2YE格板上。於28°C下將 諸菌落再生長5天，然後貯存於之下。 此重組微生物業經寄存於 ATCC且經編號爲PTA-4022 ° 實施例1 2 :龜裂鏈黴菌之轉形 採用 Pigac and S chrempf Appl. Environ Microb ., V o 1. 61, No.1, 3 5 2-3 5 6 ( 1 995 )的程序來轉形龜裂鏈黴菌。將龜 裂鏈黴菌R6 593於20毫升CRM培養基內在30 °C下旋轉 搖動器上（250 rpm)培養。24小時之後於4°C下以5,000 r p m離心5分鐘收取細胞’並再懸浮於4 C 2 0毫升的 1 0 %蔗糖中，且於4 °C下以5，0 0 0 rp m離心5分鐘。將沉 九再懸浮於4 °C 1 0毫升的1 5 %甘油內且於4 °C下以5，0 0 0 rpm離心5分鐘。將沉九再懸浮於4°C 2毫升含有100微 克/毫升溶菌酶的1 5 %甘油內且於3 7 °C下保溫3 0分鐘’於 4 °C下以5，0 0 〇 r p m離心5分鐘並再懸浮於4 °C 2耄升的 1 5 %甘油內。重複一*次1 5 %甘油洗條並將沉九再懸浮於1 -69- (64) (64)200418849 到2毫升的電穿透緩衝液之內。將細胞以5 0-200微升的 液份貯存於-8 0 °C之下。 按照對變鉛青鏈黴菌轉形所述製備連接反應物。於接 種連接反應物之後，使用dH20將體積調成100微升，加 入NaCl到0.3 Μ，並使用等體積的24: 1:1苯酚：氯 仿：異戊醇萃取反應物。加入20微克的肝醣並用2體積 的100%乙醇再- 20°C下沉澱經連接的DNA30分鐘。將該 DNA於微型離心機內沉著10分鐘，用70%乙醇洗滌一 次，於speed-vac濃縮器內乾燥5分鐘並再懸浮於5微升 dH2〇 內。 取一凍結液份的細胞在室溫下解凍並對每一 DNA分 配成5 0微升/管以用於電穿透。將細胞放置於冰上到要使 用爲止。加入 DNA/1到2微升dH20並混合。將細胞 /DNA混合物轉移到一預先在冰上冷卻的2毫米間隙的電 管 瓶（Bio-Rad Laboratories, Richmond, California， USA)。使用 Gene PulserTM (Bio-Rad Laboratories)以 2 kV (10 kV/cm)，25 // F，400 Ω的設定將細胞電穿透。將細 胞用0.75到1.0毫升的CRM (0-4 °C )稀釋，轉移到15-毫 升培養管內並於3 0°C下攪動培養3小時。將細胞置於含 有10-30微克/毫升硫鏈絲菌肽的胰蛋白酶大豆液體培養 基瓊脂板上平板培養。 實施例1 3 :高性能液體層析術 使用 Waters 2690 Separation Module 系統（Waters (65) (65)200418849</span>30 seconds, 60 ° C, 30 seconds, 7 2 ° C for 2 minutes), and 7 2 ° C for 7 minutes. PCR products were purified using a Qiagen mini-lysis system using a PCR protocol. The purified product was digested with Bglll and Hindlll and purified on a 0.7% agarose gel. A 1.469 kb band was cut from the gel and lysed using a Qiagen mini-dissolution column. Five microliters of this PCR product was ligated to 2 microliters of PANT 8 49 vector digested with Bglll and Hindlll in 10 microliters of ligation reaction. After the reaction was incubated at room temperature for 24 hours, the protoplasts of Streptomyces lividans TK24 were deformed. 20 ml of YEME medium was inoculated with frozen Streptomyces lividans TK 4 spore suspension and grown in a 125-ml double-well flask for 48 hours -68- (63) (63) 200418849. The protoplast system was prepared as described in Practical Streptomyces Genetics. The ligation reaction was mixed with the protoplasts, 500 microliters of transformation buffer was added, followed by 5 ml of p buffer. The transformation reaction was spun at 2,750 rpm for 7 minutes, resuspended in 1000 microliters of P buffer and plated on an R2YE plate. After the plate was incubated at 28 ° C for 20 hours, it was covered with 5 ml of LB 0.7% agar containing 250 micrograms / ml thiostrepton. After 7 days, the colonies were picked up on R2YE grids containing 50 μg / ml thiostrepton. Colonies were regrown for 5 days at 28 ° C and stored below. This recombinant microorganism was deposited with the ATCC and was numbered PTA-4022 ° Example 12 2: The transformation of Streptomyces rupture adopts Pigac and Schrempf Appl. Environ Microb., V o 1. 61, No. 1, 3 5 2-3 5 6 (1 995) procedures to transform Streptomyces fissures. Streptomyces rupture R6 593 was cultured in a 20 ml CRM medium on a rotary shaker (250 rpm) at 30 ° C. After 24 hours, cells were harvested by centrifugation at 5,000 rpm for 5 minutes at 4 ° C and resuspended in 10% sucrose in 4 ml of 20 C and centrifuged at 5,000 rpm for 5 minutes at 4 ° C . Shen Jiu was resuspended in 10 ml of 15% glycerol at 4 ° C and centrifuged at 5000 rpm for 5 minutes at 4 ° C. Shen Jiu was resuspended in 2 ml of 15% glycerol containing 100 μg / ml lysozyme at 4 ° C and incubated at 37 ° C for 30 minutes. 'Centrifuge at 4 ° C at 5,000 rpm for 5 minutes. Minutes and resuspended in 2 ° L of 15% glycerol at 4 ° C. Repeat one * times washing with 15% glycerol and resuspend Su Jiu in 1 -69- (64) (64) 200418849 to 2 ml of electro-penetration buffer. Store cells at 80-200 ° C in 50-200 μl portions. The ligation reaction was prepared as described for the transformation of S. lividans. After the ligation reaction was inoculated, the volume was adjusted to 100 µl using dH20, NaCl was added to 0.3 M, and the reaction was extracted with an equal volume of 24: 1: 1 phenol: chloroform: isoamyl alcohol. Add 20 micrograms of glycogen and precipitate the ligated DNA with 2 volumes of 100% ethanol for 30 minutes at -20 ° C. The DNA was allowed to stand in a microcentrifuge for 10 minutes, washed once with 70% ethanol, dried in a speed-vac concentrator for 5 minutes, and resuspended in 5 μl of dH20. A frozen aliquot of the cells was thawed at room temperature and 50 μL / tube of each DNA was dispensed for electrical penetration. Keep cells on ice until use. Add DNA / 1 to 2 μl of dH20 and mix. The cell / DNA mixture was transferred to a 2 mm gap vial pre-chilled on ice (Bio-Rad Laboratories, Richmond, California, USA). Gene PulserTM (Bio-Rad Laboratories) was used to penetrate cells electrically at a setting of 2 kV (10 kV / cm), 25 // F, 400 Ω. The cells were diluted with 0.75 to 1.0 ml of CRM (0-4 ° C), transferred to a 15-mL culture tube and cultured with stirring at 30 ° C for 3 hours. The cells were plated on trypsin soy liquid culture-based agar plates containing 10-30 micrograms / ml thiostrepton. Example 13: High performance liquid chromatography using Waters 2690 Separation Module system (Waters (65) (65) 200418849</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Corp.，Milford, MA，USA)和塡充著粒度 3.5微米的 Symmetry Shield RP82 4.6 x 150 毫米管柱（Waters Corp.， Milford，MA, USA)實施液體層析分離。以1.0毫升/分鐘 的流速使用梯度移動相程式。溶析劑A爲水/乙腈（20 : 1) + 10 mM乙酸銨。溶析劑B爲水/乙腈（20 : 1)。移動相爲 在6分鐘內從12%B到28%B的線性梯度及接著在4分鐘 內包持等溶劑組成於28%B。其後爲在20分鐘內從28%B 到1 00%B的線性梯度及接著在2分鐘內到1 2%B的線性 梯度，再於3分鐘內包持於12%B。 實施例1 4 :質譜分析 將管柱溶析液直接導到ZMD質譜分析儀（Micromass, Manchester，UK)的電噴佈離子源之內。此儀器係使用 Test Juice 參考標準品（Waters Corp·，Milford，MA，USA) 予以校準過且從注射筒栗（Harvard Apparatus, Holliston, Μ A，US A)以10微升/分鐘的流速輸送。該質譜分析儀係 以1 3.2的低質量解析度與1 1.2的高質量解析度操作。使 用m/z 100到600的掃描範圍用10質譜/秒的採集速率收 集光譜。採用的離子化技術爲陽離子電噴佈（ES)。噴佈器 電壓係保持在2900伏且將離子源錐電壓保持在17伏之電 位。 實施例15 :使用ebh基因序列（SEQ ID NO: 1)從其他微生 物分離細胞色素P4 5 0基因 (66) 200418849</span>Corp., Milford, MA, USA) and liquid chromatography were performed on a Symmetry Shield RP82 4.6 x 150 mm column (Waters Corp., Milford, MA, USA) packed with 3.5 micron particles. A gradient mobile phase program was used at a flow rate of 1.0 ml / min. The eluent A was water / acetonitrile (20: 1) + 10 mM ammonium acetate. The eluent B was water / acetonitrile (20: 1). The mobile phase was a linear gradient from 12% B to 28% B in 6 minutes and then held in isocratic solvent at 28% B in 4 minutes. It was followed by a linear gradient from 28% B to 100% B in 20 minutes and then a linear gradient to 12% B in 2 minutes, and then held at 12% B in 3 minutes. Example 14 4: Mass spectrometry The column eluate was directly introduced into the electrospray ion source of a ZMD mass spectrometer (Micromass, Manchester, UK). This instrument was calibrated using a Test Juice reference standard (Waters Corp., Milford, MA, USA) and delivered from a syringe pump (Harvard Apparatus, Holliston, M A, US A) at a flow rate of 10 μl / min. The mass spectrometer operates with a low mass resolution of 13.2 and a high quality resolution of 11.2. Spectra were collected using a scan range of m / z 100 to 600 at an acquisition rate of 10 MS / sec. The ionization technology used is cationic electrospray (ES). The sprayer voltage was maintained at 2900 volts and the ion cone voltage was maintained at a potential of 17 volts. Example 15: Isolation of cytochrome P4 50 gene from other microorganisms using ebh gene sequence (SEQ ID NO: 1) (66) 200418849</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">使用 DNAzol藥劑從一組培養物（ATCC4 3 49 1、 ATCC 1 4 93 0、ATCC 5 3 6 3 0、ATCC 5 3 5 5 0、ATCC 3 9444、 ATCC 4 3 3 3 3、AT C C 3 5 1 6 5 )分離出基因組 DNA。使用該 DNA作爲使用針對ebh基因序列設計的引子進行的PCR 之模板。使用三組引子進行擴增：NPB29-6f (SEQ ID NO:28)和 NPB29-7r (SEQ ID NO:29)，NPB29-16f (SEQ ID NO:50)和 NPB29-17r (SEQ ID NO:51)，及 NPB29-19f (SEQ ID NO:52)和 ΝΡΒ29-20Γ (SEQ ID NO:53)。 以20微升的體積製備PCR反應物，內含20 0- 5 00毫 微克的基因組DNA和前向與反向引子。所有的引子都加 到 1.4-2.0 // Μ 之最後濃度。使用 0.2 微升的</span>Use DNAzol reagent from a group of cultures (ATCC4 3 49 1, ATCC 1 4 93 0, ATCC 5 3 6 3 0, ATCC 5 3 5 5 0, ATCC 3 9444, ATCC 4 3 3 3 3, AT CC 3 5 1 65) Isolate genomic DNA. This DNA was used as a template for PCR using primers designed for the ebh gene sequence. Three sets of primers were used for amplification: NPB29-6f (SEQ ID NO: 28) and NPB29-7r (SEQ ID NO: 29), NPB29-16f (SEQ ID NO: 50), and NPB29-17r (SEQ ID NO: 51) ), And NPB29-19f (SEQ ID NO: 52) and NPB29-20Γ (SEQ ID NO: 53). Prepare a PCR reaction in a volume of 20 microliters, containing 200-500 nanograms of genomic DNA and forward and reverse primers. All primers were added to a final concentration of 1.4-2.0 // Μ. Use 0.2 μl</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">AdvantageTM 2 Taq 酵素（BD Biosciences Clontech，Palo Alto，California, USA)，2 微升的 Advantage1 M 2 Taq 緩衝 液和0.2微升的2.5 mM dNTPs，力□ dH20到20微升以製 備 PCR反應物。循環反應係在 Geneamp®97〇0系統或 Mastercycler® gradient (Eppendorf, Westbury? New York, US A)之上採用下述方案實施的：95°C五分鐘，35循環的 [96 °C 20 秒鐘，54-69°C 30 秒鐘，72°C 2 分鐘]，72°C 7分鐘。預期的PCR產物大小對於NPB29-6f (SEQ ID NO:28)和 NPB29-7r (SEQ ID NO:29)引子對爲 1 469 bp， 對於 NPB29- 16f (SEQ ID NO:50)和 NPB29-17r (SEQ ID NO:51)引子對爲 1 03 4 bp，及 NPB29-19f (SEQ ID NO:52) 和 NPB29-20r (SEQ ID NO:53)引子對爲 1318 bp。於 0.7% 瓊脂糖凝膠上分析PCR反應物。從凝膠上切取具有預期 -72- (67) 200418849 大小的PCR產物並使用Qiagen凝膠萃取法予以純化。純 化產物係使用Big-Dye定序套組於以定序且使用 ΑΒΠ10 定序儀予以分析。 實施例16:質體pPCRscript-ebh之構成</span>AdvantageTM 2 Taq enzyme (BD Biosciences Clontech, Palo Alto, California, USA), 2 μl of Advantage 1 M 2 Taq buffer and 0.2 μl of 2.5 mM dNTPs, dH20 to 20 μl were used to prepare PCR reactions. The cyclic reaction was performed on a Geneamp® 9700 system or Mastercycler® gradient (Eppendorf, Westbury? New York, US A) using the following scheme: 95 ° C for five minutes, 35 cycles of [96 ° C 20 seconds , 54-69 ° C for 30 seconds, 72 ° C for 2 minutes], 72 ° C for 7 minutes. The expected PCR product size is 1 469 bp for NPB29-6f (SEQ ID NO: 28) and NPB29-7r (SEQ ID NO: 29) primer pairs, for NPB29-16f (SEQ ID NO: 50) and NPB29-17r ( The primer pair of SEQ ID NO: 51) is 1 03 4 bp, and the primer pair of NPB29-19f (SEQ ID NO: 52) and NPB29-20r (SEQ ID NO: 53) is 1318 bp. PCR reactions were analyzed on a 0.7% agarose gel. A PCR product with the expected size of -72- (67) 200418849 was cut from the gel and purified using Qiagen gel extraction. The purified products were analyzed using Big-Dye sequencing kits and sequencing using an ΑΒΠ10 sequencer. Example 16: Composition of plastid pPCRscript-ebh</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">使用PCR擴增含有埃坡黴素B羥化酶基因和下游的 鐵氧化還原蛋白基因之1.469 bp DNA片段。50微升PCR 反應物包括5微升Taq緩衝液，2.5微升甘油，1微升的 20毫微克/微升 NPB29_1質體，0.4微升的 25 mM dNTPs，各 1 .0 微升的引子 NPB29-6f(SEQ ID NO:28)和 NPB29-7r(SEQ ID N Ο : 2 9 ) ( 5 微微莫耳 / 微升），3 8 . 1 微升 d H2 〇 和 0.5 微升 Taq 酵素（Stratagene)。在</span>A 1.467 bp DNA fragment containing the epothilone B hydroxylase gene and the downstream ferredoxin gene was amplified using PCR. 50 μl of PCR reaction includes 5 μl of Taq buffer, 2.5 μl of glycerol, 1 μl of 20 ng / μl NPB29_1 plastids, 0.4 μl of 25 mM dNTPs, 1.0 μl of each primer NPB29 -6f (SEQ ID NO: 28) and NPB29-7r (SEQ ID NO: 2 9) (5 picomoles / microliter), 38.1 microliter d H2 0 and 0.5 microliter Taq enzyme (Stratagene) . in</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Gene amp® 9 700系統上採用下述條件實施反應：95°C 5分</span>Reactions were performed on a Gene amp® 9 700 system using the following conditions: 95 ° C 5 minutes</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">鐘，然後30循環的（96t： 30秒鐘，60°C 30秒鐘，72°C 2分鐘），及72°C 7分鐘。使用Qiagen Qiaquick管柱以</span>Clock, then 30 cycles (96t: 30 seconds, 60 ° C for 30 seconds, 72 ° C for 2 minutes), and 72 ° C for 7 minutes. Use Qiagen Qiaquick columns to</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">PCR淸理程序純化PCR產物。將經純化的產物用Bglll和 Hi nd III消化並在0.7%瓊脂糖凝膠上純化。從凝膠上切取 一 1.469 kb帶並使用Qiagen Qiaquick凝膠萃取程序予以 溶析。然後將該片段使用P C R s c r i p t A m p選殖套組於以選 殖到PCRscript Amp載體之內。將含有插入物的菌落於 3 0 - 3 7 °C 下以 2 3 0 - 3 0 0 rp m，1 6 - 2 4 小時，撿取到；1 - 2 毫升 含有100微克/毫升氨节青黴素的LB(Luria Broth)內。使 用 Mo Bio微型質體製備套組實施質體分離。使用Big-Dye 定序套 組經由 循環定 序確定 插入物 的序列 。將 該質體 -73- (68) (68)200418849 命名爲 pPCRscript-ebh。 實施例1 7 : ebh基因的突變生成用以改良產率或變更特異 性 使用得自 Stratagene 的 Quikchange® XL Site-Directed Mutagenesis Kit 和 Quikchange® Multi Site-Directed Mutagenesis Kit在 ebh基因的密碼區內導入突 變。此兩種方法都採用長度爲35-45鹼且含有所欲突變 (SEQ ID NO: 5 4-5 9 fP 77)的DNA引子，一經甲基化的圓 形質體模板和 PfuTUr*b〇®DNA聚合酶（美國專利第 5,545,552和5,866,395和5,948,663號）以產生有加入在突 變生成引子內所載突變的質體模板之複本。隨後使用核酸 內切酶酵素Dpnl消化反應物，選擇地消化該甲基化質體 模板，但留下完整的非甲基化突變質體。除了在Dpnl消 化步驟中將保溫時間從1小時增長到3小時之外，所有的 程序都採用製造商的指示。使用pPCRscript-ebh載體作爲 突變生成的模板。 將1到2微升反應物轉形到XL 1-Blue®電勝任性細胞 或 XL10-G〇ld®超勝任性細胞（SUatagene)。將該細胞在 LA(Luria Agar)100微克/毫升氨苄青黴素板上平板培養到 大於1〇〇群落/板之密度，並在3 0 -3 7°C下保溫24-48小 時。將整個板再懸浮5毫升含有1 00微克/毫升氨苄青黴 素的LB內。經由離心該細胞從該再懸浮細胞而直接分離 出質體，且接著使用Mo Bio微型質體製備程序純化該質 -74- (69) 200418849</span>The PCR product was used to purify the PCR products. The purified product was digested with Bglll and Hind III and purified on a 0.7% agarose gel. A 1.469 kb band was cut from the gel and eluted using the Qiagen Qiaquick gel extraction procedure. This fragment was then cloned into a PCRscript Amp vector using the P C R s c r i p t A m p selection kit. The colonies containing the inserts were picked up at 30-37 ° C for 2 3-3 0 0 rp m, 16-24 hours, 1-2 ml of 100 μg / ml ampicillin LB (Luria Broth). Mo Bio mini plastid preparation kits were used for plastid separation. Use the Big-Dye sequencing kit to determine the sequence of the insert via cyclic sequencing. The plastid -73- (68) (68) 200418849 is named pPCRscript-ebh. Example 17: Mutation Generation of the ebh Gene to Improve Yield or Change Specificity Using the Quikchange® XL Site-Directed Mutagenesis Kit and Quikchange® Multi Site-Directed Mutagenesis Kit from Stratagene to introduce mutations in the coding region of the ebh gene . Both methods use a 35-45 base DNA primer containing the desired mutation (SEQ ID NO: 5 4-5 9 fP 77), a methylated circular plastid template, and PfuTUr * b〇® DNA polymerase (U.S. Patent Nos. 5,545,552 and 5,866,395 and 5,948,663) to produce a copy of a plastid template with mutations contained in mutation-generating primers. The reactant was subsequently digested with the endonuclease enzyme Dpnl to selectively digest the methylated plastid template, but left intact unmethylated mutant plastids. All procedures were followed by the manufacturer's instructions, except that the incubation time was increased from 1 hour to 3 hours during the Dpnl digestion step. The pPCRscript-ebh vector was used as a template for mutation generation. Transform 1 to 2 microliters of the reaction into XL 1-Blue® electric competent cells or XL10-Gold® super competent cells (SUatagene). The cells were plated on a 100 μg / ml ampicillin plate of LA (Luria Agar) to a density of more than 100 colonies / plate, and incubated at 30 to 37 ° C for 24-48 hours. The entire plate was resuspended in 5 ml of LB containing 100 μg / ml ampicillin. The plastids were directly separated from the resuspended cells by centrifuging the cells, and the plastids were then purified using a Mo Bio mini plastid preparation procedure -74- (69) 200418849</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">體。然後使用該質體作爲採用引子NPB29-6f(SEQ ID NO:28)和 NPB29-7r(SEQ ID NO:29)的 PCR 之模板以擴增 突變的表現匣帶。採用以限制酵素Bglll和Hindlll消化 1.469 kb PCR產物來製備該片段以連接到也使用Bglll和 Hindlll消化過的載體pANT849。另外，使用再懸浮細胞 接種20-50毫升含有100微克/毫升氨苄青黴素的LB並在 3 0-3 7 °C下生長 18-24小時。對培養物實施 Qiagen midi-preps 以分離 含有所 欲突變 的質體 DNA。 採 用以限 制酵素 Bglll和Hindlll的消化切取突變的表現匣帶以連接到也 使用Bglll和Hindlll消化過的質體pANT 849。按照所述 在變鉛青鏈黴菌或龜裂鏈黴菌中實施突變體的篩選。 另外，採用 Leung et al.，Technique-A Journal of</span>body. This plastid was then used as a template for PCR using primers NPB29-6f (SEQ ID NO: 28) and NPB29-7r (SEQ ID NO: 29) to amplify the mutant expression cassette. This fragment was prepared using a 1.469 kb PCR product digested with the restriction enzymes Bglll and Hindlll to ligate to the vector pANT849, which was also digested with Bglll and Hindlll. In addition, resuspended cells were used to inoculate 20-50 ml of LB containing 100 µg / ml ampicillin and grow at 30-37 ° C for 18-24 hours. Cultures were subjected to Qiagen midi-preps to isolate plastid DNA containing the desired mutations. Mutated expression cassettes were taken to limit digestion of the enzymes Bglll and Hindlll to connect to pANT 849, a plastid also digested with Bglll and Hindlll. Screening of mutants was performed as described in Streptomyces lividans or Streptomyces lividans. In addition, Leung et al., Technology-A Journal of</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Methods in Cell and Molecular Biology, Vol. 1, No. 1? 11-15 (1989)的方法產生ebh基因的隨機突變庫。使用錳及/ 或減低的d A TP濃度來控制Taq聚合酶的突變生成頻率， 使用Notl來消化質體pCRscript-ebh以線型化該質體。使 用 0.166 M (NH4)2S〇4，0.67 M Tris-HCl pH 8.8，61 mM MgC2，6 7 //M EDTA pH 8.0，1.7毫克/毫升牛血淸白蛋 白）製備聚合酶緩衝液。PCR反應物係使用下列製備成 者：10.0微升經Notl消化的pCRscript-ebh(0.1毫微克/微 升），1 〇微升聚合酶緩衝液，1 . 〇微升1 // Μ -氫硫基乙</span>Methods in Cell and Molecular Biology, Vol. 1, No. 1? 11-15 (1989) generate random mutation libraries of the ebh gene. Manganese and / or reduced d A TP concentration were used to control the mutation generation frequency of Taq polymerase, and Notl was used to digest plastid pCRscript-ebh to linearize the plastid. Polymerase buffer was prepared using 0.166 M (NH4) 2S04, 0.67 M Tris-HCl pH 8.8, 61 mM MgC2, 6 7 // M EDTA pH 8.0, 1.7 mg / ml bovine blood albumin. PCR reactions were prepared using the following: 10.0 μl NotCR-digested pCRscript-ebh (0.1 ng / μl), 10 μl polymerase buffer, 1.0 μl 1 // M-hydrosulfide Jiyi</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">醇，10.0 微升 DMSO，1.0 微升 NPB29-6f(SEQ ID ΝΟ:28) 引子（100微微莫耳/微升），1.0微升NPB29-7r(SEQ DI NO:29)引子（100微微莫耳/微升），10微升的 5 mM -75- (70) (70)200418849</span>Alcohol, 10.0 μl DMSO, 1.0 μl NPB29-6f (SEQ ID NO: 28) primer (100 picomoles / μl), 1.0 μl NPB29-7r (SEQ DI NO: 29) primer (100 picomoles / Μl), 10 μl of 5 mM -75- (70) (70) 200418849</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">MnCU，10.0 微升 l〇 mM dGTP，10.0 微升 2 mM dATP， 10·0 微升 10 mM dTTP，10.0 微升 10 mM dCTP，和 2.0 微升Taq聚合酶。加入dH20到100微升。另外也按照上 述製備沒有 MnCl2的反應物。諸循環反應係在 Geneamp®PCR系統上以下述方案實施的：9 5 °C 1分鐘， 2 5 -3 0循環的（94°C 1分鐘，55°C 3 0秒鐘，7 2 °C 4分 鐘），72°C 7分鐘。使用 Qiagen旋轉管柱在瓊脂糖凝膠 上分離PCR反應物。然後用Bglll和Hindlll消化該等片 段並用Qiagen旋轉管柱純化。接著將純化過的片段連接 到用Bglll和Hindlll消化過的P ANT 8 49質體。在變鉛青 鏈黴菌或龜裂鏈黴菌中實施突變體的篩選。 經鑑定過的突變體之表_ 突變體 位置 _取代_野生型 ebh24-16 92 纈胺酸 異白胺酸   23 7 丙胺酸 苯丙胺酸  ebh25- 1 195 絲胺酸 天冬胺醯胺   294 脯胺酸 絲胺酸  ebh 1 0-53 1 90 酪胺酸 苯丙胺酸   23 1 精胺酸 榖胺酸  ebh24-16d8 92 纈胺酸 異白胺酸 (71)200418849 23 7 丙胺酸 苯丙胺酸   67 榖胺醯胺 精胺酸  e b h 2 4 - 1 6 c 1 1 92 纈胺酸 異白胺酸   93 甘胺酸 丙胺酸   23 7 丙胺酸 苯丙胺酸   3 65 蘇胺酸 異白胺酸  ebh24-16-16 92 纈胺酸 異白胺酸   106 丙胺酸 纈胺酸   23 7 丙胺酸 苯丙胺酸  ebh24-16-74 88 組胺酸 精胺酸   92 纈胺酸 異白胺酸   23 7 丙胺酸 苯丙胺酸  ebhM- 1 8 3 1 離胺酸 榖胺酸   176 纈胺酸 甲硫胺酸  ebh24-16g8 92 纈胺酸 異白胺酸   23 7 丙胺酸 苯丙胺酸   67 榖胺醯胺 精胺酸   13 0 蘇胺酸 異白胺酸   176 丙胺酸 甲硫胺酸</span>MnCU, 10.0 μl 10 mM dGTP, 10.0 μl 2 mM dATP, 10.0 μl 10 mM dTTP, 10.0 μl 10 mM dCTP, and 2.0 μl Taq polymerase. Add dH20 to 100 μl. In addition, a reactant without MnCl2 was also prepared as described above. The cycling reactions were performed on the Geneamp® PCR system with the following protocol: 95 ° C for 1 minute, 25-30 cycles (94 ° C for 1 minute, 55 ° C for 30 seconds, 7 2 ° C for 4 minutes) Minutes), 72 ° C for 7 minutes. PCR reactions were separated on an agarose gel using a Qiagen spin column. The fragments were then digested with Bglll and Hindlll and purified using a Qiagen spin column. The purified fragment was then ligated into P ANT 8 49 plastids digested with Bglll and Hindlll. Screening of mutants in Streptomyces lividans or Streptomyces lividans. Table of identified mutants _ mutant position _ substitution _ wild type ebh24-16 92 valine isoleucine 23 7 alanine phenylalanine ebh25- 1 195 serine asparagine 294 proline Serine ebh 1 0-53 1 90 Tyrosine Phenylalanine 23 1 Arginine Phenylamine ebh24-16d8 92 Valine Isoleucine (71) 200418849 23 7 Alanine Phenylalanine 67 Phenylamine Ethylamine ebh 2 4-1 6 c 1 1 92 Valine isoleucine 93 Glycine alanine 23 7 Alanine phenylalanine 3 65 Threonine isoleucine ebh24-16-16 92 Valine isopropyl Leucine 106 Alanine Valine 23 7 Alanine Phenylalanine ebh24-16-74 88 Histamine Arginine 92 Valine Isoleucine 23 7 Alanine Phenylalanine ebhM- 1 8 3 1 Leucine Phenylamine 176 Valine Methionine ebh24-16g8 92 Valine Isoleucine 23 7 Alanine Phenylalanine 67 Phenamine Amine Arginine 13 0 Threonine Isoleucine 176 Methyl Alanine Amino acid</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">-77- (72) (72)200418849 ebh24-16b9 92 纈胺酸 異白胺酸  23 7 丙胺酸 苯丙胺酸  67 榖胺醯胺 精胺酸  140 蘇胺酸 丙胺酸  176 絲胺酸 甲硫胺酸 實施例1 8 :在表現ebh的細胞內與其突變株內的埃坡黴 素B轉換之比較 於此等實驗中，係於一 1 2 5 -毫升雙穴燒瓶內的2 0毫 升YE ME培養基中接種200微升的變鉛青鏈黴菌TK24， 變鉛青鏈黴菌（pANT849-ebh)，變鉛青鏈黴菌（PANT849-〇1^10-53)，或變鉛青鏈黴菌（1)人1^84941^24-16)的冷凍孢 子製備物並在30°C下，以23 0 rpm保溫48小時。於接種 著變鉛青鏈黴菌（pANT849- ebh)，變鉛青鏈黴菌 (pANT849-ebhl0-53)和變鉛青鏈黴菌（pANT849-ebh24-16) 的培養基中加入1 0微克/毫升的硫鏈絲菌肽。取4毫升的 培養物轉移到1 2 5 -毫升三角燒瓶內的2 0毫升R 5培養基 中並在3 0 °C下，以2 3 0 r p m保溫1 8小時。於每一培養物 中添加埃坡黴素B/100 % EtOH到0.〇5%重量/體積之最後 濃度。除了變鉛青鏈黴菌（pANT849-ebh24-l6)培養物（其 中埃坡黴素B已在48小時之際即完全轉化爲埃坡黴素F) 之外，在0，24，48和72小時採取樣品。以HPLC分析 諸樣品。將結果計算爲相對於在0時的埃坡黴素B之百分 -78- (73)200418849 比。 埃坡黴素B : 時間 TK24 p ANT 8 49- p ANT849- p ANT 849-   (時）  ebh eb h10 - 5 3 ebh24-16   0 1 0 0 % 1 0 0 % 1 0 0 % 1 0 0 %   24 9 9% 7 8% 6 9% 5 6%   48 8 7% 19% 3 9% 0% •  72 8 7% 0% 3%    埃坡黴素F :   -------   時間 TK24 p ANT849- pANT849- ——- p ANT849-   (時）  eb h eb h10 - 5 3 ebh24-16   0 0% 0% 0% ----一 0%   24 0% 4% 9% 23%   48 0% 2 1% 29% 5 2% •  72 0% 14% 4 1% --- 另外，在使用含有ebh基因和其變異體或突變體的表 現質體轉形過的龜裂鏈黴菌宿主細胞內實施埃坡黴素B變 成埃坡黴素F的生物轉化。將1 〇〇微升的凍結龜裂鏈黴菌 轉形株培養物接種到20毫升含有1 〇微克/毫升硫鏈絲菌 肽的 CRM培養基內並在3〇°C下’以23〇_3〇0 rpm培養 1 6-24小時。於每一培養物中添加埃坡黴素B/1 00 % 乙醇 -79- (74) (74)200418849 到0.05%重量/體積之最後濃度。反應典型地係在3〇°C 下’以230-300 rPm培養20-40小時。以HPLC分析測定 埃坡黴素B和F的濃度。 在龜裂鏈黴菌n - 空戀體 __入——-  ebhM- 1 8 5 5%  ebh24-16d8 7 5%  ebh24-16cl1 7 5%  ebh24-16-16 75%  ebh24-16-74 75%  ebh24-16b9 8 0%  ebh24-16g8 8 5% 實施例1 9 :壓實素變成普伐他丁的生物轉換 於一 1 2 5 -毫升燒瓶內的2 0毫升含有1 0微克/毫升硫 鏈絲菌肽的R2YE培養基中接種200微升的變鉛青鏈黴菌 (PANT849)，變鉛青鏈黴菌（pANT849-ebh)的冷凍孢子製 備物並在28°C下，以23 0 rpm保溫72小時。取4毫升培 養物接種到2〇毫升R2YE培養基中並在28t下，以230 rpm生長24小時。將1毫升培養物轉移到一丨5_毫升聚丙 烯培養管內，於每一培養物中加入10微升壓實素（40毫 克/毫升）並在2 8 °C下，以2 5 0 r p m保溫2 4小時。將5 0 0 微升的培養物液體轉移到一新的1 5 -毫升聚丙烯培養管 -80 - (75) 200418849 內。加入5 0 0微升的5 0 mM氫氧化鈉並予以迴轉。加入3 毫升的甲醇並迴轉，將該管在TJ-6桌上型離心機中以 3 000 rpm離心1〇分鐘。以HPLC分析有機相。將壓實素 和普伐他丁的値表爲相對於對照樣變鉛青鏈黴菌 (p ANT 8 49)的値。 表爲起始壓實素濃度之壓實素和普伐他丁之値： 變鉛青鏈黴菌 變鉛青鏈黴菌   (p ANT849) (p ANT849-ebh)  壓實素 3 6% 1 1 %  普伐他 1 1 % 53%  丁</span>-77- (72) (72) 200418849 ebh24-16b9 92 Valine isoleucine 23 7 Alanine Phenylalanine 67 Amine Amine Arginine 140 Threonine Alanine 176 Serine Methyl Thiamine Implementation Example 18: Comparison of the conversion of epothilone B in cells expressing ebh to its mutants. In these experiments, 20 ml of YE ME medium was inoculated in a 125-ml two-well flask. 200 μl of Streptomyces lividans TK24, Streptomyces lividans (pANT849-ebh), Streptomyces lividans (PANT849-〇1 ^ 10-53), or Streptomyces lividans (1) Human 1 ^ 84941 ^ 24-16) and incubate at 30 ° C for 48 hours at 23 0 rpm. 10 μg / ml sulfur was added to the medium inoculated with Streptomyces lividans (pANT849-ebh), Streptomyces lividans (pANT849-ebhl0-53), and Streptomyces lividans (pANT849-ebh24-16). Streptomycin. 4 ml of the culture was transferred to 20 ml of R 5 medium in a 125-ml Erlenmeyer flask and incubated at 30 ° C for 18 hours at 230 r pm. Epothilone B / 100% EtOH was added to each culture to a final concentration of 0.05% weight / volume. Except for the culture of Streptomyces lividans (pANT849-ebh24-16), in which epothilone B has been completely converted to epothilone F within 48 hours, at 0, 24, 48, and 72 hours Take a sample. The samples were analyzed by HPLC. The result was calculated as a percentage of epothilone B at -78- (73) 200418849 ratio at 0. Epothilone B: Time TK24 p ANT 8 49- p ANT849- p ANT 849- (hours) ebh eb h10-5 3 ebh24-16 0 1 0 0% 1 0 0% 1 0 0% 1 0 0% 24 9 9% 7 8% 6 9% 5 6% 48 8 7% 19% 3 9% 0% • 72 8 7% 0% 3% epothilone F: ------- time TK24 p ANT849- pANT849- ——- p ANT849- (time) eb h eb h10-5 3 ebh24-16 0 0% 0% 0% ----- 0% 24 0% 4% 9% 23% 48 0% 2 1% 29% 5 2% • 72 0% 14% 4 1% --- In addition, the use of E. pylori in host cells of Streptomyces lividans transformed with a plastid-containing transformant that contains the ebh gene and its variants or mutants Biotransformation of B into Epothilone F. One hundred microliters of a frozen Streptomyces lividans transformant culture was inoculated into 20 ml of CRM medium containing 10 micrograms / ml thiostrepton and at 30 ° C to 23-30 ° C. Incubate at 0 rpm for 16-24 hours. Add epothilone B / 1 00% ethanol -79- (74) (74) 200418849 to a final concentration of 0.05% weight / volume in each culture. The reaction is typically incubated at 30 ° C for 20-40 hours at 230-300 rPm. The concentrations of epothilone B and F were determined by HPLC analysis. In Streptomyces chrysophyllum n-empty body __ into --- ebhM- 1 8 5 5% ebh24-16d8 7 5% ebh24-16cl1 7 5% ebh24-16-16 75% ebh24-16-74 75% ebh24 -16b9 8 0% ebh24-16g8 8 5% Example 19: Bioconversion of compaction into pravastatin 20 ml in a 125-ml flask containing 10 micrograms / ml of Streptomyces The peptide's R2YE medium was inoculated with 200 microliters of Streptomyces lividans (PANT849), frozen spore preparations of Streptomyces lividans (pANT849-ebh) and incubated at 28 ° C for 72 hours at 23 0 rpm. 4 ml of the culture was inoculated into 20 ml of R2YE medium and grown at 230 rpm for 24 hours at 28 t. Transfer 1 ml of the culture to a 5-ml ml polypropylene culture tube. Add 10 μL of vasopressin (40 mg / ml) to each culture and incubate at 28 ° C at 250 rpm. Incubate for 24 hours. Transfer 500 microliters of the culture fluid into a new 15-ml polypropylene culture tube -80-(75) 200418849. Add 500 microliters of 50 mM sodium hydroxide and swirl. 3 ml of methanol was added and rotated, and the tube was centrifuged in a TJ-6 table centrifuge at 3 000 rpm for 10 minutes. The organic phase was analyzed by HPLC. The slugs of compactin and pravastatin are shown as slugs of Streptomyces lividans (p ANT 8 49) relative to the control. The table shows the initial compaction concentration of compactin and pravastatin: Streptomyces lividans (P ANT849) (p ANT849-ebh) Compaction 3 6% 1 1% Vastat 1 1% 53% D</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">實施例20 :壓實素和普伐他丁偵檢所用的高性能液體層 析術</span>Example 20: High-performance liquid tomography for compaction and pravastatin detection</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">液體層析術分離係使用Hewlett Packard 1 090 Series Separation 系統(Agilent Technologies， Palo Alto, California, US A)和塡充著粒度爲 5 微米的 Spherisorb OD S2 的 5 0 x 46 毫米管柱（K e y s t ο n e S c i e n t i f i c，I n c .， Bellefonte，Pennsylvania，USA)實施的。以 2.0 毫升 / 分鐘 的流速使用梯度移動相程式。溶析劑A爲水，1 0 mM乙 酸銨和0.05 %磷酸。溶析劑B爲乙腈。移動相爲4分鐘內 從2 0%B到90%B的線型梯度。 -81 - (76) 200418849 實施例21 :突變體ebh25-l的生物轉換產物之構造測定 分析型 HPLC 係使用 Hewlett Packard 1100 Series Liquid Chromatograph與4.6毫米內徑 x 15公分長度的 YMC Packed ODS-AQ管柱實施的。使用水（溶劑A)和乙腈 (溶劑B)的梯度系統：20%到90%B線型梯度，10分鐘； 9 0%到20%線型梯度，2分鐘。流素爲1毫升/分鐘且UV 偵檢係在2 5 4奈米進行。</span>The liquid chromatography separation system uses a Hewlett Packard 1 090 Series Separation system (Agilent Technologies, Palo Alto, California, US A) and a 50 x 46 mm column (K eyst) packed with Spherisorb OD S2 with a particle size of 5 μm. ne Scientific, Inc., Bellefonte, Pennsylvania, USA). Use a gradient mobile phase program at a flow rate of 2.0 ml / min. The eluent A was water, 10 mM ammonium acetate and 0.05% phosphoric acid. The eluent B is acetonitrile. The mobile phase is a linear gradient from 20% B to 90% B in 4 minutes. -81-(76) 200418849 Example 21: Structural determination of the biotransformation product of mutant ebh25-1 Analytical HPLC is a YMC Packed ODS-AQ tube using Hewlett Packard 1100 Series Liquid Chromatograph and 4.6 mm ID x 15 cm length Column implemented. Gradient system using water (solvent A) and acetonitrile (solvent B): 20% to 90% B linear gradient, 10 minutes; 90% to 20% linear gradient, 2 minutes. The flow rate was 1 ml / min and UV detection was performed at 254 nm.</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">製備型HPLC係使用下列儀器和條件實施的： ^ * Varian ProStar Solvent Delivery Module (Varian Inc., Palo Alto，California，USA)。偵檢器：Gynkotek UVD3 40 S 〇 管柱：YMC ODS-A管柱（30毫米內徑 X 100毫米長 度，5微米粒度）。 溶析流速：30毫升/分鐘</span>Preparative HPLC was performed using the following instruments and conditions: Varian ProStar Solvent Delivery Module (Varian Inc., Palo Alto, California, USA). Detector: Gynkotek UVD3 40 S 〇 Column: YMC ODS-A column (30 mm ID x 100 mm length, 5 micron particle size). Dissolution flow rate: 30 ml / min</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">溶析梯度：（溶劑 A :水；溶劑B :乙腈）20%B，2 分鐘；20%到60%B線型梯度，1 8分鐘；60%B，2分鐘； 60%到 90%B線型梯度，1分鐘；90%B，3分鐘；90%到 20%B線型梯度，2分鐘。 偵檢：UV，210奈米 LC/NMR係按下述實施：將40微升樣品注射到YMC ?&amp;amp;〇让6〇1003-人(3管柱（4.6毫米內徑 X 15公分長度）內。使 用D20(溶劑A)和乙腈-d3(溶劑B)梯度系統：30%B，1分 鐘；30%到80%B線型梯度，11分鐘，以1毫升/分鐘流 速溶析該管柱。溶析液係通過一 UV偵檢吸光匣（於254 -82- (77) (77)200418849 奈米監測）後再流過在 Varian AS-600 NMR分光計中的 F19/H1NMR探器。生物轉換產物係於約7.5分鐘處溶析 出並以人工停止流動使溶析液保留在NMR探器內供NMR 數據收集所用。 分離和分析係按下述實施的。將丁醇/甲醇萃取液（約 1〇毫升）在氮氣流下蒸發乾。於剩餘物（38毫克）中加入1 毫升甲醇並經由離心（ 1 3 000 r*pm，2分鐘）移除調不溶性物 質。使用0. 1毫升的上澄液進行LC/NMR硏究並用剩餘的 0.9毫升進行製備型HPLC (0.2-0.4毫升每次注射）。觀察 到兩個主要層析峰並予以收集：峰A係在1 4與1 5分鐘 之間溶析出，而峰B係在1 6.5與1 7.5分鐘之間溶析出。 分析型HPLC分析顯示出峰B微母化合物，埃坡黴素B (Rt 8.5分鐘）而峰A爲生物轉換產物（Rt 7.3分鐘）。將峰 A液份合倂並以該合倂液份取得MS分析數據。將該合倂 液份蒸發到小體積，然後冷凍乾燥而得3毫克白色固體。 該白色固體（溶解於甲醇中）的NMR和HPLC分析揭曉出 該生物轉換產物在乾燥過程中有發生部份分解。 【圖式簡單說明】</span>Dissolution gradient: (solvent A: water; solvent B: acetonitrile) 20% B, 2 minutes; 20% to 60% B linear gradient, 18 minutes; 60% B, 2 minutes; 60% to 90% B linear gradient , 1 minute; 90% B, 3 minutes; 90% to 20% B linear gradient, 2 minutes. Detection: UV, 210 nm LC / NMR is implemented as follows: 40 microliters of sample is injected into YMC® &amp;amp; 0 Jean 6〇1003-person (3 columns (4.6 mm inner diameter X 15 cm length) .D20 (solvent A) and acetonitrile-d3 (solvent B) gradient system: 30% B, 1 minute; 30% to 80% B linear gradient, 11 minutes, the column was eluted at a flow rate of 1 ml / min. The eluate was passed through a UV detection absorber (monitored at 254 -82- (77) (77) 200418849 nm) and then passed through a F19 / H1NMR detector in a Varian AS-600 NMR spectrometer. Biotransformation products It was dissolved at about 7.5 minutes and the flow was manually stopped to keep the lysate in the NMR probe for NMR data collection. Isolation and analysis were performed as follows. The butanol / methanol extraction solution (about 10%) was used. Ml) was evaporated to dryness under a stream of nitrogen. To the residue (38 mg) was added 1 ml of methanol and the insoluble matter was removed by centrifugation (13 000 r * pm, 2 minutes). 0.1 ml of the upper solution was used LC / NMR studies and preparative HPLC with the remaining 0.9 mL (0.2-0.4 mL per injection). Two main chromatographic peaks were observed and collected Peak A was eluted between 14 and 15 minutes, and Peak B was eluted between 1 6.5 and 1 7.5 minutes. Analytical HPLC analysis revealed the peak B micro-mother compound, epothilone B (Rt 8.5 minutes) and peak A is a biotransformation product (Rt 7.3 minutes). Peak A liquid was combined and MS analysis data was obtained with the combined liquid. The combined liquid was evaporated to a small volume, and then freeze-dried. 3 mg of white solid was obtained. NMR and HPLC analysis of the white solid (dissolved in methanol) revealed that the biotransformation product was partially decomposed during the drying process. [Schematic description]</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">圖1提出在1 999年12月21日提出申請的WO 00/3 92 76，美國申請序號0 9/468,8 5 4，中所述用東方鏈黴 菌菌株SC15847 (PTA 1 043 )將埃坡黴素B變成埃坡黴素F 的生物轉換之示意圖。 圖2顯示出用來設計選殖編碼埃坡黴素B羥化酶的核 -83- (78) (78)200418849 酸序列所用PCR引子之SEQ ID NO:5到SEQ ID NO:22的 序列排比（alignment)。 圖3顯示出埃坡黴素B羥化酶（SEQ ID NO:2)與 五1^?(?〇3編碼1】1&amp;gt;1鏈人；3£(51〇1^0:76)之間的序列排 比。星號指出序列相同性之處，冒號（··）爲類似殘基處。 圖4提出以圖3中所示與EryF的序列排比爲基礎之 埃坡黴素B羥化酶同質性模型。 圖5顯示出埃坡黴素B羥化酶模型（以虛線指示者）相 對於 EryF(PDB編碼1JIN ;以貫線指不者）的重標繪 圖。使用5 1個殘基的平均窗尺寸，亦即在一所給殘基位 置處的能量係以該所給殘基爲中心位置的序列中所含51 個殘基的能量平均値計算。</span>Figure 1 filed WO 00/3 92 76, filed on December 21, 999, U.S. Application Serial No. 0 9/468, 8 54, as described in Streptomyces orientalis strain SC15847 (PTA 1 043) Schematic of the bioconversion of mycin B into epothilone F. Figure 2 shows the sequence alignment of SEQ ID NO: 5 to SEQ ID NO: 22 used to design a nuclear-83- (78) (78) 200418849 acid sequence encoding the epothilone B hydroxylase. (Alignment). Figure 3 shows epothilone B hydroxylase (SEQ ID NO: 2) and five 1 ^? (? 03 code 1) 1 &amp;gt; 1 chain of people; 3 £ (51〇1 ^ 0: 76) Sequence alignment. The asterisk indicates the sequence identity, and the colon (··) indicates similar residues. Figure 4 proposes the homogeneity of epothilone B hydroxylase based on the sequence alignment of EryF shown in Figure 3 Model. Figure 5 shows rescaling plots of the epothilone B hydroxylase model (indicated by dashed lines) against EryF (PDB code 1JIN; indicated by dashes). An average window of 51 residues was used. The size, that is, the energy at a given residue position, is calculated by averaging the energy of 51 residues in a sequence centered at the given residue.</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">-84- (79) (79)200418849 5 APPENDIX 1</span>-84- (79) (79) 200418849 5 APPENDIX 1</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Atom No. Residue Atom Name X-coord Y-coord Z-coord  1 ALA9 N -39.918 -4.913 -1.651  2 ALA9 CA -38.454 »5.033 -1.537  3 ALA9 C -37.953 -4.886 -0.099  4 ALA9 〇 -38.625 -4.31 0.765  5 ALA9 C巳 -37.809 -3.967 -2.415  6 THR10 N -36.781 -5.447 0.146  7 THR10 CA -36.187 -5.437 1.49  8 THR10 C -34.916 -4.585 1.553  9 THR10 〇 -34.016 -4.735 0.72  10 THR10 CB -35.871 -6.887 1.846  11 THR10 〇G1 -37.075 -7.631 1.717  12 THR10 CG2 -35.355 -7.053 3.271  13 LEU11 N -34.858 -3.699 2.536  14 LEU11 CA -33.669 -2.853 2.745  15 LEU11 C -32.511 -3.649 3.353  16 LEU11 〇 -32.706 -4.468 4.259  17 LEU11 CB -34.033 -1.707 3.687  18 LEU11 CG -35.079 -0.78 3.078  19 LEU11 CD1 -35.53 0.265 4.091  20 LEU11 CD2 -34.555 -0.111 1.81  21 PR012 N -31.32 -3.422 2.823  22 PR012 CA -30.121 -4.119 3.302  23 PR012 C -29.652 -3.606 4.663  24 PR012 〇 -29.656 -2.397 4.918  25 PR012 CB -29.081 -3:842 2.259  26 PR012 CG -29.597 -2.771 1.309  27 PR012 CD -31.031 ‘2.493 1.729  28 LEU13 N -29.278 -4.522 5.54  29 LEU13 CA •28.676 -4.118 6.819  30 LEU13 C -27.183 -3.88 6.627  31 LEU13 〇 -26.449 -4.806 6.267  32 LEU13 CB -28.898 •5.196 7.872  33 LEU13 CG -30.374 -5.354 8.217  34 LEU13 CD1 -30.587 -6.516 9.181  35 LEU13 CD2 -30.945 -4.067 8.802  36 ALA14 N -26.72 -2.741 7.112  37 ALA14 CA •25.355 -2.266 6.825  38 ALA14 C -24.244 -2.941 7.634  39 ALA14 〇 -23.058 -2.719 7.372  40 ALA14 CB -25.311 -0.764 7.075  41 ARG15 N -24.628 -3.792 8.569  42 ARG15 CA -23.664 -4.537 9.379  43 ARG15 C -23.478 -5.983 8.91  44 ARG15 〇 -22.815 -6.767 9.599  45 ARG15 CB -24.174 -4.519 10.81  46 ARG15 CG -25.655 -4.879 10.84  47 ARG15 CD -26.2 -4.843 12.26  48 ARG15 NE -27.657 -5.039 12.256  49 ARG15 CZ -28.358 -5.301 13.36  50 ARG15 NH1 -29.69 -5.376 13.3  51 ARG15 NH2 -27.735 -5.412 14.536  52 LYS16 N -24.096 -6.351 7.798 85- (80) LYS16 CA -24.016 -7.741  LYS16 C -22.639 -8.128  LYS16 〇 -21.959 -7.359  LYS16 C巳 -25.061 -7.977  LYS16 CG -26.466 -7.985  LYS16 CD -26.605 -9.079  LYS16 CE -28.002 -9.092  LYS16 NZ -28.113 -10.128  CYS17 N -22.317 -9.392  CYS17 CA -21.061 -10.004  CYS17 C -20.737 -9.771  CYS17 〇 -19.662 -9.205  CYS17 CB -21.096 -11.501  CYS17 SG -21.33 -11.937  PR018 N -21.635 -10.003  PR018 CA •21.293 -9.756  PR018 C -21.123 -8.291  PR018 〇 -21.013 -8.061  PR018 CB -22.388 -10.383  PR018 CG -23.509 -10.812  PR018 CD •23.002 -10.554  PHE19 N -21.137 -7.33  PHE19 CA -20.792 -5.947  PHE19 C -19.279 -5.777  PHE19 〇 -18.789 -4.92  PHE19 CB -21.36 -5.007  PHE19 CG -22.8 -4.568  PHE19 CD1 -23.051 -3.27  PHE19 CD2 -23.856 -5.444  PHE19 CE1 -24.355 -2.853  PHE19 CE2 -25.159 -5.03  PHE19 CZ &amp;gt;25.409 -3.735  SER20 N Ί 8.573 -6.687  SER20 CA -17.102 -6.717  SER20 C -16.569 -7.839  SER20 〇 -16.632 -7.723  SER20 CB -16.557 -5.371  SER20 〇G -17.236 -5.019  PR021 N -15.974 -8.867  PR021 CA -15.978 •9.134  PR021 C -17.267 -9.836  PR021 〇 -18.026 -10.327  PR021 CB -14.8 -10.047  PR021 CG -14.442 -10.669  PR021 CD -15.306 -9.949  PR022 N -17.551 •9.859  PR022 CA -16.897 -9.007  PR022 C -17.4 -7.575  PR022 〇 •18.341 -7.371  PR022 C巳 -17.32 -9.591  PR022 CG -18.478 -10.549  PR022 CD -18.669 -10.604  PR023 N -16.687 -6.605  PR023 CA -17.224 -5.241 -86- (81) PR023 C -18.525 -5.21  PR023 〇 -18.524 -5.083  PR023 C巳 &amp;gt;16.159 •4.417  PR023 CG -15.004 -5.321  PR023 CD -15.388 -6.725  GLU24 N -19.62 -5.122  GLU24 CA -20.963 -5.192  GLU24 C -21.415 -3.843  GLU24 〇 •22.323 -3.794  GLU24 CB -21.934 -5.68  GLU24 CG -23.27 -6.137  GLU24 CD -23.982 -7.017  GLU24 〇E1 -24.613 -7.981  GLU24 〇E2 -23.833 -6.745  TYR25 N -20.573 -2.843  TYR25 CA -20.842 -1.47  TYR25 C -20.704 -1.311  TYR25 〇 -21.364 -0.436  TYR25 CB -19.828 -0.568  TYR25 CG -19.616 -0.882  TYR25 CD1 •20.662 -0.753  TYR25 CD2 -18.364 -1.298  TYR25 CE1 -20.461 -1.062  TYR25 CE2 -18.163 -1.605  TYR25 CZ -19.213 •1.492  TYR25 OH *19.026 -1.859  GLU26 N -20.1 -2.296  GLU26 CA -20.009 -2.293  GLU26 C -21.404 -2.483  GLU26 〇 -21.92 -1.572  GLU26 CB -19.129 -3.454  GLU26 CG -17.813 •3.593  GLU26 CD -16.94 -2.342  GLU26 〇E1 -16.345 -2.12  GLU26 〇E2 -16.773 -1.731  ARG27 N -22.105 -3.488  ARG27 CA -23.437 -3.805  ARG27 C -24.504 -2.909  ARG27 〇 -25.496 -2.591  ARG27 CB -23.752 -5.26  ARG27 CG -22.7 -6.189  ARG27 CD -23.031 -7.653  ARG27 NE -23.146 -7.926  ARG27 CZ -22.251 -8.648  ARG27 NH1 -21.16 -9.11  ARG27 NH2 -22.428 -8.879  LEU28 N -24.197 -2.331  LEU28 CA -25.11 -1.358  LEU28 C -25.131 -0.079  LEU28 〇 -26.214 0.286  LEU28 CB -24.67 -1.039  LEU28 CG -24.868 -2.224  LEU28 CD1 -24.303 -1.916  LEU28 CD2 -26.34 -2.609 -87- (82) ARG29 N -23.969 0.307  ARG29 CA -23.835 1.502  ARG29 C -24.521 1.334  ARG29 〇 -25.271 2.226  ARG29 C巳 -22.345 1.682  ARG29 CG -21.997 2.947  ARG29 CD -20.519 2.941  ARG29 NE -19.696 2.563  ARG29 CZ -18.945 1.459  ARG29 NH1 -18.872 0.673  ARG29 NH2 -18.265 1.145  ARG30 N -24.494 0.109  ARG30 CA -25.112 -0.208  ARG30 C -26.629 -0.386  ARG30 〇 -27.282 -0.429  ARG30 CB -24.503 -1.512  ARG30 CG -22.992 -1.401  ARG30 CD -22.376 -2.745  ARG30 NE -20.909 -2.659  ARG30 CZ -20.12 -3.648  ARG30 NH1 -20.658 -4.772  ARG30 NH2 -18.793 -3.508  GLU31 N -27.194 -0.493  GLU31 CA -28.653 -0.576  GLU31 C -29.207 0.713  GLU31 〇 -30.393 1.032  GLU31 CB -29.025 -1.746  GLU31 CG -28.381 -3.055  GLU31 CD -28.814 -3.443  GLU31 〇E1 •30.013 -3.448  GLU31 〇E2 -27.961 -3.944  SER32 N -28.319 1.439  SER32 CA -28.652 2.672  SER32 C -27.386 3.393  SER32 〇 -26.706 2.984  SER32 CB -29.509 2.309  SER32 〇G -28.842 1.268  PR033 N -27.148 4.543  PR033 CA -26.039 5.408  PR033 C -26.227 5.972  PR033 〇 -25.241 6.254  PR033 CB -26.023 6.511  PR〇33 CG -27.203 6.364  PR033 CD -27.933 5.107  VAL34 N -27.478 6.094  VAL34 CA -27.83 6.472  VAL34 C -28.828 5.447  VAL34 〇 -30.01 5.467  VAL34 CB -28.483 7.85  VAL34 CG1 -28.789 8.339  VAL34 CG2 -27.616 8.865  SER35 N -28.344 4.546  SER35 CA -29.186 3.438  SER35 C -29.512 3.536 - 88- (83) SER35 〇 -28.615 3.692  SER35 CB -28.456 2.126  SER35 〇G •27.19 2.169  ARG36 N -30.785 3.413  ARG36 CA -31.168 3.431  ARG36 C -30.894 2.072  ARG36 〇 -31.516 1.059  ARG36 C巳 -32.645 3.779  ARG36 CG -33.016 3.857  ARG36 CD -34.513 4.047  ARG36 NE -34.987 5.35  ARG36 CZ -36.272 5.582  ARG36 NH1 -37.16 4.59  ARG36 NH2 -36.662 6.791  VAL37 N -29.921 2.067  VAL37 CA -29.543 0.855  VAL37 C -29.982 0.926  VAL37 〇 -30.313 1.995  VAL37 CB -28.03 0.681  VAL37 CG1 -27.591 0.391  VAL37 CG2 -27.298 1.898  GLY38 N -30.064 -0.24  GLY38 CA -30.404 -0.332  GLY38 C -29.151 -0.563  GLY38 〇 -28.562 -1.652  LEU39 N -28.764 0.463  LEU39 CA -27.607 0.399  LEU39 C -27.911 -0.554  LEU39 〇 -29.028 -1.085  LEU39 CB -27.353 1.814  LEU39 CG -26.198 2.546  LEU39 CD1 -26.368 2.665  LEU39 CD2 -26.011 3.925  PRO40 N -26.919 -0.869  PRO40 CA •27.183 -1.62  PRO40 C -28.423 -1.116  PRO40 〇 -28.771 0.073  PRO40 C巳 -25.933 -1.51  PRO40 CG -24.84 -0.886  PRO40 CD -25.497 -0.52  SER41 N -29.188 •2.109  SER41 CA -30.511 -1.986  SER41 C -31.548 -1.213  SER41 〇 -32.379 -0.492  SER41 C巳 •30.387 -1.382  SER41 〇G -30.036 -0.008  GLY42 N -31.474 -1.34  GLY42 CA -32.521 -0.831  GLY42 C •32.557 0.686  GLY42 〇 -33.59 1.208  GLN43 N -31.471 1.392  GLN43 CA -31.501 2.847  GLN43 C -31.201 3.16  GLN43 〇 -30.079 2.955 89- (84) GLN43 C巳 -30.507 3.53  GLN43 CG -30.681 5.05  GLN43 CD -29.873 5.699  GLN43 〇E1 -30.31 6.682  GLN43 NE2 -28.723 5.116  THR44 N -32.227 3.582  THR44 CA -32.096 3.832  THR44 C -31.194 5.02  THR44 〇 -31.231 6.071  THR44 CB -33.475 4.077  THR44 〇G1 -34.009 5.268  THR44 CG2 -34.428 2.923  ALA45 N -30.35 4.799  ALA45 CA &amp;gt;29.426 5.833  ALA45 C -29.16 5.718  ALA45 〇 -29.105 4.619  ALA45 C巳 -28.115 5.705  TRP46 N -28.989 6.859  TRP46 CA -28.702 6.865  TRP46 C -27.212 6.698  TRP46 〇 -26.408 7.589  TRP46 CB -29.185 8.173  TRP46 CG -30.693 8.309  TRP46 CD1 •31.509 9.009  TRP46 CD2 -31.552 7.723  TRP46 NE1 -32.788 8.894  TRP46 CE2 -32.862 8.146  TRP46 CE3 &amp;gt;31.324 6.922  TRP46 CZ2 -33.913 7.774  TRP46 CZ3 -32.389 6.538  TRP46 CH2 -33.68 6.967  ALA47 N -26.863 5.559  ALA47 CA -25.475 5.257  ALA47 C -25.153 5.708  ALA47 〇 -25.772 5.272  ALA47 CB -25.248 3.756  LEU48 N -24.185 6.602  LEU48 CA -23.751 7.129  LEU48 C -22.648 6.252  LEU48 〇 -21.546 6.197  LEU48 CB -23.222 8.543  LEU48 CG -24.27 9.464  LEU48 CD1 -23.707 10.863  LEU48 CD2 -25.524 9.515  THR49 N -22.948 5.601  THR49 CA -22.01 4.636  THR49 C -21.197 5.214  THR49 〇 -20.047 4.803  THR49 CB -22.774 3.391  THR49 〇G1 -23.783 3.769  THR49 CG2 -23.458 2.703  ARG50 N -21.724 6.2  ARG50 CA -20.899 6.838  ARG50 C -20.007 7.927 90- (85) ARG50 〇 -20.456 8.712  ARG50 C巳 -21.737 7.467  ARG50 CG -22.426 6.441  ARG50 CD -22.852 7.085  ARG50 NE -23.597 8.327  ARG50 CZ -23.779 9.27  ARG50 NH1 -24.462 10.375  ARG50 NH2 -23.274 9.111  LEU51 N -18.92 8.175  LEU51 CA -17.931 9.19  LEU51 C -18.52 10.584  LEU51 〇 -18.42 11.426  LEU51 C巳 -16.726 9.066  LEU51 CG -15.377 9.193  LEU51 CD1 -14.233 9.154  LEU51 CD2 -15.267 10.433  GLU52 N -19.404 10.68  GLU52 CA &amp;gt;20.088 11.93  GLU52 C -21.101 12.314  GLU52 〇 -21.114 13.477  GLU52 CB -20.821 11.759  GLU52 CG -19.897 11.56  GLU52 CD -19.749 10.09  GLU52 〇E1 -19.796 9.24  GLU52 ' 〇E2 -19.502 9.849  ASP53 N -21.659 11.313  ASP53 CA -22.646 11.572  ASP53 C -21.953 11.905  ASP53 〇 -22.4 12.804  ASP53 CB -23.493 10.322  ASP53 CG -24.263 9.94  ASP53 〇D1 -24.319 8.749  ASP53 〇D2 -24.633 10.838  ILE54 N -20.75 11.382  ILE54 CA -19.991 11.62  ILE54 C -19.301 12.976  ILE54 〇 &amp;gt;19.36 13.7  ILE54 CB -18.963 10.509  ILE54 CG1 -19.674 9.167  ILE54 CG2 -18.113 10.671  ILE54 CD1 -18.677 8.03  ARG55 N -18.916 13.43  ARG55 CA -18.346 14.776  ARG55 C -19.44 15.836  ARG55 〇 -19.252 16.893  ARG55 CB -17.551 14.883  ARG55 CG -16.293 14.028  ARG55 CD -15.498 14.133  ARG55 NE -16.277 13.61  ARG55 CZ -15.712 13.028  ARG55 NH1 -14.383 12.947  ARG55 NH2 -16.475 12.553  GLU56 N -20.64 15.438  GLU56 CA -21.795 16.331 -91 - (86)200418849 377 GLU56 C -22.287 16.444 -1.539  378 GLU56 〇 -22.628 17.546 -1.095  379 GLU56 C巳 -22.875 15.722 -3.866  380 GLU56 CG -24.103 16.605 -4.028  381 GLU56 CD &amp;gt;25.112 15.838 -4.874  382 GLU56 〇E1 -25.906 16.463 -5.56  383 GLU56 OE2 -25.055 14.616 -4.834  384 MET57 N -22.065 15.392 -0.767  385 MET57 CA -22.379 15.386 0.665  386 MET57 C -21.4 16.241 1.459  387 MET57 〇 -21.827 17.091 2.248  388 MET57 C巳 -22.242 13.948 1.141  389 MET57 CG -22.423 13.805 2.646  390 MET 57 SD -21.979 12.184 3.306  391 MET57 CE -20.221 12.196 2.89  392 LEU58 N -20.14 16.197 1.056  393 LEU58 CA -19.089 16.973 1.726  394 LEU58 C -19.07 18.444 1.307  395 LEU58 〇 -18.398 19.263 1.946  396 LEU58 CB -17.751 16.327 1.389  397 LEU58 CG -17.638 14.941 2.013  398 LEU58 CD1 -16.504 14.133 1.394  399 LEU58 CD2 -17.49 15.03 3.528  400 SER59 N -19.807 18.776 0.261  401 SER59 CA -19.959 20.171 -0.144  402 SER59 C -21.305 20.739 0.304  403 SER59 〇 -21.531 21.951 0.204  404 SER59 CB -19.852 20.24 -1.661  405 SER59 〇G -18.59 19.697 -2.022  406 SER60 N -22.175 19.879 0.807  407 SER60 CA -23.5 20.318 1.246  408 SER60 C -23.505 20.806 2.685  409 SER60 〇 -23.464 19.996 3.62  410 SER60 C巳 -24.477 19.156 1.138  411 SER60 〇G -25.689 19.581 1.749  412 PR061 N •23.91 22.058 2.835  413 PR061 CA -24.023 22.695 4.154  414 PR061 C -25.231 22.233 4.983  415 PR061 〇 -25.41 22.7 6.113  416 PR061 C巳 -24.145 24.157 3.853  417 PR061 CG -24.401 24.343 2.364  418 PR061 CD -24.301 22.959 1.747  419 HIS62 N -26.044 21.333 4.451  420 HIS62 CA -27.21 20.856 5.18  421 HIS62 C -26.949 19.497 5.813  422 HIS62 〇 -27.863 18.935 6.427  423 HIS62 CB -28.379 20.764 4.214  424 HIS62 CG -28.703 22.084 3.55  425 HIS62 ND1 -28.955 23.252 4.171  426 HIS62 CD2 -28.796 22.32 2.198  427 HIS62 CE1 -29.197 24.205 3.248  428 HIS62 NE2 -29.098 23.627 2.029  429 PHE63 N -25.765 18.945 5.596  430 PHE63 CA -25.385 17.693 6.258 92- (87) PHE63 C -24.492 17.977  PHE63 〇 -23.261 17.885  PHE63 CB -24.686 16.783  PHE63 CG •25.651 16.13  PHE63 CD1 -26.92 15.76  PHE63 CD2 -25.265 15.901  PHE63 CE1 -27.804 15.161  PHE63 CE2 -26.147 15.298  PHE63 CZ -27.415 14.928  SER64 N -25.159 18.211  SER64 CA -24.502 18.656  SER64 C -23.765 17.525  SER64 〇 -24.07 16.34  SER64 C巳 -25.587 19.225  SER64 〇G -24.96 19.785  SER65 N -22.719 17.898  SER65 CA -22.006 16.938  SER65 C -22.463 17.032  SER65 〇 -22.031 16.247  SER65 CB -20.522 17.234  SER65 〇G -20.167 17.174  ASP66 N -23.368 17.961  ASP66 CA -23.901 18.186  ASP66 C -25.388 18.496  ASP66 〇 -25.978 18.026  ASP66 CB -23.149 19.393  ASP66 CG -22.904 19.311  ASP66 〇D1 -21.835 19.724  ASP66 OD2 -23.871 19.048  ARG67 N -25.972 19.246  ARG67 CA -27.32 19.831  ARG67 C -28.423 18.78  ARG67 〇 -28.768 18.296  ARG67 CB •27.384 20.684  ARG67 CG -26.263 21.716  ARG67 CD -26.329 22.778  ARG67 NE -25.137 23.64  ARG67 CZ -25.091 24.799  ARG67 NH1 -26.189 25.28  ARG67 NH2 -23.957 25.503  GLN68 N •28.983 18.45  GLN68 CA -30.127 17.538  GLN68 C -31.414 18.348  GLN68 〇 -31.728 19.187  GLN68 CB -30.116 16.757  GLN68 CG -31.207 15.692  GLN68 CD -31.109 14.852  GLN68 OE1 ' -31.941 14.973  GLN68 NE2 -30.137 13.955  SER69 N -32.129 18.102  SER69 CA -33.37 18.833  SER69 C -34.444 18.558  SER69 〇 -34.447 17.495  SER69 C巳 -33.885 18.387 93- (88)200418849 485 SER69 〇G -34.261 17.025 14.033  486 PRO70 N -35.332 19.526 16.499  487 PRO70 CA -36.438 19.385 17.447  488 PRO70 C -37.244 18.122 17.171  489 PRO70 〇 -37.547 17.795 16.018  490 PRO70 CB -37.267 20.622 17.291  491 PRO70 CG -36.6 21.547 16.285  492 PRO70 CD -35.348 20.824 15.815  493 SER71 N -37.424 17.369 18.245  494 SER71 CA -38.115 16.065 18.289  495 SER71 C -37.589 15.02 17.298  496 SER71 〇 -38.378 14.228 16.769  497 SER71 CB -39.625 16.244 18.111  498 SER71 〇G -39.919 16.638 16.777  499 PHE72 N -36.282 14.985 17.081  500 PHE72 CA -35.679 13.876 16.321  501 PHE72 C -34.364 13.43 16.957  502 PHE72 〇 -33.281 13.768 16.458  503 PHE72 CB -35.428 14.283 14.872  504 PHE72 CG -36.682 14.456 14.018  505 PHE72 CD1 -37.097 15.724 13.63  506 PHE72 CD2 -37.402 13.339 13.617  507 PHE72 CE1 -38.238 15.875 12.853  508 . PHE72 CE2 -38.544 13.489 12.84  509 PHE72 CZ -38.962 14.758 12.459  510 PR073 N -34.469 12.59 17.979  511 PR073 CA -33.31 12.19 18.786  512 PR073 C -32.522 11.027 18.18  513 PR073 〇 -32.606 9.895 18.668  514 PR073 CB -33.898 11.776 20.099  515 PR073 CG -35.392 11.555 19.917  516 PR073 CD -35.708 12.004 18.5  517 LEU74 N -31.772 11.304 17.127  518 LEU74 CA -30.933 10.263 16.521  519 LEU74 C -29.707 9.976 17.375  520 LEU74 〇 -29.08 10.892 17.926  521 LEU74 CB -30.474 10.697 15.135  522 LEU74 CG -31.627 10J94 14.146  523 LEU74 CD1 -31.094 11.194 12.776  524 LEU74 CD2 -32.381 9.471 14.05  525 MET75 N -29.359 8.705 17.454  526 MET75 CA -28.167 8.306 18.208  527 MET75 C -27.099 7.808 17.243  528 MET75 〇 -27.166 6.675 16.746  529 MET75 CB •28.539 7.208 19.198  530 MET75 CG -27.367 6.867 20.114  531 MET75 SD -27.678 5.549 21.31  532 MET75 CE -28.002 4.197 20.154  533 VAL76 N -26.117 8.657 16.992  534 VAL76 CA -25.071 8.327 16.017  535 VAL76 C -24.274 7.103 16.455  536 VAL76 〇 -23.953 6.925 17.636  537 VAL76 CB -24.151 9.527 15.809  538 VAL76 CG1 -24.904 10.676 15.149 94- (89) VAL76 CG2 -23.504 9.986  ALA77 N -23.836 6.34  ALA77 CA -23.158 5.062  ALA77 C -21.703 5.203  ALA77 〇 -21.033 4.194  ALA77 CB -23.22 4.212  ARG78 N -21.218 6.431  ARG78 CA -19.868 6.689  ARG78 C -19.868 7.178  ARG78 〇 -18.816 7.163  ARG78 CB -19.274 7.772  ARG78 CG •19.445 7.436  ARG78 CD -19.068 8.629  ARG78 NE -19.848 9.81  ARG78 CZ -19.36 11.053  ARG78 NH1 -18.114 11.278  ARG78 NH2 -20.12 12.072  GLN79 N -21.028 7.577  GLN79 CA -21.128 8.129  GLN79 C -22.484 7.818  GLN79 〇 -23.48 8.503  GLN79 CB -20.937 9.651  GLN79 CG -19.486 10.085  GLN79 CD -19.353 11.607  GLN79 〇E1 -19.071 12.193  GLN79 NE2 -19.508 12.226  ILE80 N -22.504 6.806  ILE80 CA -23.733 6.44  ILE80 C -23.732 7.034  ILE80 〇 -22.666 7.316  ILE80 CB &amp;gt;23.847 4.919  ILE80 CG1 -22.684 4.305  ILE80 CG2 -23.905 4.35  ILE80 CD1 -22.794 2.788  ARG81 N -24.932 7.278  ARG81 CA -25.15 7.84  ARG81 C -24.657 9.276  ARG81 〇 -23.493 9.571  ARG81 CB -24.51 6.964  ARG81 CG -25.437 5.843  ARG81 CD -25.685 5.92  ARG81 NE -26.269 7.22  ARG81 CZ -25.651 8.095  ARG81 NH1 -24.439 7.82  ARG81 NH2 -26.234 9.257  ARG82 N -25.448 10.076  ARG82 CA -25.192 11.523  ARG82 C -23.872 11.866  ARG82 〇 -23.108 12.684  ARG82 C巳 -26.32 12.122  ARG82 CG -27.683 11.796  ARG82 CD -28.801 12.301  ARG82 NE -28.71 11.659  ARG82 CZ -28.623 12.34 95- (90) ARG82 ARG82 GLU83 GLU83 GLU83 GLU83 GLU83 GLU83 GLU83 GLU83 GLU83 ASP84 ASP84 ASP84 ASP84 ASP84 ASP84 ASP84 ASP84 LYS85 LYS85 LYS85 LYS85 LYS85 LYS85 LYS85 LYS85 LYS85 PR086 PR086 PR086 PR086 PR086 PR086 PR086 PHE87 PHE87 PHE87 PHE87 PHE87 PHE87 PHE87 PHE87 PHE87 PHE87 PHE87 ARG88 ARG88 ARG88 ARG88 ARG88 ARG88 ARG88 ARG88</span>Atom No. Residue Atom Name X-coord Y-coord Z-coord 1 ALA9 N -39.918 -4.913 -1.651 2 ALA9 CA -38.454 »5.033 -1.537 3 ALA9 C -37.953 -4.886 -0.099 4 ALA9 〇-38.625 -4.31 0.765 5 ALA9 C 巳 -37.809 -3.967 -2.415 6 THR10 N -36.781 -5.447 0.146 7 THR10 CA -36.187 -5.437 1.49 8 THR10 C -34.916 -4.585 1.553 9 THR10 〇-34.016 -4.735 0.72 10 THR10 CB -35.871 -6.887 1.846 11 THR10 〇G1 -37.075 -7.631 1.717 12 THR10 CG2 -35.355 -7.053 3.271 13 LEU11 N -34.858 -3.699 2.536 14 LEU11 CA -33.669 -2.853 2.745 15 LEU11 C -32.511 -3.649 3.353 16 LEU11 〇-32.706 -4.468 4.259 17 LEU11 CB -34.033 -1.707 3.687 18 LEU11 CG -35.079 -0.78 3.078 19 LEU11 CD1 -35.53 0.265 4.091 20 LEU11 CD2 -34.555 -0.111 1.81 21 PR012 N -31.32 -3.422 2.823 22 PR012 CA -30.121 -4.119 3.302 23 PR012 C- 29.652 -3.606 4.663 24 PR012 〇-29.656 -2.397 4.918 25 PR012 CB -29.081 -3: 842 2.259 26 PR012 CG -29.597 -2.771 1.309 27 PR012 CD -31.031 '2.493 1.729 28 LEU13 N -29.278 -4.522 5.54 29 LEU13 CA • 28.676 -4.118 6.819 30 LEU13 C -27.183 -3.88 6.627 31 LEU13 〇-26.449 -4.806 6.267 32 LEU13 CB -28.898 • 5.196 7.872 33 LEU13 CG -30.374 -5.354 8.217 34 LEU13 CD1 -30.587 -6.516 9.181 35 LEU13 CD2- 30.945 -4.067 8.802 36 ALA14 N -26.72 -2.741 7.112 37 ALA14 CA • 25.355 -2.266 6.825 38 ALA14 C -24.244 -2.941 7.634 39 ALA14 〇-23.058 -2.719 7.372 40 ALA14 CB -25.311 -0.764 7.075 41 ARG15 N -24.628- 3.792 8.569 42 ARG15 CA -23.664 -4.537 9.379 43 ARG15 C -23.478 -5.983 8.91 44 ARG15 〇-22.815 -6.767 9.599 45 ARG15 CB -24.174 -4.519 10.81 46 ARG15 CG -25.655 -4.879 10.84 47 ARG15 CD -26.2 -4.843 12.26 48 ARG15 NE -27.657 -5.039 12.256 49 ARG15 CZ -28.358 -5.301 13.36 50 ARG15 NH1 -29.69 -5.376 13.3 51 ARG15 NH2 -27.735 -5.412 14.536 52 LYS16 N -24.096 -6.351 7.798 85- (80) LYS16 CA -24.016- 7.741 LYS16 C -22.639 -8.128 LYS16 〇-21.959 -7.359 LYS16 C 巳 -25.061 -7.977 LYS16 CG -26.466 -7.985 LYS16 CD -26.605 -9.079 LYS16 CE -28.002 -9.092 LYS16 NZ -28.113 -10.128 CYS17 N -22.317 -9.392 CYS17 CA -21.061 -10.004 CYS17 C -20.737 -9.771 CYS17 〇-19.662 -9.205 CYS17 CB -21.096 -11.501 CYS17 SG -21.33 -11.937 PR018 N -21.635 -10.003 CA018 21.293 -9.756 PR018 C -21.123 -8.291 PR018 〇-21.013 -8.061 PR018 CB -22.388 -10.383 PR018 CG -23.509 -10.812 PR018 CD • 23.002 -10.554 PHE19 N -21.137 -7.33 PHE19 CA -20.792 -5.947 PHE19 C -19.279- 5.777 PHE19 〇-18.789 -4.92 PHE19 CB -21.36 -5.007 PHE19 CG -22.8 -4.568 PHE19 CD1 -23.051 -3.27 PHE19 CD2 -23.856 -5.444 PHE19 CE1 -24.355 -2.853 PHE19 CE2 -25.159 -5.03 PHE19 CZ &amp;gt; 25.409 -3.735 SER20 N Ί 8.573 -6.687 SER20 CA -17.102 -6.717 SER20 C -16.569 -7.839 SER20 〇-16.632 -7.723 SER20 CB -16.557 -5.371 SER20 〇G -17.236 -5.019 PR021 N -15.974 -8.867 PR021 CA -15.978 • 9.134 PR021 C -17.267 -9.836 PR021 〇-18.026 -10.327 PR021 CB -14.8 -10.047 PR021 CG -14.442 -10.669 PR021 CD -15.306 -9.949 PR022 N -17.551 • 9.859 PR022 CA -16.897- 9.007 PR022 C -17.4 -7.575 PR022 〇 18.341 -7.371 PR022 C 巳 -17.32 -9.591 PR022 CG -18.478 -10.549 PR022 CD -18.669 -10.604 PR023 N -16.687 -6.605 PR023 CA -17.224 -5.241 -86- (81) PR023 C -18.525 -5.21 PR023 〇-18.524 -5.083 PR023 C 巳 &amp;gt; 16.159 • 4.417 PR023 CG -15.004 -5.321 PR023 CD -15.388 -6.725 GLU24 N -19.62 -5.122 GLU24 CA -20.963 -5.192 GLU24 C -21.415 -3.843 GLU24 〇22.323 -3.794 GLU24 CB -21.934 -5.68 GLU24 CG -23.27 -6.137 GLU24 CD -23.982 -7.017 GLU24 〇E1 -24.613 -7.981 GLU24 〇E2 -23.833 -6.745 TYR25 N -20.573 -2.843 TYR25 CA -20.842 -1.4 TYR25 C -20.704 -1.311 TYR25 〇-21.364 -0.436 TYR25 CB -19.828 -0.568 TYR25 CG -19.616 -0.882 TYR25 CD1 • 20.662 -0.753 TYR25 CD2 -18.364 -1.298 TYR25 CE1 -20.461 -1.062 TYR25 CEZ -18 -19.213 • 1.492 TYR25 OH * 19.026 -1.859 GLU26 N -20.1 -2.296 GLU26 CA -20.009 -2.293 GLU26 C -21.404 -2.483 GLU26 〇-21.92 -1.572 GLU26 CB -19.129 -3.454 GLU26 CG -17.813 • 3.593 GLU26 CD -16.94 -2.342 GLU26 〇E1 -16.345 -2.12 GLU26 〇E2 -16.773 -1.731 ARG27 N -22.105 -3.488 ARG27 CA -23.437 -3.805 ARG27 C -24.504 -2.909 ARG27 〇-25.496 -2.591 ARG27 CB -23.752- 5.26 ARG27 CG -22.7 -6.189 ARG27 CD -23.031 -7.653 ARG27 NE -23.146 -7.926 ARG27 CZ -22.251 -8.648 ARG27 NH1 -21.16 -9.11 ARG27 NH2 -22.428 -8.879 LEU28 N -24.197 -2.331 LEU28 CA -25.11 -1.358 LEU28 C -25.131 -0.079 LEU28 〇-26.214 0.286 LEU28 CB -24.67 -1.039 LEU28 CG -24.868 -2.224 LEU28 CD1 -24.303 -1.916 LEU28 CD2 -26.34 -2.609 -87- (82) ARG29 N -23.969 0.307 ARG29 CA -23.835 1.502 ARG29 C -24.521 1.334 ARG29 〇-25.271 2.226 ARG29 C 巳 -22.345 1.682 ARG29 CG -21.997 2.947 ARG29 CD -20.519 2.941 ARG29 NE -19.696 2.563 ARG29 CZ -18.945 1.459 ARG29 NH1 -18.872 0.673 ARG29 NH2 -18.265 1.145 A145 0.109 ARG30 CA -25.112 -0.208 ARG30 C -26.629 -0.386 ARG30 〇-27.282 -0.429 ARG30 CB -24.503 -1.512 ARG30 CG -22.992 -1.401 ARG30 CD -22.376 -2.74 5 ARG30 NE -20.909 -2.659 ARG30 CZ -20.12 -3.648 ARG30 NH1 -20.658 -4.772 ARG30 NH2 -18.793 -3.508 GLU31 N -27.194 -0.493 GLU31 CA -28.653 -0.576 GLU31 C -29.207 0.713 GLU31 〇-30.393 1.032 GLU31 CB 29.025 -1.746 GLU31 CG -28.381 -3.055 GLU31 CD -28.814 -3.443 GLU31 〇E1 • 30.013 -3.448 GLU31 〇E2 -27.961 -3.944 SER32 N -28.319 1.439 SER32 CA -28.652 2.672 SER32 C -27.386 3.393 SER32 〇-26.706 2.706 CB -29.509 2.309 SER32 〇G -28.842 1.268 PR033 N -27.148 4.543 PR033 CA -26.039 5.408 PR033 C -26.227 5.972 PR033 〇-25.241 6.254 PR033 CB -26.023 6.511 PR〇33 CG -27.203 6.364 PR033 CD -27.933 5.107 VAL34 N- 27.478 6.094 VAL34 CA -27.83 6.472 VAL34 C -28.828 5.447 VAL34 〇-30.01 5.467 VAL34 CB -28.483 7.85 VAL34 CG1 -28.789 8.339 VAL34 CG2 -27.616 8.865 SER35 N -28.344 4.546 SER35 CA -29.186 3.438 SER35 C-29-512. (83) SER35 〇-28.615 3.692 SER35 CB -28.456 2.126 SER35 〇G • 27.19 2.169 ARG36 N -30.785 3.413 ARG36 C A -31.168 3.431 ARG36 C -30.894 2.072 ARG36 〇-31.516 1.059 ARG36 C 巳 -32.645 3.779 ARG36 CG -33.016 3.857 ARG36 CD -34.513 4.047 ARG36 NE -34.987 5.35 ARG36 CZ -36.272 5.582 ARG36 NH1 -37.16 4.59 ARG36 NH 6.NH VAL37 N -29.921 2.067 VAL37 CA -29.543 0.855 VAL37 C -29.982 0.926 VAL37 〇-30.313 1.995 VAL37 CB -28.03 0.681 VAL37 CG1 -27.591 0.391 VAL37 CG2 -27.298 1.898 GLY38 N -30.064 -0.24 GLY38 CA -30.404 -32 29.151 -0.563 GLY38 〇-28.562 -1.652 LEU39 N -28.764 0.463 LEU39 CA -27.607 0.399 LEU39 C -27.911 -0.554 LEU39 〇-29.028 -1.085 LEU39 CB -27.353 1.814 LEU39 CG -26.198 2.546 LEU39 CD1 -26.368 2.665 LEU39 CD2 3.925 PRO40 N -26.919 -0.869 PRO40 CA • 27.183 -1.62 PRO40 C -28.423 -1.116 PRO40 〇-28.771 0.073 PRO40 C 巳 -25.933 -1.51 PRO40 CG -24.84 -0.886 PRO40 CD -25.497 -0.52 SER41 N -29.188 • 2.109 SER41 CA -30.511 -1.986 SER41 C -31.548 -1.213 SER41 〇-32.379 -0.492 SER41 C 巳 30.387 -1.382 SE R41 〇G -30.036 -0.008 GLY42 N -31.474 -1.34 GLY42 CA -32.521 -0.831 GLY42 C • 32.557 0.686 GLY42 〇-33.59 1.208 GLN43 N -31.471 1.392 GLN43 CA -31.501 2.847 GLN43 C -31.201 3.16 GLN43 〇-30.0 -(84) GLN43 C 巳 -30.507 3.53 GLN43 CG -30.681 5.05 GLN43 CD -29.873 5.699 GLN43 〇E1 -30.31 6.682 GLN43 NE2 -28.723 5.116 THR44 N -32.227 3.582 THR44 CA -32.096 3.832 THR44 C -31.194 5.02 THR44 6.071 THR44 CB -33.475 4.077 THR44 〇G1 -34.009 5.268 THR44 CG2 -34.428 2.923 ALA45 N -30.35 4.799 ALA45 CA &amp;gt; 29.426 5.833 ALA45 C -29.16 5.718 ALA45 〇-29.105 4.619 ALA45 C 巳 -28.115 5.705 TRP46 N -28.46. CA -28.702 6.865 TRP46 C -27.212 6.698 TRP46 〇-26.408 7.589 TRP46 CB -29.185 8.173 TRP46 CG -30.693 8.309 TRP46 CD1 • 31.509 9.009 TRP46 CD2 -31.552 7.723 TRP46 NE1 -32.788 8.894 TRP46 CE2 -32.862 8.922; &amp;gt; TRP46 CE TRP46 CZ2 -33.913 7.774 TRP46 CZ3 -32.389 6.538 TRP46 CH2 -33.68 6.967 ALA47 N -26.86 3 5.559 ALA47 CA -25.475 5.257 ALA47 C -25.153 5.708 ALA47 〇-25.772 5.272 ALA47 CB -25.248 3.756 LEU48 N -24.185 6.602 LEU48 CA -23.751 7.129 LEU48 C -22.648 6.252 LEU48 〇-21.546 6.197 LEU48 CB -23.222 -543 LEU 24.27 9.464 LEU48 CD1 -23.707 10.863 LEU48 CD2 -25.524 9.515 THR49 N -22.948 5.601 THR49 CA -22.01 4.636 THR49 C -21.197 5.214 THR49 〇-20.047 4.803 THR49 CB -22.774 3.391 THR49 〇G1 -23.783 3.769 THR49 458 A2 CG2 -21.724 6.2 ARG50 CA -20.899 6.838 ARG50 C -20.007 7.927 90- (85) ARG50 〇-20.456 8.712 ARG50 C 巳 -21.737 7.467 ARG50 CG -22.426 6.441 ARG50 CD -22.852 7.085 ARG50 NE -23.597 8.327 ARG50 CZ -23.779 9.27 ARG50 NH1 -24.462 10.375 ARG50 NH2 -23.274 9.111 LEU51 N -18.92 8.175 LEU51 CA -17.931 9.19 LEU51 C -18.52 10.584 LEU51 〇-18.42 11.426 LEU51 C 巳 -16.726 9.066 LEU51 CG -15.377 9.193 LEU51 CD1 -14.233 9.154 LEU51 10.15 GLU52 N -19.404 10.68 GLU52 CA &amp;gt; 20.088 11.93 GLU52 C -21.101 12.314 GLU52 〇-21.114 13.477 GLU52 CB -20.821 11.759 GLU52 CG -19.897 11.56 GLU52 CD -19.749 10.09 GLU52 〇E1 -19.796 9.24 GLU52 '〇E2 -19.502 9.849 ASP53 N -21.659 11.313 ASP53 CA -22.646 11.572 ASP53 C -21.953 11.905 〇-22.4 12.804 ASP53 CB -23.493 10.322 ASP53 CG -24.263 9.94 ASP53 〇D1 -24.319 8.749 ASP53 〇D2 -24.633 10.838 ILE54 N -20.75 11.382 ILE54 CA -19.991 11.62 ILE54 C -19.301 12.976 ILE54 〇 &amp;gt; 19.36 13.7 ILE54 CB 18.963 10.509 ILE54 CG1 -19.674 9.167 ILE54 CG2 -18.113 10.671 ILE54 CD1 -18.677 8.03 ARG55 N -18.916 13.43 ARG55 CA -18.346 14.776 ARG55 C -19.44 15.836 ARG55 〇-19.252 16.893 ARG55 CB -17.551 14.883 ARG55 14. CG RG-16 15.498 14.133 ARG55 NE -16.277 13.61 ARG55 CZ -15.712 13.028 ARG55 NH1 -14.383 12.947 ARG55 NH2 -16.475 12.553 GLU56 N -20.64 15.438 GLU56 CA -21.795 16.331 -91-(86) 200418849 377 GLU56 C -22.287 16.444 -1.539 378 GLU56 -22.628 17.546 -1.095 379 GLU56 C 巳 -22.875 15.72 2 -3.866 380 GLU56 CG -24.103 16.605 -4.028 381 GLU56 CD &amp;gt; 25.112 15.838 -4.874 382 GLU56 〇E1 -25.906 16.463 -5.56 383 GLU56 OE2 -25.055 14.616 -4.834 384 MET57 N -22.065 15.392 -0.767 385 MET57 CA -22.379 15.386 0.665 386 MET57 C -21.4 16.241 1.459 387 MET57 〇-21.827 17.091 2.248 388 MET57 C 巳 -22.242 13.948 1.141 389 MET57 CG -22.423 13.805 2.646 390 MET 57 SD -21.979 12.184 3.306 391 MET57 CE -20.221 12.196 2.89 392 LEU58 N- 20.14 16.197 1.056 393 LEU58 CA -19.089 16.973 1.726 394 LEU58 C -19.07 18.444 1.307 395 LEU58 〇-18.398 19.263 1.946 396 LEU58 CB -17.751 16.327 1.389 397 LEU58 CG -17.638 14.941 2.013 398 LEU58 CD1 -16.504 14.133 1.394 399. LEU58 15.03 3.528 400 SER59 N -19.807 18.776 0.261 401 SER59 CA -19.959 20.171 -0.144 402 SER59 C -21.305 20.739 0.304 403 SER59 〇-21.531 21.951 0.204 404 SER59 CB -19.852 20.24 -1.661 405 SER59 〇G -18.59 19.697 -2.022 406 SER60 N -22.175 19.879 0.807 407 SER60 CA -23.5 20.318 1.246 408 SER60 C -23.505 20.806 2.685 409 SER60 〇-23.464 19.996 3.62 410 SER60 C 巳 -24.477 19.156 1.138 411 SER60 〇G -25.689 19.581 1.749 412 PR061 N • 23.91 22.058 2.835 413 PR061 CA -24.023 22.695 4.154 414 PR061 C -25.231 22.233 4.983 415 PR061 〇-25.41 22.7 6.113 416 PR061 C 巳 -24.145 24.157 3.853 417 PR061 CG -24.401 24.343 2.364 418 PR061 CD -24.301 22.959 1.747 419 HIS62 N -26.044 21.333 4.451 420 HIS62 CA -27.21 20.856 5.18 421 HIS62 C -26.949 19.497813 422 HIS62 〇-27.863 18.935 6.427 423 HIS62 CB -28.379 20.764 4.214 424 HIS62 CG -28.703 22.084 3.55 425 HIS62 ND1 -28.955 23.252 4.171 426 HIS62 CD2 -28.796 22.32 2.198 427 HIS62 CE1 -29.197 24.205 3.248 428.29 429 HIS62 NE2 PHE63 N -25.765 18.945 5.596 430 PHE63 CA -25.385 17.693 6.258 92- (87) PHE63 C -24.492 17.977 PHE63 〇-23.261 17.885 PHE63 CB -24.686 16.783 PHE63 CG • 25.651 16.13 PHE63 CD1 -26.92 15.76 PHE63 CD2 -25.265 15.901 PHE -27.804 15.161 PHE63 CE2 -26. 147 15.298 PHE63 CZ -27.415 14.928 SER64 N -25.159 18.211 SER64 CA -24.502 18.656 SER64 C -23.765 17.525 SER64 〇-24.07 16.34 SER64 C 巳 -25.587 19.225 SER64 〇G -24.96 19.785 SER65 N -22.719 17.898 SER65 CA -2265.006 16. C -22.463 17.032 SER65 〇-22.031 16.247 SER65 CB -20.522 17.234 SER65 〇G -20.167 17.174 ASP66 N -23.368 17.961 ASP66 CA -23.901 18.186 ASP66 C -25.388 18.496 ASP66 〇-25.978 18.026 ASP66 CB -23.149 19.393 ASP66 CG -22.904 19.311 ASP66 〇D1 -21.835 19.724 ASP66 OD2 -23.871 19.048 ARG67 N -25.972 19.246 ARG67 CA -27.32 19.831 ARG67 C -28.423 18.78 ARG67 〇-28.768 18.296 ARG67 CB • 27.384 20.684 ARG67 CG -26.263 21.716 ARG67 CD -26.329 22.778 ARG67 23.64 ARG67 CZ -25.091 24.799 ARG67 NH1 -26.189 25.28 ARG67 NH2 -23.957 25.503 GLN68 N • 28.983 18.45 GLN68 CA -30.127 17.538 GLN68 C -31.414 18.348 GLN68 〇-31.728 19.187 GLN68 CB -30.68 116.67 16.757 16.719 14.852 GLN68 OE1 '-31.941 14.973 GLN68 NE2 -30.137 13.955 SER69 N -32.129 18.102 SER69 CA -33.37 18.833 SER69 C -34.444 18.558 SER69 〇-34.447 17.495 SER69 C 巳 -33.885 18.387 93- (88) 200418849 485 SER69 〇G -34.261 17.025 14.033 486 PRO70 N -35.332 19.526 16.499 487 PRO70 CA -36.438 19.385 17.447 488 PRO70 C -37.244 18.122 17.171 489 PRO70 〇-37.547 17.795 16.018 490 PRO70 CB -37.267 20.622 17.291 491 PRO70 CG -36.6 21.547 16.285 492 PRO70 CD -35.348 20.824 15.815 493 SER71 N -37.424 17.369 18.245 494 SER71 CA -38.115 16.065 18.289 495 SER71 C -37.589 15.02 17.298 496 SER71 〇-38.378 14.228 16.769 497 SER71 CB -39.625 16.244 18.111 498 SER71 〇G -39.919 16.638 16.777 499 PHE72 N -36.282 14.985081 CA -35.679 13.876 16.321 501 PHE72 C -34.364 13.43 16.957 502 PHE72 〇-33.281 13.768 16.458 503 PHE72 CB -35.428 14.283 14.872 504 PHE72 CG -36.682 14.456 14.018 505 PHE72 CD1 -37.097 15.724 13.63 506 PHE72 CD2 -37.402 13.617 13.339 13. -38.238 15 .875 12.853 508. PHE72 CE2 -38.544 13.489 12.84 509 PHE72 CZ -38.962 14.758 12.459 510 PR073 N -34.469 12.59 17.979 511 PR073 CA -33.31 12.19 18.786 512 PR073 C -32.522 11.027 18.18 513 PR073 〇-32.606 9.895 18.668 514 PR073 CB- 33.898 11.776 20.099 515 PR073 CG -35.392 11.555 19.917 516 PR073 CD -35.708 12.004 18.5 517 LEU74 N -31.772 11.304 17.127 518 LEU74 CA -30.933 10.263 16.263 519 LEU74 C -29.707 9.976 17.375 520 LEU74 〇-29.08 10.892 17.926 521 LEU74 C 10.697 15.135 522 LEU74 CG -31.627 10J94 14.146 523 LEU74 CD1 -31.094 11.194 12.776 524 LEU74 CD2 -32.381 9.471 14.05 525 MET75 N -29.359 8.705 17.454 526 MET75 CA -28.167 8.306 18.208 527 MET75 C -27.099 7.808 17.243 528 MET75 16.746 529 MET75 CB • 28.539 7.208 19.198 530 MET75 CG -27.367 6.867 20.114 531 MET75 SD -27.678 5.549 21.31 532 MET75 CE -28.002 4.197 20.154 533 VAL76 N -26.117 8.657 16.992 534 VAL76 CA -25.071 8.327 16.017 535 VAL76 C -24. 53 6 VAL76 〇-23.953 6.925 17.636 537 VAL76 CB -24.151 9.527 15.809 538 VAL76 CG1 -24.904 10.676 15.149 94- (89) VAL76 CG2 -23.504 9.986 ALA77 N -23.836 6.34 ALA77 CA -23.158 5.062 ALA77 C -21.703 5.203 ALA77 〇-21. 4.194 ALA77 CB -23.22 4.212 ARG78 N -21.218 6.431 ARG78 CA -19.868 6.689 ARG78 C -19.868 7.178 ARG78 〇-18.816 7.163 ARG78 CB -19.274 7.772 ARG78 CG • 19.445 7.436 ARG78 CD -19.068 8.629 ARG78 NE -19.848 9.81 ARG78 36. 11.053 ARG78 NH1 -18.114 11.278 ARG78 NH2 -20.12 12.072 GLN79 N -21.028 7.577 GLN79 CA -21.128 8.129 GLN79 C -22.484 7.818 GLN79 〇-23.48 8.503 GLN79 CB -20.937 9.651 GLN79 CG -19.486 10.085 GLN79 CDR7979 GLN79 CD 19.071 12.193 GLN79 NE2 -19.508 12.226 ILE80 N -22.504 6.806 ILE80 CA -23.733 6.44 ILE80 C -23.732 7.034 ILE80 〇-22.666 7.316 ILE80 CB &amp;gt; 23.847 4.919 ILE80 CG1 -22.684 4.305 ILE80 CG2 -23.905 4.35 ILE80 CD 81. -24.932 7.278 ARG81 CA -25.15 7.84 ARG81 C -24.657 9.276 ARG81 〇-23.493 9.571 ARG81 CB -24.51 6.964 ARG81 CG -25.437 5.843 ARG81 CD -25.685 5.92 ARG81 NE -26.269 7.22 ARG81 CZ -25.651 8.095 ARG81 NH1 -24.439 7.82 ARG81 NH2 -26.234 9.257 ARG82 N -25.448 10.25 11.523 ARG82 C -23.872 11.866 ARG82 〇-23.108 12.684 ARG82 C 巳 -26.32 12.122 ARG82 CG -27.683 11.796 ARG82 CD -28.801 12.301 ARG82 NE -28.71 11.659 ARG82 CZ -28.623 12.34 95- (90) ARG82 ARG82 GLU83 GLU83 GLU83 GLU83 GLU83 GLU83 GLU83 GLU83 GLU83 GLU83 GLU83 GLU83 ASP84 ASP84 ASP84 ASP84 ASP84 ASP84 ASP84 ASP84 LYS85 LYS85 LYS85 LYS85 LYS85 LYS85 LYS85 LYS85 LYS85 PR086 PR086 PR086 PR086 PR086 PR88 ARG 88 ARG A87 PHE87 PHE87 PHE87 PHE87 PHE87 PHE87 PHE87 PHE87 PHE87 PHE87 PHE87 PHE87 PHE87</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">H1H2A BGDE1E2A BGDD2A B G D E z A B G D A BGD1D2E1E2Z A B G D E NNNCC〇CCC〇〇NCC〇CC〇〇NCC〇CCCCNNCC〇CCCNCC〇CCCCCCCNCC〇CCCN -28.477 11.689  -28.606 13.675  -23.495 11.077  -22.237 11.334  -21.03 10.69  -19.894 10.902  -22.361 10.828  •23.385 11.651  -23.478 11.172  -23.428 9.967  -23.71 12.011  -21.274 9.941  -20.201 9.327  -20.095 10.012  -19.257 9.646  -20.481 7.841  -20.585 7.191  -19.547 6.906  -21.704 7.048  -20.939 11.017  -20.846 11.928  -19.997 13.228  -20.236 14.084  -22.27 12.347  -23.107 11.173  -24.573 11.567  -25.408 10.408  -26.824 10.785  -19.054 13.455  -18.316 14.731  -17.168 14.8  &amp;gt;16.339 15.713  -17.779 14.922  -17.866 13.6  -18.543 12.646  -17.14 13.906  -16.12 13.963  -16.67 14.817  •15.963 15.16  -15.848 12.556  •15.724 11.449  -16.447 10.277  -14.904 11.591  •16.358 9.254  -14.817 10.567  -15.544 9.399  -17.948 15.143  -18.629 16.037  -18.178 17.519  -18.118 18.064  -20.122 15.915  &amp;gt;20.964 16.678  -22.429 16.294  - 22.593 14.851 96- (91) ARG88 ARG88 ARG88 PR089 PR089 PR089 PR089 PR089 PR089 PR089 SER90 SER90 SER90 SER90 SER90 SER90 LEU91 LEU91 LEU91 LEU91 LEU91 LEU91 LEU91 LEU91 ILE92 ILE92 ILE92 ILE92 ILE92 ILE92 ILE92 ILE92 ALA93 ALA93 ALA93 ALA93 ALA93 MET94 MET94 MET94 MET94 MET94 MET94 MET94 MET94 ASP95 ASP95 ASP95 ASP95 ASP95 ASP95 ASP95 ASP95 PR096</span>H1H2A BGDE1E2A BGDD2A BGDE z ABGDA BGD1D2E1E2Z ABGDE NNNCC〇CCCC〇〇NCC〇CC〇〇NCC〇CCNNCC〇CCCNCC〇CCCCCCCNCC〇CCCN -28.477 11.689 -28.606 13.675 -23.495 11.077 -22.237 10.385 10.385-19.385 19.385-22.385 11.651 -23.478 11.172 -23.428 9.967 -23.71 12.011 -21.274 9.941 -20.201 9.327 -20.095 10.012 -19.257 9.646 -20.481 7.841 -20.585 7.191 -19.547 6.906 -21.704 7.048 -20.939 11.017 -20.846 11.928 -19.997 13.228 -20.236 14.084 -22.27 12.347- 23.107 11.173 -24.573 11.567 -25.408 10.408 -26.824 10.785 -19.054 13.455 -18.316 14.731 -17.168 14.8 &amp;gt; 16.339 15.713 -17.779 14.922 -17.866 13.6 -18.543 12.646 -17.14 13.906 -16.12 13.963 -16.67 14.817 • 15.963 15.16 -15.848 12.556 11.449 -16.447 10.277 -14.904 11.591 • 16.358 9.254 -14.817 10.567 -15.544 9.399 -17.948 15.143 -18.629 16.037 -18.178 17.519 -18.118 18.064 -20.122 15.915 &amp;gt; 20.964 16.678 -22.429 16.294-22.593 14.851 96- ( 91) ARG88 ARG88 ARG88 PR089 PR089 PR089 PR089 PR089 PR089 PR089 SER90 SER90 SER90 SER90 SER90 SER90 LEU91 LEU91 LEU91 LEU91 LEU91 LEU91 LEU91 LEU91 ILE92 ILE92 ILE92 ILE92 ASP94 MET94 MET92 ALA93 MET94 AMET ASP95 ASP95 ASP95 ASP95 ASP95 PR096</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1 2 12 12 1 1 2 ζ Η H A BGD A B G A B G D D A BGGD A B A BGDE A 巳 GDD CNNNCC〇CCCNCC〇C〇NCC〇CCCCNCC〇CCCCNCC〇CNCC〇CCSCNCC〇CC〇〇N -23.307 14.07  -23.373 12.757  -23.922 14.598  -17.919 18.194  -17.186 19.48  -15.737 19.333  -14.786 19.454  -17.206 20.033  -17.798 19.004  -18.208 17.832  -15.606 19.29  -14.334 19.04  -14.43 19.413  -15.534 19.592  -14.069 17.55  -15.095 16.928  -13.326 19.173  -13.154 19.564  -14.042 18.804  -14.491 19.39  -11.702 19.238  -11.325 19.637  -11.253 21.153  -9.989 19.012  -14.422 17.582  -15.199 16.791  -16.712 16.857  -17.487 16.497  -14.682 15.351  •15.288 14.488  -14.932 14.719  -14.775 13.055  -17.14 17.407  -18.578 17.414  -19.15 18.822  -20.335 19.048  -18.865 16.593  -18.294 19.776  -18.739 21.168  -18.99 21.683  -18.221 21.436  -17.695 22.042  -17.822 21.982  -16.686 23.058  -17.561 23.095  -20.089 22.398  -20.42 23.024  -19.831 24.427  -19.589 25.001  -21.938 23.082  -22.52 21.677  -22.276 20.87  -23.173 21.412  -19.488 24.936 97- (92) PR096 PR096 PR096 PR096 PR096 PR096 PR097 PR097 PR097 PR097 PR097 PR097 P 闩 097 GLU98 GLU98 GLU98 GLU98 GLU98 GLU98 GLU98 GLU98 GLU98 HIS99 HIS99 HIS99 HIS99 HIS99 HIS99 HIS99 HIS99 HIS99 HIS99 GLY100 GLY100 GLY100 GLY100 LYS101 LYS101 LYS101 LYS101 LYS101 LYS101 LYS101 LYS101 LYS101 ALA102 ALA102 ALA102 ALA102 ALA102 ARG103 ARG103 ARG103 ARG103 A BGD A BGD A B G D E1E2 A BGD1D2E1E2A A BGDEZ A B A CC〇CCCNCC〇CCCNCC〇CCC〇〇NCC〇CCNCCNNCC〇NCC〇CCCCNNCC〇CNCC〇 -19.076 26.343  -20.177 27.263  -21.353 26.892  -18.812 26.567  -19.078 25.278  -19.532 24.256  -19.817 28.38  -18.428 28.85  -17.649 28.271  -16.462 28.595  -18.567 30.329  -20.013 30.649  •20.777 29.345  -18.233 27.353  -17.555 26.761  -16.353 25.946  -15.224 26.174  -18.513 25.782  -19.894 26.372  -20.857 25.236  -20.697 24.171  -21.799 25.49  -16.575 25.223  -15.52 24.448  •14.43 25.323  -13.249 24.993  -16.19 23.646  -15.238 23.09  -14.522 21.957  -14.946 23.649  -13.779 21.805  -14.042 22.852  -14.792 26.524  -13.832 27.439  -12.859 27.944  -11.648 27.716  -13.419 28.385  -12.626 28.895  -11.711 27.823  -10.485 28.02  -13.608 29.33  -12.893 29.892  -13.829 29.939  -14.189 28.531  -12.986 27.796  -12.251 26.624  -11.474 25.523  -10.381 25.022  -9.243 24.859  -12.425 24.379  -10.622 25.091  -9.63 24.64  -8.492 25.644  -7.325 25.236 98- (93) 200418849</span>1 2 12 12 1 1 2 ζ Η HA BGD ABGABGDDA BGGD ABA BGDE A 巳 GDD CNNNCC〇CCCNCC〇CNCOCCCCCNCC〇CCCCNCC〇CNCC〇CCSCNCC〇CC〇〇N -23.307 14.07 -23.373 12.757 -23.922 14.598 -17.919 18.194 -17.186 19.48 -15.737 19.333 -14.786 19.454 -17.206 20.033 -17.798 19.004 -18.208 17.832 -15.606 19.29 -14.334 19.04 -14.43 19.413 -15.534 19.592 -14.069 17.55 -15.095 16.928 -13.326 19.173 -13.154 19.564 -14.042 18.804 -14.491 19.39 19.238 -11.325 19.637 -11.253 21.153 -9.989 19.012 -14.422 17.582 -15.199 16.791 -16.712 16.857 -17.487 16.497 -14.682 15.351 • 15.288 14.488 -14.932 14.719 -14.775 13.055 -17.14 17.407 -18.578 17.414 -19.15 18.822 -20.335 19.048 -18.865 16.59 16.59 18.294 19.776 -18.739 21.168 -18.99 21.683 -18.221 21.436 -17.695 22.042 -17.822 21.982 -16.686 23.058 -17.561 23.095 -20.089 22.398 -20.42 23.024 -19.831 24.427 -19.589 25.001 -21.938 23.082 -22.52 21.677 -22.276 20.87 -23.173 24.173 21.41297- (92) PR096 PR096 PR096 PR096 PR096 PR096 PR096 PR097 PR097 PR097 PR097 PR097 PR097 P Latch 097 GLU98 GLU98 GLU98 GLU98 GLU98 GLU98 GLU98 GLU98 GLU98 HIS99 HIS99 HIS99 HIS99 HIS99 HLY99 LY101 GLY100 GLY100 LYS 101 GLY100 GLY100 GLY100 GLY100 GLY100 GLY100 GLY100 GLY100 GLY100 LYS GLY100 GLY100 GLY100 GLY100 GLY100 GLY100 GLY100 GLY100 GLY100 GLY100 GLY100 GLY100 GLY100 GLY100 GLY100 GLY100 GLY100 GLY100 GLY100 GLY100 GLY100 GLY101 LYS101 LYS101 ALA102 ALA102 ALA102 ALA102 ALA102 ARG103 ARG103 ARG103 ARG103 A BGD A BGD ABGD E1E2 A BGD1D2E1E2A A BGDEZ ABA CC〇CCCNCC〇CCCNCC〇CCC〇〇Ｃ〇ＣＣCCCCNNCC-20CCCCCCCCCCCCCC -18.812 26.567 -19.078 25.278 -19.532 24.256 -19.817 28.38 -18.428 28.85 -17.649 28.271 -16.462 28.595 -18.567 30.329 -20.013 30.649 • 20.777 29.345 -18.233 27.353 -17.555 26.761 -16.353 25.946 -15.224 26.736 -15.224 26.672 -25.782 -15.224 26.672 -15.224 26.567 -15.224 26.567 -25.782 -15.224 -25.782 -15.224 26.672 -25.946 -15.224 26.567 -25.782 -15.224 -25.782 -15.224 -25.782 -15.224 -25.782 -15.224 -25.782 -15.224 -25.782 -15.224. 25.236 -20.697 24.171 -21.799 25.49 -16.575 25.223 -15.52 24.448 • 14.43 25.323 -13.249 24.993 -16.19 23.646 -15.238 23.09 -14.522 21.957 -14.946 23.649 -13.779 21.805 -14.042 22.852 -14. 792 26.524 -13.832 27.439 -12.859 27.944 -11.648 27.716 -13.419 28.385 -12.626 28.895 -11.711 27.823 -10.485 28.02 -13.608 29.33 -12.893 29.892 -13.829 29.939 -14.189 28.531 -12.986 27.796 -12.474 25.624 25.624523. -12.425 24.379 -10.622 25.091 -9.63 24.64 -8.492 25.644 -7.325 25.236 98- (93) 200418849</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">755 ARG103 CB  756 ARG103 CG  757 ARG103 CD  758 ARG103 NE  759 ARG103 CZ  760 ARG103 NH1  761 ARG103 NH2  762 ARG104 N  763 ARG104 CA  764 ARG104 C  765 ARG104 〇  766 ARG104 C巳  767 ARG104 CG  768 ARG104 CD  769 ARG104 NE  770 ARG104 CZ  771 ARG104 NH1  772 ARG104 NH2  773 ASP105 N  774 ASP105 CA  775 ASP105 C  776 ASP105 〇  777 ASP105 CB  778 ASP105 CG  779 ASP105 〇D1  780 ASP105 〇D2  781 VAL106 N  782 VAL106 CA  783 VAL106 C  784 VAL106 〇  785 VAL106 CB  786 VAL106 CG1  787 VAL106 CG2  788 VAL107 N  789 VAL107 CA  790 VAL107 C  791 VAL107 〇  792 VAL107 CB  793 VAL107 CG1  794 VAL107 CG2  795 GLY108 N  796 GLY108 CA  797 GLY108 C  798 GLY108 〇  799 GLU109 N  800 GLU109 CA  801 GLU109 C  802 GLU109 〇  803 GLU109 CB  804 GLU109 CG  805 GLU109 CD  806 GLU109 〇E1  807 GLU109 〇E2  808 PHE110 N -10.347 24.476 11.762  -9.496 23785 10.705  -10.366 23.455 9.496  -9.651 22.682 8.467  -9.807 21.367 8.287  -10.493 20.645 9.175  -9.174 20.755 7.285  -8.811 26.923 13.087  -7.775 27.957 13.006  -6.906 27.966 14.256  -5.675 28.083 14.149  -8.442 29.316 12.84  -9.166 29.412 11.502  -9.828 30.772 11.319  -10.874 30.999 12.329  -11.061 32.171 12.941  -10.231 33.188 12.701  -12.048 32.31 13.829  &amp;gt;7.5 27.625 15.388  •6.718 27.493 16.616  -5.828 26.253 16.594  -4.602 26.392 16.716  -7.67 27.427 17.806  -8.198 28.814 18.165  •7.389 29.588 18.666  -9.411 28.938 18.257  -6.379 25.125 16.173  -5.636 23.86 16.236  -4.51 23.761 15.214  -3.414 23.348 15.612  -6.611 22.703 16.046  -5.886 21.37 15.89  -7.587 22.637 17.212  -4.641 24.427 14.075  -3.565 24.397 13.071  •2.362 25.259 13.474  -1.225 24.918 13.123  -4.142 24.869 11.737  -3.06 25.104 10.687  •5.175 23.879 11.213  &amp;gt;2.576 26.155 14.426  -1.49 26.985 14.953  -0.511 26.183 15.813  0.685 26.491 15.837  -1.006 25.191 16.537  -0.109 24.388 17.376  0.121 22.976 16.836  1.086 22.311 17.229  -0.677 24.35 18.784  »0.577 25.728 19.424  0.886 26.1 19.659  1.612 25.244 20.147  1.22 27.255 19.442  -0.686 22.572 15.873 99- (94)200418849 809 PHE110 CA -0.511 21,269 15.221  810 PHE110 C 0.017 21.468 13.798  811 PHE110 〇 -0.547 20.963 12.819  812 PHE110 C巳 -1.866 20.568 15.206  813 PHE110 CG -1.834 19.088 14.838  814 PHE110 CD1 -0.842 18.264 15.352  815 PHE110 CD2 -2.808 18.564 13.998  816 PHE110 CE1 •0.819 16.915 15.019  817 PHE110 CE2 -2.784 17.216 13.665  818 PHE110 CZ -1.79 16.392 14.176  819 THR111 N 1.103 22.217 13.706  820 THR111 CA 1.68 22.585 12.409  821 THR111 C 2.353 21.411 11.71  822 THR111 〇 2.846 20.47 12.346  823 THR111 CB 2.745 23.65 12.628  824 THR111 〇G1 3.887 23.019 13.193  825 THR111 CG2 2.27 24.756 13.561  826 VAL112 N 2.564 21.605 10.417  827 VAL112 CA 3.302 20.63 9.605  828 VAL112 C 4.802 20.712 9.887  829 VAL112 〇 5.492 19.689 9.86  830 VAL112 CB 3.026 20.929 8.134  831 VAL112 CG1 3.819 20.01 7.21  832 VAL112 CG2 1.535 20.833 7.832  833 LYS113 N 5.227 21.845 10.425  834 LYS113 CA 6.608 22.003 10.884  835 LYS113 C 6.892 21.096 12.082  836 LYS113 〇 7.864 20.332 12.044  837 LYS113 CB 6.795 23.456 11.298  838 LYS113 CG 8.168 23.696 11.914  839 LYS113 CD 8.232 25.064 12.582  840 LYS113 CE 7.189 25.184 13.692  841 LYS113 NZ 7.407 24.178 14.747  842 ARG114 N 5.945 21.013 13.008  843 ARG114 CA 6.085 20.094 14.141  844 ARG114 C 6.098 18.627 13.713  845 ARG114 〇 7.034 17.912 14.09  846 ARG114 CB 4.916 20.313 15.096  847 ARG114 CG 4.939 19.283 16.22  848 ARG114 CD 3.721 19.388 17.131  849 ARG114 NE 3.696 20.666 17.858  850 ARG114 CZ 4.078 20.792 19.131  851 ARG114 NH1 3.903 21.953 19.766  852 ARG114 NH2 4.537 19.73 19.798  853 MET115 N 5.28 18.265 12.737  854 MET115 CA 5.23 16.862 12.311  855 MET115 C 6.438 16.467 11.456  856 MET115 〇 6.99 15.378 11.662  857 MET115 C巳 3.926 16.642 11.555  858 MET115 CG 2.739 16.915 12.474  859 MET115 SD 1.093 16.637 11.78  860 MET115 CE 1.057 17.94 10.532  861 LYS116 N 7.027 17.445 10.787  862 LYS116 CA 8.25 17.222 10.01 100- (95) LYS116 LYS116 LYS116 LYS116 LYS116 L.YS116 LYS116 ALA117 ALA117 ALA117 ALA117 ALA117 LEU118 LEU118 LEU118 LEU118 LEU118 LEU118 LEU118 LEU118 GLN119 GLN119 GLN119 GLN119 GLN119 GLN119 GLN119 GLN119 GLN119 PRO120 PRO120 PRO120 PRO120 PRO120 PRO120 PRO120 ARG121 ARG121 ARG121 ARG121 ARG121 ARG121 ARG121 ARG121 ARG121 ARG121 ARG121 ILE122 ILE122 ILE122 ILE122 ILE122 ILE122 ILE122 BGDEZ A B A BGD1D2A BGDE1E2A B G D A BGDEZH1H2A BG1G2 c〇ccccnncc〇cncc〇ccccncc〇ccc〇nncc〇cccncc〇cccncnnncc〇ccc 9.492 17.156  10.434 16.413  8.372 18.392  9.635 18.337  9.738 19.592  9.703 20.841  9.753 22.063  9.404 17.748  10.49 17.663  10.354 16.43  11.331 16  10.469 18.924  9.185 15.81  8.975 14.544  9.351 13.359  9.591 12.26  7.512 14.434  7.153 15.474  5.654 15.48  7.934 15.246  9.563 13.632  10.052 12.633  11.263 11.797  11.09 10.573  10.378 13.373  10.944 12.471  11.394 13.351  11.701 12.857  11.444 14.647  12.388 12.361  13.485 11.486  13.211 10.732  13.761 9.639  14.672 12.386  14.237 13.832  12.764 13.785  12.229 11.159  11.917 10.438  11.02 9.25  11.331 8.136  11.218 11.385  11.741 11.209  11.481 9.812  12.184 9.613  12.714 8.443  13.415 8.346  12.601 7.386  10.18 9.421  9.316 8.332  10.135 7.27  9.975 6.073  8.309 8.918  7.456 9.995  7.422 7.825 101 - (96) 917 1LE122 CD1 6.509 10.636 13.044  918 GLN123 N 11.179 7.724 12.982  919 GLN123 CA 12.088 6.827 12.269  920 GLN123 C 12.914 5.997 13.245  921 GLN123 〇 12.897 4.76 13.156  922 GLN123 C巳 12.989 7.717 11.423  923 GLN123 CG 13.978 6.941 10.567  924 GLN123 CD 14.72 7.939 9.684  925 GLN123 〇E1 15.954 7.96 9.626  926 GLN123 NE2 13.946 8.8 9.044  927 GLN124 N 13.295 6.633 14.34  928 GLN124 CA 14.049 5.959 15.394  929 GLN124 C 13.184 4.947 16.144  930 GLN124 〇 13.621 3.798 16.284  931 GLN124 CB 14.544 7.04 16.345  932 GLN124 CG 15.429 6.495 17.455  933 GLN124 CD 15.912 7.668 18.3  934 GLN124 〇E1 16.786 7.524 19.162  935 GLN124 NE2 15.357 8.832 18.008  936 ILE125 N 11.904 5.252 16.299  937 1LE125 CA 10.961 4.328 16.947  938 ILE125 C 10.716 3.072 16.112  939 ILE125 〇 10.861 1.961 16.642  940 ILE125 CB 9.638 5.064 17.148  941 ILE125 CG1 9.792 6.214 18.13  942 ILE125 CG2 8.543 4.122 17.628  943 ILE125 CD1 8.487 6.984 18.275  944 VAL126 N 10.649 3.229 14.797  945 VAL126 CA 10.44 2.064 13.928  946 VAL126 C 11.693 1.2 13.87  947 VAL126 〇 11.603 -0.021 14.062  948 VAL126 CB 10.119 2.529 12.513  949 VAL126 CG1 9.754 1.334 11.641  950 VAL126 CG2 8.988 3.544 12.503  951 ASP127 N 12.843 1.855 13.909  952 ASP127 CA 14.121 1.141 13.889  953 ASP127 C 14.314 0.34 15.17  954 ASP127 〇 14.537 -0.876 15.088  955 ASP127 CB 15.258 2.153 13.769  956 ASP127 CG 15.158 2.967 12.481  957 ASP127 〇D1 15.632 4.097 12.49  958 ASP127 〇D2 14.686 2.426 11.489  959 GLU128 N 13.903 0.919 16.288  960 GLU128 CA 14.048 0.26 17.589  961 GLU128 C 13.094 •0.915 17.762  962 GLU128 〇 13.527 -1.952 18.281  963 GLU128 CB 13.764 1.281 18.684  964 GLU128 CG 14.807 2.39 18.707  965 GLU128 CD 14.367 3.489 19.668  966 GLU128 OE1 13.584 4.333 19.247  967 GLU128 〇E2 14.794 3.452 20.812  968 HIS129 N 11.934 -0.861 17.128  969 HIS129 CA 11.002 -1.985 17.237  970 HIS129 C 11.411 -3.142 16.333 -102- (97) HIS129 〇 11.344 -4.297  HIS129 CB 9.592 -1.533  HIS129 CG 8.963 -0.57  HIS129 ND1 7.942 0.266  HIS129 CD2 9.3 -0.394  HIS129 CE1 7.647 0.969  HIS129 NE2 8.488 0.561  ILE130 N 12.061 -2.848  ILE130 CA 12.564 -3.95  ILE130 C 13.768 -4.577  ILE130 〇 13.69 -5.756  ILE130 CB 12.968 -3.449  ILE130 CG1 11.841 -2.659  ILE130 CG2 13.341 -4.632  ILE130 CD1 12.258 -2.117  ASP131 N 14.65 -3.712  ASP131 CA 15.874 -4.12  ASP131 C 15.604 -5.033  ASP131 〇 15.932 •6.226  ASP131 CB 16.565 -2.874  ASP131 CG 17.175 -1.999  ASP131 〇D1 17.222 -0.791  ASP131 OD2 17.743 -2.564  ALA132 N 14.882 -4.505  ALA132 CA 14.708 -5.198  ALA132 C 13.582 -6.228  ALA132 〇 13.489 -6.983  ALA132 CB 14.465 -4.147  LEU133 N 12.752 -6.286  LEU133 CA 11.712 -7.311  LEU133 C 12.08 -8.444  LEU133 〇 12.567 -9.492  LEU133 CB 10.366 -6.697  LEU133 CG 9.925 -5.686  LEU133 CD1 8.679 -4.93  LEU133 CD2 9.698 -6.366  LEU134 N 11.901 -8.215  LEU134 CA 12.139 -9.288  LEU134 C 12.895 -8.777  LEU134 〇 12.319 -8.632  LEU134 CB 10.808 •9.885  LEU134 CG 10.481 -11.234  LEU134 CD1 11.66 -12.193  LEU134 CD2 9.997 -11.115  ALA135 N 14.194 -8.586  ALA135 CA 15.038 -8.142  ALA135 C 15.606 -9.293  ALA135 〇 16.184 •9.051  ALA135 CB 16.193 •7.323  GLY136 N 15.402 -10.522  GLY136 CA 15.957 -11.679  GLY136 C 14.865 -12.524  GLY136 〇 14.069 -12.022  PR0137 N 14.906 -13.813 103- (98) 200418849 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 137137137137137137383838383838383838139139139139139139139 ROROROROROROYS1YS1YS1YS1YS1YS1YS1YS1YS1RORORORORORORO ppppppgggglllllppppppp ALA140 ALA140 ALAMO ALA140 ALA140 ASP141 ASP141 ASP141 ASP141 ASP141 ASP141 ASP141 ASP141 LEU142 LEU142 LEU142 LEU142 LEU142 LEU142 LEU142 LEU142 VAL143 VAL143 VAL143 VAL143 VAL143 VAL143 VAL143 GLN144 GLN144 GLN144 GLN144 CA 13.938 -14.772 11.353  C 12.589 -14.709 12.067  〇 12.21 -13.679 12.637  CB 14.573 -16.111 11.568  CG 15.748 -15.953 12.524  CD 15.899 -14.46 12.763  N 11.86 -15.811 11.945  CA 10.575 -16.043 12.639  C 9.412 -15.227 12.069  〇 9.605 -14.143 11.508  CB 10.733 -15.765 14.135  CG 11.795 -16.66 14.765  CD 12.022 -16.303 16.23  CE 13.155 -17.128 16.829  NZ 12.859 -18.567 16.746  N 8.256 -15.868 12.022  CA 6.996 -15.155 11.797  C 6.612 -14.289 12.995  〇 6.167 -14.795 14.031  CB 5.979 -16.232 11.583  CG 6.595 -17.575 11.948  CD 8.04 -17.286 12.322  N 6.749 -12.987 12.824  CA 6.355 -12.036 13.868  C 5.006 -11.411 13.552  〇 4.591 -11.359 12.391  CB 7.395 -10.931 13.953  N 4.297 -10.989 14.582  CA 3.051 -10.264 14.336  C 3.363 -8.779 14.165  〇 3.466 -8.032 15.149  CB 2.073 •10.492 15.481  CG 0.741 -9.84 15.132  〇D1 0.583 -8.673 15.465  〇D2 0.016 -10.426 14.338  N 3.261 -8.332 12.923  CA 3.692 -6.983 12.541  C 2.753 •5.893 13.048  〇 3.232 -4.806 13.4  CB 3.78 -6.96 11.012  CG 4.336 -5.66 10.428  CD1 5.227 •5.944 9.225  CD2 3.241 -4.659 10.063  N 1.509 -6.243 13.329  CA 0.585 -5.247 13.868  C 0.992 -4.867 15.287  〇 1.481 -3.748 15.477  CB -0.829 -5.809 13.859  CG1 -1.823 -4.772 14.374  CG2 -1.212 -6.26 12.457  N 1.184 -5.874 16.119  CA 1.491 -5.656 17.535  C 2,945 -5.249 17.797  〇 3.212 -4.566 18.791 -104- (99) 1079 GLN144 CB 1.203 -6.982 18.23  1080 GLN144 CG 1.485 -6.966 19.726  1081 GLN144 CD 1.232 -8.364 20.277  1082 GLN144 〇E1 1.815 -8.777 21.285  1083 GLN144 NE2 0.374 -9.091 19.582  1084 ALA145 N 3.842 -5.539 16.87  1085 ALA145 CA 5.246 -5.186 17.088  1086 ALA145 C 5.672 -3.884 16.412  1087 ALA145 〇 6.594 -3.211 16.888  1088 ALA145 C巳 6.108 -6.329 16.561  1089 LEU146 N 4.988 -3.499 15.349  1090 LEU146 CA 5.424 -2.324 14.588  1091 LEU146 C 4.294 -1.342 14.317  1092 LEU146 〇 4.308 -0.207 14.815  1093 LEU146 CB 5.964 -2.825 13.252  1094 LEU146 CG 7.225 -3.659 13.433  1095 LEU146 CD1 7.467 -4.589 12.254  1096 LEU146 CD2 8.432 &amp;gt;2.772 13.705  1097 SER147 N 3.245 -1.868 13.71  1098 SER147 CA 2.169 -1.053 13.134  1099 SER147 C 1.274 -0.369 14.164  1100 SER147 〇 0.727 0.708 13.911  1101 SER147 CB 1.325 -2.001 12.301  1102 SER147 〇G 0.198 -1.277 11.856  1103 LEU148 N 1.174 -0.97 15.331  1104 LEU148 CA 0.484 -0.358 16.464  1105 LEU148 C 1.433 0.51 17.316  1106 LEU148 〇 1.132 1.707 17.436  1107 LEU148 CB -0.204 •1.475 17.259  1108 LEU148 CG -1.13 -0.987 18.372  1109 LEU148 CD1 -2.317 -1.93 18.53  1110 LEU148 CD2 - 0.404 -0.81 19.703  1111 PR0149 N 2.553 0.008 17.848  1112 PR0149 CA 3.299 0.829 18.809  1113 PR0149 C 3.987 2.052 18.203  1114 PR0149 〇 4.043 3.07 18.9  1115 PR0149 CB 4.31 -0.075 19.439  1116 PR0149 CG 4.261 •1.43 18.764  1117 PR0149 CD 3.122 -1.352 17.766  1118 VAL150 N 4.316 2.051 16.918  1119 VAL150 CA 4.873 3.276 16.323  1120 VAL150 C 3.867 4.442 16.385  1121 VAL150 〇 4.127 5.334 17.201  1122 VAL150 CB 5.399 3.041 14.905  1123 VAL150 CG1 5.892 4.345 14.284  1124 VAL150 CG2 6.514 2.004 14.891  1125 PR0151 N 2.695 4.396 15.75  1126 PR0151 CA 1.816 5.574 15.799  1127 PR0151 C 1.187 5.843 17.167  1128 PR0151 〇 1.009 7.014 17.532  1129 PR0151 CB 0.742 5.307 14.799  1130 PR0151 CG 0.88 3.895 14.266  1131 PR0151 CD 2.136 3.336 14.896  1132 SER152 N 1.059 4.817 17.993 -105- (100)200418849 1133 SER152 CA 0.504 5.027 19.326  1134 SER152 C 1.506 5.73 20.241  1135 SER152 〇 1.136 6.724 20.879  1136 SER152 C巳 0.117 3.671 19.898  1137 SER152 〇G -0.849 3.09 19.031  1138 LEU153 N 2.785 5.428 20.079  1139 LEU153 CA 3.817 6.088 20.883  1140 LEU153 C 4.17 7.458 20.312  1141 LEU153 〇 4.34 8.406 21.091  1142 LEU153 CB 5.06 5.206 20.899  1143 LEU153 CG 6.168 5.789 21.769  1144 LEU153 CD1 5.708 5.934 23.216  1145 LEU153 CD2 7.424 4.928 21.689  1146 VAL154 N 3.995 7.622 19.009  1147 VAL154 CA 4.232 8.925 18.383  1148 VAL154 C 3.185 9.944 18.813  1149 VAL154 〇 3.566 11.036 19.256  1150 VAL154 C巳 4.205 8.777 16.864  1151 VAL154 CG1 4.148 10.134 16.169  1152 VAL154 CG2 5.402 7.976 16.368  1153 ILE155 N 1.945 9.513 18.977  1154 ILE155 CA 0.935 10.467 19.431  1155 ILE155 C 0.932 10.621 20.956  1156 ILE155 〇 0.6 11.709 21.446  1157 ILE155 CB -0.433 10.065 18.902  1158 ILE155 CG1 -1.405 11.218 19.089  1159 ILE155 CG2 -0.956 8.814 19.593  1160 ILE155 CD1 -0.954 12.46 18.327  1161 CYS156 N 1.569 9.697 21.66  1162 CYS156 CA 1.787 9.891 23.093  1163 CYS156 C 2.835 10.973 23.317  1164 CYS156 〇 2.551 11.93 24.047  1165 CYS156 C巳 2.261 8.59 23.732  1166 CYS156 SG 1.018 7.295 23.935  1167 GLU157 N 3.838 11.005 22.454  1168 GLU157 CA 4.902 12.011 22.559  1169 GLU157 C 4.512 13.364 21.957  1170 GLU157 〇 5.08 14.393 22.339  1171 GLU157 CB 6.109 11.474 21.801  1172 GLU157 CG 6.57 10.14 22.372  1173 GLU157 CD 7.588 9.499 21.434  1174 GLU157 OE1 8.764 9.522 21.767  1175 GLU157 〇E2 7.162 8.932 20.437  1176 LEU158 N 3.5 13.37 21.107  1177 LEU158 CA 3.042 14.616 20.492  1178 LEU158 C 2.03 15.308 21.401  1179 LEU158 〇 2.089 16.535 21.586  1180 LEU158 C巳 2.412 14.232 19.149  1181 LEU158 CG 2.171 15.389 18.175  1182 LEU158 CD1 2.086 14.868 16.745  1183 LEU158 CD2 0.93 16.213 18.504  1184 LEU159 N 1.211 14.518 22.072  1185 LEU159 CA 0.183 15.099 22.929  1186 LEU159 C 0.747 15.411 24.309 106- (101)   1187 LEU159  1188 LEU159  1189 LEU159  1190 LEU159  1191 LEU159  1192 GLY160  1193 GLY160  1194 GLY160  1195 GLY160  1196 VAL161  1197 VAL161  1198 VAL161  1199 VAL161  1200 VAL161  1201 VAL161  1202 VAL161  1203 PR0162  1204 PR0162  1205 PR0162  1206 PR0162  1207 PR0162  1208 PR0162  1209 PR0162  1210 TYR163  1211 TYR163  1212 TYR163  1213 TYR163  1214 TYR163  1215 TYR163  1216 TYR163  1217 TYR163  1218 TYR163  1219 TYR163  1220 TYR163  1221 TYR163  1222 SER164  1223 SER164  1224 SER164  1225 SER164  1226 SER164  1227 SER164  1228 ASP165  1229 ASP165  1230 ASP165  1231 ASP165  1232 ASP165  1233 ASP165  1234 ASP165  1235 ASP165  1236 HIS166  1237 HIS166  1238 HIS166  1239 HIS166  1240 HIS166 BGD1D2A A bg'g:a bgd&amp;gt; — JCCCCNCCONCC〇CCCNCC〇ccCJii5/wwwwwwy3</span>755 ARG103 CB 756 ARG103 CG 757 ARG103 CD 758 ARG103 NE 759 ARG103 CZ 760 ARG103 NH1 761 ARG103 NH2 762 ARG104 N 763 ARG104 CA 764 ARG104 C 765 ARG104 〇766 ARG104 C 巳 767 ARG104 CG 768 ARG104 CD 770 ARG104 ARG104 NH1 772 ARG104 NH2 773 ASP105 N 774 ASP105 CA 775 ASP105 C 776 ASP105 〇777 ASP105 CB 778 ASP105 CG 779 ASP105 〇D1 780 ASP105 〇D2 781 VAL106 N 782 VAL106 CA 783 VAL106 C 784 VAL106 〇785 VAL106 CB 786 786 VAL106 VAL106 CG2 788 VAL107 N 789 VAL107 CA 790 VAL107 C 791 VAL107 〇792 VAL107 CB 793 VAL107 CG1 794 VAL107 CG2 795 GLY108 N 796 GLY108 CA 797 GLY108 C 798 GLY108 〇799 GLU109 N 800 GLU109 CA 801 GLU109 C 802 GLU109 804 GLU109 CG 805 GLU109 CD 806 GLU109 〇E1 807 GLU109 〇E2 808 PHE110 N -10.347 24.476 11.762 -9.496 23785 10.705 -10.366 23.455 9.496 -9.651 22.682 8.467 -9.807 21.367 8.287 -10.493 20.645 9.175 -9.174 20.755 7.285 -8.811 26.923 13.087 7. 775 27.957 13.006 -6.906 27.966 14.256 -5.675 28.083 14.149 -8.442 29.316 12.84 -9.166 29.412 11.502 -9.828 30.772 11.319 -10.874 30.999 12.329 -11.061 32.171 12.941 -10.231 33.188 12.701 -12.048 32.31 13.829 &amp;gt; 7.5 27.625 15.388 16.493-6.618 27.28 28.083 26.253 16.594 -4.602 26.392 16.716 -7.67 27.427 17.806 -8.198 28.814 18.165 • 7.389 29.588 18.666 -9.411 28.938 18.257 -6.379 25.125 16.173 -5.636 23.86 16.236 -4.51 23.761 15.214 -3.414 23.348 15.612 -6.611 22.703 16.046 -5.886 21.37 15.89 -7.587 22.637 17.212 -4.641 24.427 14.075 -3.565 24.397 13.071 • 2.362 25.259 13.474 -1.225 24.918 13.123 -4.142 24.869 11.737 -3.06 25.104 10.687 • 5.175 23.879 11.213 &amp;gt; 2.576 26.155 14.426 -1.49 26.985 14.953 -0.511 26.183 15.813 0.685 26.491 15.837 -1.006 25.191 16.537 24.388 17.376 0.121 22.976 16.836 1.086 22.311 17.229 -0.677 24.35 18.784 »0.577 25.728 19.424 0.886 26.1 19.659 1.612 25.244 20.147 1.22 27.255 19.442 -0.686 22.572 1 5.873 99- (94) 200418849 809 PHE110 CA -0.511 21,269 15.221 810 PHE110 C 0.017 21.468 13.798 811 PHE110 〇-0.547 20.963 12.819 812 PHE110 C 巳 -1.866 20.568 15.206 813 PHE110 CG -1.834 19.088 14.838 814 PHE110 CD1 -0.842 18.264 15.352 815 PHE110 CD2 -2.808 18.564 13.998 816 PHE110 CE1 • 0.819 16.915 15.019 817 PHE110 CE2 -2.784 17.216 13.665 818 PHE110 CZ -1.79 16.392 14.176 819 THR111 N 1.103 22.217 13.706 820 THR111 CA 1.68 22.585 12.409 821 THR111 C 2.353 21.411 11.71 822 THR111 〇. 12.346 823 THR111 CB 2.745 23.65 12.628 824 THR111 〇G1 3.887 23.019 13.193 825 THR111 CG2 2.27 24.756 13.561 826 VAL112 N 2.564 21.605 10.417 827 VAL112 CA 3.302 20.63 9.605 828 VAL112 C 4.802 20.712 9.887 829 VAL112 〇5.492 20.689 9.86 830 830 831 VAL112 CG1 3.819 20.01 7.21 832 VAL112 CG2 1.535 20.833 7.832 833 LYS113 N 5.227 21.845 10.425 834 LYS113 CA 6.608 22.003 10.884 835 LYS113 C 6.892 21.096 12.082 836 LYS113 〇7.864 20.332 12.044 837 LYS113 CB 6.795 23.456 11.298 838 LYS113 CG 8.168 23.696 11.914 839 LYS113 CD 8.232 25.064 12.582 840 LYS113 CE 7.189 25.184 13.692 841 LYS113 NZ 7.407 24.178 14.747 842 ARG114 N 5.945 21.013 13.008 843 ARG114 CA 6.085 20.094 14.094 13.098 ARG114 〇7.034 17.912 14.09 846 ARG114 CB 4.916 20.313 15.096 847 ARG114 CG 4.939 19.283 16.22 848 ARG114 CD 3.721 19.388 17.131 849 ARG114 NE 3.696 20.666 17.858 850 ARG114 CZ 4.078 20.792 19.131 851 ARG114 NH1 3.903 21.953 19.766 852 ARG114 115 NH2 4.5 4.5 5.28 18.265 12.737 854 MET115 CA 5.23 16.862 12.311 855 MET115 C 6.438 16.467 11.456 856 MET115 〇6.99 15.378 11.662 857 MET115 C 巳 3.926 16.642 11.555 858 MET115 CG 2.739 16.915 12.474 859 MET115 SD 1.093 16.637 11.78 860 MET115 CE 1.057 17.94 10.532 7.027 861LY 17.445 10.787 862 LYS116 CA 8.25 17.222 10.01 100- (95) LYS116 LYS116 LYS116 LYS116 LYS116 L.YS116 LYS116 ALA117 ALA117 ALA117 ALA117 ALA1 17 LEU118 LEU118 LEU118 LEU118 LEU118 LEU118 LEU118 LEU118 GLN119 GLN119 GLN119 GLN119 GLN119 GLN119 GLN119 GLN119 GLN119 PRO120 PRO120 PRO120 PRO120 PRO120 PRO120 PRO120 ARG121 ARG121 ARG121 ARG121 ARG121 ARG121 ARG121 ARG121 ARG121 ARG121 ARG121 ILE122 ILE122 ILE122 ILE122 ILE122 ILE122 ILE122 BGDEZ ABA BGD1D2A BGDE1E2A BGDA BGDEZH1H2A BG1G2 c〇ccccnncc〇cncc〇ccccncc〇ccc〇nncc〇cccncc〇cccncnnncc〇ccc 9.492 17.156 10.434 16.413 8.372 18.392 9.635 18.337 9.738 19.592 9.703 20.841 9.753 22.063 9.404 17.748 10.49 17.663 10.354 16.43 11.331 16 10.469 18.924 9.185 15.81 8.975 14.544 9.351 13.359 9.591 12.26 14.434 7.153 15.474 5.654 15.48 7.934 15.246 9.563 13.632 10.052 12.633 11.263 11.797 11.09 10.573 10.378 13.373 10.944 12.471 11.394 13.351 11.701 12.857 11.444 14.647 12.388 12.361 13.485 11.486 13.211 10.732 13.761 9.639 14.672 12.386 14.237 13.832 12.764 13.785 11.229 11.159 11.917 10.438 11.02 9.25 11.331 8.136 11.218 11.218 .385 11.741 11.209 11.481 9.812 12.184 9.613 12.714 8.443 13.415 8.346 12.601 7.386 10.18 9.421 9.316 8.332 10.135 7.27 9.975 6.073 8.309 8.918 7.456 9.995 7.422 7.825 101-(96) 917 1LE122 CD1 6.509 10.636 13.044 918 GLN123 N 11.179 7.724 12.982 919 GLN123 CA 12.088 6.827 12.269 920 GLN123 C 12.914 5.997 13.245 921 GLN123 〇12.897 4.76 13.156 922 GLN123 C 巳 12.989 7.717 11.423 923 GLN123 CG 13.978 6.941 10.567 924 GLN123 CD 14.72 7.939 9.684 925 GLN123 〇E1 15.954 7.96 9.626 926 GL N123 123 13.22 14.34 928 GLN124 CA 14.049 5.959 15.394 929 GLN124 C 13.184 4.947 16.144 930 GLN124 〇13.621 3.798 16.284 931 GLN124 CB 14.544 7.04 16.345 932 GLN124 CG 15.429 6.495 17.455 933 GLN124 CD 15.912 7.668 18.3 934 GLN124 〇E1 16.786 15.832 16.935 7.832 16.935 7.832 16.926 7.832 15. 936 ILE125 N 11.904 5.252 16.299 937 1LE125 CA 10.961 4.328 16.947 938 ILE125 C 10.716 3.072 16.112 939 ILE125 〇10.861 1.961 16.642 940 ILE 125 CB 9.638 5.064 17.148 941 ILE125 CG1 9.792 6.214 18.13 942 ILE125 CG2 8.543 4.122 17.628 943 ILE125 CD1 8.487 6.984 18.275 944 VAL126 N 10.649 3.229 14.797 945 VAL126 CA 10.44 2.064 13.928 946 VAL126 C 11.693 1.2 13.87 947 VAL126 VAL11 06012.603-12.060.02 CB 10.119 2.529 12.513 949 VAL126 CG1 9.754 1.334 11.641 950 VAL126 CG2 8.988 3.544 12.503 951 ASP127 N 12.843 1.855 13.909 952 ASP127 CA 14.121 1.141 13.889 953 ASP127 C 14.314 0.34 15.17 954 ASP127 〇14.537 -0.876 15.088 955 ASP127 CB 15.258 2.153 13.769 956 15.158 2.967 12.481 957 ASP127 〇D1 15.632 4.097 12.49 958 ASP127 〇D2 14.686 2.426 11.489 959 GLU128 N 13.903 0.919 16.288 960 GLU128 CA 14.048 0.26 17.589 961 GLU128 C 13.094 • 0.915 17.762 962 GLU128 〇13.527 -1.952 18.281 963 GLU128 CB 13.764 1. GLU128 CG 14.807 2.39 18.707 965 GLU128 CD 14.367 3.489 19.668 966 GLU128 OE1 13.584 4.333 19.247 967 GLU128 〇E2 14.794 3.452 20.812 968 HIS129 N 11.934 -0.86 1 17.128 969 HIS129 CA 11.002 -1.985 17.237 970 HIS129 C 11.411 -3.142 16.333 -102- (97) HIS129 〇11.344 -4.297 HIS129 CB 9.592 -1.533 HIS129 CG 8.963 -0.57 HIS129 ND1 7.942 0.266 HIS129 CD2 9.3 -0.394 HIS129 CE1 7.647 0.969 HIS129 NE2 8.488 0.561 ILE130 N 12.061 -2.848 ILE130 CA 12.564 -3.95 ILE130 C 13.768 -4.577 ILE130 〇13.69 -5.756 ILE130 CB 12.968 -3.449 ILE130 CG1 11.841 -2.659 ILE130 CG2 13.341 -4.632 ILE130 CD1 12.258 -2.117 ASP131 N 14.65 -3.712 CA 15.874 -4.12 ASP131 C 15.604 -5.033 ASP131 〇15.932 • 6.226 ASP131 CB 16.565 -2.874 ASP131 CG 17.175 -1.999 ASP131 〇D1 17.222 -0.791 ASP131 OD2 17.743 -2.564 ALA132 N 14.882 -4.505 ALA132 CA 14.708 -5.198 ALA132 C 13.582 -6.228 ALA132 〇13.489 -6.983 ALA132 CB 14.465 -4.147 LEU133 N 12.752 -6.286 LEU133 CA 11.712 -7.311 LEU133 C 12.08 -8.444 LEU133 〇12.567 -9.492 LEU133 CB 10.366 -6.697 LEU133 CG 9.925 -5.686 LEU133 CD1 8.679 -4.93 LEU133 CD2 9.698 LEU134 N 11.901 -8 .215 LEU134 CA 12.139 -9.288 LEU134 C 12.895 -8.777 LEU134 〇12.319 -8.632 LEU134 CB 10.808 • 9.885 LEU134 CG 10.481 -11.234 LEU134 CD1 11.66 -12.193 LEU134 CD2 9.997 -11.115 ALA135 N 14.194 -8.586 ALA135 CA 15.038 -8.142 ALA135 C 15. -9.293 ALA135 〇16.184 • 9.051 ALA135 CB 16.193 • 7.323 GLY136 N 15.402 -10.522 GLY136 CA 15.957 -11.679 GLY136 C 14.865 -12.524 GLY136 〇14.069 -12.022 PR0137 N 14.906 -13.813 103- (98) 200418849 1025 1026 1027 1028 1029 1030 1030 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 137137137137137137383838383838383838139139139139139139139 ROROROROROROYS1YS1YS1YS1YS1YS1YS1YS1YS1RORORORORORORO ppppppgggglllllppppppp ALA140 ALA140 ALAMO ALA140 ALA140 ASP141 ASP141 ASP141 ASP141 ASP141 ASP141 ASP141 ASP141 LEU142 LEU142 LEU142 LEU142 LEU142 LEU142 LE U142 LEU142 VAL143 VAL143 VAL143 VAL143 VAL143 VAL143 VAL143 VAL143 GLN144 GLN144 GLN144 GLN144 CA 13.938 -14.772 11.353 C 12.589 -14.709 12.067 〇12.21 -13.679 12.637 CB 14.573 -16.111 11.568 CG 15.748 -15.953 12.524 CA 11.899 11.945 N 11.899 -14 -16.043 12.639 C 9.412 -15.227 12.069 〇9.605 -14.143 11.508 CB 10.733 -15.765 14.135 CG 11.795 -16.66 14.765 CD 12.022 -16.303 16.23 CE 13.155 -17.128 16.829 NZ 12.859 -18.567 16.746 N 8.256 -15.868 12.022 CA 6.996 -15.155 11.797 C 6.612 -14.289 12.995 〇6.167 -14.795 14.031 CB 5.979 -16.232 11.583 CG 6.595 -17.575 11.948 CD 8.04 -17.286 12.322 N 6.749 -12.987 12.824 CA 6.355 -12.036 13.868 C 5.006 -11.411 13.552 〇4.591 -11.359 12.391 CB 7.395 -10.931 13.953 N 4.297 -10.989 14.582 CA 3.051 -10.264 14.336 C 3.363 -8.779 14.165 〇3.466 -8.032 15.149 CB 2.073 • 10.492 15.481 CG 0.741 -9.84 15.132 〇D1 0.583 -8.673 15.465 〇D2 0.016 -10.426 14.338 N 3.261 -8.332 12.923 CA 3.69 2 -6.983 12.541 C 2.753 • 5.893 13.048 〇3.232 -4.806 13.4 CB 3.78 -6.96 11.012 CG 4.336 -5.66 10.428 CD1 5.227 • 5.944 9.225 CD2 3.241 -4.659 10.063 N 1.509 -6.243 13.329 CA 0.585 -5.247 13.868 C 0.992 -4.867 15.287 〇 1.481 -3.748 15.477 CB -0.829 -5.809 13.859 CG1 -1.823 -4.772 14.374 CG2 -1.212 -6.26 12.457 N 1.184 -5.874 16.119 CA 1.491 -5.656 17.535 C 2,945 -5.249 17.797 〇3.212 -4.566 18.791 -104- (99) 1079 GLN144 CB 1.203 -6.982 18.23 1080 GLN144 CG 1.485 -6.966 19.726 1081 GLN144 CD 1.232 -8.364 20.277 1082 GLN144 〇E1 1.815 -8.777 21.285 1083 GLN144 NE2 0.374 -9.091 19.582 1084 ALA145 N 3.842 -5.539 16.87 1085 ALA145 CA 5.246 -5.186 17.088 1086 C 5.672 -3.884 16.412 1087 ALA145 〇6.594 -3.211 16.888 1088 ALA145 C 巳 6.108 -6.329 16.561 1089 LEU146 N 4.988 -3.499 15.349 1090 LEU146 CA 5.424 -2.324 14.588 1091 LEU146 C 4.294 -1.342 14.317 1092 LEU146 〇4.308 -0.207 14.815 1093 LEU146 CB 5.964 -2.825 13.252 1094 LEU146 CG 7.225 -3.659 13.433 1095 LEU146 CD1 7.467 -4.589 12.254 1096 LEU146 CD2 8.432 &amp;gt; 2.772 13.705 1097 SER147 N 3.245 -1.868 13.71 1098 SER147 CA 2.169 -1.053 13.134 1099 SER147 C 1.274 -0.369 14.164 1100 SER147 〇0.727 0.708 13.911 1101 SER147 CB 1.325 2.001 12.301 1102 SER147 〇G 0.198 -1.277 11.856 1103 LEU148 N 1.174 -0.97 15.331 1104 LEU148 CA 0.484 -0.358 16.464 1105 LEU148 C 1.433 0.51 17.316 1106 LEU148 〇1.132 1.707 17.436 1107 LEU148 CB -0.204 • 1.475 17.259 1108 LEU148 CG -1.13- 0.987 18.372 1109 LEU148 CD1 -2.317 -1.93 18.53 1110 LEU148 CD2-0.404 -0.81 19.703 1111 PR0149 N 2.553 0.008 17.848 1112 PR0149 CA 3.299 0.829 18.809 1113 PR0149 C 3.987 2.052 18.203 1114 PR0149 〇4.043 3.07 18.9 1115 PR0149 CB 4.31 -0.075 19.439 19.439 PR0149 CG 4.261 • 1.43 18.764 1117 PR0149 CD 3.122 -1.352 17.766 1118 VAL150 N 4.316 2.051 16.918 1119 VAL150 CA 4.873 3.276 16.323 1120 VAL150 C 3.867 4.442 16.385 1121 VAL150 〇4.127 5.334 17.201 1122 VAL150 CB 5.399 3 .041 14.905 1123 VAL150 CG1 5.892 4.345 14.284 1124 VAL150 CG2 6.514 2.004 14.891 1125 PR0151 N 2.695 4.396 15.75 1126 PR0151 CA 1.816 5.574 15.799 1127 PR0151 C 1.187 5.843 17.167 1128 PR0151 〇1.009 7.014 17.532 1129 PR0151 CB 0.742 5.307 14.799 1799 1130 14.266 1131 PR0151 CD 2.136 3.336 14.896 1132 SER152 N 1.059 4.817 17.993 -105- (100) 200418849 1133 SER152 CA 0.504 5.027 19.326 1134 SER152 C 1.506 5.73 20.241 1135 SER152 〇1.136 6.724 20.879 1136 SER152 C 巳 0.117 3.671 19.898 1137 SER152 〇G- 0.849 3.09 19.031 1138 LEU153 N 2.785 5.428 20.079 1139 LEU153 CA 3.817 6.088 20.883 1140 LEU153 C 4.17 7.458 20.312 1141 LEU153 〇4.34 8.406 21.091 1142 LEU153 CB 5.06 5.206 20.899 1143 LEU153 CG 6.168 5.789 21.769 1144 LEU153 CD1 5.708 5.934 23.216 21.689 1146 VAL154 N 3.995 7.622 19.009 1147 VAL154 CA 4.232 8.925 18.383 1148 VAL154 C 3.185 9.944 18.813 1149 VAL154 〇3.566 11.036 19.256 1150 VAL154 C 巳 4.205 8.777 16.864 1151 VAL154 CG1 4.148 10.134 16.169 1152 VAL154 CG2 5.402 7.976 16.368 1153 ILE155 N 1.945 9.513 18.977 1154 ILE155 CA 0.935 10.467 19.431 1155 ILE155 C 0.932 10.621 20.956 1156 ILE155 〇0.6 11.709 21.446 1157 ILE155 CB -0.433 10.065 18.902 1158 1158 11.218 19.089 1159 ILE155 CG2 -0.956 8.814 19.593 1160 ILE155 CD1 -0.954 12.46 18.327 1161 CYS156 N 1.569 9.697 21.66 1162 CYS156 CA 1.787 9.891 23.093 1163 CYS156 C 2.835 10.973 23.317 1164 CYS156 〇2.551 11.93 24.047 1165 CYS59 23.52 2.2 1.018 7.295 23.935 1167 GLU157 N 3.838 11.005 22.454 1168 GLU157 CA 4.902 12.011 22.559 1169 GLU157 C 4.512 13.364 21.957 1170 GLU157 〇5.08 14.393 22.339 1171 GLU157 CB 6.109 11.474 21.801 1172 GLU157 CG 6.57 10.14 22.372 1173 GLU157 CD 7.588 9.499 21.434 1174 GLU 21.767 1175 GLU157 〇E2 7.162 8.932 20.437 1176 LEU158 N 3.5 13.37 21.107 1177 LEU158 CA 3.042 14.616 20.492 1178 LEU158 C 2.03 15.308 21.401 1179 LEU158 〇2.089 16.535 21.586 1180 LEU158 C 巳 2.412 14.232 19.149 1181 LEU158 CG 2.171 15.389 18.175 1182 LEU158 CD1 2.086 14.868 16.745 1183 LEU158 CD2 0.93 16.213 18.504 1184 LEU159 N 1.211 14.518 22.072 1185 LEU159 CA 0.183 15.099 22.929 1186 LE411159 0.71. 106- (101) 1187 LEU159 1188 LEU159 1189 LEU159 1190 LEU159 1191 LEU159 1192 GLY160 1193 GLY160 1194 GLY160 1195 GLY160 1196 VAL161 1197 VAL161 1198 VAL161 1199 VAL161 1200 VAL161 1201 VAL161 1202 VAL161 1203 PR0162 1204 PR0162 1206 1206 1206 1206 2160 PR0162 1210 TYR163 1211 TYR163 1212 TYR163 1213 TYR163 1214 TYR163 1215 TYR163 1216 TYR163 1217 TYR163 1218 TYR163 1219 TYR163 1220 TYR163 1221 TYR163 1222 ASP165 1212 ASP16512 12650 ASP165 1235 ASP165 1236 HIS166 1237 HIS166 1238 HIS166 1239 HIS166 1240 HIS166 BGD1D2A A bg'g: a bgd&gt; — JCCCCNCCONCC〇CCCNCC〇ccCJii5 / wwwwwwy3</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1 2 G G</span>1 2 G G</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A 12 12 bgddeezh</span>A 12 12 bgddeezh</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A</span>A</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">巳G A</span>巳 G A</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1 2 巳G D D</span>1 2 巳 G D D</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A</span>A</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">B 0.832 -0.979 -2.24 -2.637 -3.385 1.347 1.874 1.433 1.183 1.366 0.869 2.006 2.715 -0.111 -0.763 -1.175 2.15 3.13 2.838 1.68 3.066 1.972 1.358 3.882 3.793 3.104 2.72 5.192 6.111 6.895 6.181 7.726 7.011 7.78 8.589 2.806 2.007 0.51 -0.319 2.303 1.766 0.173 -1.215 -1.445 -2.542 -1.463 -1.331 -2.358 -0.21 •0.343 -0.299 -0.63 -0.515 1.11 16.594 14.12 14.827 15.915 13.84 14.417 14.572 13.413 13.581 12.238 11.037 10.078 9.58 10.348 9.125 11.327 9.806 8.826 7.41 7.021 8.899 9.874 10.384 6.593 5.209 4.257 3.153 4.684 4.367 5.363 3.067 5.066 2.768 3.77 3.478 4.747 3.992 4.158 3.566 4.538 5.854 5.056 5.273 4.619 4.126 6.775 7.38 7.592 7.683 4.475 3.666 2.223 1.86 3.792 24.66 23.044 23.524 22.535 23.707 24.943 26.306 27.2 28.398 26.601 27.284 27.635 26.752 26.338 26.976 25.866 28.922 29.4 28.901 28.689 30.894 31.302 30.009 28.912 28.41 29.393 29.002 28.071 29.254 29.826 29.743 30.898 30.815 31.392 32.467 30.589 31.561 31.301 32 32.952 33.017 30.389 30.002 28.649 28.344 29.944 31.343 31.968 31.732 27.929 26.71 27.09 28.266 26.129 107- (102) HIS166 CG 1.387 3.018  HIS166 ND1 0.916 3.295  HIS166 CD2 2.174 1.896  HIS166 CE1 1.378 2.374  HIS166 NE2 2.156 1.51  GLU167 N -1.239 1.506  GLU167 CA -1.754 0.127  GLU167 C -3.12 0.07  GLU167 〇 -4.04 -0.549  GLU167 CB •0.743 -0.752  GLU167 CG 0.54 -0.919  GLU167 CD 1.593 -1.638  GLU167 〇E1 1.207 -2.478  GLU167 OE2 2.766 -1.386  PHE168 N -3.329 0.846  PHE168 CA -4.652 0.854  PHE168 C -5.586 1.779  PHE168 〇 -6.692 1.36  PHE168 CB -4.53 1.304  PHE168 CG -5.824 1.165  PHE168 CD1 -6.696 0.117  PHE168 CD2 -6.126 2.078  PHE168 CE1 -7.875 -0.01  PHE168 CE2 -7.305 1.951  PHE168 CZ -8.18 0.908  PHE169 N -5.016 2.851  PHE169 CA -5.773 3.717  PHE169 C -5.944 3.029  PHE169 〇 -7.031 3.098  PHE169 CB -5.003 5.024  PHE169 CG -5.736 6.088  PHE169 CD1 -6.361 7.145  PHE169 CD2 -5.758 6.022  PHE169 CE1 -7.037 8.111  PHE169 CE2 -6.436 6.985  PHE169 CZ -7.082 8.028  GLN170 N -5.019 2.134  GLN170 CA -5.042 1.407  GLN170 C -6.148 0.359  GLN170 〇 -6.903 0.281  GLN170 C巳 -3.705 0.693  GLN170 CG -3.611 -0.121  GLN170 CD -3.411 0.818  GLN170 〇E1 -2.392 1.516  GLN170 NE2 -4.408 0.885  SER171 N -6.372 -0.281  SER171 CA -7.424 -1.295  SER171 C -8.811 -0.665  SER171 〇 -9.706 -1.107  SER171 C巳 &amp;gt;7.171 -2.209  SER171 〇G *7.132 -1.427  CYS172 N -8.906 0.511  CYS172 CA -10.204 1.184  CYS172 C -10.569 1.806 108- (103) CYS172 〇 -11.691 1.593  CYS172 CB -10.149 2.266  CYS172 SG -9.817 1.701  SER173 N -9.559 2.253  SER173 CA -9.781 2.826  SER173 C -9.949 1.765  SER173 〇 -10.363 2.096  SER173 CB -8.612 3.741  SER173 〇G -7.418 2.972  SER174 N -9.687 0.509  SER174 CA -10.001 -0.575  SER174 C -11.395 -1.133  SER174 〇 -12.128 -1.464  SER174 CB -8.949 -1.668  SER174 〇G -7.691 -1.099  ARG175 N -11.85 -0.974  ARG175 CA -13.224 -1.373  ARG175 C -14.226 -0.342  ARG175 〇 -15.298 -0.72  ARG175 CB -13.371 -1.514  ARG175 CG -12.486 -2.622  ARG175 CD -12.761 -2.871  ARG175 NE -12.544 -1.662  ARG175 CZ -13.06 -1.512  ARG175 NH1 -12.78 -0.421  ARG175 NH2 -13.816 -2.478  MET176 N -13.739 0.876  MET176 CA -14.516 1.951  MET176 C -14.649 1.843  MET176 〇 -15.284 2.71  MET176 CB -13.806 3.259  MET176 CG -13.86 3.657  MET176 SD -13.036 5.228  MET176 CE -13.493 5.972  LEU177 N -14.036 0.846  LEU177 CA -14.184 0.676  LEU177 C -15.219 -0.388  LEU177 〇 -15.593 -0.533  LEU177 CB -12.836 0.29  LEU177 CG -11.824 1.426  LEU177 CD1 -10.568 1.035  LEU177 CD2 -12.4 2.713  SER178 N -15.706 -1.099  SER178 CA -16.693 -2.149  SER178 C -18.117 -1.673  SER178 〇 -18.628 -1.797  SER178 C巳 -16.344 -3.402  SER178 OG 16.323 •3.095  ARG179 N -18.765 -1.209  ARG179 CA -20.148 -0.697  ARG179 C -21.17 -1.832  ARG179 〇 -21.743 -2.266  ARG179 C巳 -20.4 0.027  ARG179 CG -19.286 1.01 109- (104)200418849 1349 ARG179 CD -19.098 1.114 13.922  1350 ARG179 NE -18.628 -0.179 13.39  1351 ARG179 CZ -19.337 -0.967 12.576  1352 ARG179 NH1 -18.903 -2.2 12.307  1353 ARG179 NH2 -20.546 -0.583 12.156  1354 GLU180 N -21.375 -2.313 18.405  1355 GLU180 CA -22.261 -3.454 18.627  1356 GLU180 C -23.553 -3.038 19.318  1357 GLU180 〇 -23.676 -1.923 19.833  1358 GLU180 CB -21.517 -4.449 19.508  1359 GLU180 CG -20.175 -4.838 18.899  1360 GLU180 CD -19.442 -5.795 19.828  1361 GLU180 〇E1 -20.124 -6.592 20.457  1362 GLU180 〇E2 -18.219 -5.763 19.834  1363 VAL181 N -24.492 -3.969 19.374  1364 VAL181 CA -25.72 -3.744 20.147  1365 VAL181 C -25.463 -4.084 21.616  1366 VAL181 〇 -26.012 -3.452 22.525  1367 VAL181 CB -26.823 -4.627 19.569  1368 VAL181 CG1 -28.119 -4.498 20.362  1369 VAL181 CG2 -27.062 -4.297 18.099  1370 THR182 N -24.438 -4.897 21.822  1371 THR182 CA -23.936 -5.215 23.166  1372 THR182 C -22.767 -4.302 23.547  1373 THR182 〇 -21.827 -4.739 24.222  1374 THR182 CB -23.459 -6.664 23.183  1375 THR182 OG1 -22.348 -6.789 22.302  1376 THR182 CG2 -24.551 -7.622 22.719  1377 ALA183 N -22.882 &amp;gt;3.025 23.214  1378 ALA183 CA -21.777 -2.062 23.352  1379 ALA183 C -21.585 -1.459 24.748  1380 ALA183 〇 -21.031 -0.36 24.855  1381 ALA183 C巳 -21.993 -0.933 22.352  1382 GLU184 N -21.832 -2.224 25.799  1383 GLU184 CA -21.706 -1.688 27.158  1384 GLU184 C -20.242 -1.537 27.568  1385 GLU184 〇 -19.888 -0.536 28.199  1386 GLU184 CB •22.415 -2.636 28.117  1387 GLU184 CG -22.387 -2.118 29.551  1388 GLU184 CD -23.145 -3.086 30.454  1389 GLU184 OE1 -22.924 -3.047 31.655  1390 GLU184 OE2 -23.953 -3.832 29.917  1391 GLU185 N •19.374 •2.344 26.978  1392 GLU185 CA ►17.936 -2.201 27.244  1393 GLU185 C -17.307 -1.143 26.337  1394 GLU185 〇 -16.294 -0.542 26.708  1395 GLU185 CB -17.216 -3.541 27.073  1396 GLU185 CG -17.189 -4.388 28.351  1397 GLU185 CD -18.561 -4.959 28.705  1398 GLU185 〇E1 -19.308 -5.237 27.774  1399 GLU185 〇E2 -18.899 -4.953 29.879  1400 ARG186 N -18.044 -0.74 25.316  1401 ARG186 CA -17.607 0.339 24.434  1402 ARG186 C -18.008 1.676 25.049 110- 4 (105) ARG186 〇 -17.213 2.624  ARG186 CB -18.317 0.135  ARG186 CG -17.936 1.175  ARG186 CD -18.718 0.942  ARG186 NE -18.234 1.82  ARG186 CZ -19.002 2.705  ARG186 NH1 -20.296 2.816  ARG186 NH2 -18.474 3.477  MET187 N -19.086 1.627  MET187 CA -19.545 2.775  MET187 C -18.651 2.978  MET187 〇 -18.251 4.113  MET187 CB -20.958 2.459  MET187 CG -21.569 3.594  MET187 SD -23.104 3.161  MET187 CE -23.995 2.43  THR188 N -18.13 1.874  THR188 CA -17.174 1.925  THR188 C -15.819 2.442  THR188 〇 -15.237 3.307  THR188 CB -17.013 0.516  THR188 〇G1 -18.274 0.091  THR188 CG2 -16.011 0.473  ALA189 N -15.477 2.139  ALA189 CA -14.243 2.652  ALA189 C -14.333 4.147  ALA189 〇 -13.403 4.884  ALA189 CB -13.996 1.884  PHE190 N -15.518 4.605  PHE190 CA -15.762 6.042  PHE190 C -15.632 6.81  PHE190 〇 -14.815 7.736  PHE190 C巳 -17.194 6.258  PHE190 CG •17.566 5.772  PHE190 CD1 -16.652 5.837  PHE190 CD2 -18.848 5.293  PHE190 CE1 -17.013 5.406  PHE190 CE2 -19.208 4.861  PHE190 CZ -18.291 4.917  GLU191 N -16.281 6.297  GLU191 CA -16.292 6.969  GLU191 C -14.921 6.971  GLU191 〇 -14.432 8.05  GLU191 CB -17.28 6.233  GLU191 CG -17.348 6.853  GLU191 CD -18.28 6.023  GLU191 〇E1 -18.424 4.843  GLU191 〇E2 -18.894 6.597  SER192 N -14.202 5.866  SER192 CA -12.877 5.76  SER192 C -11.82 6.545  SER192 〇 -10.892 7.077  SER192 CB -12.467 4.291  SER192 〇G -12.37 3.801 111 - (106) LEU193 N -12.082 6.827  LEU193 CA &amp;gt;11.152 7.64  LEU193 C -11.441 9.127  LEU193 〇 -10.514 9.943  LEU193 CB -11.243 7.218  LEU193 CG -9.95 6.547  LEU193 CD1 -9.372 5.603  LEU193 CD2 -10.117 5.842  GLU194 N -12.63 9.438  GLU194 CA -12.93 10.811  GLU194 C -12.368 11.096  GLU194 〇 -11.82 12.182  GLU194 CB -14.437 11.017  GLU194 CG -14.97 11.164  GLU194 CD -14.35 12.405  GLU194 〇E1 &amp;gt;13.524 12.237  GLU194 〇E2 -14.826 13.487  ASN195 N -12.26 10.058  ASN195 CA -11.645 10.215  ASN195 C -10.126 10.268  ASN195 〇 -9.479 11.112  ASN195 CB -12.076 9.054  ASN195 CG -13.582 9.104  ASN195 〇D1 -14.272 8.076  ASN195 ND2 •14.076 10.3  TYR196 N -9.64 9.613  TYR196 CA -8.236 9.692  TYR196 C -7.88 11.104  TYR196 〇 -6.953 11.707  TYR196 CB -8.065 8.757  TYR196 CG -7.054 7.633  TYR196 CD1 -5.806 7.739  TYR196 CD2 -7.39 6.5  TYR196 CE1 •4.884 6.711  TYR196 CE2 -6.466 5.472  TYR196 CZ -5.216 5.581  TYR196 OH •4.301 4.56  LEU197 N •8.76 11.708  LEU197 CA -8.543 13.084  LEU197 C -8.718 14.131  LEU197 〇 -7.966 15.11  LEU197 CB -9.53 13.394  LEU197 CG -9.196 12.63  LEU197 CD1 -10.305 12.816  LEU197 CD2 -7.852 13.072  ASP198 N -9.49 13.83  ASP198 CA -9.6 14.749  ASP198 C -8.257 14.841  ASP198 〇 -7.698 15.938  ASP198 CB -10.627 14.209  ASP198 CG -12.016 14.052  ASP198 〇D1 -12.428 14.949  ASP198 〇D2 -12.706 13.123  GLU199 N -7.629 13.685 112- (107)   GLU199 CA -6.334 13.598 34.368  GLU199 C -5.221 14.182 33.506  GLU199 〇 -4.521 15.091 33.965  GLU199 CB •6.053 12.121 34.608  GLU199 CG -7.157 11.486 35.444  GLU199 CD -7.084 9.966 35.341  GLU199 〇E1 -7.502 9.312 36.287  GLU199 〇E2 -6.717 9.484 34.277  LEU200 N -5.26 13.885 32.219  LEU200 CA -4.209 14.315 31.289  LEU200 C -4.22 15.821 31.02  LEU200 〇 -3.168 16.467 31.128  LEU200 C巳 -4.459 13.57 29.982  LEU200 CG -3.421 13.888 28.914  LEU200 CD1 -2.036 13.415 29.338  LEU200 CD2 -3.815 13.251 27.587  VAL201 N -5.406 16.402 30.938  VAL201 CA -5.521 17.832 30.642  VAL201 C -5.196 18.69 31.859  VAL201 〇 •4.491 19.7 31.709  VAL201 C巳 -6.945 18.094 30.153  VAL201 CG1 -7.324 19.57 30.184  VAL201 CG2 -7.159 17.508 28.761  THR202 N -5.431 18.149 33.045  THR202 CA -5.103 18.884 34.267  THR202 C -3.643 18.677 34.654  THR202 〇 -2.981 19.624 35.101  THR202 CB -6.02 18.391 35.378  THR202 〇G1 •7.359 18.589 34.945  THR202 CG2 -5.814 19.173 36.671  LYS203 N -3.08 17.579 34.182  LYS203 CA -1.672 17.284 34.434  LYS203 C 0.755 18.113 33.539  LYS203 〇 0.305 18.539 34.015  LYS203 C巳 •1.474 15.79 34.209  LYS203 CG - 0.041 15.331 34.439  LYS203 CD 0.025 13.812 34.569  LYS203 CE -0.557 13.099 33.352  LYS203 NZ 0.265 13.325 32.154  LYS204 N -1.256 18.545 32.391  LYS204 CA -0.505 19.493 31.553  LYS204 C -0.788 20.954 31.896  LYS204 〇 -0.031 21.846 31.499  LYS204 C巳 -0.821 19.218 30.092  LYS204 CG -0.076 17.965 29.664  LYS204 CD 1.425 18.213 29.729  LYS204 CE 2.202 16.906 29.69  LYS204 NZ 1.918 16.115 30.896  GLU205 N -1.781 21.179 32.741  GLU205 CA •2.033 22.524 33.264  GLU205 C -1.215 22.777 34.526  GLU205 〇 -1.027 23.931 34.927  GLU205 CB -3.518 22.66 33.57  GLU205 CG -4.309 22.726 32.273</span>B 0.832 -0.979 -2.24 -2.637 -3.385 1.347 1.874 1.433 1.183 1.366 0.869 2.006 2.715 -0.111 -0.763 -1.175 2.15 3.13 2.838 1.68 3.066 1.972 1.358 3.882 3.793 3.104 2.72 5.192 6.111 6.895 6.181 7.726 7.011 7.78 8.589 2.806 2.007 0.51 -0.319 2.303 1.766 0.173 -1.215 -1.445 -2.542 -1.463 -1.331 -2.358 -0.21 • 0.343 -0.299 -0.63 -0.515 1.11 16.594 14.12 14.827 15.915 13.84 14.417 14.572 13.413 13.581 12.238 11.037 10.078 9.58 10.348 9.125 11.327 9.806 8.826 7.41 7.021 8.899 9.874 10.384 6.593 5.209 4.257 3.153 4.684 4.367 5.363 3.067 5.066 2.768 3.77 3.478 4.747 3.992 4.158 3.566 4.538 5.854 5.056 5.273 4.619 4.126 6.775 7.38 7.592 7.683 4.475 3.666 2.223 1.86 3.792 24.66 23.044 23.524 22.535 23.707 24.943 26.306 27.2 28.398 26.601 27.284 27.635 26.752 26.338 26.976 25.866 28.922 29.4 28.901 28.689 30.894 31.302 30.009 28.912 28.41 29.393 29.002 28.071 29.254 29.826 29.743 30.898 30.815 31.392 32.467 30.589 31.561 31.301 32 32.952 33.017 30.389 30.002 28.649 28.344 29.944 31.343 31.968 31.73 2 27.929 26.71 27.09 28.266 26.129 107- (102) HIS166 CG 1.387 3.018 HIS166 ND1 0.916 3.295 HIS166 CD2 2.174 1.896 HIS166 CE1 1.378 2.374 HIS166 NE2 2.156 1.51 GLU167 N -1.239 1.506 GLU167 CA -1.754 0.127 GLU167 C -3.12 0.07 4.04 GLU167 -0.549 GLU167 CB • 0.743 -0.752 GLU167 CG 0.54 -0.919 GLU167 CD 1.593 -1.638 GLU167 〇E1 1.207 -2.478 GLU167 OE2 2.766 -1.386 PHE168 N -3.329 0.846 PHE168 CA -4.652 0.854 PHE168 C -5.586 1.779 PHE168 〇-6.692 1.36 PHE168 CB -4.53 1.304 PHE168 CG -5.824 1.165 PHE168 CD1 -6.696 0.117 PHE168 CD2 -6.126 2.078 PHE168 CE1 -7.875 -0.01 PHE168 CE2 -7.305 1.951 PHE168 CZ -8.18 0.908 PHE169 N -5.016 2.851 PHE169 CA -5.773 3.717 PHE169 C -5.944 3.029 PHE169 〇-7.031 3.098 PHE169 CB -5.003 5.024 PHE169 CG -5.736 6.088 PHE169 CD1 -6.361 7.145 PHE169 CD2 -5.758 6.022 PHE169 CE1 -7.037 8.111 PHE169 CE2 -6.436 6.985 PHE169 CZ -7.082 8.028 GLN170 N -5.019 2.13442 GLN407 CA -5.0 GLN170 C -6.148 0.359 GLN170 〇-6.90 3 0.281 GLN170 C 巳 -3.705 0.693 GLN170 CG -3.611 -0.121 GLN170 CD -3.411 0.818 GLN170 〇E1 -2.392 1.516 GLN170 NE2 -4.408 0.885 SER171 N -6.372 -0.281 SER171 CA -7.424 -1.295 SER171 C -8.811 -0.665 SER171 〇 -9.706 -1.107 SER171 C 巳 &amp;gt; 7.171 -2.209 SER171 〇G * 7.132 -1.427 CYS172 N -8.906 0.511 CYS172 CA -10.204 1.184 CYS172 C -10.569 1.806 108- (103) CYS172 〇-11.691 1.593 CYS172 CB -10.149 2.266 CYS172 SG -9.817 1.701 SER173 N -9.559 2.253 SER173 CA -9.781 2.826 SER173 C -9.949 1.765 SER173 〇-10.363 2.096 SER173 CB -8.612 3.741 SER173 〇G -7.418 2.972 SER174 N -9.687 0.509 SER174 CA -10.001 -0.575 SER174 C -11.395 -1.133 SER174 〇-12.128 -1.464 SER174 CB -8.949 -1.668 SER174 〇G -7.691 -1.099 ARG175 N -11.85 -0.974 ARG175 CA -13.224 -1.373 ARG175 C -14.226 -0.342 ARG175 〇-15.298 -0.72 ARG175 CB -13.371- 1.514 ARG175 CG -12.486 -2.622 ARG175 CD -12.761 -2.871 ARG175 NE -12.544 -1.662 ARG175 CZ -13.06 -1.512 ARG175 NH1 -12.78 -0.4 21 ARG175 NH2 -13.816 -2.478 MET176 N -13.739 0.876 MET176 CA -14.516 1.951 MET176 C -14.649 1.843 MET176 〇-15.284 2.71 MET176 CB -13.806 3.259 MET176 CG -13.86 3.657 MET176 SD -13.036 5.228 MET176 CE -13.493 5.972 LE 14.036 0.846 LEU177 CA -14.184 0.676 LEU177 C -15.219 -0.388 LEU177 〇-15.593 -0.533 LEU177 CB -12.836 0.29 LEU177 CG -11.824 1.426 LEU177 CD1 -10.568 1.035 LEU177 CD2 -12.4 2.713 SER178 N -15.706 -1.099 SER178 CA -16.693 2.149 SER178 C -18.117 -1.673 SER178 〇-18.628 -1.797 SER178 C 巳 -16.344 -3.402 SER178 OG 16.323 • 3.095 ARG179 N -18.765 -1.209 ARG179 CA -20.148 -0.697 ARG179 C -21.17 -1.832 ARG179 〇-21.743 -2.266 ARG179 C 巳 -20.4 0.027 ARG179 CG -19.286 1.01 109- (104) 200418849 1349 ARG179 CD -19.098 1.114 13.922 1350 ARG179 NE -18.628 -0.179 13.39 1351 ARG179 CZ -19.337 -0.967 12.576 1352 ARG179 NH1 -18.903 -2.2 12.307 1353 ARG179 NH2 -20.546 -0.583 12.156 1354 GLU180 N -21.375 -2.313 18.405 1355 GLU180 CA -22. 261 -3.454 18.627 1356 GLU180 C -23.553 -3.038 19.318 1357 GLU180 〇-23.676 -1.923 19.833 1358 GLU180 CB -21.517 -4.449 19.508 1359 GLU180 CG -20.175 -4.838 18.899 1360 GLU180 CD -19.442 -5.795 19.828 1361 GLU180 〇E1 -20.124 -6.592 20.457 1362 GLU180 〇E2 -18.219 -5.763 19.834 1363 VAL181 N -24.492 -3.969 19.374 1364 VAL181 CA -25.72 -3.744 20.147 1365 VAL181 C -25.463 -4.084 21.616 1366 VAL181 〇-26.012 -3.452 22.525 1367 VAL181 CB -26.823- 4.627 19.569 1368 VAL181 CG1 -28.119 -4.498 20.362 1369 VAL181 CG2 -27.062 -4.297 18.099 1370 THR182 N -24.438 -4.897 21.822 1371 THR182 CA -23.936 -5.215 23.166 1372 THR182 C -22.767 -4.302 23.547 1373 THR182 〇-21.827 -4.739 24 1374 THR182 CB -23.459 -6.664 23.183 1375 THR182 OG1 -22.348 -6.789 22.302 1376 THR182 CG2 -24.551 -7.622 22.719 1377 ALA183 N -22.882 &amp;gt; 3.025 23.214 1378 ALA183 CA -21.777 -2.062 23.352 1379 ALA183 C -21.585 -1.459 24.748 1 ALA183 〇-21.031 -0.36 24.855 1381 ALA183 C 巳 -21.99 3 -0.933 22.352 1382 GLU184 N -21.832 -2.224 25.799 1383 GLU184 CA -21.706 -1.688 27.158 1384 GLU184 C -20.242 -1.537 27.568 1385 GLU184 〇-19.888 -0.536 28.199 1386 GLU184 CB • 22.415 -2.636 28.117 1387 GLU184 CG -22.387 2.118 29.551 1388 GLU184 CD -23.145 -3.086 30.454 1389 GLU184 OE1 -22.924 -3.047 31.655 1390 GLU184 OE2 -23.953 -3.832 29.917 1391 GLU185 N • 19.374 • 2.344 26.978 1392 GLU185 CA ►17.936 -2.201 27.244 1393 GLU185 C-17 1394 GLU185 〇-16.294 -0.542 26.708 1395 GLU185 CB -17.216 -3.541 27.073 1396 GLU185 CG -17.189 -4.388 28.351 1397 GLU185 CD -18.561 -4.959 28.705 1398 GLU185 〇E1 -19.308 -5.237 27.774 1399 GLU185 〇E2 -29.899 1400 ARG186 N -18.044 -0.74 25.316 1401 ARG186 CA -17.607 0.339 24.434 1402 ARG186 C -18.008 1.676 25.049 110- 4 (105) ARG186 〇-17.213 2.624 ARG186 CB -18.317 0.135 ARG186 CG -17.936 1.175 ARG186 CD -18.718 0.942 ARG -18.234 1.82 ARG186 CZ -19.002 2.705 ARG186 NH1 -20 .296 2.816 ARG186 NH2 -18.474 3.477 MET187 N -19.086 1.627 MET187 CA -19.545 2.775 MET187 C -18.651 2.978 MET187 〇-18.251 4.113 MET187 CB -20.958 2.459 MET187 CG -21.569 3.594 MET187 SD -23.104 3.161 MET187 CE -23.995 2.943 -18.13 1.874 THR188 CA -17.174 1.925 THR188 C -15.819 2.442 THR188 〇-15.237 3.307 THR188 CB -17.013 0.516 THR188 〇G1 -18.274 0.091 THR188 CG2 -16.011 0.473 ALA189 N -15.477 2.139 ALA189 CA -14.243 2.652 ALA189 C 〇-13.403 4.884 ALA189 CB -13.996 1.884 PHE190 N -15.518 4.605 PHE190 CA -15.762 6.042 PHE190 C -15.632 6.81 PHE190 〇-14.815 7.736 PHE190 C 巳 -17.194 6.258 PHE190 CG • 17.566 5.772 PHE190 CD1 -16.652 5.837 PHE190 CD2 -18 PHE190 CE1 -17.013 5.406 PHE190 CE2 -19.208 4.861 PHE190 CZ -18.291 4.917 GLU191 N -16.281 6.297 GLU191 CA -16.292 6.969 GLU191 C -14.921 6.971 GLU191 〇-14.432 8.05 GLU191 CB -17.28 6.233 GLU191 CG -17.348 6.-18 GLU GLU191 〇E 1 -18.424 4.843 GLU191 〇E2 -18.894 6.597 SER192 N -14.202 5.866 SER192 CA -12.877 5.76 SER192 C -11.82 6.545 SER192 〇-10.892 7.077 SER192 CB -12.467 4.291 SER192 〇G -12.37 3.801 111-(106) LEU193 N -12.082 6.827 LEU193 CA &amp;gt; 11.152 7.64 LEU193 C -11.441 9.127 LEU193 〇-10.514 9.943 LEU193 CB -11.243 7.218 LEU193 CG -9.95 6.547 LEU193 CD1 -9.372 5.603 LEU193 CD2 -10.117 5.842 GLU194 N -12.63 9.438 GLU194 CA -12.93 10.811 12.368 11.096 GLU194 〇-11.82 12.182 GLU194 CB -14.437 11.017 GLU194 CG -14.97 11.164 GLU194 CD -14.35 12.405 GLU194 〇E1 &amp;gt; 13.524 12.237 GLU194 〇E2 -14.826 13.487 ASN195 N -12.26 10.058 ASN195 CA -11.645 10.215 ASN195 ASN195 〇-9.479 11.112 ASN195 CB -12.076 9.054 ASN195 CG -13.582 9.104 ASN195 〇D1 -14.272 8.076 ASN195 ND2 • 14.076 10.3 TYR196 N -9.64 9.613 TYR196 CA -8.236 9.692 TYR196 C -7.88 11.104 TYR196 -8.0-5.953 11.65 8.757 TYR196 CG -7.054 7.633 TYR196 CD1 -5.806 7.739 TYR196 CD2 -7.39 6.5 TYR196 CE1 • 4.884 6.711 TYR196 CE2 -6.466 5.472 TYR196 CZ -5.216 5.581 TYR196 OH • 4.301 4.56 LEU197 N • 8.76 11.708 LEU197 CA -8.543 13.084 LEU197 C -8.718 14.131 LEU197 〇-7.966B 15. -9.53 13.394 LEU197 CG -9.196 12.63 LEU197 CD1 -10.305 12.816 LEU197 CD2 -7.852 13.072 ASP198 N -9.49 13.83 ASP198 CA -9.6 14.749 ASP198 C -8.257 14.841 ASP198 〇-7.698 15.938 ASP198 CB -10.627 14.209 ASP198 CG -12.016 14.052 ASP198 〇 D1 -12.428 14.949 ASP198 〇D2 -12.706 13.123 GLU199 N -7.629 13.685 112- (107) GLU199 CA -6.334 13.598 34.368 GLU199 C -5.221 14.182 33.506 GLU199 〇-4.521 15.091 33.965 GLU199 CB • 6.053 12.121 34.608 GLU199 CG -7.157 11.486 35.444 GLU199 CD -7.084 9.966 35.341 GLU199 〇E1 -7.502 9.312 36.287 GLU199 〇E2 -6.717 9.484 34.277 LEU200 N -5.26 13.885 32.219 LEU200 CA -4.209 14.315 31.289 LEU200 C -4.22 15.821 31.02 LEU200 〇-3.168 16.467 31.128 LE459200 C 巳29.982 LEU2 00 CG -3.421 13.888 28.914 LEU200 CD1 -2.036 13.415 29.338 LEU200 CD2 -3.815 13.251 27.587 VAL201 N -5.406 16.402 30.938 VAL201 CA -5.521 17.832 30.642 VAL201 C -5.196 18.69 31.859 VAL201 〇 • 4.491 19.7 31.709 VAL201 C 巳 -6153 945 18.094 CG1 -7.324 19.57 30.184 VAL201 CG2 -7.159 17.508 28.761 THR202 N -5.431 18.149 33.045 THR202 CA -5.103 18.884 34.267 THR202 C -3.643 18.677 34.654 THR202 〇-2.981 19.624 35.101 THR202 CB -6.02 18.391 35.378 THR202 18.589 349951CG17.31 -5.814 19.173 36.671 LYS203 N -3.08 17.579 34.182 LYS203 CA -1.672 17.284 34.434 LYS203 C 0.755 18.113 33.539 LYS203 〇0.305 18.539 34.015 LYS203 C 巳 • 1.474 15.79 34.209 LYS203 CG-0.041 15.331 34.439 LYS203 CD 0.525 13.099 13.099 LYS203 NZ 0.265 13.325 32.154 LYS204 N -1.256 18.545 32.391 LYS204 CA -0.505 19.493 31.553 LYS204 C -0.788 20.954 31.896 LYS204 〇-0.031 21.846 31.499 LYS204 C 巳 -0.821 19.218 30.092 LYS204 CG -0.076 17.965 29.664 LYS204 CD 1.425 18.213 29.729 LYS204 CE 2.202 16.906 29.69 LYS204 NZ 1.918 16.115 30.896 GLU205 N -1.781 21.179 32.741 GLU205 CA • 2.033 22.524 33.264 GLU205 C -1.215 22.777 34.526 GLU205 〇-1.027 23.66 34.927 34.927 34.927 GLU205 CG -4.309 22.726 32.273</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">-113- (108)   GLU205 CD -5.788 22.444 32.51  GLU205 〇E1 -6.547 22.661 31.573  GLU205 〇E2 -6.093 21.798 33.504  ALA206 N -0.712 21.707 35.12  ALA206 CA 0.208 21.844 36.249  ALA206 C 1.649 21.772 35.756  ALA206 〇 2.464 22.661 36.034  ALA206 C巳 -0.059 20.711 37.233  ASN207 N 1.92 20.765 34.945  ASN207 CA 3.253 20.587 34.366  ASN207 C 3.307 21.204 32.976  ASN207 〇 2.922 20.574 31.982  ASN207 CB 3.568 19.096 34.27  ASN207 CG 3.565 18.441 35.65  ASN207 〇D1 4.361 18.793 36.527  ASN207 ND2 2.641 17.515 35.835  ALA208 N 3.786 22.435 32.932  ALA208 CA 3.924 23.166 31.668  ALA208 C 5.045 22.601 30.795  ALA208 〇 6.235 22.809 31.052  ALA208 C巳 4.202 24.631 31.982  THR209 N 4.636 21.874 29.77  THR209 CA 5.581 21.251 28.834  THR209 C 5.499 21.873 27.446  THR209 〇 4.665 22.737 27.168  THR209 CB 5.253 19.774 28.706  THR209 〇G1 3.938 19.693 28.18  THR209 CG2 5.296 19.059 30.052  GLU210 N 6.34 21.363 26.562  GLU210 CA 6.411 21.861 25.18  GLU210 C 5.542 21.076 24.19  GLU210 〇 5.586 21.361 22.989  GLU210 C巳 7.861 21.818 24.692  GLU210 CG 8.791 22.752 25.467  GLU210 CD 9.689 21.967 26.424  GLU210 〇E1 9.258 20.906 26.861  GLU210 〇E2 10.778 22.442 26.707  ASP211 N 4.786 20.097 24.662  ASP211 CA 3.977 19.273 23.746  ASP211 C 2.732 20.003 23.249  ASP211 〇 2.331 21.027 23.817  ASP211 CB 3.605 17.956 24.418  ASP211 CG 2.942 18.154 25.781  ASP211 〇D1 2.12 19.054 25.925  ASP211 OD2 3.336 17.427 26.681  ASP212 N 2.034 19.382 22.309  ASP212 CA 0.906 20.044 21.64  ASP212 C -0.365 20.067 22.496  ASP212 〇 -1.223 20.928 22.262  ASP212 CB 0.653 19.331 20.312  ASP212 CG •0.355 20.078 19.435  ASP212 〇D1 -0.505 21.277 19.623  ASP212 〇D2 -1.022 19.415 18.653  LEU213 N -0.398 19.318 23.589</span>-113- (108) GLU205 CD -5.788 22.444 32.51 GLU205 〇E1 -6.547 22.661 31.573 GLU205 〇E2 -6.093 21.798 33.504 ALA206 N -0.712 21.707 35.12 ALA206 CA 0.208 21.844 36.249 ALA206 C 1.649 21.772 35.756 ALA206 〇2.464 22.661 36.034 ALA -0.059 20.711 37.233 ASN207 N 1.92 20.765 34.945 ASN207 CA 3.253 20.587 34.366 ASN207 C 3.307 21.204 32.976 ASN207 〇2.922 20.574 31.982 ASN207 CB 3.568 19.096 34.27 ASN207 CG 3.565 18.441 35.65 ASN207 〇D1 4.361 18.793 36.527 3.835 ASN207 ND2 ALA208 CA 3.924 23.166 31.668 ALA208 C 5.045 22.601 30.795 ALA208 〇6.235 22.809 31.052 ALA208 C 巳 4.202 24.631 31.982 THR209 N 4.636 21.874 29.77 THR209 CA 5.581 21.251 28.834 THR209 C 5.499 21.873 27.446 THR209 〇4.665 22.737 27.168 THR209C HR209C 19.693 28.18 THR209 CG2 5.296 19.059 30.052 GLU210 N 6.34 21.363 26.562 GLU210 CA 6.411 21.861 25.18 GLU210 C 5.542 21.076 24.19 GLU210 〇5.586 2 1.361 22.989 GLU210 C 巳 7.861 21.818 24.692 GLU210 CG 8.791 22.752 25.467 GLU210 CD 9.689 21.967 26.424 GLU210 〇E1 9.258 20.906 26.861 GLU210 〇E2 10.778 22.442 26.707 ASP211 N 4.786 20.097 24.662 ASP211 CA 3.977 19.273 23.746 ASP211 C 2.732 20.2.3 23.249 ASP211 ASP211 CB 3.605 17.956 24.418 ASP211 CG 2.942 18.154 25.781 ASP211 〇D1 2.12 19.054 25.925 ASP211 OD2 3.336 17.427 26.681 ASP212 N 2.034 19.382 22.309 ASP212 CA 0.906 20.044 21.64 ASP212 C -0.365 20.067 22.496 ASP212 〇-1.223 20.928 22.262 ASP212 CB 0.653 19.331 20.312 • 0.355 20.078 19.435 ASP212 〇D1 -0.505 21.277 19.623 ASP212 〇D2 -1.022 19.415 18.653 LEU213 N -0.398 19.318 23.589</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">114- (109)   LEU213 CA -1.529 19.451 24.508  LEU213 C -1.474 20.819 25.18  LEU213 〇 -2.372 21.628 24.907  LEU213 CB -1.498 18.346 25.557  LEU213 CG -2.75 18.365 26.427  LEU213 CD1 -4.011 18.334 25.574  LEU213 CD2 -2.751 17.202 27.41  LEU214 N -0.306 21.193 25.691  LEU214 CA -0.187 22.52 26.307  LEU214 C -0.094 23.607 25.241  LEU214 〇 -0.613 24.711 25.445  LEU214 C巳 1.034 22.608 27.21  LEU214 CG 0.987 23.94 27.954  LEU214 CD1 -0.18 23.972 28.934  LEU214 CD2 2.288 24.25 28.671  GLY215 N 0.35 23.222 24.056  GLY215 CA 0.292 24.093 22.882  GLY215 C -1.121 24.618 22.629  GLY215 〇 -1.327 25.838 22.586  ARG216 N -2.103 23.733 22.582  ARG216 CA -3.473 24.198 22.351  ARG216 C -4.154 24.727 23.616  ARG216 〇 -5.077 25.542 23.506  ARG216 C巳 -4.3 23.068 21.765  ARG216 CG -3.636 22.456 20.539  ARG216 CD -4.555 21.415 19.912  ARG216 NE -5.402 20.812 20.953  ARG216 CZ -5.073 19.756 21.699  ARG216 NH1 -3.937 19.093 21.471  ARG216 NH2 -5.905 19.342 22.652  GLN217 N -3.583 24.445 24.776  GLN217 CA -4.102 25.002 26.031  GLN217 C -3.624 26.435 26.28  GLN217 〇 -4.198 27.131 27.125  GLN217 CB &amp;gt;3.648 24.109 27.181  GLN217 CG -4.235 22.711 27.043  GLN217 CD -3.691 21.772 28.114  GLN217 OE1 -2.544 21.311 28.052  GLN217 NE2 -4.552 21.446 29.059  ILE218 N -2.608 26.875 25.551  ILE218 CA -2.179 28.276 25.625  ILE218 C -2.638 29.086 24.409  ILE218 〇 -2.242 30.25 24.267  ILE218 C巳 -0.66 28.352 25.774  ILE218 CG1 0.061 27.755 24.572  ILE218 CG2 -0.211 27.665 27.059  ILE218 CD1 1.574 27.781 24.754  LEU219 N -3.431 28.478 23.538  LEU219 CA -3.953 29.194 22.365  LEU219 C -4.858 30.352 22.75  LEU219 〇 -5.716 30.229 23.629  LEU219 CB -4.756 28.24 21.493  LEU219 CG -3.859 27.411 20.59  LEU219 CD1 -4.674 26.345 19.873</span>114- (109) LEU213 CA -1.529 19.451 24.508 LEU213 C -1.474 20.819 25.18 LEU213 〇-2.372 21.628 24.907 LEU213 CB -1.498 18.346 25.557 LEU213 CG -2.75 18.365 26.427 LEU213 CD1 -4.011 18.334 25.574 LEU213 CD2 -2.751214 N 202.41 LEU213 0.306 21.193 25.691 LEU214 CA -0.187 22.52 26.307 LEU214 C -0.094 23.607 25.241 LEU214 〇-0.613 24.711 25.445 LEU214 C 巳 1.034 22.608 27.21 LEU214 CG 0.987 23.94 27.954 LEU214 CD1 -0.18 23.972 28.934 LEU214 CD2 2.288 24.25 28.215 GYLY. GLY 0.292 24.093 22.882 GLY215 C -1.121 24.618 22.629 GLY215 〇-1.327 25.838 22.586 ARG216 N -2.103 23.733 22.582 ARG216 CA -3.473 24.198 22.351 ARG216 C -4.154 24.727 23.616 ARG216 〇-5.077 25.542 23.506 ARG216 C 巳 -4.3 23.068 21.765 ARG216 CG 22.456 20.539 ARG216 CD -4.555 21.415 19.912 ARG216 NE -5.402 20.812 20.953 ARG216 CZ -5.073 19.756 21.699 ARG216 NH1 -3.937 19.093 21.471 ARG216 NH2 -5.905 19.342 22.652 GLN217 N -3.583 24.445 24.776 GLN21 7 CA -4.102 25.002 26.031 GLN217 C -3.624 26.435 26.28 GLN217 〇-4.198 27.131 27.125 GLN217 CB &amp;gt; 3.648 24.109 27.181 GLN217 CG -4.235 22.711 27.043 GLN217 CD -3.691 21.772 28.114 GLN217 OE1-2.54.521.21. N -2.608 26.875 25.551 ILE218 CA -2.179 28.276 25.625 ILE218 C -2.638 29.086 24.409 ILE218 〇-2.242 30.25 24.267 ILE218 C 巳 -0.66 28.352 25.774 ILE218 CG1 0.061 27.755 24.572 ILE218 CG2 -0.211 27.665 27.59 1.754 UILE218 CD1 28.478 23.538 LEU219 CA -3.953 29.194 22.365 LEU219 C -4.858 30.352 22.75 LEU219 〇-5.716 30.229 23.629 LEU219 CB -4.756 28.24 21.493 LEU219 CG -3.859 27.411 20.59 LEU219 CD1 -4.674 26.345 19.873</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">-115- (110) (110)   LEU219 CD2  LYS220 N  LYS220 CA  LYS220 C  LYS220 〇  LYS220 C巳  LYS220 CG  LYS220 CD  LYS220 CE  LYS220 NZ  GLN221 N  GLN221 CA  GLN221 C  GLN221 〇  GLN221 C巳  GLN221 CG  GLN221 CD  GLN221 〇E1  GLN221 NE2  ARG222 N  ARG222 CA  ARG222 C  ARG222 〇  ARG222 CB  ARG222 CG  ARG222 CD  ARG222 NE  ARG222 CZ  ARG222 NH1  ARG222 NH2  GLU223 N  GLU223 CA  GLU223 C  GLU223 〇  GLU223 CB  GLU223 CG  GLU223 CD  GLU223 〇E1  GLU223 〇E2  SER224 N  SER224 CA  SER224 C  SER224 〇  SER224 CB  SER224 〇G  GLY225 N  GLY225 CA  GLY225 C  GLY225 〇  GLU226 N  GLU226 CA  GLU226 C  GLU226 〇  GLU226 C巳 -3.135 -4.667 -5.484 -5.341 -4.556 -5.01 -5.91 -5.389 -6.258 -5.74 •6.048 •5.987 -6.904 -7.981 -6.389 -5.417 -5.828 -7.019 -4.823 •6.553 -7.309 -8.774 -9.669 -6.649 -7.362 -6.787 -7.505 -8.368 -8.626 -8.98 -9.009 -10.382 -10.985 -12.083 -10.395 -9.977 -9.946 -9.041 -10.749 -10.28 -10.803 -11.036 -11.791 -9.789 -9.509 -10.409 -10.436 -9.539 -8.577 -9.863 -9.128 •10.067 -11.22 -8.424 28.304 31.454 32.654 33.562 34.519 33.38 34.56 35.289 36.494 37.191 33.217 34.031 35.234 35.112 33.179 32.015 31.088 30.872 30.508 36.345 37.589 37.467 37.72 38.705 40.034 41.134 42.401 42.909 42.255 44.068 36.864 36.702 35.329 35.029 36.959 38.396 38.649 39.35 38.047 34.5 33.162 32.957 32.067 32.13 32.374 33.796 33.613 32.435 32.109 31.807 30.613 29.417 29.553 30.894 19.588 22.047 22.234 21.012 21.016 23.489 23.842 25.074 25.418 26.607 19.951 18.732 18.892 19.48 17.535 17.369 16.227 15.966 15.595 18.268 18.486 18.066 18.877 17.685 17.911 17.026 17.232 16.349 15.213 16.604 16.912 16.426 16.735 16.257 14.926 14.634 13.13 12.701 12.434 17.488 17.775 19.266 19.67 17.308 15.941 20.069 21.517 21.884 21.174 22.998 23.422 23.535 23.963 24.745</span>-115- (110) (110) LEU219 CD2 LYS220 N LYS220 CA LYS220 C LYS220 〇LYS220 C 巳 LYS220 CG LYS220 CD LYS220 CE LYS220 NZ GLN221 N GLN221 CA GLN221 C GLN221 〇GLN221 C 巳 GLN221 CG GLN CD ARG222 N ARG222 CA ARG222 C ARG222 〇ARG222 CB ARG222 CG ARG222 CD ARG222 NE ARG222 CZ ARG222 NH1 ARG222 NH2 GLU223 N GLU223 CA GLU223 C GLU223 〇GLU223 CB GLU223 CG GLU223 CD GLU223 〇E1 GSER223 〇224 SER224 CB SER224 〇G GLY225 N GLY225 CA GLY225 C GLY225 〇GLU226 N GLU226 CA GLU226 C GLU226 〇GLU226 C 巳 -3.135 -4.667 -5.484 -5.341 -4.556 -5.01 -5.91 -5.389 -6.258 -5.74 • 6.048 • 5.987 -6.904 -7.981 -6.389 -5.417 -5.828 -7.019 -4.823 • 6.553 -7.309 -8.774 -9.669 -6.649 -7.362 -6.787 -7.505 -8.368 -8.626 -8.98 -9.009 -10.382 -10.985 -12.083 -10.395 -9.977 -9.946 -9.041 -10.749 -10.28 -10.803 -11.036 -11.791 -9.789 -9.509 -10.409 -10.436 -9.539 -8.577 -9.863 -9.128 • 1 0.067 -11.22 -8.424 28.304 31.454 32.654 33.562 34.519 33.38 34.56 35.289 36.494 37.191 33.217 34.031 35.234 35.112 33.179 32.015 31.088 30.872 30.508 36.345 37.589 37.467 37.467. 3.3.2.359.359.36.359.359. 33.796 33.613 32.435 32.109 31.807 30.613 29.417 29.553 30.894 19.588 22.047 22.234 21.012 21.016 23.489 23.842 25.074 25.418 26.607 19.951 18.732 18.892 19.48 17.535 17.369 16.227 15.966 15.595 18.268 18.486 18.066 18.877 17.685 17.911 16.026 16.232 16.349 15.213 16.604 16.912 16.426 16.726 16.735 16.735 19.266 19.67 17.308 15.941 20.069 21.517 21.884 21.174 22.998 23.422 23.535 23.963 24.745</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">-116- (111)   GLU226 CG -9.368 31.316 25.86  GLU226 CD -8.548 31.714 27.084  GLU226 〇E1 -8.364 30.873 27.952  GLU226 〇E2 -8.166 32.875 27.147  ALA227 N -9.567 28.262 23.127  ALA227 CA -10.372 27.035 23.163  ALA227 C -10.725 26.657 24.598  ALA227 〇 -9.859 26.603 25.477  ALA227 CB -9.587 25.904 22.508  ASP228 N -12.009 26.456 24.833  ASP228 CA -12.471 26.085 26.175  ASP228 C -12.163 24.618 26.455  ASP228 〇 -11.944 23.836 25.52  ASP228 C巳 -13.961 26.399 26.323  ASP228 CG -14.816 25.698 25.268  ASP228 OD1 -14.745 24.475 25.201  ASP228 〇D2 -15.656 26.364 24.686  HIS229 N •12.329 24.215 27.704  HIS229 CA -11.958 22.854 28.129  HIS229 C -12.84 21.733 27.559  HIS229 〇 -12.334 20.622 27.37  HIS229 C巳 -11.971 22.807 29.658  HIS229 CG -13.265 23.255 30.319  HIS229 ND1 -14.34 22.487 30.584  HIS229 CD2 -13.557 24.519 30.78  HIS229 CE1 -15.293 23.238 31.171  HIS229 NE2 -14.808 24.494 31.292  GLY230 N -14.024 22.066 27.068  GLY230 CA -14.88 21.073 26.412  GLY230 C -14.27 20.684 25.07  GLY230 〇 -13.958 19.508 24.84  GLU231 N -13.866 21.704 24.329  GLU231 CA -13.239 21.508 23.021  GLU231 C -11.809 21.001 23.152  GLU231 〇 -11.365 20.21 22.315  GLU231 CB -13.196 22.856 22.318  GLU231 CG -14.589 23.417 22.086  GLU231 CD -14.471 24.888 21.707  GLU231 OE1 -15.12 25.296 20.756  GLU231 〇E2 -13.758 25.592 22.418  LEU232 N -11.181 21.28 24.281  LEU232 CA -9.822 20.803 24.524  LEU232 C -9.841 19.292 24.755  LEU232 〇 -9.061 18.578 24.112  LEU232 C巳 -9.297 21.541 25.756  LEU232 CG -7.777 21.685 25.784  LEU232 CD1 -7.057 20.385 26.124  LEU232 CD2 -7.256 22.293 24.486  VAL233 N -10.877 18.804 25.419  VAL233 CA -11.016 17.36 25.627  VAL233 C -11.406 16.646 24.331  VAL233 〇 •10.729 15.676 23.963  VAL233 CB -12.066 17.13 26.71  VAL233 CG1 -12.478 15.667 26.802</span>-116- (111) GLU226 CG -9.368 31.316 25.86 GLU226 CD -8.548 31.714 27.084 GLU226 〇E1 -8.364 30.873 27.952 GLU226 〇E2 -8.166 32.875 27.147 ALA227 N -9.567 28.262 23.127 ALA227 CA -10.372 27.035 23.163 ALA227 C 657 ALA227 〇-9.859 26.603 25.477 ALA227 CB -9.587 25.904 22.508 ASP228 N -12.009 26.456 24.833 ASP228 CA -12.471 26.085 26.175 ASP228 C -12.163 24.618 26.455 ASP228 〇-11.944 23.836 25.52 ASP228 C 巳 -13.961 26.399 26.323 ASP228 CG -25 268 268 OD1 -14.745 24.475 25.201 ASP228 〇D2 -15.656 26.364 24.686 HIS229 N • 12.329 24.215 27.704 HIS229 CA -11.958 22.854 28.129 HIS229 C -12.84 21.733 27.559 HIS229 〇-12.334 20.622 27.37 HIS229 C 巳 -11.971229 22.255 29IS 658 HIS229 ND1 -14.34 22.487 30.584 HIS229 CD2 -13.557 24.519 30.78 HIS229 CE1 -15.293 23.238 31.171 HIS229 NE2 -14.808 24.494 31.292 GLY230 N -14.024 22.066 27.068 GLY230 CA -14.88 21.073 26.412 GLY230 C -14.27 20.684 25.0 7 GLY230 〇-13.958 19.508 24.84 GLU231 N -13.866 21.704 24.329 GLU231 CA -13.239 21.508 23.021 GLU231 C -11.809 21.001 23.152 GLU231 〇-11.365 20.21 22.315 GLU231 CB -13.196 22.856 22.318 GLU231 CG -14.589 23.417 22.086 GLU231 CD 21.-14. OE1 -15.12 25.296 20.756 GLU231 〇E2 -13.758 25.592 22.418 LEU232 N -11.181 21.28 24.281 LEU232 CA -9.822 20.803 24.524 LEU232 C -9.841 19.292 24.755 LEU232 〇-9.061 18.578 24.112 LEU232 C 巳 -9.297 21.541 25.756 LEU232 685 -7.7 CD1 -7.057 20.385 26.124 LEU232 CD2 -7.256 22.293 24.486 VAL233 N -10.877 18.804 25.419 VAL233 CA -11.016 17.36 25.627 VAL233 C -11.406 16.646 24.331 VAL233 〇 • 10.729 15.676 23.963 VAL233 CB -12.066 17.13 26.71802. VAL233 15.CG1 -12</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">-117 (112)</span>-117 (112)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">VAL233 CG2  GLY234 N  GLY234 CA  GLY234 C  GLY234 〇  LEU235 N  LEU235 CA  LEU235 C  LEU235 〇  LEU235 CB  LEU235 CG  LEU235 CD1  LEU235 CD2  ALA236 N  ALA236 CA  ALA236 C  ALA236 〇  ALA236 CB  PHE237 N  PHE237 CA  PHE237 C  PHE237 〇  PHE237 CB  PHE237 CG  PHE237 CD1  PHE237 CD2  PHE237 CE1  PHE237 CE2  PHE237 CZ  LEU238 N  LEU238 CA  LEU238 C  LEU238 〇  LEU238 C巳  LEU238 CG  LEU238 CD1  LEU238 CD2  LEU239 N  LEU239 CA  LEU239 C  LEU239 〇  LEU239 CB  LEU239 CG  LEU239 CD1  LEU239 CD2  LEU240 N  LEU240 CA  LEU240 C  LEU240 〇  LEU240 CB  LEU240 CG  LEU240 CD1  LEU240 CD2  ILE241 N -11.571 -12.258 -12.641 -11.443 -11.116 -10.687 -9.532 -8.375 -7.846 -9.04 -10.08 -9.781 -10.2 -8.162 -7.065 -7.38 -6.525 -6.861 -8.66 -9.11 -8.956 -8.27 -10.58 -11.12 •10.824 -11.885 -11.305 -12.366 -12.076 -9.329 •9.272 -7.845 -7.532 -10.056 -11.539 -12.279 -12.145 -6.947 -5.551 -4.861 -4.202 -4.821 -5.364 -4.722 -5.169 -5.275 •4.667 -5.217 -4.445 -4.952 -3.966 -2.53 -4.227 -6.425 17.632 17.278 16.729 16.59 15.477 17.668 17.691 16.809 16.046 19.13 20.034 21.505 19.75 16.713 15.885 14.407 13.633 16.193 14.095 12.723 12.273 11.274 12.657 11.24 10.394 10.786 9.095 9.486 8.644 13.135 12.754 12.681 11.745 13.766 13.75 14.795 12.369 13.467 13.397 12.158 11.444 14.652 15.898 17.162 15.82 11.736 10.56 9.265 8.316 10.634 9.808 10.2 9.976 9.337 28.062 23.536 22.227 21.287 20.849 21.146 20.238 20.702 19.882 20.146 19.495 19.761 18.003 22.006 22.523 22.375 21.922 24.002 22.475 22.306 20.864 20.617 22.682 22.674 23.733 21.608 23.736 21.61 22.676 19.931 18.516 17.984 17.236 17.695 18.042 17.221 17.814 18.554 18.122 18.68 17.913 18.586 17.894 18.454 16.384 19.864 20.485 19.877 19.674 21.981 22.798 22.479 24.289 19.333 118- (113) ILE241 ILE241 ILE241 ILE241 ILE241 ILE241 ILE241 ALA242 ALA242 ALA242 ALA242 ALA242 GLY243 GLY243 GLY243 GLY243 HIS244 HIS244 H1S244 HIS244 HIS244 HIS244 HIS244 HIS244 HIS244 HIS244 GLU245 GLU245 GLU245 GLU245 GLU245 GLU245 GLU245 GLU245 GLU245 THR246 THR246 THR246 THR246 THR246 THR246 THR246 THR247 THR247 THR247 THR247 THR247 THR247 THR247 ALA248 ALA248 ALA248 ALA248 ALA248 12 1 12 12 A BGGDA 巳 A A BGDDEE UCOCCCCNCCOCNCCONCCOCC —</span>VAL233 CG2 GLY234 N GLY234 CA GLY234 C GLY234 〇LEU235 N LEU235 CA LEU235 C LEU235 〇LEU235 CB LEU235 CG LEU235 CD1 LEU235 CD2 ALA236 N ALA236 CA ALA236 C ALA236 〇ALA236 CB PHE237 N PHE237 CA PHE237 C PHE237 C PHE237 C PHE237 C PHE237 CD2 PHE237 CE1 PHE237 CE2 PHE237 CZ LEU238 N LEU238 CA LEU238 C LEU238 〇LEU238 C 巳 LEU238 CG LEU238 CD1 LEU238 CD2 LEU239 N LEU239 CA LEU239 C LEU239 〇LEU239 CB LEU239 CG LEU239 CD1 LEU239 CDU 240 LEU240 CB LEU240 CG LEU240 CD1 LEU240 CD2 ILE241 N -11.571 -12.258 -12.641 -11.443 -11.116 -10.687 -9.532 -8.375 -7.846 -9.04 -10.08 -9.781 -10.2 -8.162 -7.065 -7.38 -6.525 -6.861 -8.66 -9.11- 8.956 -8.27 -10.58 -11.12 • 10.824 -11.885 -11.305 -12.366 -12.076 -9.329 • 9.272 -7.845 -7.532 -10.056 -11.539 -12.279 -12.145 -6.947 -5.551 -4.861 -4.202 -4.821 -5.364 -4.722 -5.169- 5.275 • 4.667 -5.217 -4.445 -4.952 -3.966 -2.53 -4.227 -6.425 17.632 1 7.278 16.729 16.59 15.477 17.668 17.691 16.809 16.046 19.13 20.034 21.505 19.75 16.713 15.885 14.407 13.633 16.193 14.095 12.723 12.273 11.274 12.657 11.24 10.394 10.786 9.095 9.486 8.644 13.135 12.754 12.681 11.745 13.766 13.75 14.795 12.369 13.467 13.397 12.158 11.444 14.652 15.898 17.162 15.82 11.736 10.56 9.808 8.265 8.316 8.316 10.2 9.976 9.337 28.062 23.536 22.227 21.287 20.849 21.146 20.238 20.702 19.882 20.146 19.495 19.761 18.003 22.006 22.523 22.375 21.922 24.002 22.475 22.306 20.864 20.617 22.682 22.674 23.733 21.608 23.736 21.61 22.676 19.931 18.516 17.984 17.236 17.695 17.695 18.042 17.221 18.814 18.554 18.122 18.68 17.913 18.586 18.894 18.485 19.877 19.674 21.981 22.798 22.479 24.289 19.333 118- (113) ILE241 ILE241 ILE241 ILE241 ILE241 ILE241 ILE241 ALA242 ALA242 ALA242 ALA242 ALA242 GLY243 GLY243 GLY243 GLY243 HIS244 HIS244 HIS244 H245 G245 GLULU245 G245LULU245 GLULU244 HR246 THR246 THR246 THR246 THR246 THR247 THR247 THR247 THR247 THR247 THR247 THR247 ALA248 ALA248 ALA248 ALA248 ALA248 12 1 12 12 A BGGDA 巳 A A BGDDEE UCOCCCCNCCOCNCCONCCOCC —</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[ [ n EL i/ rt /V</span>[[n EL i / rt / V</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A BGDE1E2</span>A BGDE1E2</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A</span>A</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">12 巳G G</span>12 巳 G G</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A</span>A</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1 2 巳G G -7.027 8.197 18.621  •6.509 8.091 17.184  -6.406 6.98 16.64  -8.544 8.391 18.599  -9.122 8.403 20.008  -9.233 7.311 17.771  -8.939 7.06 20.699  -5.959 9.182 16.676  •5.353 9.154 15.345  -4.049 8.363 15.361  -3.842 7.511 14.487  -5.09 10.583 14.884  -3.34 8.426 16.473  -2.135 7.612 16.614  -2.461 6.175 17.012  -2.095 5.238 16.289  -3.274 6.021 18.047  -3.556 4.687 18.603  -4.424 3.78 17.729  -4.288 2.555 17.808  -4.271 4.846 19.946  -3.394 5.206 21.132  •2.995 6.436 21.502  -2.87 4.327 22.051  -2.232 6.348 22.61  -2.156 5.042 22.95  -5.298 4.33 16.905  -6.157 3.454 16.101  -6.041 3.723 14.61  -5.883 2.788 13.812  -7.616 3.66 16.504  -7.895 3.313 17.963  -7.613 1.839 18.255  -7.721 1.028 17.348  -7.228 1.562 19.381  -5.987 4.996 14.26  -6.101 5.374 12.849  -4.863 4.962 12.066  -4.949 4.04 11.244  -6.314 6.88 12.759  -7.415 7.225 13.59  -6.614 7.344 11.338  -3.702 5.384 12.532  -2.48 5.072 11.792  -2.013 3.634 12.044  -1.437 3.032 11.132  -1.4 6.078 12.171  -1.937 7.39 12.062  -0.192 5.981 11.246  -2.533 3.007 13.09  -2.225 1.596 13.35  -2.915 0.676 12.342  -2.236 -0.089 11.643  -2.678 1.25 14.763 119- (114) ASN249 ASN249 ASN249 ASN249 ASN249 ASN249 ASN249 ASN249 MET250 MET250 MET250 MET250 MET250 MET250 MET250 MET250 ILE251 ILE251 ILE251 ILE251 ILE251 ILE251 ILE251 ILE251 SER252 SER252 SER252 SER252 SER252 SER252 LEU253 LEU253 LEU253 LEU253 LEU253 LEU253 LEU253 LEU253 GLY254 GLY254 GLY254 GLY254 THR255 THR255 THR255 THR255 THR255 THR255 THR255 VAL256 VAL256 VAL256 VAL256 VAL256 zcacocbcgodndncacocbcgsdcencacocbcgcgcdncacocbogncacocbcgwcd: BGD1D2 A bgde a BG1G2D1 2</span>1 2 巳 GG -7.027 8.197 18.621 • 6.509 8.091 17.184 -6.406 6.98 16.64 -8.544 8.391 18.599 -9.122 8.403 20.008 -9.233 7.311 17.771 -8.939 7.06 20.699 -5.959 9.182 16.676 • 5.353 9.154 15.345 -4.049 8.363 15.361 -3.842 7.511 14.487 -5.09 10.583 14.884 -3.34 8.426 16.473 -2.135 7.612 16.614 -2.461 6.175 17.012 -2.095 5.238 16.289 -3.274 6.021 18.047 -3.556 4.687 18.603 -4.424 3.78 17.729 -4.288 2.555 17.808 -4.271 4.846 19.946 -3.394 5.206 21.132 • 2.995 6.436 21.502 -2.87 4.327 22.051 -2.232 6.348 22.61 -2.156 5.042 22.95 -5.298 4.33 16.905 -6.157 3.454 16.101 -6.041 3.723 14.61 -5.883 2.788 13.812 -7.616 3.66 16.504 -7.895 3.313 17.963 -7.613 1.839 18.255 -7.721 1.028 17.348 -7.228 1.562 19.381 -5.987 4.996 14.26 -6.101 5.374 12.849 -4.863 4.962 12.066 -4.949 4.04 11.244 -6.314 6.88 12.759 -7.415 7.225 13.59 -6.614 7.344 11.338 -3.702 5.384 12.532 -2.48 5.072 11.792 -2.013 3.634 12.044 -1.437 3.032 11.132 -1.4 6.078 12.171 -1.937 7.39 12 .062 -0.192 5.981 11.246 -2.533 3.007 13.09 -2.225 1.596 13.35 -2.915 0.676 12.342 -2.236 -0.089 11.643 -2.678 1.25 14.763 119- (114) ASN249 ASN249 ASN249 ASN249 ASN249 ASN249 ASN249 ASN249 MET250 MET250 MET250 MET250 MET250 MET250 MET250 MET250 MET250 MET250 MET250 MET250 MET250 MET250 MET250 MET250 MET250 MET250 MET250 MET250 MET250 MET250 MET250 ILE251 ILE251 ILE251 ILE251 ILE251 ILE251 SER252 SER252 SER252 SER252 SER252 SER252 LEU253 LEU253 LEU253 LEU253 LEU253 LEU253 LEU253 LEU253 GLY254 GLY254 GLY254 GLY254 THR255 THR255 THR255 THR255 THR255 THR255 THR255 VAL256 VAL256 VAL256 VAL256 VAL256 zcacocbcgodndncacocbcgsdcencacocbcgcgcdncacocbogncacocbcgwcd: BGD1D2 A bgde a BG1G2D1 2</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A</span>A</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A G1G2 -4.175 0.958 12.049  -4.878 0.157 11.042  -4.453 0.517 9.624  -4.313 -0.39 8.791  -6.377 0.361 11.199  •6.902 -0.561 12.291  -6.261 -1.569 12.613  -8.133 -0.32 12.703  -3.945 1.727 9.463  -3.472 2.183 8.159  -2.137 1.529 7.787  -2.018 1.009 6.669  -3.231 3.702 8.255  -3.343 4.33 6.851  -2.234 5.768 6.665  •1.954 6.241 8.406  -1.267 1.317 8.764  0.019 0.667 8.477  -0.132 -0.844 8.328  0.449 -1.427 7.402  1.001 0.949 9.613  1.293 2.434 9.757  2.305 0.188 9.404  2.264 2.698 10.902  -1.081 -1.421 9.047  -1.254 -2.875 8.973  -1.947 -3.301 7.679  -1.444 -4.204 6.998  -2.03 -3.36 10.197  -3.28 -2.684 10.279  •2.85 -2.465 7.194  -3.558 -2.762 5.948  -2.699 -2.386 4.739  -2.665 -3.129 3.748  -4.857 -1.963 5.994  -5.781 -2.185 4.804  -6.009 -3.665 4.521  -7.109 -1.479 5.058  -1.818 -1.42 4.948  -0.841 -1.031 3.933  0.161 -2.148 3.671  0.267 -2.62 2.531  0.707 -2.706 4.742  1.711 -3.772 4.62  1.123 -5.042 4.017  1.715 -5.592 3.079  2.255 -4.105 6.007  2.837 -2.935 6.563  3.334 -5.18 5.938  •0.133 -5.321 4.331  -0.797 -6.505 3.781  -1.11 -6.37 2.291  -0.832 -7.307 1.531  -2.083 •6.706 4.571 120- (115) VAL256 CG1 -3.028 -7.693 3.905  VAL256 CG2 -1.774 -7.144 5.993  THR257 N -1.372 -5.158 1.833  THR257 CA -1.675 -4.982 0.413  THR257 C •0.401 -4.902 -0.427  THR257 〇 -0.357 -5.499 -1.512  THR257 C巳 -2.502 -3.717 0.248  THR257 〇G1 -3.63 -3.818 1.106  THR257 CG2 -3.002 -3.558 -1.183  LEU258 N 0.69 -4.465 0.185  LEU258 CA 1.976 -4.434 -0.526  LEU258 C 2.588 -5.828 -0.61  LEU258 〇 3.147 -6.205 -1.648  LEU258 C巳 2.936 -3.524 0.233  LEU258 CG 2.45 -2.08 0.263  LEU258 CD1 3.329 -1.229 1.172  LEU258 CD2 2.391 -1.492 -1.141  LEU259 N 2.248 -6.652 0.368  LEU259 CA 2.721 -8.034 0.407  LEU259 C 1.818 -8.965 -0.407  LEU259 〇 2.223 -10.083 -0.747  LEU259 CB 2.742 -8.462 1.869  LEU259 CG 3.979 -9.291 2.183  LEU259 CD1 5.235 -8.559 1.727  LEU259 CD2 4.05 -9.61 3.672  GLU260 N 0.649 -8.473 -0.791  GLU260 CA -0.221 •9.215 -1.707  GLU260 C 0.163 -8.932 -3.151  GLU260 〇 0.033 -9.804 -4.019  GLU260 CB -1.67 -8.773 -1.531  GLU260 CG -2.53 -9.85 -0.883  GLU260 CD -2.442 -9.78 0.637  GLU260 OE1 -1.632 -10.498 1.204  GLU260 OE2 -3.287 -9.103 1.202  ASN261 N 0.693 -7.743 -3.382  ASN261 CA 1.158 -7.381 -4.723  ASN261 C 2.669 -7.181 -4.742  ASN261 〇 3.134 -6.032 -4.804  ASN261 CB 0.468 -6.089 •5.161  ASN261 CG -0.986 -6.311 -5.586  ASN261 〇D1 -1.784 -6.942 -4.881  ASN261 ND2 -1.339 -5.701 -6.705  PR0262 N 3.404 -8.259 -4.986  PR0262 CA 4.864 -8.219 -4.846  PR0262 C 5.563 -7.432 -5.958  PR0262 〇 6.612 -6.834 •5.706  PR0262 CB 5.298 •9.652 -4.871  PR0262 CG 4.108 -10.533 -5.223  PR0262 CD 2.912 -9.601 -5.319  ASP263 N 4.884 -7.222 -7.077  ASP263 CA 5.442 -6.411 -8.166  ASP263 C 5.27 -4.909 •7.918  ASP263 〇 6.133 -4.124 -8.327  ASP263 CB 4.783 -6.822 -9.488</span>A G1G2 -4.175 0.958 12.049 -4.878 0.157 11.042 -4.453 0.517 9.624 -4.313 -0.39 8.791 -6.377 0.361 11.199 • 6.902 -0.561 12.291 -6.261 -1.569 12.613 -8.133 -0.32 12.703 -3.945 1.727 9.463 -3.472 2.183 8.159 -2.137 1.529 7.787 -2.018 1.009 6.669 -3.231 3.702 8.255 -3.343 4.33 6.851 -2.234 5.768 6.665 • 1.954 6.241 8.406 -1.267 1.317 8.764 0.019 0.667 8.477 -0.132 -0.844 8.328 0.449 -1.427 7.402 1.001 0.949 9.613 1.293 2.434 9.757 2.305 0.188 9.404 2.264 2.698 10.902 -1.081 -1.421 9.047 -1.254 -2.875 8.973 -1.947 -3.301 7.679 -1.444 -4.204 6.998 -2.03 -3.36 10.197 -3.28 -2.684 10.279 • 2.85 -2.465 7.194 -3.558 -2.762 5.948 -2.699 -2.386 4.739 -2.665 -3.129 3.748 -4.857 -1.963 5.994 -5.781 -2.185 4.804 -6.009 -3.665 4.521 -7.109 -1.479 5.058 -1.818 -1.42 4.948 -0.841 -1.031 3.933 0.161 -2.148 3.671 0.267 -2.62 2.531 0.707 -2.706 4.742 1.711 -3.772 4.62 1.123 -5.042 4.017 1.715- 5.592 3.079 2.255 -4.105 6.007 2.837 -2.935 6.563 3.334 -5.18 5.938 • 0.133 -5.321 4.331 -0.797 -6.505 3.781 -1.11 -6.37 2.291 -0.832 -7.307 1.531 -2.083 • 6.706 4.571 120- (115) VAL256 CG1 -3.028 -7.693 3.905 VAL256 CG2 -1.774 -7.144 5.993 THR257 N -1.372- 5.158 1.833 THR257 CA -1.675 -4.982 0.413 THR257 C • 0.401 -4.902 -0.427 THR257 〇-0.357 -5.499 -1.512 THR257 C 巳 -2.502 -3.717 0.248 THR257 〇G1 -3.63 -3.818 1.106 THR257 CG2 -3.002 -3.558 -1.183 LEU258 N 0.69 -4.465 0.185 LEU258 CA 1.976 -4.434 -0.526 LEU258 C 2.588 -5.828 -0.61 LEU258 〇 3.147 -6.205 -1.648 LEU258 C 巳 2.936 -3.524 0.233 LEU258 CG 2.45 -2.08 0.263 LEU258 CD1 3.329 -1.229 1.172 LEU258 CD2 2.391 -1.492 -1.141 LEU259 N 2.248 -6.652 0.368 LEU259 CA 2.721 -8.034 0.407 LEU259 C 1.818 -8.965 -0.407 LEU259 〇2.223 -10.083 -0.747 LEU259 CB 2.742 -8.462 1.869 LEU259 CG 3.979 -9.291 2.183 LEU259 CD1 5.235 -8.559 1.727 LEU259 CD2 4.05- 9.61 3.672 GLU260 N 0.649 -8.473 -0.791 GLU260 CA -0.221 • 9.215 -1.707 GLU260 C 0.163 -8.932 -3.151 GLU260 〇0.033 -9.804 -4.019 GLU260 CB -1.67 -8.773 -1.531 GLU260 CG -2.53 -9.85 -0.883 GLU260 CD -2.442 -9.78 0.637 GLU260 OE1 -1.632 -10.498 1.204 GLU260 OE2 -3.287 -9.103 1.202 ASN261 N 0.693 -7.743 -3.382 ASN261 CA 1.158 -7.381 -4.723 ASN261 C 2.669 -7.181 -4.742 ASN261 〇3.134 -6.032 -4.804 ASN261 CB 0.468 -6.089 • 5.161 ASN261 CG -0.986 -6.311 -5.586 ASN261 〇D1 -1.784 -6.942 -4.881 ASN261 ND2 -1.339- 5.701 -6.705 PR0262 N 3.404 -8.259 -4.986 PR0262 CA 4.864 -8.219 -4.846 PR0262 C 5.563 -7.432 -5.958 PR0262 〇6.612 -6.834 • 5.706 PR0262 CB 5.298 • 9.652 -4.871 PR0262 CG 4.108 -10.533 -5.223 PR0262 CD 2.912 -9.601 -5.319 ASP263 N 4.884 -7.222 -7.077 ASP263 CA 5.442 -6.411 -8.166 ASP263 C 5.27 -4.909 • 7.918 ASP263 〇6.133 -4.124 -8.327 ASP263 CB 4.783 -6.822 -9.488</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">121 - (116) ASP263 CG 3.253 -6.778 -9.42  ASP263 〇D1 2.69 -5.734 -9.721  ASP263 OD2 2.673 •7.766 -8.992  GLN264 N 4.358 -4.558 -7.024  GLN264 CA 4.149 -3.154 -6.675  GLN264 C 5.104 •2.803 -5.545  GLN264 〇 5.782 -1.769 -5.59  GLN264 C巳 2.709 -3.002 -6.206  GLN264 CG 1.723 •3.483 -7.265  GLN264 CD 1.637 -2.485 -8.412  GLN264 〇E1 1.631 -1.274 -8.178  GLN264 NE2 1.592 -2.991 -9.63  LEU265 N 5.398 -3.825 -4.758  LEU265 CA 6.389 -3.701 -3.693  LEU265 C 7.808 -3.677 -4.263  LEU265 〇 8.639 -2.888 -3.798  LEU265 CB 6.218 -4.903 -2.775  LEU265 CG 7.134 -4.809 -1.565  LEU265 CD1 6.869 -3.518 -0.802  LEU265 CD2 6.958 -6.023 -0.662  ALA266 N 7.993 -4.309 -5.411  ALA266 CA 9.286 -4.267 -6.093  ALA266 C 9.528 -2.929 -6.785  ALA266 〇 10.66 -2.434 -6.737  ALA266 CB 9.333 -5.39 -7.123  LYS267 N 8.466 -2.235 -7.167  LYS267 CA 8.641 -0.891 -7.725  LYS267 C 8.887 0.136 -6.625  LYS267 〇 9.706 1.042 -6.818  LYS267 C巳 7.406 -0.501 -8.523  LYS267 CG 7.223 -1.394 -9.742  LYS267 CD 6.072 -0.894 -10.604  LYS267 CE 4.779 -0.825 -9.803  LYS267 NZ 3.688 -0.267 -10.615  ILE268 N 8.413 •0.162 •5.427  ILE268 CA 8.717 0.664 -4.254  ILE268 C 10.181 0.531 -3.84  ILE268 〇 10.879 1.544 -3.697  ILE268 CB 7.827 0.171 •3.117  ILE268 CG1 6.38 0.576 -3.335  ILE268 CG2 8.311 0.638 -1.75  ILE268 CD1 5.504 0.057 -2.205  LYS269 N 10.693 •0.688 -3.902  LYS269 CA 12.068 -0.95 -3.463  LYS269 C 13.116 •0.675 -4.542  LYS269 〇 14.306 -0.554 -4.228  LYS269 CB 12.126 -2.405 -3.021  LYS269 CG 11.167 -2.628 -1.858  LYS269 CD 10.997 -4.107 -1.542  LYS269 CE 12.315 -4.756 •1.148  LYS269 NZ 12.106 -6.181 -0.856  ALA270 N 12.679 -0.53 -5.782  ALA270 CA 13.585 -0.106 -6.851  ALA270 C 13.478 1.396 -7.101</span>121-(116) ASP263 CG 3.253 -6.778 -9.42 ASP263 〇D1 2.69 -5.734 -9.721 ASP263 OD2 2.673 • 7.766 -8.992 GLN264 N 4.358 -4.558 -7.024 GLN264 CA 4.149 -3.154 -6.675 GLN264 C 5.104 • 2.803 -5.545 GLN264 〇 5.782 -1.769 -5.59 GLN264 C 巳 2.709 -3.002 -6.206 GLN264 CG 1.723 • 3.483 -7.265 GLN264 CD 1.637 -2.485 -8.412 GLN264 〇E1 1.631 -1.274 -8.178 GLN264 NE2 1.592 -2.991 -9.63 LEU265 N 5.398 -3.825 -4.758 LEU265 CA 6.389 -3.701 -3.693 LEU265 C 7.808 -3.677 -4.263 LEU265 〇8.639 -2.888 -3.798 LEU265 CB 6.218 -4.903 -2.775 LEU265 CG 7.134 -4.809 -1.565 LEU265 CD1 6.869 -3.518 -0.802 LEU265 CD2 6.958 -6.023 -0.662 ALA266 N 7.993 -4.309 -5.411 ALA266 CA 9.286 -4.267 -6.093 ALA266 C 9.528 -2.929 -6.785 ALA266 〇 10.66 -2.434 -6.737 ALA266 CB 9.333 -5.39 -7.123 LYS267 N 8.466 -2.235 -7.167 LYS267 CA 8.641 -0.891 -7.725 LYS267 C 8.887 0.136 -6.625 LYS267 〇9.706 1.042 -6.818 LYS267 C 巳 7.406 -0.501 -8.523 LYS267 CG 7.223 -1.394 -9.742 LYS267 CD 6.072 -0 .894 -10.604 LYS267 CE 4.779 -0.825 -9.803 LYS267 NZ 3.688 -0.267 -10.615 ILE268 N 8.413 • 0.162 • 5.427 ILE268 CA 8.717 0.664 -4.254 ILE268 C 10.181 0.531 -3.84 ILE268 〇10.879 1.544 -3.697 ILE268 CB 7.827 0.171 • 3.117 ILE268 CG1 6.38 0.576 -3.335 ILE268 CG2 8.311 0.638 -1.75 ILE268 CD1 5.504 0.057 -2.205 LYS269 N 10.693 • 0.688 -3.902 LYS269 CA 12.068 -0.95 -3.463 LYS269 C 13.116 • 0.675 -4.542 LYS269 〇14.306 -0.554 -4.228 LYS269 CB126 12. -3.021 LYS269 CG 11.167 -2.628 -1.858 LYS269 CD 10.997 -4.107 -1.542 LYS269 CE 12.315 -4.756 • 1.148 LYS269 NZ 12.106 -6.181 -0.856 ALA270 N 12.679 -0.53 -5.782 ALA270 CA 13.585 -0.106 -6.851 ALA270 C 13.478 1.396 -7.101</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">122- (117) ALA270 ALA270 ASP271 ASP271 ASP271 ASP271 ASP271 ASP271 ASP271 ASP271 PR0272 PR0272 PR0272 PR0272 PR0272 PR0272 PR0272 GLY273 GLY273 GLY273 GLY273 LYS274 LYS274 LYS274 LYS274 LYS274 LYS274 LYS274 LYS274 LYS274 THR275 THR275 THR275 THR275 THR275 THR275 THR275 LEU276 LEU276 LEU276 LEU276 LEU276 LEU276 LEU276 LEU276 ALA277 ALA277 ALA277 ALA277 ALA277 ALA278 ALA278 ALA278 ALA278 〇CBNCAcoCBCGODODNCAcoCBCG8NCACONCAcoCBCG8CENZNCAcoCBOGCGNCAcoCBCGCDCDNCAcoCBNCAco D1D2</span>122- (117) ALA270 ALA270 ASP271 ASP271 ASP271 ASP271 ASP271 ASP271 ASP271 ASP271 PR0272 PR0272 PR0272 PR0272 PR0272 PR0272 PR0272 GLY273 GLY273 GLY273 GLY273 LYS274 LYS274 LYS274 LYS274 LE276 THR276 THR276 THR276 THR276 THR276 THR276 THR276 ALA277 ALA277 ALA277 ALA277 ALA277 ALA278 ALA278 ALA278 ALA278 〇CBNCAcoCBCGODODNCAcoCBCG8NCACONCAcoCBCG8CENZNCAcoCBOGCGNCAcoCBCGCDCDNCAcoCBNCAco D1D2</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">12 B G I 14.286 1.974 -7.838  13.233 -0.863 -8.125  12.486 2.017 -6.486  12.271 3.453 -6.649  11.505 4.006 -5.448  10.267 4.02 -5.445  11.48 3.653 -7.944  11.354 5.125 -8.337  10.975 5.919 -7.482  11.493 5.405 -9.517  12.238 4.705 -4.592  11.686 5.248 -3.337  10.72 6.438 -3.497  9.973 6.74 -2.558  12.887 5.657 -2.54  14.133 5.544 -3.406  13.673 4.968 -4.734  10.586 6.971 -4.702  9.607 8.03 -4.968  8.207 7.423 -5.037  7.257 7.968 -4.456  8.167 6.171 -5.473  6.916 5.418 •5.566  6.39 4.954 -4.21  5.225 4.55 -4.144  7.138 4.184 -6.431  7.528 4.547 -7.856  7.755 3.287 -8.681  8.177 3.615 •10.107  8.465 2.383 -10.858  7.12 5.182 -3.127  6.593 4.814 -1.813  5.522 5.804 -1.352  4.516 5.354 -0.798  7.725 4.76 -0.789  8.169 6.074 -0.485  8.912 3.963 -1.305  5.564 7.036 -1.844  4.543 8.012 •1.446  3.312 7.905 -2.346  2.175 8.051 -1.876  5.14 9.411 -1.538  4.182 10.462 -0.987  3.836 10.177 0.472  4.77 11.861 •1.133  3.53 7.375 -3.539  2.417 7.126 -4.451  1.711 5.836 -4.052  0.475 5.796 -4.026  2.963 7.021 -5.869  2.472 4.947 -3.431  1.909 3.727 -2.859  1.12 4.01 -1.591  0.051 3.416 -1.427 123- (118) ALA278 ILE279 ILE279 ILE279 ILE279 ILE279 ILE279 ILE279 ILE279 GLU280 GLU280 GLU280 GLU280 GLU280 GLU280 GLU280 GLU280 GLU280 GLU281 GLU281 GLU281 GLU281 GLU281 GLU281 GLU281 GLU281 GLU281 LEU282 LEU282 LEU282 LEU282 LEU282 LEU282 LEU282 LEU282 LEU283 LEU283 LEU283 LEU283 LEU283 LEU283 LEU283 LEU283 ARG284 ARG284 ARG284 A 闩 G284 ARG284 ARG284 ARG284 ARG284 ARG284 ARG284 ARG284</span>12 BGI 14.286 1.974 -7.838 13.233 -0.863 -8.125 12.486 2.017 -6.486 12.271 3.453 -6.649 11.505 4.006 -5.448 10.267 4.02 -5.445 11.48 3.653 -7.944 11.354 5.125 -8.337 10.975 5.919 -7.482 11.493 5.405 -9.517 12.238 4.705 -4.592 11.686 5.248- 3.337 10.72 6.438 -3.497 9.973 6.74 -2.558 12.887 5.657 -2.54 14.133 5.544 -3.406 13.673 4.968 -4.734 10.586 6.971 -4.702 9.607 8.03 -4.968 8.207 7.423 -5.037 7.257 7.968 -4.456 8.167 6.171 -5.473 6.916 5.418 • 5.566 6.39 4.954 -4.21 5.225 4.55 -4.144 7.138 4.184 -6.431 7.528 4.547 -7.856 7.755 3.287 -8.681 8.177 3.615 • 10.107 8.465 2.383 -10.858 7.12 5.182 -3.127 6.593 4.814 -1.813 5.522 5.804 -1.352 4.516 5.354 -0.798 7.725 4.76 -0.789 8.169 6.074 -0.485 8.912 3.963- 1.305 5.564 7.036 -1.844 4.543 8.012 • 1.446 3.312 7.905 -2.346 2.175 8.051 -1.876 5.14 9.411 -1.538 4.182 10.462 -0.987 3.836 10.177 0.472 4.77 11.861 • 1.133 3.53 7.375 -3.539 2.417 7.126 -4.451 1.711 5.836 -4.052 0.475 5.796 -4. 4. 026 2.963 7.021 -5.869 2.472 4.947 -3.431 1.909 3.727 -2.859 1.12 4.01 -1.591 0.051 3.416 -1.427 123- (118) ALA278 ILE279 ILE279 ILE279 ILE279 ILE279 ILE279 ILE279 ILE279 GLU280 GLU280 GLU280 GLU280 GLU280 GLU280 GLU280 GLU280 GLU280 GLU280 GLU280 GLU280 GLU280 GLU280 GLU281 GLU281 GLU281 LEU282 LEU282 LEU282 LEU282 LEU282 LEU282 LEU282 LEU282 LEU283 LEU283 LEU283 LEU283 LEU283 LEU283 LEU283 LEU283 LEU283 ARG284 ARG284 ARG284 A Latch G284 ARG284 ARG284 ARG284 ARG284 ARG284 ARG284 ARG284</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">BA BGGD A 巳 GD E1E2 A CNCC〇CCCCNCC〇CCC〇〇NCC</span>BA BGGD A 巳 GD E1E2 A CNCC〇CCCCNCC〇CCC〇〇NCC</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">BGDEE2A BGD1D2A BGD1D2A BGDEZH1H2 〇CCC〇〇NCC〇CCCCNCC〇CCCCNCC〇CCCNCNN 3.048 2.773 -2.523  1.472 5.064 -0.867  0.698 5.447 0.324  -0.692 5.926 -0.078  -1.691 5.368 0.396  1.401 6.588 1.063  2.806 6.209 1.513  0.577 7.041 2.264  2.805 4.984 2.416  -0.748 6.688 -1.159  -2.037 7.217 -1.616  -2.849 6.159 -2.358  -4.075 6.123 -2.217  -1.784 8.404 -2.537  -0.943 9.484 -1.862  -1.616 9.992 -0.587  -2.453 10.875 -0.699  -1.19 9.569 0.479  -2.169 5.173 -2.916  -2.857 4.083 -3.604  -3.402 3.048 -2.616  -4.497 2.514 -2.842  -1.846 3.441 -4.546  •2.451 2.329 -5.39  -3.395 2.862 -6.465  -3.893 2.017 -7.199  -3.446 4.068 -6.653  -2.776 2.957 -1.452  -3.272 2.102 -0.369  -4.527 2.703 0.232  -5.563 2.03 0.269  -2.212 2.019 0.727  -1.025 1.151 0.332  0.163 1.385 1.256  -1.415 -0.319 0.305  -4.511 4.018 0.378  -5.666 4.738 0.922  -6.823 4.808 -0.066  -7.989 4.766 0.346  -5.202 6.145 1.257  -4.178 6.103 2.379  -3.386 7.399 2.461  -4.848 5.766 3.706  -6.512 4.723 -1.346  -7.561 4.67 -2.355  -8.306 3.337 -2.3  -9.482 3.316 -1.923  -6.921 4.824 -3.726  -7.99 4.956 -4.798  -7.417 4.674 -6.18  -6.879 3.305 -6.258  -7.603 2.231 -6.583  -8.911 2.35 -6.816  -7.021 1.032 -6.658 -124- ILE285 N -7.588 2.233 -2.423  ILE285 CA -8.284 0.942 -2.519  ILE285 C -8.742 0.397 -1.155  ILE285 〇 -9.703 -0.385 -1.087  ILE285 C巳 -7.36 -0.039 -3.247  ILE285 CG1 -8.033 -1.383 -3.499  ILE285 CG2 -6.045 -0.238 -2.501  ILE285 CD1 -7.119 -2.327 -4.272  PHE286 N -8.188 0.934 -0.082  PHE286 CA -8.543 0.5 1.268  PHE286 C -8.451 1.645 2.27  PHE286 〇 -7.544 1.66 3.115  PHE286 CB -7.575 -0.594 1.708  PHE286 CG -7.737 -1.948 1.025  PHE286 CD1 -6.675 -2.503 0.323  PHE286 CD2 -8.943 -2.632 1.117  PHE286 CE1 -6.822 •3.736 -0.298  PHE286 CE2 -9.09 -3.865 0.495  PHE286 CZ -8.03 -4.417 -0.213  THR287 N -9.377 2.584 2.193  THR287 CA -9.413 3.636 3.212  THR287 C -9.931 3.053 4.519  THR287 〇 -10.843 2.216 4.543  THR287 CB -10.294 4.801 2.77  THR287 〇G1 -10.207 5.833 3.745  THR287 CG2 -11.759 4.423 2.643  ILE288 N -9.305 3.459 5.609  ILE288 CA -9.745 2.966 6.911  ILE288 C -10.966 3.747 7.391  ILE288 〇 -11.856 3.155 8.014  ILE288 CB -8.584 3.044 7.894  ILE288 CG1 -8.04 4.459 8.013  ILE288 CG2 -7.469 2.097 7.461  ILE288 CD1 -6.938 4.507 9.052  ALA289 N -11.116 4.965 6.89  ALA289 CA -12.34 5.743 7.09  ALA289 C -13.315 5.37 5.982  ALA289 〇 -13.433 6.062 4.964  ALA289 CB -12.003 7.228 7.013  GLU290 N •13.969 4.239 6.174  GLU290 CA -14.796 3.652 5.128  GLU290 C -16.223 4.179 5.178  GLU290 〇 •16.891 4.234 4.138  GLU290 C巳 -14.766 2.14 5.34  GLU290 CG •15.669 1.375 4.381  GLU290 CD •15.736 -0.091 4.802  GLU290 〇E1 -16.751 •0.475 5.367  GLU290 OE2 -14.809 -0.819 4.472  THR291 N -16.659 4.619 6.347  THR291 CA -17.992 5.216. 6.481  THR291 C -17.983 6.47 7.349  THR291 〇 •17.68 6.437 8.55  THR291 CB -18.978 4.219 7.094  THR291 〇G1 -18.522 3.832 8.382</span>BGDEE2A BGD1D2A BGD1D2A BGDEZH1H2 〇CCC〇〇NCC〇CCCCNCC〇CCCCNCC〇CCCNCNN 3.048 2.773 -2.523 1.472 5.064 -0.867 0.698 5.447 0.324 -0.692 5.926 -0.078-1.691 5.368 0.396 1.401 6.588 2.063 2.806 6.806 6.1.5 6.209 -1.159 -2.037 7.217 -1.616 -2.849 6.159 -2.358 -4.075 6.123 -2.217 -1.784 8.404 -2.537 -0.943 9.484 -1.862 -1.616 9.992 -0.587 -2.453 10.875 -0.699 -1.19 9.569 0.479 -2.169 5.173 -2.916 -2.857 4.083- 3.604 -3.402 3.048 -2.616 -4.497 2.514 -2.842 -1.846 3.441 -4.546 • 2.451 2.329 -5.39 -3.395 2.862 -6.465 -3.893 2.017 -7.199 -3.446 4.068 -6.653 -2.776 2.957 -1.452 -3.272 2.102 -0.369 -4.527 2.703 0.232 -5.563 2.03 0.269 -2.212 2.019 0.727 -1.025 1.151 0.332 0.163 1.385 1.256 -1.415 -0.319 0.305 -4.511 4.018 0.378 -5.666 4.738 0.922 -6.823 4.808 -0.066 -7.989 4.766 0.346 -5.202 6.145 1.257 -4.178 6.103 2.379 -3.386 7.399 2.461- 4.848 5.766 3.706 -6.512 4.723 -1.346 -7.561 4.67 -2.355 -8. 306 3.337 -2.3 -9.482 3.316 -1.923 -6.921 4.824 -3.726 -7.99 4.956 -4.798 -7.417 4.674 -6.18 -6.879 3.305 -6.258 -7.603 2.231 -6.583 -8.911 2.35 -6.816 -7.021 1.032 -6.658 -124- ILE285 N- 7.588 2.233 -2.423 ILE285 CA -8.284 0.942 -2.519 ILE285 C -8.742 0.397 -1.155 ILE285 〇-9.703 -0.385 -1.087 ILE285 C 巳 -7.36 -0.039 -3.247 ILE285 CG1 -8.033 -1.383 -3.499 ILE285 CG2 -6.045 -0.238- 2.501 ILE285 CD1 -7.119 -2.327 -4.272 PHE286 N -8.188 0.934 -0.082 PHE286 CA -8.543 0.5 1.268 PHE286 C -8.451 1.645 2.27 PHE286 〇-7.544 1.66 3.115 PHE286 CB -7.575 -0.594 1.708 PHE286 CG -7.737 -1.948 1.025 PHE286 CD1 -6.675 -2.503 0.323 PHE286 CD2 -8.943 -2.632 1.117 PHE286 CE1 -6.822 • 3.736 -0.298 PHE286 CE2 -9.09 -3.865 0.495 PHE286 CZ -8.03 -4.417 -0.213 THR287 N -9.377 2.584 2.193 THR287 CA -9.413 3.636 3.212 THR287 C- 9.931 3.053 4.519 THR287 〇-10.843 2.216 4.543 THR287 CB -10.294 4.801 2.77 THR287 〇G1 -10.207 5.833 3.745 THR287 CG2 -11.759 4.423 2.643 ILE 288 N -9.305 3.459 5.609 ILE288 CA -9.745 2.966 6.911 ILE288 C -10.966 3.747 7.391 ILE288 〇-11.856 3.155 8.014 ILE288 CB -8.584 3.044 7.894 ILE288 CG1 -8.04 4.459 8.013 ILE288 CG2 -7.469 2.097 7.461 ILE288 CD1 -6.938 4.507 9.052 A -11.116 4.965 6.89 ALA289 CA -12.34 5.743 7.09 ALA289 C -13.315 5.37 5.982 ALA289 〇-13.433 6.062 4.964 ALA289 CB -12.003 7.228 7.013 GLU290 N • 13.969 4.239 6.174 GLU290 CA -14.796 3.652 5.128 GLU290 C -16.223 4.179 5.16 GLU290 〇. 4.234 4.138 GLU290 C 巳 -14.766 2.14 5.34 GLU290 CG • 15.669 1.375 4.381 GLU290 CD • 15.736 -0.091 4.802 GLU290 〇E1 -16.751 • 0.475 5.367 GLU290 OE2 -14.809 -0.819 4.472 THR291 N -16.659 4.619 6.347 THR291 CA -17.992 5.216. THR291 C -17.983 6.47 7.349 THR291 〇 17.68 6.437 8.55 THR291 CB -18.978 4.219 7.094 THR291 〇G1 -18.522 3.832 8.382</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">125- (120) THR291 ALA292 ALA292 ALA292 ALA292 ALA292 THR293 THR293 THR293 THR293 THR293 THR293 THR293 SER294 SER294 SER294 SER294 SER294 SER294 ARG295 ARG295 ARG295 ARG295 ARG295 ARG295 ARG295 ARG295 ARG295 ARG295 ARG295 PHE296 PHE296 PHE296 PHE296 PHE296 PHE296 PHE296 PHE296 PHE296 PHE296 PHE296 ALA297 ALA297 ALA297 ALA297 ALA297 THR298 THR298 THR298 THR298 THR298 THR298 THR298 ALA299 2 12 1 2 12 12 1 2 G A B A bgg a b g a 巳 gdezhh a bgddeez a b a bgg cncc〇cncc〇c〇cncc〇c〇ncc〇cccncnnncc〇cccccccncc〇cncc〇c〇cn -19.168 2.961 6.257  -18.397 7.562 6.734  •18.676 8.799 7.471  -20.103 8.704 8.001  -21.051 9.169 7.355  -18.552 9.986 6.521  -20.231 8.1 9.172  -21.535 7.709 9.721  -22.161 8.802 10.585  -22.152 8.733 11.82  -21.308 6.447 10.546  -20.564 5.523 9.756  -22.617 5.788 10.962  -22.703 9.805 9.913  -23.293 10.956 10.601  -24.198 11.766 9.675  -25.386 11.443 9.529  -22.167 11.822 11.164  -20.976 11.559 10.426  -23.598 12.789 9.076  -24.233 13.782 8.187  -25.738 13.903 8.366  -26.524 13.3 7.627  -23.905 13.424 6.747  -22.4 13.455 6.518  -21.819 14.841 6.786  -20.362 14.859 6.577  -19.475 14.679 7.56  -19.892 14.437 8.805  -18.167 14.719 7.293  -26.119 14.646 9.387  -27.528 14.825 9.712  -28.176 15.754 8.701  -27.736 16.899 8.529  -27.623 15.428 11.11  -29.052 15.695 11.562  -29.564 16.985 11.533  -29.843 14.643 12.002  -30.871 17.221 11.936  -31.149 14.879 12.406  -31.663 16.167 12.37  -29.2 15.255 8.032  -29.931 16.073 7.065  -30.783 17.111 7.781  -31.769 16.781 8.45  -30.819 15.165 6.224  -30.369 18.361 7.668  -31.129 19.47 8.255  -32.139 20.005 7.246  -33.087 20.712 7.603  -30.17 20.586 8.659  -29.565 21.12 7.488  -29.068 20.082 9.582  -31.926 19.649 5.992 -126- (121) 200418849</span>125- (120) THR291 ALA292 ALA292 ALA292 ALA292 ALA292 THR293 THR293 THR293 THR293 THR293 THR293 THR293 SER294 SER294 SER294 SER294 SER294 SER294 SER294 ARG295 ARG295 ARG295 ARG295LA296 P296 PHE295 PHE PHE PHE PHE PHE PHE PHE PHE ALA297 THR298 THR298 THR298 THR298 THR298 THR298 THR298 ALA299 2 12 1 2 12 12 1 2 GABA bgg abga 巳 gdezhh a bgddeez aba bgg cncc〇cncc〇ccncc〇c〇ncc〇cccncnnncc〇cccccccncc〇cncc〇96100cn-19-19168 6.257 -18.397 7.562 6.734 • 18.676 8.799 7.471 -20.103 8.704 8.001 -21.051 9.169 7.355 -18.552 9.986 6.521 -20.231 8.1 9.172 -21.535 7.709 9.721 -22.161 8.802 10.585 -22.152 8.733 11.82 -21.308 6.447 10.546 -20.564 5.523 9.756 -22.617 5.788 10.962- 22.703 9.805 9.913 -23.293 10.956 10.601 -24.198 11.766 9.675 -25.386 11.443 9.529 -22.167 11.822 11.164 -20.976 11.559 10.426 -23.598 12.789 9.076 -24.233 13.782 8.187 -25.738 13.9 03 8.366 -26.524 13.3 7.627 -23.905 13.424 6.747 -22.4 13.455 6.518 -21.819 14.841 6.786 -20.362 14.859 6.577 -19.475 14.679 7.56 -19.892 14.437 8.805 -18.167 14.719 7.293 -26.119 14.646 9.387 -27.528 14.825 9.712 -28.176 15.754 8.701 -27.736 16.899 8.899 -27.623 15.428 11.11 -29.052 15.695 11.562 -29.564 16.985 11.533 -29.843 14.643 12.002 -30.871 17.221 11.936 -31.149 14.879 12.406 -31.663 16.167 12.37 -29.2 15.255 8.032 -29.931 16.073 7.065 -30.783 17.111 7.781 -31.769 16.781 8.45 -30.819 15.369 6.165 6.224 18.361 7.668 -31.129 19.47 8.255 -32.139 20.005 7.246 -33.087 20.712 7.603 -30.17 20.586 8.659 -29.565 21.12 7.488 -29.068 20.082 9.582 -31.926 19.649 5.992 -126- (121) 200418849</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">2267 ALA299 CA  2268 ALA299 C  2269 ALA299 〇  2270 ALA299 C巳  2271 ASP300 N  2272 ASP300 CA  2273 ASP300 C  2274 ASP300 〇  2275 ASP300 CB  2276 ASP300 CG  2277 ASP300 OD1  2278 ASP300 〇D2  2279 VAL301 N  2280 VAL301 CA  2281 VAL301 C  2282 VAL301 〇  2283 VAL301 CB  2284 VAL301 CG1  2285 VAL301 CG2  2286 GLU302 N  2287 GLU302 CA  2288 GLU302 C  2289 GLU302 0  2290 GLU302 CB  2291 GLU302 CG  2292 GLU302 CD  2293 GLU302 〇E1  2294 GLU302 OE2  2295 ILE303 N  2296 ILE303 CA  2297 ILE303 C  2298 ILE303 〇  2299 ILE303 CB  2300 ILE303 CG1  2301 ILE303 CG2  2302 ILE303 CD1  2303 GLY304 N  2304 GLY304 CA  2305 GLY304 C  2306 GLY304 〇  2307 GLY305 N  2308 GLY305 CA  2309 GLY305 C  2310 GLY305 〇  2311 THR306 N  2312 THR306 CA  2313 THR306 C  2314 THR306 0  2315 THR306 CB  2316 THR306 OG1  2317 THR306 CG2  2318 LEU307 N  2319 LEU307 CA  2320 LEU307 C -32.881 19.968 4.932  -33.091 18.734 4.068  -32.427 17.712 4.27  -32.331 21.11 4.086  -34.041 18.817 3.151  -34.256 17.727 2.191  -33.253 17.852 1.048  -33.498 18.545 0.053  -35.679 17.801 1.648  -36.682 17.714 2.793  -36.686 16.69 3.463  -37.289 18.733 3.09  -32.128 17.177 1.199  -31.029 17.337 0.244  -31.065 16.261 -0.833  -30.956 15.062 -0.55  -29.711 17.263 1.007  -28.543 17.673 0.118  -29.756 18.154 2.24  •31.242 16.695 -2.067  -31.23 15.75 -3.184  -29.799 15.413 -3.603  -29.141 16.178 -4.318  -31.98 16.355 •4.363  -32.053 15.344 •5.497  -32.662 15.959 -6.75  -33.484 16.852 -6.606  -32.169 15.628 -7.82  •29.365 14.227 -3.222  -28.014 13.766 -3.539  -28.053 12.812 -4.726  -28.452 11.647 -4.6  -27.438 13.076 -2.307  -27.329 14.056 -1.148  -26.066 12.49 -2.608  -26.305 15.146 -1.441  -27.715 13.356 -5.885  -27.705 12.592 •7.139  -29.056 11.935 -7.402  -29.187 10.708 -7.311  -30.079 12.757 -7.573  -31.432 12.229 -7.805  -32.226 11.982 -6.517  -33.289 12.584 -6.314  •31.694 11.132 -5.653  -32.399 10.717 -4.431  -32.569 11.859 -3.43  •31.597 12.497 -3.015  -31.591 9.598 -3.782  -31.461 8.534 -4.716  -32.278 9.051 -2.537  -33.811 12.127 -3.066  -34.093 13.162 -2.068  -33.971 12.6 •0.652 127 - (122)</span>2267 ALA299 CA 2268 ALA299 C 2269 ALA299 〇2270 ALA299 C 巳 2271 ASP300 N 2272 ASP300 CA 2273 ASP300 C 2274 ASP300 〇2275 ASP300 CB 2276 ASP300 CG 2277 ASP300 OD1 2278 ASP300 〇D2 2279 VAL301 N 2280 VAL301 CA 2281 VAL301 C 2282 VAL301 2283 VAL301 CB 2284 VAL301 CG1 2285 VAL301 CG2 2286 GLU302 N 2287 GLU302 CA 2288 GLU302 C 2289 GLU302 0 2290 GLU302 CB 2291 GLU302 CG 2292 GLU302 CD 2293 GLU302 〇E1 2294 GLU302 OE2 2295 ILE303 N 2296 ILE303 2ILE ILE303 2 ILE303 CB 2300 ILE303 CG1 2301 ILE303 CG2 2302 ILE303 CD1 2303 GLY304 N 2304 GLY304 CA 2305 GLY304 C 2306 GLY304 〇2307 GLY305 N 2308 GLY305 CA 2309 GLY305 C 2310 GLY305 〇2311 THR306 N 2312 THR306 CA 2313 THR306 C 2316 THR306 OG1 2317 THR306 CG2 2318 LEU307 N 2319 LEU307 CA 2320 LEU307 C -32.881 19.968 4.932 -33.091 18.734 4.068 -32.427 17.712 4.27 -32.331 21.11 4.086 -34.041 18.817 3.151 -34.256 17.727 2.191 -33 .253 17.852 1.048 -33.498 18.545 0.053 -35.679 17.801 1.648 -36.682 17.714 2.793 -36.686 16.69 3.463 -37.289 18.733 3.09 -32.128 17.177 1.199 -31.029 17.337 0.244 -31.065 16.261 -0.833 -30.956 15.062 -0.55 -29.711 17.263 1.007 -28.543 17.673 0.118 -29.756 18.154 2.24 • 31.242 16.695 -2.067 -31.23 15.75 -3.184 -29.799 15.413 -3.603 -29.141 16.178 -4.318 -31.98 16.355 • 4.363 -32.053 15.344 • 5.497 -32.662 15.959 -6.75 -33.484 16.852 -6.606 -32.169 15.628 -7.82 • 29.365 14.227 -3.222 -28.014 13.766 -3.539 -28.053 12.812 -4.726 -28.452 11.647 -4.6 -27.438 13.076 -2.307 -27.329 14.056 -1.148 -26.066 12.49 -2.608 -26.305 15.146 -1.441 -27.715 13.356 -5.885 -27.705 12.592 • 7.139- 29.056 11.935 -7.402 -29.187 10.708 -7.311 -30.079 12.757 -7.573 -31.432 12.229 -7.805 -32.226 11.982 -6.517 -33.289 12.584 -6.314 • 31.694 11.132 -5.653 -32.399 10.717 -4.431 -32.569 11.859 -3.43 • 31.597 12.497 -3.015- 31.591 9.598 -3.782 -31.461 8.534 -4.716 -32 .278 9.051 -2.537 -33.811 12.127 -3.066 -34.093 13.162 -2.068 -33.971 12.6 • 0.652 127-(122)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(122)   LEU307 〇  LEU307 CB  LEU307 CG  LEU307 CD1  LEU307 CD2  ILE308 N  ILE308 CA  ILE308 C  ILE308 〇  ILE308 C巳  ILE308 CG1  ILE308 CG2  ILE308 CD1  ARG309 N  ARG309 CA  ARG309 C  ARG309 〇  ARG309 CB  ARG309 CG  ARG309 CD  ARG309 NE  ARG309 CZ  ARG309 NH1  ARG309 NH2  ALA310 N  ALA310 CA  ALA310 C  ALA310 〇  ALA310 CB  GLY311 N  GLY311 CA  GLY311 C  GLY311 〇  GLU312 N  GLU312 CA  GLU312 C  GLU312 〇  GLU312 CB  GLU312 CG  GLU312 CD  GLU312 〇E1  GLU312 〇E2  GLY313 N  GLY313 CA  GLY313 C  GLY313 〇  VAL314 N  VAL314 CA  VAL314 C  VAL314 〇  VAL314 CB  VAL314 CG1  VAL314 CG2  VAL315 N -34.803 -35.513 -35.845 -34.946 -37.31 -32.93 -32.738 -33.586 •33.481 -31.253 -30.456 -30.976 -28.974 -34.466 -35.386 -34.674 -33.807 &amp;gt;36.447 -37.117 -38.079 -38.721 -40.046 -40.85 -40.566 -35.099 -34.597 -34.952 -36.005 -35.223 -34 -34.172 -33.475 -33.472 -32.982 -32.294 -30.776 -30.236 -32.743 -34.243 -34.639 -34.686 -34.723 -30.107 -28.64 -28.079 -28.674 -26.996 -26.33 -24.93 -24.127 -26.28 -25.639 -27.681 -24.674 11.799 13.67 14.852 16.039 15.248 13.021 12.616 13.486 14.719 12.742 11.77 12.507 11.794 12.834 13.543 14.125 13.486 12.563 11.841 10.778 10.055 9.951 10.528 9.278 15.325 15.999 15.189 14.542 17.386 15.115 14.325 12.968 12.217 12.611 11.322 11.471 12.577 10.651 10.386 9.537 10.083 8.33 10.356 10.335 9.813 8.944 10.429 10.028 9.467 10.02 11.246 10.942 11.804 8.328 -0.209 -2.295 -1.391 -1.71 -1.534 0.045 1.439 2.362 2.356 1.764 0.901 3.245 1.246 3.101 3.993 5.209 5.824 4.474 3.312 3.83 2.721 2.594 3.49 1.566 5.566 6.763 8.003 8.07 6.853 8.913 10.13 10.042 11.023 8.866 8.719 8.737 8.599 7.429 7.453 6.252 5.156 6.419 8.981 8.994 7.673 7.02 7.237 5.994 6.267 7.033 5.073 3.724 4.861 5.649 -128- (123)   VAL315 CA -23.386 7.646 5.773  VAL315 C -22.647 7.666 4.435  VAL315 〇 •23.025 6.975 3.479  VAL315 C巳 -23.634 6.207 6.213  VAL315 CG1 -22.325 5.437 6,347  VAL315 CG2 -24.404 6.163 7.528  GLY316 N -21.6 8.467 4.374  GLY316 CA -20.789 8.539 3.152  GLY316 C -19.797 7.382 3.096  GLY316 〇 -18.903 7.28 3.946  LEU317 N -19.978 6.508 2.121  LEU317 CA -19.102 5.343 1.978  LEU317 C -17.841 5.722 1.218  LEU317 〇 -17.758 5.485 0.009  LEU317 C巳 -19.835 4.256 1.199  LEU317 CG -20.312 3.094 2.064  LEU317 CD1 -19.129 2.374 2.697  LEU317 CD2 -21.328 3.519 3.121  SER318 N -16.794 6.056 1.951  SER318 CA -15.563 6.559 1.34  SER318 C -14.789 5.483 0.588  SER318 〇 -14.286 5.777 -0.503  SER318 CB -14.689 7.158 2.434  SER318 〇G -13.375 7.32 1.915  ASN319 N -14.954 4.222 0.954  ASN319 CA -14.267 3.196 0.162  ASN319 C -15.089 2.774 -1.058  ASN319 〇 -14.498 2.343 -2.052  ASN319 CB -13.899 1.982 1.004  ASN319 CG -12.531 1.507 0.516  ASN319 〇D1 -11.628 2.333 0.321  ASN319 ND2 -12.378 0.209 0.332  ALA320 N -16.362 3:139 -1.091  ALA320 CA -17.181 2.889 -2.283  ALA320 C -17.001 4.055 -3.248  ALA320 〇 -16.897 3.856 -4.464  ALA320 CB -18.642 2.78 -1.875  GLY321 N -16.68 5.197 -2.666  GLY321 CA -16.233 6.36 -3.426  GLY321 C -14.942 6.045 -4.17  GLY321 〇 -14.924 6.106 •5.404  ASN322 N -13.958 5.508 -3.466  ASN322 CA -12.683 5.172 -4.113  ASN322 C -12.765 3.924 -5.006  ASN322 〇 -11.954 3.769 -5.927  ASN322 CB -11.651 4.902 -3.035  ASN322 CG -11.54 6.013 -1.994  ASN322 〇D1 -11.701 7.211 -2.278  ASN322 ND2 -11.095 5.595 -0.824  HIS323 N -13.785 3.103 -4.807  HIS323 CA -14.068 1.985 -5.716  HIS323 C -15.037 2.337 -6.846  HIS323 〇 •15.541 1.435 -7.525  HIS323 CB -14.625 0.804 -4.939</span>(122) LEU307 〇LEU307 CB LEU307 CG LEU307 CD1 LEU307 CD2 ILE308 N ILE308 CA ILE308 C ILE308 〇ILE308 C 巳 ILE308 CG1 ILE308 CG2 ILE308 CD1 ARG309 N ARG309 CA ARG309 C ARG309 〇ARG309 CB ARG309 CG ARG309 CD ARG309 CD ARG309 NH2 ALA310 N ALA310 CA ALA310 C ALA310 〇ALA310 CB GLY311 N GLY311 CA GLY311 C GLY311 〇GLU312 N GLU312 CA GLU312 C GLU312 〇GLU312 CB GLU312 CG GLU312 CD GLU312 〇E1 GLU312 〇E2 GLY313 N GLY313 N G313 VAL314 CA VAL314 C VAL314 〇VAL314 CB VAL314 CG1 VAL314 CG2 VAL315 N -34.803 -35.513 -35.845 -34.946 -37.31 -32.93 -32.738 -33.586 • 33.481 -31.253 -30.456 -30.976 -28.974 -34.466 -35.386 -34.674. 36.447 -37.117 -38.079 -38.721 -40.046 -40.85 -40.566 -35.099 -34.597 -34.952 -36.005 -35.223 -34 -34.172 -33.475 -33.472 -32.982 -32.294 -30.776 -30.236 -32.743 -34.243 -34.639 -34.686 -34.723 -34.686 30.107 -28.64 -28.079 -28.674 -26.996 -26.33 -24.93 -2 4.127 -26.28 -25.639 -27.681 -24.674 11.799 13.67 14.852 16.039 15.248 13.021 12.616 13.486 14.719 12.742 11.77 12.507 11.794 12.834 13.543 14.125 13.486 12.563 11.841 10.778 10.055 9.951 10.528 9.278 15.325 15.999 15.189 14.542 17.386 15.115 14.325 12.968 12.217 12.611 11.322 11.471 12.577 10.651 10.651 10.386 9.386 8.33 10.356 10.335 9.813 8.944 10.429 10.028 9.467 10.02 11.246 10.942 11.804 8.328 -0.209 -2.295 -1.391 -1.71 -1.534 0.045 1.439 2.362 2.356 1.764 0.901 3.245 1.246 3.101 3.993 5.209 5.824 4.474 3.312 3.83 2.721 2.594 3.49 1.566 5.566 6.763 8.003 8.07 6.853 8.913 10.13 10.042 11.023 8.866 8.719 8.737 8.599 7.429 7.453 6.252 5.156 6.419 8.981 8.994 7.673 7.02 7.237 5.994 6.267 7.033 5.073 3.724 4.861 5.649 -128- (123) VAL315 CA -23.386 7.646 5.773 VAL315 C -22.647 7.666 4.435 VAL315 〇23.025 6.975 3.479 VAL315 C 巳- 23.634 6.207 6.213 VAL315 CG1 -22.325 5.437 6,347 VAL315 CG2 -24.404 6.163 7.528 GLY316 N -21.6 8.467 4.374 GLY316 CA -20.789 8.539 3.152 GLY316 C -19.797 7.382 3.096 GLY316 〇-18.903 7.28 3.946 LEU317 N -19.978 6.508 2.121 LEU317 CA -19.102 5.343 1.978 LEU317 C -17.841 5.722 1.218 LEU317 〇-17.758 5.485 0.009 LEU317 C 巳 -19.835 4.256 1.199 LEU317 CG -20.312 3.094 2.064 LEU317 -19.129 2.374 2.697 LEU317 CD2 -21.328 3.519 3.121 SER318 N -16.794 6.056 1.951 SER318 CA -15.563 6.559 1.34 SER318 C -14.789 5.483 0.588 SER318 〇-14.286 5.777 -0.503 SER318 CB -14.689 7.158 2.434 SER318 〇G -13.375 N32 1.915 1.915 -14.954 4.222 0.954 ASN319 CA -14.267 3.196 0.162 ASN319 C -15.089 2.774 -1.058 ASN319 〇-14.498 2.343 -2.052 ASN319 CB -13.899 1.982 1.004 ASN319 CG -12.531 1.507 0.516 ASN319 〇D1 -11.628 2.333 0.321 ASN319 0.2ND2 -12.378 N -16.362 3: 139 -1.091 ALA320 CA -17.181 2.889 -2.283 ALA320 C -17.001 4.055 -3.248 ALA320 〇-16.897 3.856 -4.464 ALA320 CB -18.642 2.78 -1.875 GLY321 N -16.68 5.197 -2.666 GLY321 CA -16.233 6.36 -3.426 GLY321 C -14.942 6.045 -4.17 GLY321 〇-14.924 6.106 • 5.404 ASN322 N -13.958 5.508 -3.466 ASN322 CA -12.683 5.172 -4.113 ASN322 C -12.765 3.924 -5.006 ASN322 〇-11.954 3.769 -5.927 ASN322 CB -11.651 4.902 -3.035 ASN322 CG -11.54 6.013 -1.994 ASN322 〇 D1 -11.701 7.211 -2.278 ASN322 ND2 -11.095 5.595 -0.824 HIS323 N -13.785 3.103 -4.807 HIS323 CA -14.068 1.985 -5.716 HIS323 C -15.037 2.337 -6.846 HIS323 〇 15.541 1.435 -7.525 HIS323 CB -14.625 0.804 -4.939</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">-129- (124) HIS323 HIS323 HIS323 HIS323 HIS323 ASP324 ASP324 ASP324 ASP324 ASP324 ASP324 ASP324 ASP324 PR0325 PR0325 PR0325 PR0325 PR0325 PR0325 PR0325 ASP326 ASP326 ASP326 ASP326 ASP326 ASP326 ASP326 ASP326 GLY327 GLY327 GLY327 GLY327 PHE328 PHE328 PHE328 PHE328 PHE328 PHE328 PHE328 PHE328 PHE328 PHE328 PHE328 GLU329 GLU329 GLU329 GLU329 GLU329 GLU329 GLU329 GLU329 GLU329 ASN330 ASN330</span>-129- (124) HIS323 HIS323 HIS323 HIS323 HIS323 ASP324 ASP324 ASP324 ASP324 ASP324 ASP324 ASP324 ASP324 PR0325 PR0325 PR0325 PR0325 PR0325 PR0325 PR0325 PR0325 ASP326 ASP326 ASP326 ASP326 ASP326 ASP326 ASP326 ASP326 GLY327 PHE328 PHE328 PHE328 PHE328 PHE328 PHE328 PHE328 PHE328 PHE328 PHE328 PHE328 PHE328 PHE328 PHE328 PHE328 PHE328 PHE328 PHE328 GLU329 GLU329 GLU329 GLU329 GLU329 GLU329 GLU329 GLU329 ASN330 ASN330</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">12 12 ϋ D D E E N O c N</span>12 12 ϋ D D E E N O c N</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">3A</span>3A</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1 2 1 2 D D A bgd a bgdd -7 r 汐 r-/rw_/r 夕 o y r-/o 3 y D</span>1 2 1 2 D D A bgd a bgdd -7 r t r- / rw_ / r evening o y r- / o 3 y D</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A</span>A</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A 12 12 B G D d:e:e:z</span>A 12 12 B G D d: e: e: z</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A</span>A</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">B G DE1E</span>B G DE1E</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A -13.581 0.008 -4.19  -13.802 -0.807 -3.144  -12.233 -0.04 -4.46  -12.634 -1.351 -2.748  -11.664 -0.875 -3.563  -15.353 3.608 -7.007  -16.209 4.041 •8.109  -15.409 4.076 -9.411  -14.628 5.012 -9.642  -16.72 5.431 -7.737  -17.711 6.002 -8.74  -18.738 6.476 -8.275  -17.28 6.257 -9.859  -15.831 3.237 -10.349  -15.082 2.989 -11.595  -15.201 4.099 -12.648  -14.504 4.065 -13.667  -15.653 1.713 -12.134  -16.9 1.346 -11.345  •17.01 2.374 -10.232  •16.008 5.11 -12.361  -16.206 6.248 -13.259  -15.146 7.312 -12.983  -14.924 8.216 -13.797  -17.597 6.826 -12.994  -18.675 5.753 -13.155  -19.125 5.571 -14.277  -18.963 5.068 -12.179  -14.468 7.162 -11.857  -13.318 8.005 -11.542  -12.061 7.145 -11.594  -11.166 7.366 -12.418  -12.046 6.12 -10.76  -10.893 5.218 -10.705  -11.119 4.009 -11.602  -11.92 3.114 -11.3  -10.653 4.81 -9.257  -10.261 5.995 -8.376  -9.098 6.702 -8.651  -11.07 6.379 -7.314  -8.737 7.784 -7.858  -10.709 7.459 •6.519  -9.542 8.161 -6.791  -10.377 4.006 -12.696  •10.511 2.993 -13.752  -10.048 1.63 -13.253  -8.847 1.399 -13.092  -9.673 3.409 •14.962  -10.104 4.752 -15.557  -9.106 5.864 -15.215  -8.54 5.804 -14.132  -8.904 6.724 •16.059  -10.987 0.698 -13.249  -10.826 -0.597 -12.566 -130- (125)   ASN330 C -10.252 -0.375 -11.171  ASN330 〇 -9.065 -0.629 -10.929  ASN330 C巳 -9.925 -1.547 -13.355  ASN330 CG -9.943 -2.959 -12.75  ASN330 〇D1 -9.958 -3.151 -11.523  ASN330 ND2 -9.893 -3.939 -13.632  PR0331 N -11.157 -0.201 -10.224  PR0331 CA -10.787 0.129 -8.843  PR0331 C -10.287 -1.061 -8.012  PR0331 〇 -9.994 -0.904 •6.822  PR0331 C巳 -12.044 0.673 -8.25  PR0331 CG -13.21 0.356 -9.172  PR0331 CD -12.608 •0.26 -10.416  ASP332 N -10.198 -2.236 •8.615  ASP332 CA -9.742 -3.417 -7.889  ASP332 C -8.267 -3.667 •8.179  ASP332 〇 -7.609 -4.447 •7.478  ASP332 CB -10.557 -4.617 -8.358  ASP332 CG -12.048 -4.356 -8.173  ASP332 〇D1 -12.43 -3.961 -7.08  ASP332 〇D2 -12.784 -4.566 -9.127  THR333 N -7.744 -2.97 -9.173  THR333 CA -6.339 -3.153 -9.535  THR333 C -5.433 -2.224 -8.735  THR333 〇 -5.283 -1.042 -9.06  THR333 CB -6.189 -2.877 -11.026  THR333 〇G1 -7.072 -3.748 -11.718  THR333 CG2 -4.769 •3.147 -11.514  PHE334 N -4.84 -2.772 -7.688  PHE334 CA -3.868 -2.017 -6.89  PHE334 C -2.589 -1.762 -7.684  PHE334 〇 -1.817 -2.686 -7.979  PHE334 CB -3.543 -2.812 -5.63  PHE334 CG -2.485 -2.162 •4.744  PHE334 CD1 -2.784 -1 •4.047  PHE334 CD2 -1.221 -2.728 -4.638  PHE334 CE1 -1.82 -0.404 •3.246  PHE334 CE2 -0.256 -2.132 -3.837  PHE334 CZ -0.556 -0.969 -3.142  ASP335 N -2.407 -0.509 »8.064  ASP335 CA -1.206 -0.106 -8.794  ASP335 C -0.697 1.24 -8.283  ASP335 〇 -1.322 2.277 -8.525  ASP335 CB -1.55 •0.019 -10.277  ASP335 CG -0.276 0.2 -11.084  ASP335 〇D1 0.34 -0.792 -11.448  ASP335 〇D2 0.15 1.347 -11.159  ILE336 N 0.532 1.249 -7.794  ILE336 CA 1.118 2.426 -7.127  ILE336 C 1.596 3.552 -8.058  ILE336 〇 2.207 4.512 -7.579  ILE336 CB 2.303 1.948 •6.301  ILE336 CG1 3.437 1.48 -7.203  ILE336 CG2 1.873 0.817 -5.375</span>A -13.581 0.008 -4.19 -13.802 -0.807 -3.144 -12.233 -0.04 -4.46 -12.634 -1.351 -2.748 -11.664 -0.875 -3.563 -15.353 3.608 -7.007 -16.209 4.041 • 8.109 -15.409 4.076 -9.411 -14.628 5.012 -9.642 -16.72 5.431 -7.737 -17.711 6.002 -8.74 -18.738 6.476 -8.275 -17.28 6.257 -9.859 -15.831 3.237 -10.349 -15.082 2.989 -11.595 -15.201 4.099 -12.648 -14.504 4.065 -13.667 -15.653 1.713 -12.134 -16.9 1.346 -11.345 • 17.01 2.374 -10.232 • 16.008 5.11 -12.361 -16.206 6.248 -13.259 -15.146 7.312 -12.983 -14.924 8.216 -13.797 -17.597 6.826 -12.994 -18.675 5.753 -13.155 -19.125 5.571 -14.277 -18.963 5.068 -12.179 -14.468 7.162 -13.318 8.005 -11.542 -12.061 7.145 -11.594 -11.166 7.366 -12.418 -12.046 6.12 -10.76 -10.893 5.218 -10.705 -11.119 4.009 -11.602 -11.92 3.114 -11.3 -10.653 4.81 -9.257 -10.261 5.995 -8.376 -9.098 6.702 -8.651 -11.07 6.379 -7.314 -8.737 7.784 -7.858 -10.709 7.459 • 6.519 -9.542 8.161 -6.791 -10.377 4.006 -12.696 • 10.511 2.99 3 -13.752 -10.048 1.63 -13.253 -8.847 1.399 -13.092 -9.673 3.409 • 14.962 -10.104 4.752 -15.557 -9.106 5.864 -15.215 -8.54 5.804 -14.132 -8.904 6.724 • 16.059 -10.987 0.698 -13.249 -10.826 -0.597 -12.566- 130- (125) ASN330 C -10.252 -0.375 -11.171 ASN330 〇-9.065 -0.629 -10.929 ASN330 C 巳 -9.925 -1.547 -13.355 ASN330 CG -9.943 -2.959 -12.75 ASN330 〇D1 -9.958 -3.151 -11.523 ASN330 ND2- 9.893 -3.939 -13.632 PR0331 N -11.157 -0.201 -10.224 PR0331 CA -10.787 0.129 -8.843 PR0331 C -10.287 -1.061 -8.012 PR0331 〇-9.994 -0.904 • 6.822 PR0331 C 巳 -12.044 0.673 -8.25 PR0331 CG -13.21 0.356- 9.172 PR0331 CD -12.608 • 0.26 -10.416 ASP332 N -10.198 -2.236 • 8.615 ASP332 CA -9.742 -3.417 -7.889 ASP332 C -8.267 -3.667 • 8.179 ASP332 〇-7.609 -4.447 • 7.478 ASP332 CB -10.557 -4.617 -8.358 ASP332 CG -12.048 -4.356 -8.173 ASP332 〇D1 -12.43 -3.961 -7.08 ASP332 〇D2 -12.784 -4.566 -9.127 THR333 N -7.744 -2.97 -9.173 THR333 CA -6.339 -3.153 -9.535 THR3 33 C -5.433 -2.224 -8.735 THR333 〇-5.283 -1.042 -9.06 THR333 CB -6.189 -2.877 -11.026 THR333 〇G1 -7.072 -3.748 -11.718 THR333 CG2 -4.769 • 3.147 -11.514 PHE334 N -4.84 -2.772 -7.688 PHE334 CA -3.868 -2.017 -6.89 PHE334 C -2.589 -1.762 -7.684 PHE334 〇-1.817 -2.686 -7.979 PHE334 CB -3.543 -2.812 -5.63 PHE334 CG -2.485 -2.162 • 4.744 PHE334 CD1 -2.784 -1 • 4.047 PHE334 CD2- 1.221 -2.728 -4.638 PHE334 CE1 -1.82 -0.404 • 3.246 PHE334 CE2 -0.256 -2.132 -3.837 PHE334 CZ -0.556 -0.969 -3.142 ASP335 N -2.407 -0.509 »8.064 ASP335 CA -1.206 -0.106 -8.794 ASP335 C -0.697 1.24 -8.283 ASP335 〇-1.322 2.277 -8.525 ASP335 CB -1.55 • 0.019 -10.277 ASP335 CG -0.276 0.2 -11.084 ASP335 〇D1 0.34 -0.792 -11.448 ASP335 〇D2 0.15 1.347 -11.159 ILE336 N 0.532 1.249 -7.794 ILE336 CA 1.118 2.426- 7.127 ILE336 C 1.596 3.552 -8.058 ILE336 〇2.207 4.512 -7.579 ILE336 CB 2.303 1.948 • 6.301 ILE336 CG1 3.437 1.48 -7.203 ILE336 CG2 1.873 0.817 -5.375</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">131 - (126)</span>131-(126)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(126)   ILE336 CD1  GLU337 N  GLU337 CA  GLU337 C  GLU337 〇  GLU337 C巳  GLU337 CG  GLU337 CD  GLU337 OE1  GLU337 〇E2  ARG338 N  ARG338 CA  ARG338 C  ARG338 〇  ARG338 CB  ARG338 CG  ARG338 CD  ARG338 NE  ARG338 CZ  ARG338 NH1  ARG338 NH2  GLY339 N  GLY339 CA  GLY339 C  GLY339 〇  ALA340 N  ALA340 CA  ALA340 C  ALA340 〇  ALA340 CB  ARG341 N  ARG341 CA  ARG341 C  ARG341 〇  ARG341 CB  ARG341 CG  ARG341 CD  ARG341 NE  ARG341 CZ  ARG341 NH1  ARG341 NH2  HIS342 N  HIS342 CA  HIS342 C  HIS342 〇  HIS342 C巳  HIS342 CG  HIS342 ND1  HIS342 CD2  HIS342 CE1  HIS342 NE2  HIS343 N  HIS343 CA  HIS343 C 1.131 3.407 4.496 5.236 6.246 3.936 3.412 2.871 3.167 2.089 4.719 5.376 6.636 6.625 4.393 4.977 3.961 2.729 I. 847 2.056 0.757 7.735 8.98 8.895 9.045 8.767 8.646 9.982 10.145 7.907 10.917 12.25 12.179 11.307 13.131 13.264 14.135 14.303 15.463 16.534 15.551 13.009 13.12 11.888 11.621 13.367 14.641 15.877 14.758 16.758 16.064 II. 15-10.075 10.661 4.676 1.41 1.712 0.434 0.487 2.393 3.788 4.442 3.934 5.372 •0.697 -1.982 -2.095 -1.809 -3.085 -4.484 -5.532 -5.375 -6.357 -7.549 -6.143 -2.423 -2.685 -4.038 -5.086 -3.994 •5.202 -5.871 -6.419 -4.817 -5.844 -6.395 -7.904 -8.571 -6.045 -4.535 -4.175 -2.718 -2.142 -2.898 -0.813 -8.378 -9.801 -10.342 -11.547 •10.644 -10.32 •10.757 •9.536 -10.259 -9.504 -9.49 -10.02 -10.572 -6.396 -9.361 -10.291 -10.681 -11.393 -11.533 -11.213 -12.481 -13.552 -12.348 -10.229 -10.464 -9.615 -8.412 -10.082 -10.234 -9.809 -10.591 -10.77 -10.207 -11.509 -10.271 -9.55 -8.852 -9.489 -7.534 -6.691 -6.335 -5.237 -5.414 -7.27 -7.043 -6.87 -7.436 -8.235 -8.387 -9.583 -9.691 -10.016 -10.271 -10.092 •5.954 -5.603 -4.88 -4.961 -6.855 -7.606 -7.303 -8.731 •8.195 -9.078 -4.184 -3.346 •2.053</span>(126) ILE336 CD1 GLU337 N GLU337 CA GLU337 C GLU337 〇GLU337 C 巳 GLU337 CG GLU337 CD GLU337 OE1 GLU337 〇E2 ARG338 N ARG338 CA ARG338 C ARG338 〇ARG338 CB ARG338 CG ARG338 CD ARG338 NE ARG338 CZ ARG338 NH2 NH1 CA GLY339 C GLY339 〇ALA340 N ALA340 CA ALA340 C ALA340 〇ALA340 CB ARG341 N ARG341 CA ARG341 C ARG341 〇ARG341 CB ARG341 CG ARG341 CD ARG341 NE ARG341 CZ ARG341 NH1 ARG341 NH2 HIS342 N HIS342 CA HIS342 C HHI342 C HIS342 ND1 HIS342 CD2 HIS342 CE1 HIS342 NE2 HIS343 N HIS343 CA HIS343 C 1.131 3.407 4.496 5.236 6.246 3.936 3.412 2.871 3.167 2.089 4.719 5.376 6.636 6.625 4.393 4.977 3.961 2.729 I. 847 2.056 0.757 7.735 8.98 8.895 9.045 8.767 8.646 9.982 10.145 7.179 10.907 9.307 9.307 13.131 13.264 14.135 14.303 15.463 16.534 15.551 13.009 13.12 11.888 11.621 13.367 14.641 15.877 14.758 16.758 16.064 II. 15-10.075 10.661 4.676 1.41 1.712 0.434 0.487 2.393 3.788 4. 442 3.934 5.372 • 0.697 -1.982 -2.095 -1.809 -3.085 -4.484 -5.532 -5.375 -6.357 -7.549 -6.143 -2.423 -2.685 -4.038 -5.086 -3.994 • 5.202 -5.871 -6.419 -4.817 -5.844 -6.395 -7.904- 8.571 -6.045 -4.535 -4.175 -2.718 -2.142 -2.898 -0.813 -8.378 -9.801 -10.342 -11.547 • 10.644 -10.32 • 10.757 • 9.536 -10.259 -9.504 -9.49 -10.02 -10.572 -6.396 -9.361 -10.291 --10.681- 11.393 -11.533 -11.213 -12.481 -13.552 -12.348 -10.229 -10.464 -9.615 -8.412 -10.082 -10.234 -9.809 -10.591 -10.77 -10.207 -11.509 -10.271 -9.55 -8.852 -9.489 -7.534 -6.691 -6.335 -5.237- 5.414 -7.27 -7.043 -6.87 -7.436 -8.235 -8.387 -9.583 -9.691 -10.016 -10.271 -10.092 • 5.954 -5.603 -4.88 -4.961 -6.855 -7.606 -7.303 -8.731 • 8.195 -9.078 -4.184 -3.346 • 2.053</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">132- (127)</span>132- (127)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(127)   HIS343 〇  HIS343 C巳  HIS343 CG  HIS343 ND1  HIS343 CD2  HIS343 CE1  HIS343 NE2  VAL344 N  VAL344 CA  VAL344 C  VAL344 〇  VAL344 C巳  VAL344 CG1  VAL344 CG2  ALA345 N  ALA345 CA  ALA345 C  ALA345 〇  ALA345 CB  PHE346 N  PHE346 CA  PHE346 C  PHE346 〇  PHE346 CB  PHE346 CG  PHE346 CD1  PHE346 CD2  PHE346 CE1  PHE346 CE2  PHE346 CZ  GLY347 N  GLY347 CA  GLY347 C  GLY347 〇  PHE348 N  PHE348 CA  PHE348 C  PHE348 〇  PHE348 C巳  PHE348 CG  PHE348 CD1  PHE348 CD2  PHE348 CE1  PHE348 CE2  PHE348 CZ  GLY349 N  GLY349 CA  GLY349 C  GLY349 〇  VAL350 N  VAL350 CA  VAL350 C  VAL350 〇  VAL350 CB -9.984 -8.988 -7.691 -7.374 -6.597 -6.125 •5.643 -11.634 -12.278 -11.732 -12.271 -13.787 -14.412 -14.141 -10.581 •9.947 -9.419 -9.242 -8.757 -9.169 -8.763 -9.885 -9.652 •7.571 -6.223 -5.295 -5.921 -4.061 -4.687 -3.756 -11.068 -12.177 -12.007 •10.882 -13.123 -13.084 -13.98 •14.185 -13.497 -12.375 -12.654 -11.075 -11.633 -10.054 -10.332 -14.438 -15.269 -14.484 -13.286 -15.121 -14.426 •13.865 -12.964 -15.384 11.572 8.965 9.253 10.313 8.421 10.166 8.993 10.052 10.521 9.82 9.998 10.343 11.457 8.977 9.178 8.411 9.24 8.703 7.686 10.518 11.424 12.363 13.29 12.253 11.583 11.513 11.048 10.916 10.451 10.388 12.169 13.091 14.367 14.764 14.988 16.264 17.307 17.307 16.085 15.613 14.749 16.06 14.322 15.633 14.763 18.227 19.339 20.194 20.433 20.525 21.29 20.408 20.854 22.334 -1.455 -3.085 -2.333 -1.562 •2.319 -1.079 -1.549 -1.563 -0.331 0.915 2.015 -0.45 -1.282 -1.019 0.768 1.849 3.02 4.12 1.237 2.787 3.867 4.291 5.083 3.409 3.635 2.605 4.881 2.825 5.101 4.073 3.731 3.979 3.158 2.825 2.822 2.097 2.752 3.976 0.64 -0.285 -1.333 -0.081 -2.172 -0.918 -1.963 1.918 2.376 3.353 3.165 4.458 5.493 6.613 7.327 6.062</span>(127) HIS343 〇HIS343 C 巳 HIS343 CG HIS343 ND1 HIS343 CD2 HIS343 CE1 HIS343 NE2 VAL344 N VAL344 CA VAL344 C VAL344 〇VAL344 C 巳 VAL344 CG1 VAL344 CG2 ALA345 N ALA345 CA ALA345 C ALA345 〇ALA345 CB PHEHE346 N 〇PHE346 CB PHE346 CG PHE346 CD1 PHE346 CD2 PHE346 CE1 PHE346 CE2 PHE346 CZ GLY347 N GLY347 CA GLY347 C GLY347 〇PHE348 N PHE348 CA PHE348 C PHE348 〇PHE348 C 巳 PHE348 CE1 PHE348 CD1 PHE348 CD2 PHE348 CE1 P1 GLY349 C GLY349 〇VAL350 N VAL350 CA VAL350 C VAL350 〇VAL350 CB -9.984 -8.988 -7.691 -7.374 -6.597 -6.125 • 5.643 -11.634 -12.278 -11.732 -12.271 -13.787 -14.412 -14.141 -10.581 • 9.947 -9.419 -9.242 -8.757 -9.169 -8.763 -9.885 -9.652 • 7.571 -6.223 -5.295 -5.921 -4.061 -4.687 -3.756 -11.068 -12.177 -12.007 • 10.882 -13.123 -13.084 -13.98 • 14.185 -13.497 -12.375 -12.654 -11.075 -11.633 -10.054 -10.332 -14.438 -15.269 -14.484 -13.286 -15.12 1 -14.426 • 13.865 -12.964 -15.384 11.572 8.965 9.253 10.313 8.421 10.166 8.993 10.052 10.521 9.82 9.998 10.343 11.457 8.977 9.178 8.411 9.24 8.703 7.686 10.518 11.424 12.363 13.29 12.253 11.583 11.513 11.048 11.916 10.916 10.451 10.388 12.169 13.091 14.367 14.764 14.988 16.264 17.307 17.307 16.307 16.085 16.06 14.322 15.633 14.763 18.227 19.339 20.194 20.433 20.525 21.29 20.408 20.854 22.334 -1.455 -3.085 -2.333 -1.562 • 2.319 -1.079 -1.549 -1.563 -0.331 0.915 2.015 -0.45 -1.282 -1.019 0.768 1.849 3.02 4.12 1.237 2.787 3.867 4.291 5.083 3.409 3.635 2.605 4.881 2.825 5.101 4.073 3.731 3.979 3.158 2.825 2.822 2.097 2.752 3.976 0.64 -0.285 -1.333 -0.081 -2.172 -0.918 -1.963 1.918 2.376 3.353 3.165 4.458 5.493 6.613 7.327 6.062</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">-133- (128)</span>-133- (128)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">VAL350 VAL350 HIS351 HIS351 HIS351 HIS351 HIS351 HIS351 ,HIS351 HIS351 HIS351 HIS351 GLN352 GLN352 GLN352 GLN352 GLN352 GLN352 GLN352 GLN352 GLN352 CYS353 CYS353 CYS353 CYS353 CYS353 CYS353 LEU354 LEU354 LEU354 LEU354 LEU354 LEU354 LEU354 LEU354 GLY355 GLY355 GLY355 GLY355 GLN356 GLN356 GLN356 GLN356 GLN356 GLN356 GLN356 GLN356 GLN356 ASN357 ASN357 ASN357 ASN357 ASN357 ASN357 CG1 -15.675 23.433 5.047  CG2 -16.682 21.709 6.561  N -14.217 19.133 6.631  CA -13.875 18.287 7.784  C -12.75 17.284 7.532  〇 •12.711 16.259 8.223  C巳 -15.113 17.514 8.23  CG -16.205 18.349 8.87  ND1 -16.137 18.987 10.054  CD2 -17.46 18.588 8.36  CE1 -17.304 19.619 10.29  NE2 -18.122 19.372 9.242  N -11.876 17.53 6.568  CA -10.852 16.518 6.26  C -9.793 16.385 7.357  〇 -9.716 17.193 8.291  C巳 -10.178 16.785 4.923  CG -9.244 17.98 4.902  CD -8.308 17.803 3.712  〇E1 -7.316 18.528 3.568  NE2 -8.572 16.766 2.934  N -9.049 15.296 7.271  CA -8.044 14.964 8.287  C -6.883 15.962 8.319  〇 -6.101 16.072 7.366  CB -7.524 13.567 7.961  SG -6.412 12.816 9.17  N •6.724 16.61 9.464  CA -5.607 17.549 9.666  C -4.308 16.852 10.059  〇 -3.224 17.358 9.747  C巳 -5.967 18.561 10.748  CG -6.805 Ί9.7 10.188  CD1 -7.148 20.701 11.284  CD2 -6.054 20.396 9.057  N -4.414 15.6 10.478  CA -3.223 14.791 10.772  C -2.835 13.936 9.566  〇 -2.119 12.936 9.702  N -3.078 14.499 8.393  CA -2.896 13.81 7.119  C -1.414 13.677 6.799  〇 -0.939 12.562 6.544  CB •3.598 14.696 6.094  CG -3.657 14.117 4.691  CD -4.524 15.024 3.818  OE1 -4.609 14.834 2.599  NE2 -5.231 15.939 4.463  N -0.67 14.7 7.191  CA 0.781 14.7 7.005  C 1.476 13.761 7.989  〇 2.328 12.977 7.554  CB 1.258 16.137 7.203  CG 2.78 16.244 7.261</span>VAL350 VAL350 HIS351 HIS351 HIS351 HIS351 HIS351 HIS351, HIS351 HIS351 HIS351 HIS351 GLN352 GLN352 GLN352 GLN352 GLN352 GLN352 GLN352 GLN352 GLN352 CYS353 CYS353 CYS353 CYS353 CYS353 CYS353 LEU354 LEU354 LEU354 LEU354 LEU354 LEU354 LEU354 LEU354 GLY355 GLY355 GLY355 GLY355 GLN356 GLN356 GLN356 GLN356 GLN356 GLN356 GLN356 GLN356 GLN356 ASN357 ASN357 ASN357 ASN357 ASN357 ASN357 CG1 -15.675 23.433 5.047 CG2 -16.682 21.709 6.561 N -14.217 19.133 6.631 CA -13.875 18.287 7.784 C -12.75 17.284 7.532 〇12.711 16.259 8.223 C 巳 -15.113 17.514 8.23 CG -16.205 18.349 8.137 18.ND1-16 10.054 CD2 -17.46 18.588 8.36 CE1 -17.304 19.619 10.29 NE2 -18.122 19.372 9.242 N -11.876 17.53 6.568 CA -10.852 16.518 6.26 C -9.793 16.385 7.357 〇-9.716 17.193 8.291 C 巳 -10.178 16.785 4.923 CG -9.244 17.98 4.902 CD -8.308 17.803 3.712 〇E1 -7.316 18.528 3.568 NE2 -8.572 16.766 2.934 N -9.049 15.296 7.271 CA -8.044 14.964 8.287 C -6.883 15.962 8.319 〇-6.101 16.072 7.366 CB -7.524 13.567 7.961 SG -6.412 12.816 9.17 N • 6.724 16.61 9.464 CA -5.607 17.549 9.666 C -4.308 16.852 10.059 〇-3.224 17.358 9.747 C 巳 -5.967 18.561 10.748 CG -6.805 Ί9.7 10.188 CD1 -7.148 20.701 11.284 CD2- 6.054 20.396 9.057 N -4.414 15.6 10.478 CA -3.223 14.791 10.772 C -2.835 13.936 9.566 〇-2.119 12.936 9.702 N -3.078 14.499 8.393 CA -2.896 13.81 7.119 C -1.414 13.677 6.799 〇-0.939 12.562 6.544 CB • 3.598 14.696 6.094 CG- 3.657 14.117 4.691 CD -4.524 15.024 3.818 OE1 -4.609 14.834 2.599 NE2 -5.231 15.939 4.463 N -0.67 14.7 7.191 CA 0.781 14.7 7.005 C 1.476 13.761 7.989 〇2.328 12.977 7.554 CB 1.258 16.137 7.203 CG 2.78 16.244 7.261</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">-134- (129)</span>-134- (129)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(129)   ASN357 〇D1  ASN357 ND2  LEU358 N  LEU358 CA  LEU358 C  LEU358 〇  LEU358 CB  LEU358 CG  LEU358 CD1  LEU358 CD2  ALA359 N  ALA359 CA  ALA359 C  ALA359 〇  ALA359 CB  ARG360 N  ARG360 CA  ARG360 C  ARG360 〇  ARG360 CB  ARG360 CG  ARG360 CD  ARG360 NE  ARG360 CZ  ARG360 NH1  ARG360 NH2  LEU361 N  LEU361 CA  LEU361 C  LEU361 〇  LEU361 C巳  LEU361 CG  LEU361 CD1  LEU361 CD2  GLU362 N  GLU362 CA  GLU362 C  GLU362 〇  GLU362 CB  GLU362 CG  GLU362 CD  GLU362 〇E1  GLU362 〇E2  LEU363 N  LEU363 CA  LEU363 C  LEU363 〇  LEU363 C巳  LEU363 CG  LEU363 CD1  LEU363 CD2  GLN364 N  GLN364 CA  GLN364 C 3.324 3.444 0.896 1.515 1.271 2.234 0.908 1.612 3.089 0.931 0.102 -0.235 0.571 1.204 -1.723 0.794 1.585 3.078 3.747 1.354 -0.081 -0.325 -0.144 0.509 0.602 1.045 3.518 4.921 5.238 6.174 5.159 6.612 7.537 6.778 4.306 4.499 4.413 5.31 3.418 3.519 2.341 1.268 2.517 3.541 3.389 4.61 5.174 2.184 0.977 0.35 -0.056 5.151 6.296 7.559 16.808 15.745 13.592 12.727 11.264 10.487 13.034 12.261 12.639 12.493 10.986 9.616 9.151 8.089 9.558 10.045 9.681 9.603 8.677 10.721 10.681 11.752 13.097 14.076 15.283 13.853 10.379 10.356 9.078 8.36 11.566 11.69 11.811 12.888 8.658 7.431 6.2 5.352 7.347 8.493 8.447 8.901 7.891 6.253 5.125 4.946 3.844 5.364 4.517 4.995 4.54 6.047 5.955 5.544 8.217 6.233 9.166 10.168 9.826 9.791 11.53 12.639 12.712 13.982 9.272 8.887 7.679 7.756 8.566 6.728 5.546 5.853 5.374 4.459 3.954 2.898 3.463 2.833 3.393 1.631 6.83 7.239 8.005 7.628 8.133 8.572 7.365 9.498 8.846 9.622 8.73 8.793 10.694 11.693 12.662 12.284 13.736 7.736 6.814 5.927 5.889 5.914 6.298 7.601 5.179 5.432 4.529 5.276</span>(129) ASN357 〇D1 ASN357 ND2 LEU358 N LEU358 CA LEU358 C LEU358 〇LEU358 CB LEU358 CG LEU358 CD1 LEU358 CD2 ALA359 N ALA359 CA ALA359 C ALA359 〇ALA359 CB ARG360 N ARG360 CA ARG360 C ARG360 RG ARG360 CB ARG360 CZ ARG360 NH1 ARG360 NH2 LEU361 N LEU361 CA LEU361 C LEU361 〇LEU361 C 巳 LEU361 CG LEU361 CD1 LEU361 CD2 GLU362 N GLU362 CA GLU362 C GLU362 〇GLU362 CB GLU362 CG GLU362 CD GLU362 〇E1 LEU363 363 〇LEU363 C 巳 LEU363 CG LEU363 CD1 LEU363 CD2 GLN364 N GLN364 CA GLN364 C 3.324 3.444 0.896 1.515 1.271 2.234 0.908 1.612 3.089 0.931 0.102 -0.235 0.571 1.204 -1.723 0.794 1.585 3.078 3.747 1.354 -0.081 -0.325 -0.144 0.509 0.602 1.921 3.518 6.174 5.159 6.612 7.537 6.778 4.306 4.499 4.413 5.31 3.418 3.519 2.341 1.268 2.517 3.541 3.389 4.61 5.174 2.184 0.977 0.35 -0.056 5.151 6.296 7.559 16.808 15.745 13.592 12.727 11.264 10.487 13.034 12.261 12 .639 12.493 10.986 9.616 9.151 8.089 9.558 10.045 9.681 9.603 8.677 10.721 10.681 11.752 13.097 14.076 15.283 13.853 10.379 10.356 9.078 8.36 11.566 11.69 11.811 12.888 8.658 7.431 6.2 5.352 7.347 8.493 8.493 8.447 8.901 7.891 6.253 5.125 4.946 3.844 5.364 4.517 4.995 4.54 6.047 5.955 5.544 8.217 6.233 9.233 10.168 9.826 9.791 11.53 12.639 12.712 13.982 9.272 8.887 7.679 7.756 8.566 6.728 5.546 5.853 5.374 4.459 3.954 2.898 3.463 2.833 3.833 1.393 6.631 7.83 7.239 8.005 7.628 8.133 8.572 7.365 9.498 8.846 9.622 8.73 8.793 10.694 11.693 12.662 12.284 13.736 7.736 6.814 5.927 5.889 5.914 6.298 7.601 5.179 5.179 5.276</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">135- (130) 200418849 2753 GLN364 〇  2754 GLN364 C巳  2755 GLN364 CG  2756 GLN364 CD  2757 GLN364 OE1  2758 GLN364 NE2  2759 ILE365 N  2760 ILE365 CA  2761 ILE365 C  2762 ILE365 〇  2763 ILE365 C巳  2764 ILE365 CG1  2765 ILE365 CG2  2766 ILE365 CD1  2767 VAL366 N  2768 VAL366 CA  2769 VAL366 C  2770 VAL366 〇  2771 VAL366 CB  2772 VAL366 CG1  2773 VAL366 CG2  2774 PHE367 N  2775 PHE367 CA  2776 PHE367 C  2777 PHE367 〇  2778 PHE367 C巳  2779 PHE367 CG  2780 PHE367 CD1  2781 PHE367 CD2  2782 PHE367 CE1  2783 PHE367 CE2  2784 PHE367 CZ  2785 ASP368 N  2786 ASP368 CA  2787 ASP368 C  2788 ASP368 〇  2789 ASP368 C巳  2790 ASP368 CG  2791 ASP368 〇D1  2792 ASP368 〇D2  2793 THR369 N  2794 THR369 CA  2795 THR369 C  2796 THR369 〇  2797 THR369 C巳  2798 THR369 〇G1  2799 THR369 CG2  2800 LEU370 N  2801 LEU370 CA  2802 LEU370 C  2803 LEU370 〇  2804 LEU370 CB  2805 LEU370 CG  2806 LEU370 CD1 8.219 4.588 4.843  6.505 7.308 3.86  7.624 7.232 2.83  7.846 8.592 2.181  7,741 9.637 2.835  8.108 8.565 0.886  7.707 6.019 6.503  8.879 5.644 7.298  8.835 4.171 7.691  9.772 3.438 7.339  8.94 6.511 8.554  9.202 7.973 8.208  10.012 5.996 9.506  10.539 8.151 7.497  7.667 3.695 8.099  7.555 2.301 8.53  7.703 1.335 7.361  8.611 0.497 7.417  6.21 2.076 9.217  6.011 0.606 9.565  6.085 2.923 10.477  7.094 1.641 6.225  7.145 0.701 5.097  8.524 0.663 4.453  9.066 -0.434 4.254  6.125 1.099 4.034  4.662 1.012 4.458  3.726 1.83 3.841  4.258 0.112 5.435  2.391 1.767 4.216  2.924 0.052 5.813  1.99 0-88 5.206  9.187 1.808 4.423  10.522 1.869 3.83  11.52 1.102 4.686  12.115 0.138 4.185  10.964 3.326 3.707  10.101 4.09 2.701  10.208 5.31 2.678  9.508 3.443 1.847  11.438 1.285 5.995  12.381 0.606 6.892  12.07 -0.88 7.076  13.004 -1.658 7.287  12.376 1.294 8.252  11.058 1.242 8.778  12.797 2.756 8.149  10.848 -1.302 6.793  10.523 -2.729 6.862  11.145 -3.486 5.703  12.038 -4.319 5.916  9.012 -2.919 6.78  8.302 -2.463 8.044  6.792 -2.589 7.882 136- (131)   LEU370 CD2 8.79 -3.256 9.248  PHE371 N 10.872 -3.006 4.502  PHE371 CA 11.266 -3.75 3.303  PHE371 C 12.728 -3.529 2.918  PHE371 〇 13.332 -4.398 2.278  PHE371 CB 10.333 -3.34 2.169  PHE371 CG 8.861 -3.634 2.463  PHE371 CD1 7.935 -2.599 2.503  PHE371 CD2 8.447 -4.94 2.692  PHE371 CE1 6.601 -2.867 2.784  PHE371 CE2 7.112 -5.209 2.971  PHE371 CZ 6.19 -4.172 3.019  ARG372 N 13.335 -2.472 3.436  ARG372 CA 14.773 -2.281 3.231  ARG372 C 15.606 -2.901 4.353  ARG372 〇 16.834 -2.982 4.229  ARG372 CB 15.084 -0.795 3.116  ARG372 CG 14.397 -0.176 1.904  ARG372 CD 14.777 1.291 1.76  ARG372 NE 14.497 2.015 3.008  ARG372 CZ 14.919 3.257 3.251  ARG372 NH1 14.646 3.835 4.423  ARG372 NH2 15.631 3.911 2.331  ARG373 N 14.958 -3.347 5.418  ARG373 CA 15.671 -4.087 6.457  ARG373 C 15.659 -5.559 6.09  ARG373 〇 16.694 -6.238 6.097  ARG373 CB 14.937 -3.926 7.783  ARG373 CG 15.657 -4.637 8.922  ARG373 CD 16.912 -3.879 9.335  ARG373 NE 16.548 -2.554 9.862  ARG373 CZ 16.405 -2.304 11.165  ARG373 NH1 16.663 -3.261 12.059  ARG373 NH2 16.046 -1.087 11.576  VAL374 N 14.474 -6.032 5.749  VAL374 CA 14.314 -7.425 5.338  VAL374 C 13.644 -7.499 3.971  VAL374 〇 12.43 -7.307 3.841  VAL374 CB 13.473 -8.164 6.376  VAL374 CG1 13.297 -9.625 5.984  VAL374 CG2 14.086 -8.075 7.77  PR0375 N 14.432 •7.873 2.976  PR0375 CA 13.929 -8.036 1.606  PR0375 C 13.088 •9.304 1.369  PR0375 〇 12.539 -9.472 0.275  PR0375 CB 15.165 -8.072 0.76  PR0375 CG 16.384 -8.221 1.658  PR0375 CD 15.865 -8.159 3.084  GLY376 N 12.945 -10.158 2.371  GLY376 CA 12.162 -11.386 2.21  GLY376 C 11.071 -11.52 3.271  GLY376 〇 11.012 -12.523 3.992  ILE377 N 10.225 -10.508 3.367  ILE377 CA 9.092 -10.568 4.299</span>135- (130) 200418849 2753 GLN364 〇2754 GLN364 C 巳 2755 GLN364 CG 2756 GLN364 CD 2757 GLN364 OE1 2758 GLN364 NE2 2759 ILE365 N 2760 ILE365 CA 2761 ILE365 C 2762 ILE365 〇2763 ILE365 C 巳 2764 ILE 365365 CG1 ILE1 2767 VAL366 N 2768 VAL366 CA 2769 VAL366 C 2770 VAL366 〇2771 VAL366 CB 2772 VAL366 CG1 2773 VAL366 CG2 2774 PHE367 N 2775 PHE367 CA 2776 PHE367 C 2777 PHE367 〇2778 PHE367 C 巳 2779 PHE367 CG 2780 PHE367 CD1 2781 2781 PHE367 CE2 2784 PHE367 CZ 2785 ASP368 N 2786 ASP368 CA 2787 ASP368 C 2788 ASP368 〇2789 ASP368 C 巳 2790 ASP368 CG 2791 ASP368 〇D1 2792 ASP368 〇D2 2793 THR369 N 2794 THR369 CA 2795 THR369 C 2796 THR369 〇2797 THR369 C 巳 2798 T 〇G1 2799 THR369 CG2 2800 LEU370 N 2801 LEU370 CA 2802 LEU370 C 2803 LEU370 〇 2804 LEU370 CB 2805 LEU370 CG 2806 LEU370 CD1 8.219 4.588 4.843 6.505 7.308 3.86 7.624 7.232 2.83 7.846 8.592 2.181 7,741 9.637 2.8 35 8.108 8.565 0.886 7.707 6.019 6.503 8.879 5.644 7.298 8.835 4.171 7.691 9.772 3.438 7.339 8.94 6.511 8.554 9.202 7.973 8.208 10.012 5.996 9.506 10.539 8.151 7.497 7.667 3.695 8.099 7.555 2.301 8.53 7.703 1.335 7.361 8.611 0.497 7.417 6.21 2.076 9.217 6.011 0.606 9.565 6.085 2.923 10.477 1.641 6.225 7.145 0.701 5.097 8.524 0.663 4.453 9.066 -0.434 4.254 6.125 1.099 4.034 4.662 1.012 4.458 3.726 1.83 3.841 4.258 0.112 5.435 2.391 1.767 4.216 2.924 0.052 5.813 1.99 0-88 5.206 9.187 1.808 4.423 10.522 1.869 3.83 11.52 1.102 4.686 12.115 0.138 4.185 10.964 3.326 3.326 3.707 10.101 4.09 2.701 10.208 5.31 2.678 9.508 3.443 1.847 11.438 1.285 5.995 12.381 0.606 6.892 12.07 -0.88 7.076 13.004 -1.658 7.287 12.376 1.294 8.252 11.058 1.242 8.778 12.797 2.756 8.149 10.848 -1.302 6.793 10.523 -2.729 6.862 11.145 -3.486 5.703 12.038 -4.319 5.916 9.012 -012 2.919 6.78 8.302 -2.463 8.044 6.792 -2.589 7.882 136- (131) LEU370 CD2 8.79 -3.256 9.248 PHE371 N 10.872 -3.006 4.502 PHE371 CA 11.266 -3.75 3.303 PHE371 C 12.728 -3.529 2.918 PHE371 〇13.332 -4.398 2.278 PHE371 CB 10.333 -3.34 2.169 PHE371 CG 8.861 -3.634 2.463 PHE371 CD1 7.935 -2.599 2.503 PHE371 CD2 8.447 -4.94 2.692 PHE371 CE1 -2.867 2.784 PHE371 CE2 7.112 -5.209 2.971 PHE371 CZ 6.19 -4.172 3.019 ARG372 N 13.335 -2.472 3.436 ARG372 CA 14.773 -2.281 3.231 ARG372 C 15.606 -2.901 4.353 ARG372 〇16.834 -2.982 4.229 ARG372 CB 15.084 -0.795 3.116 ARG372 CG 14.397 -0.1 1.904 ARG372 CD 14.777 1.291 1.76 ARG372 NE 14.497 2.015 3.008 ARG372 CZ 14.919 3.257 3.251 ARG372 NH1 14.646 3.835 4.423 ARG372 NH2 15.631 3.911 2.331 ARG373 N 14.958 -3.347 5.418 ARG373 CA 15.671 -4.087 6.457 ARG373 C 15.659 -5.559 6.09 ARG373 3.8. ARG373 CB 14.937 -3.926 7.783 ARG373 CG 15.657 -4.637 8.922 ARG373 CD 16.912 -3.879 9.335 ARG373 NE 16.548 -2.554 9.862 ARG373 CZ 16.405 -2.304 11.165 ARG373 NH1 16.663 -3.261 12.059 ARG373 NH2 16.046 -1.087 11.576 VAL374 N 14.474 -6.032 5.749 VAL374 CA 14.314 -7.425 5.338 VAL374 C 13.644 -7.499 3.971 VAL374 〇12.43 -7.307 3.841 VAL374 CB 13.473 -8.164 6.376 VAL374 CG1 13.297 -9.625 5.984 VAL374 CG2 14.086 -8.075 7.77 PR0375 N 14.432 • 7.87373. CA 13.929 -8.036 1.606 PR0375 C 13.088 • 9.304 1.369 PR0375 〇12.539 -9.472 0.275 PR0375 CB 15.165 -8.072 0.76 PR0375 CG 16.384 -8.221 1.658 PR0375 CD 15.865 -8.159 3.084 GLY376 N 12.945 -10.158 2.371 GLY376 CA 12.162 -11.386 2.21 GLY376 C 11.071 -11.52 3.271 GLY376 〇11.012 -12.523 3.992 ILE377 N 10.225 -10.508 3.367 ILE377 CA 9.092 -10.568 4.299</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">137- (132)</span>137- (132)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">2861 ILE377 C  2862 ILE377 〇  2863 ILE377 CB  2864 ILE377 CG1  2865 ILE377 CG2  2866 ILE377 CD1  2867 ARG378 N  2868 ARG378 CA  2869 ARG378 C  2870 ARG378 〇  2871 ARG378 C巳  2872 ARG378 CG  2873 ARG378 CD  2874 ARG378 NE  2875 ARG378 CZ  2876 ARG378 NH1  2877 ARG378 NH2  2878 ILE379 N  2879 ILE379 CA  2880 ILE379 C  2881 ILE379 〇  2882 ILE379 CB  2883 ILE379 CG1  2884 ILE379 CG2  2885 ILE379 CD1  2886 ALA380 N  2887 ALA380 CA  2888 ALA380 C  2889 ALA380 〇  2890 ALA380 CB  2891 VAL381 N  2892 VAL381 CA  2893 VAL381 C  2894 VAL381 〇  2895 VAL381 CB  2896 VAL381 CG1  2897 VAL381 CG2  2898 PR0382 N  2899 PR0382 CA  2900 PR0382 C  2901 PR0382 〇  2902 PR0382 CB  2903 PR0382 CG  2904 PR0382 CD  2905 VAL383 N  2906 VAL383 CA  2907 VAL383 C  2908 VAL383 〇  2909 VAL383 CB  2910 VAL383 CG1  2911 VAL383 CG2  2912 ASP384 N  2913 ASP384 CA  2914 ASP384 C 7.921 -11.29b   7.217 -10.731 2.801  8.663 -9.148 4.656  9.836 -8.352 5.203  7.529 -9.169 5.674  9.433 -6.919 5.526  7.743 -12.55 4.009  6.648 -13.342 3.451  5.468 -13.417 4.409  5.629 -13.304 5.627  7.186 -14.734 3.163  8.265 -14.671 2.089  8.975 -16.01 1.929  9.756 -16.33 3.134  9.57 -17.431 3.864  8.587 -18.28 3.556  10.338 -17.659 4.931  4.277 -13.531 3.854  3.096 -13.713 4.703  3.14 -15.13 5.272  3.519 &amp;gt;16.07 4.563  1.841 -13.536 3.855  2.108 -12.589 2.692  0.702 •12.984 4.709  0.882 -12.447 1.798  2.872 -15.267 6.56  2.895 -16.598 7.174  1.533 -17.277 7.07  1.435 -18.51 7.097  3.306 -16.471 8.635  0.498 -16.47 6.917  -0.839 -17.005 6.651  -1.231 -16.745 5.2  -0.782 •15.768 4.59  -1.847 -16.359 7.599  -1.705 -16.897 9.018  -1.747 -14.839 7.57  -1.999 -17.662 4.635  -2.615 -17.424 3.329  -3.477 -16.166 3.352  -4.045 -15.802 4.391  -3.422 -18.651 3.039  -3.29 -19.627 4.198  -2.414 -18.938 5.231  -3.721 -15.621 2.172  -4.415 -14.327 2.051  -5.892 -14.388 2.452  -6.376 -13.473 3.126  -4.302 -13.886 0.593  -5.05 -12.578 0.343  -2.838 -13.751 0.177  •6.478 -15.572 2.355  -7.876 -15.767 2.759  -8.031 -15.962 4.271 -138- (133)200418849 2915 ASP384 〇 -9.156 -16.094 4.761  2916 ASP384 CB -8.42 -17.003 2.048  2917 ASP384 CG -8.293 -16.849 0.534  2918 ASP384 〇D1 -9.1 -16.128 -0.032  2919 ASP384 〇D2 -7.312 -17.346 -0.002  2920 GLU385 N -6.926 -15.995 5  2921 GLU385 CA -6.994 -16.177 6.448  2922 GLU385 C -6.674 -14.884 7.194  2923 GLU385 〇 •6.638 -14.896 8.429  2924 GLU385 CB -6.01 -17.259 6.874  2925 GLU385 CG -6.219 -18.561 6.111  2926 GLU385 CD -7.651 -19.079 6.248  2927 GLU385 〇E1 -8.017 -19.462 7.349  2928 GLU385 OE2 -8.266 -19.256 5.205  2929 LEU386 N -6.406 -13.81 6.463  2930 LEU386 CA -6.082 -12.519 7.093  2931 LEU386 C -7.266 -11.953 7.874  2932 LEU386 〇 -8.342 -11.71 7.315  2933 LEU386 CB -5.676 -11.542 5.996  2934 LEU386 CG -4.348 -11.943 5.365  2935 LEU386 CD1 -4.081 -11.153 4.091  2936 LEU386 CD2 -3.204 -11.773 6.357  2937 PR0387 N -7.063 -11.798 9.173  2938 PR0387 CA -8.132 &amp;gt;11.39 10.091  2939 PR0387 C •8.419 -9.89 10.047  2940 PR0387 〇 -7.84 -9.095 10.805  2941 PR0387 CB -7.647 -11.801 11.445  2942 PR0387 CG -6.191 -12.224 11.339  2943 PR0387 CD -5.817 -12.105 9.873  2944 PHE388 N -9.314 •9.528 9.143  2945 PHE388 CA -9.775 -8.145 9.012  2946 PHE388 C -10.688 -7.79 10.176  2947 PHE388 〇 -11.522 -8.597 10.603  2948 PHE388 CB -10.558 -7.999 7.709  2949 PHE388 CG -9.785 -8.343 6.437  2950 PHE388 CD1 -8.78 -7.498 5.987  2951 PHE388 CD2 -10.097 -9.492 5.721  2952 PHE388 CE1 -8.076 -7.809 4.831  2953 PHE388 CE2 -9.393 •9.804 4.565  2954 PHE388 CZ -8.381 -8.963 4.121  2955 LYS389 N -10.5 -6.599 10.707  2956 LYS389 CA -11.364 -6.141 11.792  2957 LYS389 C -12.626 -5.52 11.203  2958 LYS389 〇 &amp;gt;12.542 -4.581 10.4  2959 LYS389 CB -10.611 -5.115 12.633  2960 LYS389 CG -11.439 -4.708 13.847  2961 LYS389 CD -10.677 -3.763 14.767  2962 LYS389 CE -11.487 -3.466 16.023  2963 LYS389 NZ -10.719 -2.637 16.96  2964 HIS390 N -13.775 -6.068 11.571  2965 HIS390 CA -15.055 -5.523 11.102  2966 HIS390 C -15.385 -4.226 11.836  2967 HIS390 〇 -15.845 -4.213 12.983  2968 HIS390 CB -16.162 -6.548 11.316 139- (134)200418849 2969 HIS390  2970 HIS390  2971 HIS390  2972 HIS390  2973 HIS390  2974 ASP391  2975 ASP391  2976 ASP391  2977 ASP391  2978 ASP391  2979 ASP391  2980 ASP391  2981 ASP391  2982 SER392  2983 SER392  2984 SER392  2985 SER392  2986 SER392  2987 SER392  2988 THR393  2989 THR393  2990 THR393  2991 THR393  2992 THR393  2993 THR393  2994 THR393  2995 ILE394  2996 ILE394  2997 ILE394  2998 ILE394  2999 ILE394  3000 ILE394  3001 ILE394  3002 ILE394  3003 TYR395  3004 TYR395  3005 TYR395  3006 TYR395  3007 TYR395  3008 TYR395  3009 TYR395  3010 TYR395  3011 TYR395  3012 TYR395  3013 TYR395  3014 TYR395  3015 GLY396  3016 GLY396  3017 GLY396  3018 GLY396  3019 LEU397  3020 LEU397  3021 LEU397  3022 LEU397</span>2861 ILE377 C 2862 ILE377 〇2863 ILE377 CB 2864 ILE377 CG1 2865 ILE377 CG2 2866 ILE377 CD1 2867 ARG378 N 2868 ARG378 CA 2869 ARG378 C 2870 ARG378 〇2871 ARG378 C 巳 2872 ARG378 CG 2873 ARG378 CD 2874 ARG378 CZ 2875 ANH378 2NH ARG378 NH2 2878 ILE379 N 2879 ILE379 CA 2880 ILE379 C 2881 ILE379 〇2882 ILE379 CB 2883 ILE379 CG1 2884 ILE379 CG2 2885 ILE379 CD1 2886 ALA380 N 2887 ALA380 CA 2888 ALA380 C 2889 ALA380 〇2890 ALA380 CB 2891 VAL 891 2381 VAL 2894 VAL381 〇2895 VAL381 CB 2896 VAL381 CG1 2897 VAL381 CG2 2898 PR0382 N 2899 PR0382 CA 2900 PR0382 C 2901 PR0382 〇2902 PR0382 CB 2903 PR0382 CG 2904 PR0382 CD 2905 VAL383 N 2906 VAL383 CA 2907 VAL383 C 2908 VAL10 CG1 2911 VAL383 CG2 2912 ASP384 N 2913 ASP384 CA 2914 ASP384 C 7.921 -11.29b 7.217 -10.731 2.801 8.663 -9.148 4.656 9.836 -8.352 5.203 7.529 -9.169 5.674 9.433 -6.919 5.526 7.743 -12.55 4 .009 6.648 -13.342 3.451 5.468 -13.417 4.409 5.629 -13.304 5.627 7.186 -14.734 3.163 8.265 -14.671 2.089 8.975 -16.01 1.929 9.756 -16.33 3.134 9.57 -17.431 3.864 8.587 -18.28 3.556 10.338 -17.659 4.931 4.277 -13.531 3.854 3.096 -13.713 4.703 3.14 -15.13 5.272 3.519 &amp;gt; 16.07 4.563 1.841 -13.536 3.855 2.108 -12.589 2.692 0.702 • 12.984 4.709 0.882 -12.447 1.798 2.872 -15.267 6.56 2.895 -16.598 7.174 1.533 -17.277 7.07 1.435 -18.51 7.097 3.306 -16.471 8.635 0.498 -16.47 6.98 0.839 -17.005 6.651 -1.231 -16.745 5.2 -0.782 • 15.768 4.59 -1.847 -16.359 7.599 -1.705 -16.897 9.018 -1.747 -14.839 7.57 -1.999 -17.662 4.635 -2.615 -17.424 3.329 -3.477 -16.166 3.352 -4.045 -15.802 4.391- 3.422 -18.651 3.039 -3.29 -19.627 4.198 -2.414 -18.938 5.231 -3.721 -15.621 2.172 -4.415 -14.327 2.051 -5.892 -14.388 2.452 -6.376 -13.473 3.126 -4.302 -13.886 0.593 -5.05 -12.578 0.343 -2.838 -13.751 0.177 • 6.478 -15.572 2.355 -7.876 -15.767 2.759 -8.031 -15.96 2 4.271 -138- (133) 200418849 2915 ASP384 〇-9.156 -16.094 4.761 2916 ASP384 CB -8.42 -17.003 2.048 2917 ASP384 CG -8.293 -16.849 0.534 2918 ASP384 〇D1 -9.1 -16.128 -0.032 2919 ASP384 〇D2 -7.312- 17.346 -0.002 2920 GLU385 N -6.926 -15.995 5 2921 GLU385 CA -6.994 -16.177 6.448 2922 GLU385 C -6.674 -14.884 7.194 2923 GLU385 〇6.638 -14.896 8.429 2924 GLU385 CB -6.01 -17.259 6.874 2925 GLU385 CG -6.219 -18.561 6.111 2926 GLU385 CD -7.651 -19.079 6.248 2927 GLU385 〇E1 -8.017 -19.462 7.349 2928 GLU385 OE2 -8.266 -19.256 5.205 2929 LEU386 N -6.406 -13.81 6.463 2930 LEU386 CA -6.082 -12.519 7.093 2931 LEU386 C -7.266 -11.953 7.874 2932 LEU386 〇-8.342 -11.71 7.315 2933 LEU386 CB -5.676 -11.542 5.996 2934 LEU386 CG -4.348 -11.943 5.365 2935 LEU386 CD1 -4.081 -11.153 4.091 2936 LEU386 CD2 -3.204 -11.773 6.357 2937 PR0387 N -7.063 -11.798 9.173 2938 CA -8.132 &amp;gt; 11.39 10.091 2939 PR0387 C • 8.419 -9.89 10.047 2940 PR0387 〇-7.84 -9.095 10.805 29 41 PR0387 CB -7.647 -11.801 11.445 2942 PR0387 CG -6.191 -12.224 11.339 2943 PR0387 CD -5.817 -12.105 9.873 2944 PHE388 N -9.314 • 9.528 9.143 2945 PHE388 CA -9.775 -8.145 9.012 2946 PHE388 C -10.688 -7.79 10.176 2947 PHE388 〇-11.522 -8.597 10.603 2948 PHE388 CB -10.558 -7.999 7.709 2949 PHE388 CG -9.785 -8.343 6.437 2950 PHE388 CD1 -8.78 -7.498 5.987 2951 PHE388 CD2 -10.097 -9.492 5.721 2952 PHE388 CE1 -8.076 -7.809 4.831 2953 PHE388 CE2- 9.393 • 9.804 4.565 2954 PHE388 CZ -8.381 -8.963 4.121 2955 LYS389 N -10.5 -6.599 10.707 2956 LYS389 CA -11.364 -6.141 11.792 2957 LYS389 C -12.626 -5.52 11.203 2958 LYS389 〇 &amp;gt; 12.542 -4.581 10.4 2959 LYS389 CB -5.115 12.633 2960 LYS389 CG -11.439 -4.708 13.847 2961 LYS389 CD -10.677 -3.763 14.767 2962 LYS389 CE -11.487 -3.466 16.023 2963 LYS389 NZ -10.719 -2.637 16.96 2964 HIS390 N -13.775 -6.068 11.571 2965 HIS390 CA -15.055 11.102 2966 HIS390 C -15.385 -4.226 11.836 2967 HIS390 〇-15.845 -4.213 1 2.983 2968 HIS390 CB -16.162 -6.548 11.316 139- (134) 200418849 2969 HIS390 2970 HIS390 2971 HIS390 2972 HIS390 2973 HIS390 2974 ASP391 2975 ASP391 2976 ASP391 2977 ASP391 2978 ASP391 2979 ASP391 2980 ASP391 2981 ASP391 2982 SER392 2983 SER392 2984 SER392 2987 SER392 2988 THR393 2989 THR393 2990 THR393 2991 THR393 2992 THR393 2993 THR393 2994 THR393 2995 ILE394 2996 ILE394 2997 ILE394 2998 ILE394 2999 ILE394 3000 ILE394 3001 ILER 30010 TYR3953 TYR3955 3005TY 3005TY 3005TY 3005 TYR395 3012 TYR395 3013 TYR395 3014 TYR395 3015 GLY396 3016 GLY396 3017 GLY396 3018 GLY396 3019 LEU397 3020 LEU397 3021 LEU397 3022 LEU397</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">CGND1CD2CE1NE2NCAC OSCGOD1OD2NCA i— 2 i· 2 1 u— 2 i. 2 B G A bgg a bggd a bgddeezh a a C〇C〇NCC〇C〇CNCC〇CCCCNCC〇CCCCCCC〇NCC〇NCC〇 -17.525 -17.895 -18.62 -19.181 -19.629 -15.053 -15.269 -15.392 -14.395 -14.068 -14.172 -14.984 -13.241 -16.582 -16.835 -16.261 -15.99 -18.342 -18.876 -15.944 -15.451 -13.931 -13.294 -16.183 -17.557 -15.703 -13.365 -11.899 -11.525 -11.205 -11.37 -11.744 -9.847 -10.977 -11.59 -11.29 •9.792 -8.997 -11.747 -11.784 -10.958 -12.648 -10.991 -12.682 -11.852 -11.882 -9.433 •8.007 -7.732 -8.601 -6.493 -6.031 -5.334 -4.297 ‘6.094 -5.893 -5.81 -5.487 -5.437 -3.138 -1.789 -0.871 -0.539 -1.414 -0.02 0.771 0.324 -0.335 0.448 1.863 2.431 0.537 1.383 2.392 3.768 3.822 4.722 4.53 4.561 5.972 2.816 2.665 1.204 0.419 3.095 4.533 2:978 5.529 0.854 -0.503 -0.786 0.149 -0.572 -1.967 -2.272 &amp;gt;2.927 -3.543 -4.199 -4.502 -5.763 -2.053 -2.401 -3.871 -4.74 -4.132 -5.497 -5.577 -4.938 10.826 9.545 11.607 9.511 10.786 11.167 11.683 10.48 9.835 12.553 13.18 12.707 13.884 10.283 9.075 9.129 8.07 8.868 9.878 10.297 10.313 10.468 9.909 11.411 11.04 11.528 11.118 11.203 10.92 11.824 12.577 12.921 12.624 12.055 9.649 9.179 9.302 9.447 7.721 7.101 6.026 7.612 5.465 7.052 5.982 5.427 9.421 9.468 9.759 9.609 10.134 10.406 11.751 11.961 -140- (135)200418849 3023 LEU397  3024 LEU397  3025 LEU397  3026 LEU397  3027 HIS398  3028 HIS398  3029 HIS398  3030 HIS398  3031 HIS398  3032 HIS398  3033 HIS398  3034 HIS398  3035 HIS398  3036 HIS398  3037 ALA399  3038 ALA399  3039 ALA399  3040 ALA399  3041 ALA399  3042 LEU400  3043 LEU400  3044 LEU400  3045 LEU400  3046 LEU400  3047 LEU400  3048 LEU400  3049 LEU400  3050 PRO401  3051 PRO401  3052 PRO401  3053 PRO401  3054 PRO401  3055 PRO401  3056 PRO401  3057 VAL402  3058 VAL402  3059 VAL402  3060 VAL402  3061 VAL402  3062 VAL402  3063 VAL402  3064 THR403  3065 THR403  3066 THR403  3067 THR403  3068 THR403  3069 THR403  3070 THR403  3071 TRP404  3072 TRP404  3073 TRP404  3074 TRP404  3075 TRP404  3076 TRP404</span>CGND1CD2CE1NE2NCAC OSCGOD1OD2NCA i— 2 i · 2 1 u— 2 i. 2 BGA bgg a bggd a bgddeezh aa C〇C〇NCC〇C〇CNCC〇CCCNCC〇CCCCCCC〇NCC〇NCC〇-17.525 -17.895 -18.62 -19.181 -19.181-19.629 -15.053 -15.269 -15.392 -14.395 -14.068 -14.172 -14.984 -13.241 -16.582 -16.835 -16.261 -15.99 -18.342 -18.876 -15.944 -15.451 -13.931 -13.294 -16.183 -17.557 -15.703 -13.365 -11.205 -11.899 -11.525 -11.37 -11.744 -9.847 -10.977 -11.59 -11.29 • 9.792 -8.997 -11.747 -11.784 -10.958 -12.648 -10.991 -12.682 -11.852 -11.882 -9.433 • 8.007 -7.732 -8.601 -6.493 -6.031 -5.334 -4.297 '6.094 -5.893 -5.81 -5.487 -5.437 -3.138 -1.789 -0.871 -0.539 -1.414 -0.02 0.771 0.324 -0.335 0.448 1.863 2.431 0.537 1.383 2.392 3.768 3.822 4.722 4.53 4.561 5.972 2.816 2.665 1.204 0.419 3.095 4.533 2: 978 5.529 0.854 -0.503 -0.503- 0.786 0.149 -0.572 -1.967 -2.272 &amp;gt; 2.927 -3.543 -4.199 -4.502 -5.763 -2.053 -2.401 -3.871 -4.74 -4.132 -5.497 -5.577 -4.938 10.826 9.545 11.607 9.511 10.786 11.167 11.683 10.48 9.835 12.553 13.18 12. 707 13.884 10.283 9.075 9.129 8.07 8.868 9.878 10.297 10.313 10.468 9.909 11.411 11.04 11.528 11.118 11.203 10.92 11.824 12.577 12.921 12.624 12.055 9.649 9.179 9.302 9.447 7.721 7.101 6.026 7.612 5.465 7.052 5.982 5.427 9.421 9.468 9.759 9.609 10.134 10.406 11.751 11.961 -140- (135) 200418849 3023 LEU397 3024 LEU397 3025 LEU397 3026 LEU397 3027 HIS398 3028 HIS398 3029 HIS398 3030 HIS398 3031 HIS398 3032 HIS398 3033 HIS398 3034 HIS398 3035 HIS398 3036 HIS398 3037 ALA399 30LE LEUUU 3030 3044 LEAUU 3042 ALA399 3040 ALA400 3048 LEU400 3049 LEU400 3050 PRO401 3051 PRO401 3052 PRO401 3053 PRO401 3054 PRO401 3055 PRO401 3056 PRO401 3057 VAL402 3058 VAL402 3059 VAL402 3060 VAL402 3061 VAL402 3062 VAL402 3063 VAL402 3064 THR403 3065 THR403 3066 THR403 3067 THR403 30HR THR403 3068 THR403 30HR 3073 TRP404 3074 TRP404 3075 TRP404 3076 TRP404</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">CBCGCDCDNCACOCBCGND8CENENCACOCBNCACOCBCG88NCACOCBCGCDNCACOCBCGCGNCACOCBOGCGNCACOCBCG -5.051 -5773 -5.037 -5.979 -5.87 -5.274 •4.348 -3.651 -6.363 -6.737 -7.052 -6.795 -7.311 -7.152 -4.306 -3.343 -2.7 •3.373 -4.014 -1.383 -0.567 0.772 1.712 -0.307 0.615 0.005 0.973 0.815 2.084 2.88 2.413 1.686 0.197 -0.308 4.074 5.008 6.358 7.008 5.194 3.968 5.553 6.772 8.039 9.135 9.102 7.888 6.715 9.077 10.089 11.177 12.136 12.984 11.969 11.163 -5.894 -6.502 -6.225 -7.996 -6.402 •6.514 -7.718 -7.848 -6.528 -5.14 -4.804 -3.984 -3.482 -2.975 -8.567 -9.671 -9.903 -10.014 -10.936 -10.004 -10.204 -10.856 -10.165 -8.845 -8.952 -9.826 -7.572 -12.178 -12.9 -12.822 -13.242 -14.312 -14.466 -13.08 -12.267 -12.183 -12.814 -12.485 -10.723 •10.185 -9.84 -13.729 -14.428 -13.709 -13.66 -15.853 -16.403 -16.723 -13.156 -12.406 -13.344 -12.835 -11.654 -10.949 9.311 8.12 6.822 8.325 12.634 13.967 14.107 15.12 15.033 15.525 16.79 14.781 16.851 15.607 13.094 13.12 11.756 10.724 13.633 11.794 10.589 10.935 11.35 9.946 8.736 7.644 8.197 10.881 10.974 9.671 8.602 11.269 10.993 10.625 9.78 8.653 8.998 9.998 .8.25 7.523 9.44 8.146 8.342 7.571 6.335 7.827 8.406 8.22 8.298 7.66 6.931 6.21 8.719 9.79 141 - (136) TRP404 TRP404 TRP404 TRP404 TRP404 TRP404 TRP404 TRP404 TRP404 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 IHEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1</span>CBCGCDCDNCACOCBCBCGND8CENENCACOCBNCACOCBCG88NCACOCBCGCDNCACOCBCGCGNCACOCBOGCGNCACOCBCG -5.051 -5773 -5.037 -5.979 -5.87 -5.274 • 4.348 -3.651 -6.363 -6.737 -73 -73 -73 -67 -73 0.815 2.084 2.88 2.413 1.686 0.197 -0.308 4.074 5.008 6.358 7.008 5.194 3.968 5.553 6.772 8.039 9.135 9.102 7.888 6.715 9.077 10.089 11.177 12.136 12.984 11.969 11.163 -5.894 -6.502 -6.225 -7.996 -6.402 • 6.514 -7.718 -7.848 -6.528 -5.14 -4.804 -3.984 -3.482 -2.975 -8.567 -9.671 -9.903 -10.014 -10.936 -10.004 -10.204 -10.856 -10.165 -8.845 -8.952 -9.826 -7.572 -12.178 -12.9 -12.822 -13.242 -14.312 -14.466 -13.08 -12.267 -12.183 -12.814 -12.485 -10.723 • 10.185 -9.84 -13.729 -14.428 -13.709 -13.66 -15.853 -16.403 -16.723 -13.156 -12.406 -13.344 -12.835 -11.654 -10.949 9.311 8.12 6.822 8.325 12.634 13.967 14.107 15.12 15.033 15.525 16.79 14.781 16.781 16.781 13.094 13.12 11.756 10.724 13.633 11.794 10.589 10.935 11.35 9.9 46 8.736 7.644 8.197 10.881 10.974 9.671 8.602 11.269 10.993 10.625 9.78 8.653 8.998 9.998 .8.25 7.523 9.44 8.146 8.342 7.571 6.335 7.827 8.406 8.22 8.298 7.66 6.931 6.21 8.719 9.79 141-(136) TRP404 TRP404 TRP404 TRP404 HRP1EM1 HEM404 HEM404 HEM404 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1 HEM1</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">12123232T aaaabb BBB1BBBCC DDEEEZZHXEA1234H1B432MABH1C CCNCCCCCOFNCCCCCCNCCCCCCCCN</span>12123232T aaaabb BBB1BBBCC DDEEEZZHXEA1234H1B432MABH1C CCNCCCCCOFNCCCCCCNCCCCCCCCCCN</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">C4C C3C C2C CMC CAC CBC CHD C1D ND C4D C3D C2D CMD CAD CBD CGD 〇1D 〇2D CHA CMA CAA CBA CGA 〇1A 〇2A 10.886 -11.444  10.559 -9.637  10.155 •10.524  9.943 -9.428  10.506 -8.656  9.278 -8.237  9.838 •7.468  9.226 -7.257  12.117 -14.53  -8.08 12.05  -9.653 12.085  -10.7 13.004  -11.687 12.681  -11.292 11.525  -10.019 11.174  -9.224 10.115  -7.931 9.83  -7.308 10.582  -6.086 9.964  -5.946 8.85  -7.068 8.771  -7.416 7.755  -4.833 8.031  -4.44 7.051  -5.212 10.298  -5.439 11.223  -6.519 12.039  -6.227 12.887  -4.926 12.636  -4.491 11.556  -3.265 10.712  -4.462 13.435  -3.452 13.231  -7.061 13.855  -8.237 14.203  -8.777 13.572  -9.915 14.313  -10.045 15.413  -9.006 15.334  -8.71 16.241  -11.178 16.421  -10.91 17.624  -12.079 18.574  -13.198 18.167  -11.889 19.736  -10.849 14.026  -12.005 10.703  -12.907 13.51  -14.087 13.112  -15.442 13.596  -15.522 14.131  -16.439 13.4 142-</span>C4C C3C C2C CMC CAC CBC CHD C1D ND C4D C3D C2D CMD CAD CBD CGD 〇1D 〇2D CHA CMA CAA CBA CGA 〇1A 〇2A 10.886 -11.444 10.559 -9.637 10.155 • 10.524 9.943 -9.428 10.506 -8.656 9.278 -8.237 9.838 9.226 -7.257 12.117 -14.53 -8.08 12.05 -9.653 12.085 -10.7 13.004 -11.687 12.681 -11.292 11.525 -10.019 11.174 -9.224 10.115 -7.931 9.83 -7.308 10.582 -6.086 9.964 -5.946 8.85 -7.068 8.771 -7.416 7.755 -4.833 8.031 -4.44 7.051 -5.212 10.298 -5.439 11.223 -6.519 12.039 -6.227 12.887 -4.926 12.636 -4.491 11.556 -3.265 10.712 -4.462 13.435 -3.452 13.231 -7.061 13.855 -8.237 14.203 -8.777 13.572 -9.915 14.313 -10.045 15.413 -9.006 15.334 -8.71 16.241- 11.178 16.421 -10.91 17.624 -12.079 18.574 -13.198 18.167 -11.889 19.736 -10.849 14.026 -12.005 10.703 -12.907 13.51 -14.087 13.112 -15.442 13.596 -15.522 14.131 -16.439 13.4 142-</span>
  </p>
</description>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(1)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result">translated from Chinese</div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><claims mxw-id="PCLM106681387" lang="EN" load-source="google" class="style-scope patent-text">
  <claim num="1" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(1)  (1)200418849  拾、申請專利範圍  1 . 一種編碼埃坡黴素B羥化酶及其突變體與變異體之 經離析的核酸序列。  2 .如申請專利範圍第i項之經離析的核酸序列，.其包 括 SEQ ID NO ： 1，30，32，34，36，37，38，39，40， 41 ， 42 ， 60 ， 62 ， 64 ， 66 ， 68 ， 72 Μ 74 °  3 .如申請專利範圍第〗項之經離析的核酸序列，其包 括 SEQ ID NO : 1。  4.如申請專利範圍第1項之經離析的核酸序列，其編 碼在埃坡黴素B羥化酶酵素之活性部位中具有至少一個胺 基酸取代的突變體。  5 .如申請專利範圍第1項之經離析的核酸序列，其編  碼具有至少一個在 SEQ ID NO : 2之胺基酸 GLU3 1， ARG67，ARG88，ILE92，ALA93，VAL106，ILE130， ALA140 ， MET 176 ， PHE190 ， GLU23 1 ， SER294 ，  PHE23 7，或ILE3 6 5處的胺基酸取代之突變體。  6 .如申請專利範圍第1項之經離析的核酸序列，其編  碼具有至少一個在 SEQ ID NO : 2之胺基酸 LEU39, GLN43，ALA45, MET57，LEU58，HIS62，PHE63，SER64, SER65, ASP66, ARG67，GLN68, SER69，LEU74，MET75, VAL76, ALA77，ARG78，GLN79，ILE80，ASP84，LYS85, PR086，PHE87, ARG88，PR089, SER90，LEU91，ILE92, ALA93，MET94，ASP95，HIS99，ARG103, PHE110，ILE155, PHE169, GLN170, CYS172, SER173, SER174, ARG175,  -143 -  (2)  200418849  MET 1 76, LEU177, SERI 78, ARG1 79, ARG1 86,  LEU193, VAL23 3, GLY23 4, LEU23 5, AL A2 3 6,  LEU23 8, LEU23 9, LEU240, ILE241, AL A242,  HIS244， GLU24 5, THR246, THR247, ALA24 8,  MET2 5 0, LEU28 3, THR2 8 7, ILE2 8 8, AL A2 89,  THR29 1， AL A292, THR2 93, SER294, ARG29 5,  AL A297, THR298, GLU3 12, GLY3 1 3, VAL3 1 4,  GL Y3 1 6, VAL3 44, ALA3 4 5, PHE3 46, GLY3 47,  V AL3 5 0, HIS3 5 1 , GLN3 5 2, C YS 3 5 3， LEU3 54,  GLN3 5 6, LEU3 5 8, ALA3 5 9, GLU3 62, LYS3 8 9,  SER3 92, THR3 9 3, ILE394 和 TYR3 9 5處的胺基酸  變體。  7 .如申請專利範圍第1項之經離析的核酸序 碼包括 SEQ ID NO: 43，44，45，46，47，48 %  異體。  8 . —種由申請專利範圍第1項之經離析的核 編碼之多肽。  9. 一種經離析的核酸分子，其能夠在65°C 中1 6小時的雜交條件下雜交至申請專利範圍第 酸序列或該核酸序列的互補序列，該經離析的核 夠在在5 5 °C 0.5 X S S C中3 0分鐘的洗滌條件下 到該核酸序列或該核酸序列的互補序列。  10. —種包括SEQ ID NO : 2的經離析之多肽  11. 一種具有SEQ ID NO: 2的埃坡黴素B  PHE190, PHE23 7, GLY24 3, ASN249, GLU290, PHE296, VAL3 1 5, PHE3 4 8, GLY3 5 5, ASP391， 取代之突 列’其編 3 49之變 酸序列所 3X SSC 2項之核 酸分子能 保持雜交  羥化酶之  -144,  (3)  (3)200418849  經離析的突變多肽，其包括在具有SEQ ID NO : 2的埃玻 黴素B羥化酶酵素之活性部位中經至少一個胺基酸取代的 胺基酸序列。  12.—種具有SEQ ID NO : 2的埃坡黴素B羥化酶之 經離析的突變多肽，其編碼具有至少一個在SEQ ID NO : 2 之胺基酸 GLU31，ARG67，ARG88，ILE92，ALA93， VAL106 ， ILE130 ， ALA 140 ， MET 1 76 ， PHE1 90 ，  GLU231，SER294，PHE237，或 ILE3 6 5 處的胺基酸取代 之胺基酸序列。  13·—種具有SEQ ID NO ·· 2的埃坡黴素B羥化酶之  經離析的突變多肽，其編碼具有至少一個在SEQ ID NO :  2 之胺 基酸 LEU39， GLN43， ALA45, MET5 7, LEU58,  HIS62, PHE63, SER64, SER65, ASP66， ARG67, GLN68,  SER69, LEU74, MET75, VAL76, ALA77, ARG78, GLN79,  ILE80， ASP84， LYS85, PR086, PHE87, ARG88， PR089,  SER90, LEU91 , ILE92, ALA93, MET94, ASP95， HIS99,  ARG103, PHE 1 1 0, ILE155, PHE169, GLN1 70， C YS 1 72,  SER1 73， SER1 74, ARG1 75, MET 1 76, LEU1 77, SER1 78,  ARG1 79, ARG186, PHE 1 90, LEU193, VAL 2 3 3, GLY23 4,  LEU23 5, ALA23 6, PHE23 7, LEU23 8, LEU23 9, LEU240,  ILE241 , ALA242， GLY243, HIS244， GLU245, THR246,  THR247, AL A248, ASN249, MET2 5 0, LEU28 3, THR28 7,  ILE2 8 8, ALA2 8 9, GLU290, THR2915 AL A292， THR293 ,  SER294, ARG295, PHE296, ALA297, THR298, GLU3 12,  -145-  (4)  (4)200418849  GLY3 13, V AL3 1 4, VAL3 1 5, GLY3 1 6, VAL3 44, ALA3 4 5,  PHE3 46, GLY3 47, PHE3 4 8, VAL3 5 0, HIS351， GLN3 5 2,  CYS 3 5 3, LEU3 5 4, GLY3 5 5, GLN3 5 6, LEU3 5 8, ALA3 5 9,  GLU3 62, LYS 3 8 9， ASP3 91， SER3 92，THR3 9 3, ILE3 94 和  TYR3 95處的胺基酸取代之突變體。  14. 一 種包括 SEQ ID NO: 31，33，35，61，63，  6 5，6 7，6 9，7 1，7 3或7 5的埃坡黴素B羥化酶之經離析 的突變多肽。 φ  15. — 種包括 SEQ ID NO: 43，44，45，46，47，  48，或49的埃坡黴素B羥化酶之經離析的變異多肽。  1 6 . —種編碼鐵氧化還原蛋白之經離析的核酸序列。  1 7 .如申請專利範圍第1 6項之經離析的核酸序列，其 包括 SEQIDNO:3。  1 8 . —種由申請專利範圍第1 6項之經離析的核酸序列 所編碼之多肽。  19.一種經離析的核酸分子，其能夠在65°C 3X SSC ®  中1 6小時的雜交條件下雜交至SEQ ID NO : 3之核酸序 列或該SEQ ID NO : 3之核酸序列的互補序列，該經離析 的核酸分子能夠在5 5 °C 0.5 X S S C中3 0分鐘的洗滌條件 下保持雜交至SEQ ID NO: 3之核酸序列或該SEQ ID NO : 3之核酸序列的互補序列。  2 〇 . —種包括申請專利範圍第1項之經離析的核酸序 列之載體。  2 1 .如申請專利範圍第2 0項之載體，其進一步包括編  -146-  (5)  (5)200418849  碼鐵氧化還原蛋白之經離析的核酸序列。  22.—種包括如申請專利範圍第20項之載體的宿主細  胞。  2 3 . —種包括如申請專利範圍第2 1項之載體的宿主細  胞。  2 4 . —種製造重組微生物之方法，該微生物可羥基化 具有末端烷基的埃坡黴素以產生具有末端羥烷基的埃坡黴 素，該方法包括使用申請專利範圍第20或2 1項之載體以 轉染微生物。  2 5 . —種經重組產製的微生物，其可羥基化具有末端 烷基的埃坡黴素以產生具有末端羥烷基的埃坡黴素。  26. 如申請專利範圍第25項之經重組產製的微生物，  其中該微生物可表現具有SEQ ID NO : : 1，30，32，  34 ， 36 ， 37 ， 38 ， 39 ， 40 ， 41 ， 42 ， 60 ， 62 ， 64 ， 66 ，  6 8，7 2或7 4之核酸序列。  27. —種製造具有至少一種具有下述式I的埃坡黴素 之方法  HO-CH2-(Ai)n-(Q)m-(A2)〇.E (I) 其中  A i和A2爲獨立地選自包括下列的群組中：視需要經 取代的Ci-Cs-烷基和烯基；  Q爲視需要經取代的環系統，其包括1到3個環與在  -147-  200418849</span>(1) (1) 200418849 Scope of patent application 1. An isolated nucleic acid sequence encoding epothilone B hydroxylase and its mutants and variants. 2. The isolated nucleic acid sequence according to item i of the patent application scope, which includes SEQ ID NOs: 1, 30, 32, 34, 36, 37, 38, 39, 40, 41, 42, 60, 62, 64 , 66, 68, 72 M 74 ° 3. The isolated nucleic acid sequence according to the scope of the patent application, which includes SEQ ID NO: 1. 4. The isolated nucleic acid sequence according to item 1 of the patent application, which encodes a mutant having at least one amino acid substitution in the active site of the epothilone B hydroxylase enzyme. 5. The isolated nucleic acid sequence according to item 1 of the scope of patent application, which encodes at least one amino acid GLU3 1, SEQ ID NO: 2, ARG67, ARG88, ILE92, ALA93, VAL106, ILE130, ALA140, MET 176 , PHE190, GLU23 1, SER294, PHE23 7, or ILE3 6 5 mutants. 6. The isolated nucleic acid sequence according to item 1 of the scope of patent application, which encodes at least one amino acid LEU39, GLN43, ALA45, MET57, LEU58, HIS62, PHE63, SER64, SER65, ASP66 with SEQ ID NO: 2 , ARG67, GLN68, SER69, LEU74, MET75, VAL76, ALA77, ARG78, GLN79, ILE80, ASP84, LYS85, PR086, PHE87, ARG88, PR089, SER90, LEU91, ILE92, ALA93, MET94, ASP95, HIS99, ARG103, PHE110 , ILE155, PHE169, GLN170, CYS172, SER173, SER174, ARG175, -143-(2) 200418849 MET 1 76, LEU177, SERI 78, ARG1 79, ARG1 86, LEU193, VAL23 3, GLY23 4, LEU23 5, AL A2 3 6, LEU23 8, LEU23 9, LEU240, ILE241, AL A242, HIS244, GLU24 5, THR246, THR247, ALA24 8, MET2 5 0, LEU28 3, THR2 8 7, ILE2 8 8, AL A2 89, THR29 1, AL A292, THR2 93, SER294, ARG29 5, AL A297, THR298, GLU3 12, GLY3 1 3, VAL3 1 4, GL Y3 1 6, VAL3 44, ALA3 4 5, PHE3 46, GLY3 47, V AL3 5 0, HIS3 5 1, GLN3 5 2, C YS 3 5 3, LEU3 54, GLN3 5 6, LEU3 5 8, ALA3 5 9, GLU3 62, LYS3 8 9, SER3 92, THR3 9 3, ILE394 and TYR3 9 5 amine Acid variant. 7. The isolated nucleic acid sequence according to item 1 of the patent application scope includes SEQ ID NO: 43, 44, 45, 46, 47, 48% allosome. 8. A polypeptide encoded by the isolated core of the scope of patent application No. 1. 9. An isolated nucleic acid molecule capable of hybridizing to a patent application range of an acid sequence or a complementary sequence of the nucleic acid sequence under a hybridization condition at 65 ° C for 16 hours. C 0.5 XSSC to the nucleic acid sequence or the complementary sequence of the nucleic acid sequence under a 30-minute washing condition. 10. An isolated polypeptide comprising SEQ ID NO: 2 11. An epothilone B having SEQ ID NO: 2 PHE190, PHE23 7, GLY24 3, ASN249, GLU290, PHE296, VAL3 1 5, PHE3 4 8, GLY3 5 5, ASP391, the superseded nucleic acid molecule of item 3X SSC 2 of the acid-sequence sequence of its 3 49 can retain hybrid hydroxylase-144, (3) (3) 200418849 isolated mutation A polypeptide comprising an amino acid sequence substituted with at least one amino acid in the active site of an epothilone B hydroxylase enzyme having SEQ ID NO: 2. 12. An isolated mutant polypeptide having epothilone B hydroxylase of SEQ ID NO: 2, which encodes at least one amino acid GLU31, ARG67, ARG88, ILE92, ALA93 in SEQ ID NO: 2 , VAL106, ILE130, ALA 140, MET 1 76, PHE1 90, GLU231, SER294, PHE237, or ILE3 6 5 amino acid substituted amino acid sequence. 13 · —An isolated mutant polypeptide of epothilone B hydroxylase having SEQ ID NO ·· 2, which encodes at least one amino acid LEU39, GLN43, ALA45, MET5 having SEQ ID NO: 2 , LEU58, HIS62, PHE63, SER64, SER65, ASP66, ARG67, GLN68, SER69, LEU74, MET75, VAL76, ALA77, ARG78, GLN79, ILE80, ASP84, LYS85, PR086, PHE87, ARG88, PR089, SER90, LEU91, LEU91 , ALA93, MET94, ASP95, HIS99, ARG103, PHE 1 1 0, ILE155, PHE169, GLN1 70, C YS 1 72, SER1 73, SER1 74, ARG1 75, MET 1 76, LEU1 77, SER1 78, ARG1 79, ARG186, PHE 1 90, LEU193, VAL 2 3 3, GLY23 4, LEU23 5, ALA23 6, PHE23 7, LEU23 8, LEU23 9, LEU240, ILE241, ALA242, GLY243, HIS244, GLU245, THR246, THR247, AL A248, ASN249, MET2 5 0, LEU28 3, THR28 7, ILE2 8 8, ALA2 8 9, GLU290, THR2915 AL A292, THR293, SER294, ARG295, PHE296, ALA297, THR298, GLU3 12, -145- (4) (4) 200418849 GLY3 13, V AL3 1 4, VAL3 1 5, GLY3 1 6, VAL3 44, ALA3 4 5, PHE3 46, GLY3 47, PHE3 4 8, VAL3 5 0, HIS351, GLN3 5 2, CYS 3 5 3, LEU 3 5 4, GLY3 5 5, GLN3 5 6, LEU3 5 8, ALA3 5 9, GLU3 62, LYS 3 8 9, ASP3 91, SER3 92, THR3 9 3, ILE3 94 and TYR3 95 mutant. 14. An isolated mutant polypeptide comprising epothilone B hydroxylase comprising SEQ ID NO: 31, 33, 35, 61, 63, 6 5, 6, 7, 6, 9, 7, 1, 3 or 75 . φ 15. — An isolated mutant polypeptide of epothilone B hydroxylase including SEQ ID NO: 43, 44, 45, 46, 47, 48, or 49. 16. An isolated nucleic acid sequence encoding a ferredoxin. 17. The isolated nucleic acid sequence according to item 16 of the patent application, which includes SEQ ID NO: 3. 18. A polypeptide encoded by the isolated nucleic acid sequence in the 16th patent application. 19. An isolated nucleic acid molecule capable of hybridizing to a nucleic acid sequence of SEQ ID NO: 3 or a complementary sequence of the nucleic acid sequence of SEQ ID NO: 3 under hybridization conditions at 65 ° C 3X SSC® for 16 hours, The isolated nucleic acid molecule can maintain hybridization to the nucleic acid sequence of SEQ ID NO: 3 or the complementary sequence of the nucleic acid sequence of SEQ ID NO: 3 under washing conditions at 5 ° C 0.5 XSSC for 30 minutes. 2.. — A vector comprising the isolated nucleic acid sequence of the scope of patent application No. 1. 2 1. The vector of claim 20 in the scope of patent application, further comprising an isolated nucleic acid sequence of -146- (5) (5) 200418849 code iron redox protein. 22. A host cell comprising a vector such as the one claimed in claim 20. 2 3. A host cell comprising a vector such as the item 21 of the patent application. 2 4. A method for manufacturing a recombinant microorganism which can hydroxylate epothilone having a terminal alkyl group to produce epothilone having a terminal hydroxyalkyl group, and the method includes using patent application No. 20 or 2 1 The vectors are used to transfect microorganisms. 25. A recombinantly produced microorganism that can hydroxylate epothilone with a terminal alkyl group to produce epothilone with a terminal hydroxyalkyl group. 26. For example, a microorganism produced by recombination produced in the scope of application for a patent No. 25, wherein the microorganism can express SEQ ID NO :: 1, 30, 32, 34, 36, 37, 38, 39, 40, 41, 42, Nucleic acid sequences of 60, 62, 64, 66, 68, 72 or 74. 27. A method for producing at least one epothilone having the following formula I HO-CH2- (Ai) n- (Q) m- (A2) .E (I) wherein A i and A 2 are independent The ground is selected from the group consisting of Ci-Cs-alkyl and alkenyl, which are optionally substituted; Q is a ring system which is optionally substituted, which includes 1 to 3 rings and -147- 200418849</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(6)  至少一個環中的至少一個碳對碳雙鍵；  η，m和〇爲選自包括下列的群組中之整數：〇和1， 且m或η或〇中至少有一者爲1，且 Ε爲一埃坡黴素核；  該方法包括將至少一種具有下面式11的埃坡黴素 CH3-(Ai)n.(Q)m-(A2)〇-E (II)  其中Ai，Q，A2，E，n，m和〇皆爲上面所定義者；  與一種能夠選擇性地催化該式II的羥基化之經重組 產製的微生物，或其所衍生的酵素接觸，及促成該羥基  化。  2 8 . —種製備式A埃坡黴素類似物之方法</span>(6) at least one carbon-to-carbon double bond in at least one ring; η, m and 0 are integers selected from the group consisting of: 0 and 1, and at least one of m or η or 〇 is 1, And E is an epothilone core; the method includes at least one epothilone CH3- (Ai) n. (Q) m- (A2) 〇-E (II) having the following formula 11 , A2, E, n, m and 0 are all defined above; contact with a recombinantly produced microorganism capable of selectively catalyzing the hydroxylation of the formula II, or an enzyme derived therefrom, and promote the hydroxyl group Into. 2 8. Method for preparing epothilone analogue of formula A</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">該方法包括經由與包括SEQ ID NO : 3 1的突變體埃坡黴 素B羥化酶酵素溫浸而將埃坡黴素B生物轉換成式a埃 坡黴素類似物。  2 9 . —種式A化合物  -148-  200418849</span>The method includes biologically converting epothilone B to an epothilone analog of formula a via warm dipping with a mutant epothilone B hydroxylase enzyme comprising SEQ ID NO: 31. 2 9. —A compound of formula A -148- 200418849</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">或其藥學上可接受的鹽。  3 〇 · —種埃坡黴素B羥化酶的同質模體，其在重疊於 附錄1中所列的構造座標所述對應的骨架原子之上時具有 小於約4.0 A的保守性殘基骨架原子根均方偏差。</span>Or a pharmaceutically acceptable salt thereof. 3 〇 — a homomorphic motif of an epothilone B hydroxylase, which has a conservative residue skeleton of less than about 4.0 A when superimposed on the corresponding skeleton atom described in the structural coordinates listed in Appendix 1. Atomic root mean square deviation.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">3 1 . —種產生一相對於埃坡黴素B羥化酶具有變更的 生物學性質、功能、合意產物的產率、反應速率、受質特 異性、或活性之突變體的方法，該方法包括下列諸步驟： 鑑別出要突變的SEQ ID NO : 2所含一胺基酸；及突變該 經鑑別出的胺基酸以造出一突變體蛋白質。</span>31. A method for producing a mutant having altered biological properties, function, yield of a desired product, reaction rate, substrate specificity, or activity relative to epothilone B hydroxylase, the method The steps include: identifying an amino acid contained in SEQ ID NO: 2 to be mutated; and mutating the identified amino acid to create a mutant protein.</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">3 2.如申請專利範圍第3 1項之方法，其中係使用在重 疊於附錄1中所列構造座標所述對應的骨架原子之上時具 有小於約4.0 A的保守性殘基骨架原子根均方偏差之埃坡 黴素B羥化酶的同質性模型來鑑別出要突變的 SEQ ID NO : 2所含一胺基酸。  3 3 .如申請專利範圍第3 1項之方法，其中該經鑑別出  之胺基酸爲 SEQ ID NO :2的 LEU39, GLN43, ALA45,  MET5 7, LEU58, HIS62， PHE63, SER64, SER65, ASP66,  ARG67, GLN68 , SER69， LEU74, MET75, VAL76, ALA77,  ARG78, GLN79, ILE80， ASP84, LYS85, PR086, PHE87,  ARG88, PR089, SER90, LEU91， ILE92, ALA93， MET94,  稱 ASP95， HIS99, ARG103， PHE110， ILE155， PHE169,  -149-  (8)  200418849  GLN 1 70, C YS 1 72， SER173， SER1 74, ARG1 75, MET 1 76,  LEU 1 77, SER178, ARG1 79， ARG1 86, PHE 1 90, LEU193,  VAL 2 3 3, GLY23 4, LEU23 5， ALA2 3 6, PHE2 3 7, LEU2 3 8,  LEU23 9, LEU240， ILE241， ALA242, GLY243， HIS244,  GLU24 5, THR246， THR247, ALA248, ASN249, MET2 5 0,  LEU283, THR287， ILE28 8， ALA289, GLU290, THR29 1,  AL A292, THR293, SER294, ARG295, PHE296, ALA297,  THR298, GLU3 12, GLY3 13， VAL3 14, VAL3 15, GLY3 1 6,  VAL344, AL A3 4 5， PHE3 46， GLY3 47, PHE3 4 8, VAL 3 5 0,  HIS3 5 1， GLN3 5 2， CYS 3 5 3， LEU3 54， GLY 3 5 5, GLN3 5 6,  LEU3 5 8, AL A3 5 9， GLU3 62, LYS 3 89, ASP391， SER3 92,  THR3 93, ILE394 和 TYR3 9 5。     3 4 .如申請專利範圍第3 1 項之方法 ，其中該經鑑別出  之胺基酸爲SEQ ID | NO : 2 的 GLU3 1， ARG67， ARG88，  ILE92，ALA93，VAL106，ILE130，ALA140，MET176， PHE190，GLU23 1，SER294，PHE23 7，或 ILE3 65。  3 5 .如申請專利範圍第31項之方法，其中相對於使用 埃坡黴素B羥化酶所得合意產物的產率該突變蛋白質可改 良合意產物的產率。  3 6 .如申請專利範圍第3 5項之方法，其中該合意產物 爲埃坡黴素F。  3 7 .如申請專利範圍第31項之方法，其中相對於使用 埃坡黴素B羥化酶所得反應速率該突變體可改良反應速 率 〇  -150-  200418849  Ο)  3 8 .如申請專利範圍第3 1項之方法，其中相對於埃坡 黴素B羥化酶的受質特異性該突變體展現出變更的受質特 異性。  3 9 .如申請專利範圍第3 8項之方法，其中係胺基酉爱 SER294受到突變。  4 0 .如申請專利範圍第3 1項之方法，其中該突變體展 現出基本上類似於埃坡黴素B羥化酶的的生物學活性或％ 能。  4 1 · 一種機械可讀取型數據貯存介質，其包括由附錄1 所列出的構造座標所編碼的數據貯存資料。  -151 -</span>3 2. The method according to item 31 of the scope of patent application, wherein the roots of skeleton atoms with conservative residues of less than about 4.0 A are superimposed on the corresponding skeleton atoms described in the structural coordinates listed in Appendix 1. The homogeneity model of epothilone B hydroxylase with a square deviation to identify the amino acid contained in SEQ ID NO: 2 to be mutated. 3 3. The method according to item 31 of the scope of patent application, wherein the identified amino acid is LEU39, GLN43, ALA45, MET5 7, LEU58, HIS62, PHE63, SER64, SER65, ASP66 of SEQ ID NO: 2 , ARG67, GLN68, SER69, LEU74, MET75, VAL76, ALA77, ARG78, GLN79, ILE80, ASP84, LYS85, PR086, PHE87, ARG88, PR089, SER90, LEU91, ILE92, ALA93, MET94, called ASP95, HIS99, ARG PHE110, ILE155, PHE169, -149- (8) 200418849 GLN 1 70, C YS 1 72, SER173, SER1 74, ARG1 75, MET 1 76, LEU 1 77, SER178, ARG1 79, ARG1 86, PHE 1 90, LEU193, VAL 2 3 3, GLY23 4, LEU23 5, ALA2 3 6, PHE2 3 7, LEU2 3 8, LEU23 9, LEU240, ILE241, ALA242, GLY243, HIS244, GLU24 5, THR246, THR247, ALA248, ASN249, MET2 5 0, LEU283, THR287, ILE28 8, ALA289, GLU290, THR29 1, AL A292, THR293, SER294, ARG295, PHE296, ALA297, THR298, GLU3 12, GLY3 13, VAL3 14, VAL3 15, GLY3 1 6, VAL344, AL A3 4 5, PHE3 46, GLY3 47, PHE3 4 8, VAL 3 5 0, HIS3 5 1, GLN3 5 2, CYS 3 5 3, LEU3 54, GLY 3 5 5, GLN3 5 6, LEU3 5 8, AL A3 5 9, GLU3 62, LYS 3 89, ASP391, SER3 92, THR3 93, ILE394 and TYR3 9 5. 3 4. The method according to item 31 of the scope of patent application, wherein the identified amino acid is GLU3 1, SEQ ID | NO: 2, ARG67, ARG88, ILE92, ALA93, VAL106, ILE130, ALA140, MET176, PHE190, GLU23 1, SER294, PHE23 7, or ILE3 65. 35. The method of claim 31, wherein the mutant protein can improve the yield of the desired product relative to the yield of the desired product using epothilone B hydroxylase. 36. The method of claim 35, wherein the desired product is epothilone F. 37. The method according to item 31 of the scope of patent application, wherein the mutant can improve the reaction rate with respect to the reaction rate obtained by using epothilone B hydroxylase 0-150-200418849 0) 3 8 The method of item 31, wherein the mutant exhibits an altered receptor specificity with respect to the receptor specificity of epothilone B hydroxylase. 39. The method according to item 38 of the scope of patent application, wherein the amino group SER294 is mutated. 40. The method of claim 31, wherein the mutant exhibits a biological activity or% energy that is substantially similar to epothilone B hydroxylase. 4 1 · A mechanically readable data storage medium that includes data storage data encoded by structural coordinates listed in Appendix 1. -151-</span>
    </claim-text>
  </claim>
</claims>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (1)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CN114480343A/en"><a id="link" href="#" class="style-scope state-modifier">CN114480343A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2020-10-27</span>
                    <span class="td style-scope patent-result">2022-05-13</span>
                    <span class="td style-scope patent-result">湖北大学</span>
                    <span class="td style-scope patent-result">PET hydrolase with improved activity 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner, † Cited by third party, ‡ Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/8587822105951080055"><a id="link" href="#" class="style-scope state-modifier">Crawford et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009</span>
                    <span class="td style-scope patent-result">Structural basis for biosynthetic programming of fungal aromatic polyketide cyclization</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2510079A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2510079A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-07-22</span>
                    <span class="td style-scope patent-result">Compositions and methods for hydroxilating epothilones 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/FI123078B/en"><a id="link" href="#" class="style-scope state-modifier">FI123078B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-10-31</span>
                    <span class="td style-scope patent-result">
  Process for producing a modified G-CSF polypeptide
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/1765667907273872356"><a id="link" href="#" class="style-scope state-modifier">Mathews et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001</span>
                    <span class="td style-scope patent-result">Crystal structure of human uroporphyrinogen III synthase</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/12376180974097662589"><a id="link" href="#" class="style-scope state-modifier">Schuller et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999</span>
                    <span class="td style-scope patent-result">Crystal structure of human heme oxygenase-1</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/1775668287547023050"><a id="link" href="#" class="style-scope state-modifier">Sampathkumar et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005</span>
                    <span class="td style-scope patent-result">Structure of the Mycobacterium tuberculosis flavin dependent thymidylate synthase (MtbThyX) at 2.0 Å resolution</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/7033649903646586429"><a id="link" href="#" class="style-scope state-modifier">Keller et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2014</span>
                    <span class="td style-scope patent-result">ε, a new subunit of RNA polymerase found in gram-positive bacteria</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/16936713803327824159"><a id="link" href="#" class="style-scope state-modifier">Rebelo et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000</span>
                    <span class="td style-scope patent-result">Gene sequence and crystal structure of the aldehyde oxidoreductase from Desulfovibrio desulfuricans ATCC 27774</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/3886937502396946879"><a id="link" href="#" class="style-scope state-modifier">Maresca et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004</span>
                    <span class="td style-scope patent-result">The bchU gene of Chlorobium tepidum encodes the C-20 methyltransferase in bacteriochlorophyll c biosynthesis</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/12494476445777767715"><a id="link" href="#" class="style-scope state-modifier">Prosise et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003</span>
                    <span class="td style-scope patent-result">Crystal structures of Tritrichomonas foetus inosine monophosphate dehydrogenase in complex with substrate, cofactor and analogs: a structural basis for the random-in ordered-out kinetic mechanism</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/18257130416091149217"><a id="link" href="#" class="style-scope state-modifier">Schlatter et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005</span>
                    <span class="td style-scope patent-result">Crystal engineering yields crystals of cyclophilin D diffracting to 1.7 Å resolution</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/18327126370599117060"><a id="link" href="#" class="style-scope state-modifier">Walker</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995</span>
                    <span class="td style-scope patent-result">Determination of the structures of respiratory enzyme complexes from mammalian mitochondria</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/DE60214869T2/en"><a id="link" href="#" class="style-scope state-modifier">DE60214869T2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-04-12</span>
                    <span class="td style-scope patent-result">
  CYTOCHROME P450 2C9 CRYSTALS, STRUCTURES AND ITS USE
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/9119808320419361451"><a id="link" href="#" class="style-scope state-modifier">Capitani et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001</span>
                    <span class="td style-scope patent-result">Structure of the soluble domain of a membrane-anchored thioredoxin-like protein from Bradyrhizobium japonicum reveals unusual properties</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2004078978A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2004078978A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-09-16</span>
                    <span class="td style-scope patent-result">Compositions and methods for hydroxylating epothilones 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TW200301697A/en"><a id="link" href="#" class="style-scope state-modifier">TW200301697A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2003-07-16</span>
                    <span class="td style-scope patent-result">Compositions and methods for hydroxylating epothilones 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/17540999795658846448"><a id="link" href="#" class="style-scope state-modifier">Xu et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2021</span>
                    <span class="td style-scope patent-result">Identification of a novel class of photolyases as possible ancestors of their family</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/10216262557399986210"><a id="link" href="#" class="style-scope state-modifier">Jagdev et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2023</span>
                    <span class="td style-scope patent-result">Crystal structure of the N-terminal domain of MtClpC1 in complex with the anti-mycobacterial natural peptide Lassomycin</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/10975332985836425871"><a id="link" href="#" class="style-scope state-modifier">Drake et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016</span>
                    <span class="td style-scope patent-result">1.2 Å resolution crystal structure of the periplasmic aminotransferase PvdN from Pseudomonas aeruginosa</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TW200418849A/en"><a id="link" href="#" class="style-scope state-modifier">TW200418849A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2004-10-01</span>
                    <span class="td style-scope patent-result">Compositions and methods for hydroxylating epothilones 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/18127315651054525788"><a id="link" href="#" class="style-scope state-modifier">Arai et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2006</span>
                    <span class="td style-scope patent-result">Structure of human ubiquitin-conjugating enzyme E2 G2 (UBE2G2/UBC7)</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU6523100A/en"><a id="link" href="#" class="style-scope state-modifier">AU6523100A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-03-05</span>
                    <span class="td style-scope patent-result">Crystallization and structure determination of staphylococcus aureus udp-n-acetylenolpyruvylglucosamine reductase (s. aureus murb) 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/17607114704826848597"><a id="link" href="#" class="style-scope state-modifier">Arachea et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010</span>
                    <span class="td style-scope patent-result">Expansion of the aspartate β-semialdehyde dehydrogenase family: the first structure of a fungal ortholog</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/7092265086593046443"><a id="link" href="#" class="style-scope state-modifier">He et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000</span>
                    <span class="td style-scope patent-result">Structure of a new neurotoxin from the scorpion Buthus martensii Karsch at 1.76 Å</span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="scholar/9204121381966057643"><a id="link" href="#" class="style-scope state-modifier">Huang et al.</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2005</span>
                    <span class="td style-scope patent-result">Structure of recombinant human cyclophilin J, a novel member of the cyclophilin family</span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (2)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <template is="dom-if" class="style-scope patent-result"></template>
                        US34427101P<template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2001-12-26</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6884608B2/en"><a id="link" href="#" class="style-scope state-modifier">US10/321,188</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">2002-12-17</span>
                    <span class="td style-scope patent-result">Compositions and methods for hydroxylating epothilones 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.2406055087" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.2406055087" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=717250989" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>